Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABCC9	"CMD1O, SUR2"	ENSG00000069431	"ATP binding cassette subfamily C member 9"	O60706	12	21797389-21942529	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Atrial fibrillation, Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 45.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 60.3;Astrocytes: 72.1;Hepatocytes: 99.4;Sertoli cells: 131.5;Smooth muscle cells: 140.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.9;BJ hTERT+: 14.0;CACO-2: 20.8;HSkMC: 27.1;U-138 MG: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007279	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA007279: AB_1844435"	"unprognostic (4.82e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.51e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.47e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (1.85e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.10e-3)"	"unprognostic (8.22e-5)"	27.4	5.9	4.5	3.4	5.4	1.7	9.2	3.1	9.2	8.2	11.6	7.4	4.0	19.1	8.3	6.2	12.3	11.7	28.3	5.4	3.6	6.6	45.2	7.7	3.5	4.8	7.4	10.9	3.5	1.9	2.2	3.6	3.7	7.9	1.8	3.2	4.5	9.9	41.9	4.2	3.1	21.0	3.4	4.4	8.1	1.2	5.1	1.8	6.3	30.3	1.5	5.3	5.1	7.2	0.9	0.2	11.9	0.3	24.9	11.0	0.3	6.1	14.0	7.0	3.5	20.8	1.0	0.5	1.2	0.6	0.8	0.3	0.0	0.0	7.2	0.3	0.2	0.5	0.8	0.3	0.1	0.5	0.6	27.1	0.0	6.7	2.5	0.4	0.0	0.4	0.3	1.2	0.3	1.4	0.2	0.4	1.4	1.2	0.6	0.5	0.3	0.3	0.0	1.2	0.4	1.7	0.4	0.5	0.2	1.7	1.2	0.3	0.3	27.0	1.9	2.2	8.7	1.1	1.3	0.4	6.7	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	4.5	5.4	3.1	9.2	5.4	3.6	4.8	7.4	3.7	3.4	5.1	7.2	33.8	35.3	60.3	72.1	0.2	3.4	1.5	5.0	0.6	0.8	0.5	0.8	38.2	0.0	25.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.6	0.8	20.6	19.7	0.0	0.0	17.2	0.2	0.1	26.2	1.1	0.6	24.0	0.0	7.1	99.4	0.1	1.7	1.0	0.0	0.0	2.4	5.9	0.1	0.3	2.5	10.6	2.8	0.0	15.9	0.0	1.5	1.4	0.1	0.0	0.4	0.0	0.5	0.0	0.1	20.4	1.2	131.5	11.1	140.7	0.4	1.6	1.1	2.3	0.3	2.5	0.2	0.0	2.2
ACTA2	ACTSA	ENSG00000107796	"Actin alpha 2, smooth muscle"	P62736	10	88935074-88991339	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 6678.8;seminal vesicle: 5920.3;smooth muscle: 8099.9"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 1007.7;Peritubular cells: 5290.7;Sertoli cells: 3030.6;Smooth muscle cells: 2394.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 58.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 390.6;fHDF/TERT166: 641.1;HHSteC: 625.8;HSkMC: 345.1;hTERT-RPE1: 743.4;SuSa: 296.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"midbrain: 101.0"	"CAB000002, CAB003761, CAB013531, HPA041264, HPA041271"	Enhanced		Supported	"Actin filaments"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments"		"CAB000002: AB_2223500, CAB003761: AB_562031, CAB013531: , HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (7.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.30e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (1.37e-8)"	"unprognostic (1.87e-3)"	"unprognostic (2.30e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.09e-3)"	1035.2	241.6	54.0	728.1	61.4	3.9	838.4	52.7	121.1	2000.3	61.4	2755.1	248.9	6678.8	1360.1	1509.9	3104.3	906.1	1069.2	53.4	54.6	312.2	161.8	732.8	173.7	59.0	55.9	798.0	91.4	80.6	60.8	771.3	55.3	2642.8	866.4	8.2	414.7	5920.3	202.1	355.7	701.6	8099.9	54.1	452.1	1427.1	263.9	56.1	56.5	312.0	214.0	48.4	3002.5	1367.0	52.9	3.9	19.0	49.3	102.7	198.1	390.6	9.5	109.8	136.8	11.9	45.4	0.0	8.8	7.2	11.5	641.1	8.6	1.4	1.8	25.4	11.3	60.6	11.3	0.4	5.6	119.3	625.8	0.8	3.2	345.1	44.9	73.9	28.5	743.4	11.3	3.0	0.0	7.1	128.8	10.8	1.0	28.3	2.5	0.2	1.2	1.4	0.2	4.6	27.1	5.0	0.7	7.6	10.2	7.9	1.0	296.8	32.4	1.0	27.9	24.0	4.0	30.2	9.3	21.1	1.6	0.6	29.6	10.2	26.1	28.1	12.3	17.5	17.6	8.7	13.8	6.0	14.1	19.8	10.8	1.8	1.5	10.7	11.1	4.0	14.2	0.4	58.7	10.7	54.0	61.4	52.7	121.1	53.4	54.6	59.0	55.9	55.3	54.1	56.1	52.9	65.4	9.6	6.1	5.5	4.4	43.2	23.4	16.5	22.8	1.1	22.7	1007.7	25.1	2.8	5.2	0.0	6.2	16.3	7.3	1.9	1.9	1.8	11.1	11.1	225.4	41.1	0.0	4.0	3.6	0.9	16.8	316.3	10.7	8.2	5.7	448.9	474.0	4.6	37.7	0.0	1.1	2.7	4.1	5.4	67.6	48.8	141.4	12.6	55.2	61.8	4.2	13.4	4.1	1.0	0.3	2.0	3.0	5290.7	3.7	17.5	3.4	9.5	10.9	1.4	3030.6	72.0	2394.6	4.0	13.8	11.1	40.5	23.7	16.5	36.0	5.7	10.4
ACTG2	"ACTA3, ACTL3, ACTSG"	ENSG00000163017	"Actin gamma 2, smooth muscle"	P63267	2	73892314-73919865	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 8846.3;seminal vesicle: 6238.4;smooth muscle: 8607.9"	"Group enriched"	"Detected in many"	4	"Breast myoepithelial cells: 394.2;Smooth muscle cells: 287.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 255.0;stomach cancer: 237.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"T-reg: 8.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 8.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 63.8;BJ hTERT+: 53.5;BJ hTERT+ SV40 Large T+: 214.8;HHSteC: 55.1;SuSa: 52.5;U-251 MG: 229.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"midbrain: 11.8;spinal cord: 4.7"	"HPA041264, HPA041271"	Supported					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (5.79e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.50e-1)"	"unprognostic (8.05e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.75e-2)"	"prognostic unfavorable (3.95e-7)"	"unprognostic (9.30e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.57e-3)"	189.6	37.1	2.8	724.8	3.9	0.0	138.2	2.8	10.0	494.7	4.8	8846.3	392.1	3622.6	124.6	1954.7	857.3	330.4	30.4	2.9	2.9	11.3	10.8	137.5	6.8	3.4	3.1	88.5	8.1	0.9	6.1	96.4	3.1	2250.2	1179.0	0.0	75.1	6238.4	16.3	91.8	1353.8	8607.9	2.9	16.6	2099.7	4.8	3.1	2.8	33.8	6.9	1.2	2914.5	667.3	2.8	0.7	0.3	20.5	0.3	0.0	0.0	63.8	13.5	53.5	214.8	38.6	6.7	0.0	0.3	0.9	0.0	0.4	0.1	36.9	0.0	28.3	0.1	0.0	0.0	2.9	0.5	55.1	0.2	0.6	0.5	0.3	29.0	0.0	1.5	0.0	0.2	0.0	0.0	0.5	0.0	2.9	7.9	0.2	0.0	0.1	0.2	0.4	3.1	0.5	13.6	0.6	2.3	0.3	2.8	1.2	52.5	0.0	0.3	0.0	1.1	2.3	2.5	229.9	0.1	0.3	0.8	0.7	1.0	0.9	0.2	0.5	0.3	0.2	0.3	0.1	0.1	0.8	0.3	0.4	0.1	0.4	0.5	0.1	0.2	0.4	0.1	8.6	2.4	2.8	3.9	2.8	10.0	2.9	2.9	3.4	3.1	3.1	2.9	3.1	2.8	3.5	0.0	0.5	0.0	0.4	4.5	2.7	0.5	0.6	0.0	9.8	394.2	14.6	0.0	0.1	0.0	0.0	7.4	0.7	0.0	0.0	0.0	5.8	2.8	1.5	3.1	0.0	0.0	0.1	0.0	36.8	74.1	0.0	4.8	0.0	1.0	22.9	0.3	5.4	0.0	0.1	0.0	0.0	0.0	10.4	26.6	0.3	1.0	7.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.0	10.8	0.0	0.4	0.8	0.0	6.6	1.8	287.8	0.2	3.2	0.4	7.7	6.4	1.7	8.4	0.0	3.7
ADAMTS1	"C3-C5, KIAA1346, METH1"	ENSG00000154734	"ADAM metallopeptidase with thrombospondin type 1 motif 1"	Q9UHI8	21	26835755-26845409	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 314.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 365.2;Endometrial stromal cells: 235.3;Endothelial cells: 275.9;Extravillous trophoblasts: 240.8;Fibroblasts: 243.9;Sertoli cells: 210.4;Smooth muscle cells: 452.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"gdT-cell: 4.5;NK-cell: 6.6"	"Group enriched"	"Detected in many"	56	"NK-cells: 6.6;T-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 382.0;BJ: 451.4;hTEC/SVTERT24-B: 250.0;hTERT-HME1: 248.2;LHCN-M2: 295.3;RPTEC TERT1: 343.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"spinal cord: 35.6"	"CAB016394, HPA031498"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		4100000	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"CAB016394: AB_626637, HPA031498: AB_2673907"	"unprognostic (6.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.70e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.57e-1)"	234.6	46.4	22.2	71.3	24.9	1.4	94.1	20.8	28.9	87.4	22.3	54.6	8.7	97.1	9.0	82.6	161.2	111.8	95.9	21.5	23.5	76.0	39.0	79.7	10.1	24.8	25.5	314.4	29.4	18.5	25.5	245.1	25.2	88.2	59.3	15.6	19.2	13.9	48.9	21.9	44.6	162.6	25.3	13.9	56.0	8.2	26.4	12.2	50.1	40.3	5.4	143.1	50.6	30.5	0.1	0.0	6.8	0.1	382.0	104.9	21.8	451.4	199.6	90.4	61.1	0.0	0.0	0.0	29.5	120.1	2.0	9.2	4.6	23.6	150.0	0.4	120.3	0.0	29.7	0.1	85.6	15.5	0.0	103.0	0.3	250.0	248.2	15.1	35.4	3.7	7.3	0.0	295.3	0.0	1.7	0.3	21.9	0.0	14.5	0.0	151.6	0.6	343.9	25.1	0.2	32.7	21.4	0.0	2.2	16.0	0.2	3.8	34.9	99.6	4.3	156.0	63.1	0.5	0.0	0.0	80.8	0.5	29.7	0.0	0.0	0.0	4.5	0.0	0.5	0.0	0.2	0.4	0.0	0.0	0.1	0.7	0.0	6.6	0.0	0.0	0.0	0.8	22.2	24.9	20.8	28.9	21.5	23.5	24.8	25.5	25.2	25.3	26.4	30.5	365.2	6.4	22.4	2.9	0.5	121.2	32.5	10.4	53.5	0.6	13.9	54.9	179.5	12.8	9.6	57.0	0.0	71.1	13.1	0.2	1.9	47.4	1.4	86.5	235.3	275.9	0.0	0.4	3.2	22.3	240.8	243.9	11.7	148.2	2.5	0.3	157.8	2.2	16.5	0.0	3.3	0.2	2.0	5.0	38.5	4.4	109.0	5.8	53.4	7.5	0.6	52.2	20.6	2.0	19.9	20.6	0.0	41.8	3.6	26.3	0.0	6.3	3.3	3.3	210.4	91.0	452.4	0.4	1.0	22.8	41.6	54.9	10.1	8.8	0.0	16.8
ADAMTS10	ADAM-TS10	ENSG00000142303	"ADAM metallopeptidase with thrombospondin type 1 motif 10"	Q9H324	19	8580240-8610735	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 18.3;Excitatory neurons: 21.4;Inhibitory neurons: 19.9;Microglial cells: 30.9;Skeletal myocytes: 15.9;Smooth muscle cells: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 7.2;hTERT-RPE1: 7.5;NB-4: 37.0;REH: 9.8"	"Region enriched"	"Detected in many"	5	"cerebellum: 8.8"	"Low region specificity"	"Detected in all"			HPA040223	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA040223: AB_10795376"	"unprognostic (2.60e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.91e-4)"	"unprognostic (4.98e-3)"	"unprognostic (4.06e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (6.86e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.12e-2)"	15.9	8.2	7.1	2.3	7.3	1.8	9.5	5.0	11.9	13.0	5.8	7.3	0.8	12.7	0.7	4.1	10.2	1.9	8.5	7.6	8.7	6.9	6.3	8.2	3.2	7.1	6.8	8.3	7.8	0.8	4.1	1.7	6.7	8.4	0.5	0.4	4.1	1.5	2.8	8.8	6.3	1.5	6.0	5.4	3.8	2.4	8.1	1.4	6.2	0.8	1.3	5.7	8.7	6.5	0.0	4.6	2.5	0.0	0.4	0.3	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	2.2	1.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.0	7.2	0.0	0.3	0.0	0.1	1.8	0.0	0.0	0.0	7.5	0.1	0.3	0.1	0.0	0.0	0.0	0.3	37.0	1.5	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	1.2	0.1	0.4	2.0	3.1	4.4	2.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	7.3	5.0	11.9	7.6	8.7	7.1	6.8	6.7	6.0	8.1	6.5	5.6	0.0	0.0	18.3	0.3	1.7	0.6	0.1	0.0	1.5	1.2	1.5	1.3	5.7	0.1	0.0	0.0	0.1	6.9	0.0	0.0	8.8	5.1	0.4	7.4	5.8	0.0	1.3	21.4	0.5	0.0	6.4	1.1	0.4	0.0	1.8	6.8	2.0	0.9	0.0	19.9	0.3	0.0	2.7	6.0	2.4	7.5	3.3	0.0	30.9	0.6	0.8	11.3	9.5	1.2	0.9	0.0	6.0	1.3	0.2	0.0	0.1	0.0	0.2	6.6	15.9	15.0	0.1	0.4	0.1	0.9	0.4	3.2	0.6	0.1	0.3
ADAMTS4	"ADAMTS-2, ADMP-1, KIAA0688"	ENSG00000158859	"ADAM metallopeptidase with thrombospondin type 1 motif 4"	O75173	1	161184302-161199054	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 116.8;ovary: 95.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 80.3;Endothelial cells: 115.5;Fibroblasts: 88.8;Oligodendrocytes: 56.0;Sertoli cells: 52.6;Smooth muscle cells: 313.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 4.4"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 11.8;HUVEC TERT2: 14.4;SH-SY5Y: 7.9;TIME: 12.2;U-138 MG: 7.4;U-251 MG: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025876, HPA051296, HPA068374"	Uncertain		Supported	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA		11000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978"	"unprognostic (2.70e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.20e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.27e-7)"	"unprognostic (1.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.13e-2)"	116.8	9.8	6.1	16.3	31.5	0.7	43.4	31.1	19.2	16.4	5.8	18.2	0.8	15.0	0.2	6.2	34.6	14.3	53.6	8.1	15.2	26.0	8.7	50.3	1.6	38.2	29.6	95.9	9.0	2.1	13.0	3.2	31.6	16.9	2.0	1.5	5.2	0.5	13.3	5.0	9.4	10.5	28.3	1.8	22.8	1.8	26.2	1.1	21.3	0.4	0.3	31.8	12.2	48.0	0.0	0.0	0.2	0.1	6.4	4.0	0.6	5.4	0.2	0.5	3.0	0.2	0.2	0.2	4.4	1.7	0.0	0.1	0.0	0.0	1.9	0.1	0.3	0.2	0.5	1.3	0.6	0.0	0.1	4.5	0.0	11.8	0.1	0.0	14.4	0.1	0.2	0.3	0.4	0.1	0.0	0.2	5.3	0.0	0.0	0.1	5.1	0.1	0.0	0.1	0.1	7.9	0.0	0.1	0.1	0.3	0.2	0.5	12.2	7.4	0.1	0.4	10.8	0.2	0.1	0.1	2.2	0.1	0.1	0.5	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.0	4.4	0.2	0.1	6.1	31.5	31.1	19.2	8.1	15.2	38.2	29.6	31.6	28.3	26.2	48.0	80.3	0.0	4.1	0.0	0.2	31.2	3.2	0.0	2.2	2.2	8.6	5.5	5.5	0.0	0.6	0.0	0.0	0.3	0.5	0.2	0.0	0.3	0.0	0.3	13.0	115.5	0.0	0.0	0.4	0.0	0.3	88.8	0.5	0.5	0.0	0.3	43.2	0.9	1.0	3.3	0.1	0.0	0.0	1.0	32.6	0.2	0.3	3.2	35.6	2.8	1.0	0.5	0.0	0.0	56.0	0.0	0.0	1.2	0.7	9.8	0.0	0.1	0.0	1.0	52.6	21.2	313.7	2.7	0.6	2.7	19.0	0.4	3.7	1.6	0.3	7.7
ADAMTS9	KIAA1312	ENSG00000163638	"ADAM metallopeptidase with thrombospondin type 1 motif 9"	Q9P2N4	3	64515654-64688000	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 41.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 166.3;Astrocytes: 84.2;Basal prostatic cells: 87.2;Endometrial stromal cells: 179.1;Endothelial cells: 221.0;Prostatic glandular cells: 115.7;Smooth muscle cells: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 23.6;RPTEC TERT1: 27.1;SH-SY5Y: 128.3;SuSa: 40.5;WM-115: 28.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028567, HPA028577, HPA028601"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	No	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	"Endoplasmic reticulum"	"HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: AB_2672694"	"unprognostic (2.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.46e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.00e-3)"	41.2	4.8	4.0	12.2	5.0	0.1	19.0	5.5	5.3	16.2	7.9	8.1	1.2	13.2	1.1	5.3	10.2	7.8	15.6	4.4	5.6	9.5	2.7	13.6	1.9	10.8	8.1	7.3	9.8	6.3	2.2	31.7	8.5	7.9	2.7	1.4	3.2	3.7	7.4	2.6	3.7	12.1	8.0	4.1	4.7	0.8	8.1	1.0	7.3	7.3	1.1	22.5	9.0	6.4	0.0	1.2	13.9	0.0	0.6	0.1	1.3	0.2	0.0	0.0	0.0	1.9	0.0	0.0	2.3	0.3	0.4	0.0	1.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.9	0.0	8.8	2.6	0.0	0.0	0.5	0.0	23.6	0.0	0.5	0.0	0.3	0.1	0.0	0.0	7.5	1.1	0.0	0.0	2.4	0.1	27.1	0.3	0.1	128.3	0.0	0.0	0.0	40.5	0.0	0.7	5.4	0.8	0.4	0.0	0.8	0.0	0.0	0.0	0.5	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	5.0	5.5	5.3	4.4	5.6	10.8	8.1	8.5	8.0	8.1	6.4	166.3	3.2	4.8	84.2	0.0	17.5	87.2	0.0	4.6	0.0	6.9	15.9	6.6	2.8	2.6	38.6	2.1	1.0	0.2	1.1	0.0	69.7	0.9	13.2	179.1	221.0	1.2	0.0	4.2	3.3	0.6	31.4	1.5	33.8	0.0	8.4	27.1	0.3	7.5	0.0	14.3	1.1	0.0	0.3	20.1	0.4	2.5	2.7	26.6	21.5	0.0	0.2	0.0	26.7	0.6	45.5	1.0	2.2	0.0	115.7	0.0	10.8	0.1	0.1	0.0	20.7	94.8	0.3	0.7	1.3	13.5	1.6	3.2	12.1	0.9	36.7
ADCY3	AC3	ENSG00000138031	"Adenylate cyclase 3"	O60266	2	24819169-24920237	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis, Olfaction, Sensory transduction"	"Calmodulin-binding, Lyase"	Obesity	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 58.4;Sertoli cells: 111.7;Smooth muscle cells: 62.8;Theca cells: 92.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010223	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB010223: AB_630839"	"unprognostic (3.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.39e-3)"	"unprognostic (5.01e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.06e-2)"	"unprognostic (8.43e-2)"	"unprognostic (6.89e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (1.32e-9)"	"unprognostic (3.74e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.55e-3)"	94.4	17.3	43.5	17.3	55.1	17.7	74.6	36.7	50.1	66.7	28.4	27.5	10.9	56.4	20.5	30.4	62.1	23.0	36.6	43.3	43.4	25.9	6.6	42.5	18.9	41.6	43.8	71.9	15.7	17.0	41.7	83.6	41.1	40.6	15.8	4.2	21.6	33.0	15.2	38.4	34.4	35.3	36.9	30.4	25.0	9.8	50.6	11.4	36.8	20.4	18.1	36.4	48.9	44.9	76.5	40.4	17.2	28.3	84.5	75.4	29.6	32.3	65.9	37.1	37.8	38.6	25.1	26.0	6.2	53.2	51.0	54.5	43.1	54.5	24.0	58.4	55.8	43.0	40.0	1.7	64.0	24.0	24.6	55.7	47.5	36.6	50.8	23.6	33.8	27.9	15.5	49.2	19.3	43.6	17.9	2.1	14.9	39.9	24.4	38.8	75.3	59.5	15.5	38.7	31.6	19.1	45.8	54.2	30.2	13.0	13.5	22.5	33.5	59.7	34.2	39.1	54.1	42.4	101.6	113.6	18.7	39.2	31.4	2.6	1.5	0.0	0.4	1.6	0.3	5.5	0.9	0.5	9.5	6.0	0.7	0.5	0.0	1.2	0.4	9.0	3.4	1.0	43.5	55.1	36.7	50.1	43.3	43.4	41.6	43.8	41.1	36.9	50.6	44.9	14.6	0.0	1.8	17.0	8.2	11.0	4.2	4.1	5.2	3.0	18.6	8.0	2.8	0.0	1.3	1.8	0.0	1.0	5.2	5.0	0.0	0.9	0.3	1.9	42.2	10.6	1.2	5.2	40.1	0.0	2.1	25.5	2.0	2.2	18.4	3.7	5.0	0.3	12.6	0.0	36.8	6.0	2.0	5.4	6.9	3.9	58.4	10.1	7.2	21.5	4.0	1.6	0.0	15.1	33.2	1.0	5.8	29.3	4.9	11.2	8.3	0.2	1.1	2.2	111.7	6.5	62.8	0.4	2.4	4.4	11.8	1.2	7.2	92.9	12.1	3.9
ADRA1D	"ADRA1, ADRA1A, ADRA1R"	ENSG00000171873	"Adrenoceptor alpha 1D"	P25100	20	4220630-4249287	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.6;cervix: 7.2"	"Cell type enhanced"	"Detected in some"		"Endothelial cells: 1.2;Excitatory neurons: 2.1;Inhibitory neurons: 2.4;Oligodendrocyte precursor cells: 1.0;Smooth muscle cells: 2.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.7;BJ: 7.5;CAPAN-2: 3.3;fHDF/TERT166: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038789	Uncertain					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA038789: AB_10673475"	"unprognostic (5.37e-2)"	"unprognostic (4.65e-1)"	"unprognostic (8.73e-2)"	"unprognostic (7.75e-11)"	"unprognostic (7.83e-3)"	"unprognostic (1.54e-2)"	"unprognostic (7.62e-2)"	"unprognostic (7.82e-4)"	"unprognostic (4.41e-3)"	"unprognostic (8.37e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.24e-3)"	"unprognostic (7.71e-7)"	"unprognostic (5.21e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.32e-5)"	1.2	0.4	5.0	0.0	0.6	0.0	0.8	0.3	4.8	7.2	0.0	2.0	0.0	3.5	0.3	0.2	2.0	0.2	0.3	7.5	4.2	0.3	0.1	2.3	0.0	2.7	4.9	0.6	0.3	0.2	0.0	0.1	2.4	3.4	0.1	0.0	0.2	1.7	0.5	0.4	0.2	0.3	1.3	1.4	1.6	0.7	9.6	0.0	0.8	0.4	0.0	2.4	2.9	1.1	0.0	1.7	0.1	0.0	0.0	0.0	0.0	7.5	1.3	0.4	0.1	0.3	3.3	0.0	0.0	4.4	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.6	0.3	4.8	7.5	4.2	2.7	4.9	2.4	1.3	9.6	1.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	2.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1
ADRA2A	"ADRA2, ADRA2R, ADRAR"	ENSG00000150594	"Adrenoceptor alpha 2A"	P08913	10	111077029-111080907	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 50.5;cervix: 46.6"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 52.9;Paneth cells: 105.9;Smooth muscle cells: 118.7"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 17.7"	"Region enhanced"	"Detected in all"		"pons: 26.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.5;ASC TERT1: 12.9;HEL: 20.3;HeLa: 10.7;HSkMC: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.87e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (8.06e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.64e-3)"	"unprognostic (5.86e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.08e-6)"	"unprognostic (1.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.89e-3)"	50.5	1.7	3.4	4.9	3.4	0.0	32.9	1.6	4.3	46.6	7.7	7.4	10.0	6.8	1.6	2.9	4.1	19.9	2.1	3.4	7.4	6.0	1.1	4.3	11.2	5.9	5.8	18.1	30.5	1.3	2.3	3.7	26.8	6.9	3.7	0.0	7.0	6.1	1.0	10.9	4.9	2.8	1.4	14.7	3.7	5.0	3.2	1.0	9.0	0.6	13.1	15.9	23.4	6.1	0.0	0.0	0.0	0.0	10.5	12.9	0.0	0.1	0.0	1.1	2.5	0.0	0.0	0.0	0.1	6.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	20.3	10.7	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.4	1.6	4.3	3.4	7.4	5.9	5.8	26.8	1.4	3.2	6.1	8.3	0.0	1.3	1.0	0.0	10.3	0.4	0.0	1.2	0.0	17.2	12.2	1.5	52.9	1.3	0.0	0.0	0.1	0.0	11.7	0.0	5.9	3.5	6.9	9.1	4.9	12.4	0.0	2.2	3.3	0.1	7.3	10.7	25.8	7.0	19.4	0.7	0.0	0.1	0.0	5.9	3.5	0.0	0.3	17.3	1.2	22.4	7.3	28.4	1.0	0.0	0.0	0.0	0.0	0.2	0.3	105.9	4.9	0.0	0.9	3.5	0.6	0.0	0.0	6.6	3.1	118.7	5.4	0.1	0.2	6.1	0.1	1.2	8.5	8.6	1.1
ADRA2B	"ADRA2L1, ADRA2RL1, ADRARL1"	ENSG00000274286	"Adrenoceptor alpha 2B"	P18089	2	96112876-96116571	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 9.0;Langerhans cells: 8.0;Sertoli cells: 32.9;Smooth muscle cells: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;EFO-21: 1.0"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.5;cerebellum: 1.0;thalamus: 3.2"	"Low region specificity"	"Detected in some"			"HPA066029, HPA074948"	Approved		Supported	Vesicles,Cytosol		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	Cytosol	"HPA066029: AB_2685599, HPA074948: "	"unprognostic (6.16e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.93e-4)"	"unprognostic (1.84e-2)"	"unprognostic (5.24e-2)"	"unprognostic (6.80e-5)"	"unprognostic (4.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.55e-2)"	6.4	2.1	1.5	0.3	1.7	0.8	3.0	1.4	2.7	1.5	4.9	2.3	0.3	1.9	3.8	0.7	3.0	0.6	10.1	1.2	1.4	5.1	7.0	0.5	0.2	1.8	1.6	1.7	0.8	0.5	0.5	0.8	1.7	1.4	0.3	0.0	2.2	1.5	6.4	1.9	2.6	0.7	1.3	8.6	2.2	1.6	2.6	0.2	1.3	5.0	0.1	2.5	1.8	2.4	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.4	2.7	1.2	1.4	1.8	1.6	1.7	1.3	2.6	2.4	2.9	0.0	0.0	0.0	0.9	1.1	0.7	0.7	0.6	0.0	0.9	0.9	2.5	0.0	1.5	1.8	0.0	0.8	2.9	0.1	0.0	0.2	0.0	2.2	1.0	2.4	2.4	0.0	0.0	0.6	0.2	1.0	1.1	9.0	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.2	0.0	0.3	8.0	0.0	1.8	5.1	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.4	0.7	0.0	0.1	1.4	0.0	32.9	0.7	13.3	0.0	0.3	0.6	1.4	0.4	2.8	0.1	0.1	0.3
AGAP2	CENTG1	ENSG00000135439	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 2"	Q99490	12	57723761-57742157	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 219.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 16.4;Excitatory neurons: 22.2;Inhibitory neurons: 12.3;NK-cells: 17.5;Sertoli cells: 32.9;Smooth muscle cells: 16.2;T-cells: 16.4"	"Cancer enriched"	"Detected in many"	12	"glioma: 20.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 219.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.3;Karpas-707: 39.8;RH-30: 98.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023474, HPA075831"	Enhanced		Supported	"Nucleoplasm,Midbody ring,Cytosol"		Yes	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Midbody ring"	"HPA023474: AB_1855378, HPA075831: "	"unprognostic (1.87e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.26e-2)"	"unprognostic (5.56e-4)"	"unprognostic (3.95e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.81e-9)"	"unprognostic (3.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.75e-2)"	6.3	2.5	85.4	10.0	69.0	14.5	1.8	0.6	219.9	0.8	0.0	2.2	2.9	2.0	0.3	2.3	1.0	4.3	23.5	162.1	0.0	0.8	1.1	3.4	16.9	0.0	0.0	1.5	3.7	1.8	7.5	2.5	0.0	1.9	1.5	4.6	2.3	0.8	15.1	3.2	5.8	1.0	0.0	11.4	3.3	1.0	0.0	15.0	2.5	9.9	11.3	3.2	1.0	38.7	7.3	10.5	19.8	5.8	0.0	0.0	11.3	4.8	0.9	0.1	0.5	1.2	6.6	18.4	1.5	0.0	3.6	4.4	0.1	0.2	0.0	20.3	3.1	20.5	1.6	3.4	0.1	21.2	40.3	0.0	0.0	0.1	0.1	8.4	0.0	21.3	0.0	39.8	0.0	12.6	37.4	13.5	3.2	2.3	10.6	15.5	98.8	13.4	0.0	6.0	5.6	20.5	2.6	3.6	4.3	0.1	2.6	14.8	11.2	5.5	9.0	10.5	3.6	16.8	10.9	9.4	9.8	13.9	9.4	3.8	0.5	0.6	2.7	0.8	2.9	1.2	2.8	3.0	0.8	0.8	1.1	1.7	3.8	1.4	0.4	0.8	4.2	1.1	85.4	69.0	0.6	219.9	162.1	0.0	0.0	0.0	0.0	0.0	0.0	38.7	3.6	3.2	1.1	0.0	5.7	0.0	0.3	0.0	0.0	10.0	0.8	0.5	5.8	1.5	0.6	0.0	0.0	0.1	16.4	0.2	0.0	0.1	0.4	0.1	0.7	4.2	0.0	2.1	22.2	0.0	0.2	0.9	2.0	0.2	2.5	0.0	1.1	0.1	1.3	8.4	12.3	0.5	0.0	2.2	1.1	1.1	0.0	3.0	0.0	1.9	3.9	0.5	17.5	5.0	1.2	0.1	0.1	0.7	11.4	0.3	0.3	0.1	0.0	2.3	32.9	2.2	16.2	0.8	0.4	0.2	0.4	0.0	16.4	0.3	0.2	0.0
AL592183.1		ENSG00000273748			Unmapped	54224-83311	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 37.4;Ionocytes: 42.7;Langerhans cells: 34.4"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 103.6"					"Low region specificity"	"Detected in all"			HPA049380	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"		"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA049380: AB_2680736"																		33.2	24.0	7.9	24.4	13.5	27.7	30.0	17.6	22.3	21.4	8.4	28.3	32.5	55.2	69.3	32.3	22.3	70.8	30.7	9.5	16.5	37.4	21.6	13.2	69.3	9.8	9.5	30.7	24.3	15.1		26.4	12.3	22.6	25.8	49.2	30.2	32.8	20.5	39.0	21.5	20.2	8.8	26.5	29.0	15.3	9.4	18.5	49.1	6.8	42.7	18.9		16.7	60.5	5.9	1.2	33.2	36.7	44.3	7.3	43.9	35.0	23.8	39.4	2.9	44.2	35.5	17.4	11.2	21.1	31.7	8.9	0.9	28.5	73.5	30.9	31.7	10.4	15.5	0.9	47.7	47.9	49.5	5.0	9.2	21.5	60.4	15.2	28.5	64.8	103.6	15.6	2.0	34.3	27.9	4.8	5.0	3.8	46.7	6.6	18.9	31.7	27.8	4.9	45.7	3.4	14.0	5.5	13.6	10.0	30.9	15.5	7.4	3.5	5.5	8.2	56.7	91.6	19.1	42.8	8.7	11.9	9.2	2.5	7.3	3.5	3.0	4.9	8.1	4.7	4.6	2.7	6.8	5.7	5.7	2.4	4.8	5.2	4.2	4.8	3.4	7.9	13.5	17.6	22.3	9.5	16.5	9.8	9.5	12.3	8.8	9.4	16.7	3.0	6.4	9.5	0.0	5.6	14.8	20.0	37.4	0.6	2.5	3.5	8.4	0.0	5.7	16.9	3.7	2.1	2.2	1.7	0.7	7.9	4.0	0.2	2.1	1.9	7.4	1.2	4.8	0.0	1.3	0.7	5.6	0.0	1.2	16.4	1.7	6.4	1.8	2.5	0.0	0.0	3.4	42.7	12.9	34.4	0.5	5.0	4.1	17.8	0.0	2.8	5.0	1.0	0.0	0.0	2.2	1.3	7.2	2.0	4.8	1.5	3.3	18.2	5.2	13.1	7.8	6.7	0.3	1.6	1.1	12.4	1.9	8.2	1.0	3.4	11.9
ANGPT1	"Ang1, KIAA0003"	ENSG00000154188	"Angiopoietin 1"	Q15389	8	107249482-107498055	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 33.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 60.4;Fibroblasts: 20.4;Inhibitory neurons: 37.6;Smooth muscle cells: 48.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 5.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 87.9;HEL: 53.1;HSkMC: 145.5;U-138 MG: 70.5;WM-115: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017815, HPA018793, HPA018816"	Approved				"Secreted to blood"	NA	NA	32000000	110000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB017815: , HPA018793: AB_1844820, HPA018816: AB_1844821"	"unprognostic (7.71e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.11e-3)"	"unprognostic (7.36e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.22e-3)"	"unprognostic (3.29e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.40e-4)"	"unprognostic (4.56e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.76e-1)"	25.1	5.6	3.2	2.6	4.5	0.7	4.6	4.5	2.2	5.8	2.5	3.4	2.3	3.5	4.8	3.5	3.0	13.2	4.8	4.5	6.1	11.1	2.1	21.7	1.4	8.0	3.5	9.5	1.6	1.2	5.8	20.5	4.8	17.7	3.3	0.6	12.0	33.5	23.4	1.2	2.6	3.3	4.8	11.0	4.0	2.3	2.1	2.1	3.5	7.0	1.0	3.9	3.7	11.9	0.0	2.4	9.3	5.3	87.9	30.2	6.6	30.0	25.8	8.1	11.9	6.2	0.1	0.0	0.1	16.0	0.0	0.0	4.2	0.1	10.5	0.0	1.4	53.1	0.6	0.0	24.5	0.7	0.0	145.5	0.0	4.9	0.6	7.5	0.6	0.0	28.2	5.1	10.9	0.0	1.1	7.9	9.6	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.1	4.2	1.1	0.6	0.0	11.6	2.2	0.0	0.3	70.5	0.9	2.5	0.7	0.2	3.2	0.0	9.7	1.1	47.5	0.1	0.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.8	0.1	0.3	0.0	0.0	0.6	3.2	4.5	4.5	2.2	4.5	6.1	8.0	3.5	4.8	4.8	2.1	11.9	9.0	0.0	2.3	60.4	0.0	0.6	10.1	0.4	5.2	0.9	0.5	2.8	3.3	0.0	2.2	7.3	0.0	5.2	0.0	0.0	1.9	0.3	8.1	0.7	9.1	5.6	0.0	10.1	6.5	0.0	7.6	20.4	1.5	1.9	0.0	0.0	3.3	0.1	0.5	0.0	37.6	0.0	2.0	0.3	1.0	2.4	2.5	2.9	0.0	6.5	1.5	0.5	0.0	3.0	0.6	0.0	0.0	3.8	1.1	1.2	0.0	2.8	0.8	0.0	6.6	3.5	48.6	1.6	5.4	4.0	0.1	2.7	0.8	1.7	0.1	1.2
ANGPT2	Ang2	ENSG00000091879	"Angiopoietin 2"	O15123	8	6499632-6563409	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 81.7;Endothelial cells: 182.2;Smooth muscle cells: 79.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 12.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"HMC-1: 17.9;HSkMC: 39.9;HUVEC TERT2: 62.6;WM-115: 22.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011437, CAB017626"	Approved				"Secreted to blood"	NA	NA	3780000	110000	"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB011437: , CAB017626: AB_1118956"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.99e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (6.36e-5)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (4.48e-4)"	"unprognostic (2.94e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.52e-7)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.44e-2)"	15.7	0.5	5.6	3.8	5.0	0.4	9.9	6.3	9.0	6.2	2.6	2.9	1.2	4.3	1.1	2.2	4.2	4.9	7.3	4.9	6.3	5.4	2.7	4.6	6.8	12.3	5.8	2.5	0.8	2.3	0.8	11.3	12.3	3.3	1.8	1.6	2.5	2.7	4.0	3.1	2.5	6.8	7.7	0.5	1.8	0.9	7.6	6.4	8.2	2.0	2.8	10.6	3.2	7.5	0.1	0.2	0.3	0.1	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.1	4.7	0.4	0.1	0.9	0.0	17.9	39.9	0.0	0.0	0.0	0.1	62.6	0.1	0.1	0.4	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.8	0.0	0.0	0.1	0.3	0.1	0.1	1.3	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.1	22.7	1.7	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.3	0.2	0.2	0.1	0.3	0.1	0.1	5.6	5.0	6.3	9.0	4.9	6.3	12.3	5.8	12.3	7.7	7.6	7.5	81.7	9.6	0.0	5.2	7.8	8.2	2.7	2.5	1.8	9.3	1.5	1.4	2.8	2.8	1.6	0.0	29.2	1.8	3.6	0.6	0.0	1.3	3.2	4.2	5.4	182.2	13.8	1.3	17.0	0.5	1.5	6.3	1.5	5.9	4.5	2.0	30.4	0.9	0.6	38.7	16.1	1.7	0.0	2.5	10.9	5.0	43.5	2.7	16.0	26.2	2.4	2.9	7.2	24.6	11.3	1.3	1.2	3.8	0.9	9.9	2.6	1.0	1.4	12.5	0.0	8.1	79.8	1.6	1.6	0.3	8.0	30.6	5.5	2.9	1.3	4.7
ANKRD40	MGC15396	ENSG00000154945	"Ankyrin repeat domain 40"	Q6AI12	17	50693198-50707914	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 164.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021668, HPA021759, HPA074884"	Uncertain		Approved	"Nucleoli fibrillar center,Golgi apparatus,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	"Nucleoli fibrillar center, Cytosol"	"HPA021668: AB_1844843, HPA021759: AB_2227411, HPA074884: "	"unprognostic (2.73e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.32e-1)"	42.8	19.7	126.7	15.5	163.3	7.8	25.7	130.4	159.3	20.6	63.4	32.0	11.8	23.8	13.7	18.4	19.4	16.2	27.6	98.5	115.4	17.8	17.8	22.5	16.6	150.3	152.4	20.6	19.4	26.9	10.8	23.1	142.2	18.3	16.3	20.7	15.0	24.7	107.0	14.4	16.3	27.9	141.3	20.5	18.7	10.3	135.2	16.9	16.9	84.0	14.4	25.3	16.9	164.8	41.1	38.6	34.2	34.6	48.2	39.8	29.9	36.2	39.5	41.3	38.7	82.6	20.5	43.3	49.2	46.4	44.3	22.8	49.3	29.4	66.8	40.0	31.7	59.1	25.1	40.7	26.4	41.6	24.0	34.3	29.5	40.3	50.1	30.2	32.9	35.1	34.0	42.3	34.4	32.0	52.2	15.1	38.0	33.0	36.1	35.2	61.9	30.8	32.5	34.8	18.1	50.5	20.2	27.2	39.6	59.1	31.4	27.4	40.4	55.8	44.1	29.2	46.7	44.3	43.4	38.3	30.6	15.9	46.4	7.4	7.0	3.1	10.9	11.2	12.5	9.8	12.0	12.3	7.1	9.2	11.1	13.4	1.8	10.7	12.3	14.2	9.3	4.6	126.7	163.3	130.4	159.3	98.5	115.4	150.3	152.4	142.2	141.3	135.2	164.8	39.0	16.0	11.4	11.4	13.9	45.0	24.2	6.1	11.4	14.3	19.8	11.7	31.7	12.8	4.9	18.4	4.2	14.9	19.9	13.5	27.4	16.6	1.8	10.4	20.3	31.4	6.0	7.4	16.0	17.5	18.9	19.6	5.6	16.1	9.5	14.3	32.9	21.9	19.0	35.3	15.6	12.3	6.1	32.4	25.1	3.1	34.2	16.3	26.6	11.2	13.2	19.6	8.2	12.1	32.2	19.9	8.4	37.6	4.5	30.5	9.6	24.8	5.0	12.0	46.0	39.1	27.3	17.5	21.1	10.4	33.2	10.7	15.7	9.7	12.8	24.1
AOC3	"HPAO, VAP-1, VAP1"	ENSG00000131471	"Amine oxidase copper containing 3"	Q16853	17	42851184-42858130	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 422.8"	"Group enriched"	"Detected in many"	4	"Adipocytes: 58.2;Peritubular cells: 74.9;Sertoli cells: 118.3;Smooth muscle cells: 93.0;Theca cells: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"ASC diff: 307.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA000980, CAB025797"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted - unknown location"	NA	NA		240000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Golgi apparatus"	"CAB025797: , HPA000980: AB_1078170"	"unprognostic (2.20e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (6.98e-4)"	422.8	48.4	2.6	31.9	3.2	1.4	169.2	2.5	4.2	52.8	2.7	210.8	17.3	95.1	33.5	88.0	84.8	50.7	50.2	2.9	2.5	24.1	19.1	218.6	12.4	2.5	2.5	26.5	12.0	8.4	5.4	28.0	2.6	59.1	41.0	1.7	14.7	103.6	17.8	24.6	57.6	144.8	2.3	21.4	66.6	12.8	2.4	5.9	28.2	22.9	3.9	142.1	50.9	2.5	0.1	1.5	0.2	1.0	307.5	0.3	5.0	0.3	0.1	0.2	0.8	0.9	0.0	0.7	0.7	0.1	0.2	0.5	0.8	0.2	0.8	1.5	5.7	0.4	0.5	18.4	0.8	0.3	1.0	3.3	1.0	0.3	0.8	0.0	0.2	2.2	0.3	1.7	0.6	0.2	0.2	1.4	0.7	0.1	0.4	0.7	0.8	3.0	0.1	2.2	0.3	0.4	0.0	0.2	2.0	2.2	0.1	0.1	0.0	0.3	2.7	1.2	0.4	4.8	5.9	0.6	0.4	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	3.2	2.5	4.2	2.9	2.5	2.5	2.5	2.6	2.3	2.4	2.5	58.2	3.2	6.0	0.0	0.5	2.9	0.1	0.0	2.2	0.0	1.1	2.2	9.5	0.0	1.9	0.0	0.0	0.1	0.4	0.1	0.0	0.2	4.5	0.8	2.3	12.3	0.0	0.0	0.4	0.2	0.1	11.3	0.0	1.4	1.3	2.1	20.7	0.2	1.4	0.0	0.3	0.1	0.0	1.4	2.7	2.6	3.4	0.9	3.6	3.7	0.0	0.2	0.0	0.0	0.1	0.2	0.0	74.9	0.0	0.4	0.1	1.4	1.0	0.4	118.3	2.6	93.0	1.1	1.3	0.7	1.8	0.3	0.6	74.6	0.1	0.3
ARHGAP1	"CDC42GAP, p50rhoGAP, RhoGAP"	ENSG00000175220	"Rho GTPase activating protein 1"	Q07960	11	46677080-46700619	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004689, HPA008285"	Approved	Approved	Approved	Vesicles		NA	NA		11000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA004689: AB_1078194, HPA008285: AB_1078195"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.05e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.24e-2)"	84.5	49.2	40.9	38.0	48.3	33.4	61.8	33.4	46.1	71.3	31.2	62.8	25.7	93.7	21.5	75.0	68.4	50.7	112.3	39.1	41.0	41.5	46.2	38.4	30.7	45.7	43.2	46.4	36.5	24.7	36.8	39.0	39.0	64.9	32.6	9.6	46.1	62.6	30.0	65.3	46.7	80.6	38.0	58.4	49.0	15.8	49.8	23.2	44.6	20.5	34.6	107.9	63.4	57.4	23.0	56.7	27.9	39.8	135.4	99.6	32.9	50.3	50.7	45.3	41.2	34.2	29.5	33.1	26.7	102.3	40.7	55.8	22.4	76.0	33.5	23.3	24.6	36.8	27.7	40.4	44.5	31.3	52.3	131.9	46.7	34.5	42.9	46.8	39.1	27.1	24.3	30.3	55.9	82.6	21.2	30.9	72.1	78.5	29.4	25.0	39.9	49.3	42.3	85.2	10.0	31.6	45.8	69.8	19.1	40.1	88.0	35.4	49.1	82.1	25.5	98.7	51.0	32.0	38.2	24.8	77.4	52.0	39.3	27.6	33.0	33.1	26.7	56.9	19.3	14.3	20.8	22.8	32.3	14.7	17.9	20.8	37.3	23.7	72.0	34.1	27.4	24.9	40.9	48.3	33.4	46.1	39.1	41.0	45.7	43.2	39.0	38.0	49.8	57.4	25.2	19.2	18.7	16.6	18.3	8.5	13.4	24.6	10.8	11.9	22.3	24.6	50.2	10.0	18.1	29.5	27.1	25.1	35.2	35.2	3.9	22.2	0.4	17.9	26.9	19.6	19.4	15.3	13.0	27.9	31.0	29.2	31.6	27.6	19.6	21.3	25.7	32.1	30.4	16.8	15.3	36.0	14.2	30.7	8.4	1.7	23.6	19.1	8.8	11.2	28.2	11.0	36.0	23.1	92.3	27.3	19.2	35.3	10.1	11.4	22.4	13.3	10.9	14.2	59.2	28.0	55.9	3.1	3.5	24.7	13.1	16.6	19.9	9.4	21.5	18.7
ARHGAP10	"FLJ20896, FLJ41791, GRAF2"	ENSG00000071205	"Rho GTPase activating protein 10"	A1A4S6	4	147732063-148072776	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 137.6;Oligodendrocyte precursor cells: 124.7;Peritubular cells: 121.1;Rod photoreceptor cells: 132.9;Sertoli cells: 144.7;Smooth muscle cells: 107.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 16.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 80.2"	HPA039589			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039589: "	"unprognostic (8.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (2.40e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.57e-2)"	"prognostic favorable (8.15e-5)"	"prognostic unfavorable (6.26e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.09e-2)"	35.0	11.4	4.6	7.0	6.3	3.3	22.6	2.0	7.1	35.1	9.8	47.0	4.9	16.9	9.8	35.7	35.1	13.0	38.7	6.0	2.6	9.7	7.9	15.1	5.8	3.1	4.7	33.4	9.2	16.0	6.2	10.7	3.5	26.0	8.0	14.4	11.1	20.0	38.6	22.2	16.6	13.3	3.6	9.8	26.3	11.8	5.5	11.3	16.9	33.1	6.7	44.2	30.8	4.1	21.0	8.3	4.4	9.2	33.2	45.1	46.0	28.3	23.5	17.9	13.8	21.6	11.8	0.0	4.7	24.4	15.0	10.1	16.4	23.4	21.5	11.4	10.9	7.2	6.2	0.7	51.2	7.1	8.0	23.4	17.9	22.3	19.0	22.7	22.0	6.0	1.0	38.3	32.3	25.5	4.5	0.0	4.1	13.9	4.0	8.1	12.7	24.5	12.3	19.0	10.7	5.1	7.4	29.6	7.9	19.0	3.7	0.6	21.9	16.8	12.9	10.3	13.8	14.2	1.8	0.1	25.5	0.9	15.1	0.0	1.7	16.7	5.3	0.1	10.5	0.0	4.1	6.2	3.0	0.0	1.2	6.0	0.2	5.3	0.1	0.1	5.4	2.4	4.6	6.3	2.0	7.1	6.0	2.6	3.1	4.7	3.5	3.6	5.5	4.1	18.5	3.2	4.1	5.5	1.5	14.4	7.9	7.0	16.5	7.1	13.0	15.4	64.8	5.7	3.5	1.8	43.8	29.0	11.1	0.2	0.0	5.8	13.6	16.3	83.5	11.8	0.0	1.3	63.3	16.0	48.2	45.6	11.2	31.8	1.3	21.7	4.2	13.0	20.9	3.3	26.7	0.4	0.0	6.2	33.7	10.2	137.6	24.2	5.4	46.9	58.4	8.2	8.2	124.7	2.1	14.0	0.1	121.1	3.2	4.5	0.8	15.0	1.3	132.9	144.7	22.7	107.3	4.7	13.3	15.7	10.2	12.7	16.0	9.1	1.1	3.1
ARHGEF17	"KIAA0337, p164-RhoGEF, TEM4"	ENSG00000110237	"Rho guanine nucleotide exchange factor 17"	Q96PE2	11	73308276-73369388	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 38.5;Endometrial stromal cells: 40.5;Sertoli cells: 85.5;Smooth muscle cells: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007991	Uncertain		Approved	Cytosol		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA007991: AB_1845005"	"unprognostic (2.36e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (8.27e-5)"	"unprognostic (6.96e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.54e-3)"	"unprognostic (7.12e-3)"	"unprognostic (6.85e-3)"	"unprognostic (3.42e-3)"	32.8	12.2	32.7	9.1	39.5	3.3	24.1	24.1	45.7	37.0	15.3	38.2	5.5	39.9	15.2	10.0	30.5	17.6	34.5	29.6	33.7	24.9	5.4	31.2	5.9	38.2	31.6	24.2	8.2	19.1	15.3	23.6	37.6	25.4	5.3	7.2	11.7	27.3	11.5	10.7	16.4	22.6	21.3	12.8	19.8	7.1	36.9	3.1	36.0	12.2	2.7	26.9	20.2	28.8	9.6	11.4	24.1	28.4	18.7	15.7	14.8	26.6	38.2	25.9	16.5	30.2	8.2	0.0	18.2	50.7	11.8	14.5	8.1	10.8	10.8	16.9	2.4	0.0	21.0	11.9	21.6	0.8	0.5	27.1	12.2	15.6	9.3	16.9	19.4	1.2	0.9	0.2	14.6	13.7	0.3	17.4	3.2	6.4	2.4	4.0	27.3	0.6	16.5	6.7	15.8	12.1	22.6	26.4	31.3	22.0	43.8	8.2	12.9	12.5	25.5	5.3	8.6	1.6	0.3	0.1	4.4	1.9	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	32.7	39.5	24.1	45.7	29.6	33.7	38.2	31.6	37.6	21.3	36.9	28.8	13.9	16.0	16.3	38.5	0.2	3.4	2.4	6.0	5.7	12.6	11.1	12.3	25.5	8.6	7.4	7.3	0.0	7.2	0.1	1.5	0.0	6.4	1.1	10.5	40.5	10.9	1.2	1.3	29.5	0.7	5.3	10.7	2.6	8.9	0.0	13.7	10.8	0.6	2.0	23.5	24.8	0.7	0.0	0.3	4.2	2.0	10.8	1.4	1.8	8.4	1.1	11.1	0.0	10.6	2.0	2.4	0.4	20.3	1.6	4.1	0.0	4.3	5.4	2.3	85.5	5.2	67.5	1.6	8.3	1.1	2.7	6.2	0.6	2.0	1.0	1.5
ARHGEF25	"GEFT, p63RhoGEF"	ENSG00000240771	"Rho guanine nucleotide exchange factor 25"	Q86VW2	12	57610180-57617245	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 151.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 20.8;Leydig cells: 24.8;Peritubular cells: 45.9;Sertoli cells: 26.3;Smooth muscle cells: 38.9"	"Cancer enhanced"	"Detected in all"		"glioma: 23.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 59.1;RH-30: 129.7;SH-SY5Y: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052016	Approved					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA052016: AB_2681695"	"unprognostic (8.43e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.13e-3)"	"unprognostic (6.95e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (4.20e-7)"	"unprognostic (1.41e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.82e-3)"	"unprognostic (3.22e-3)"	34.4	12.0	30.7	10.7	38.7	0.1	29.1	38.5	72.1	64.5	12.6	151.2	10.3	92.8	44.3	29.6	85.5	23.6	24.6	72.0	21.7	17.7	5.0	21.7	6.2	20.6	21.1	58.2	8.5	9.4	26.4	9.4	20.8	60.6	19.5	13.2	13.9	80.4	11.4	12.0	34.4	68.8	17.3	20.1	45.0	10.6	22.5	2.1	14.1	13.8	4.9	84.3	51.4	40.5	0.8	8.9	41.6	26.1	0.1	0.0	3.3	12.7	37.4	16.5	20.2	5.2	8.1	3.5	10.7	23.4	7.7	0.4	16.2	0.7	13.9	11.7	13.9	7.4	6.1	11.4	11.6	0.2	19.2	11.5	3.5	7.5	1.1	59.1	6.5	2.0	15.5	16.0	12.2	3.0	2.7	0.3	26.5	0.4	0.4	0.0	129.7	0.7	0.7	0.7	24.1	58.7	2.4	1.2	4.8	14.8	4.3	8.9	0.0	14.8	14.0	9.7	4.7	33.5	5.4	0.1	12.4	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	38.7	38.5	72.1	72.0	21.7	20.6	21.1	20.8	17.3	22.5	40.5	5.6	0.0	0.0	8.5	0.0	2.0	1.8	0.2	4.6	17.7	1.8	8.6	11.6	0.0	0.6	0.0	2.1	0.2	0.6	0.0	0.0	0.5	0.2	1.1	20.8	4.4	0.0	0.0	15.3	1.4	0.5	12.6	0.5	0.6	0.0	2.6	6.8	0.0	0.5	8.4	8.5	0.0	0.0	0.0	1.7	1.5	24.8	0.2	0.0	8.4	0.0	5.4	2.1	3.0	1.6	0.3	0.0	45.9	0.3	0.8	0.0	0.4	0.0	2.8	26.3	6.3	38.9	1.4	1.4	0.9	1.1	0.3	0.5	9.6	0.0	0.4
ARID5A	"MRF-1, RP11-363D14"	ENSG00000196843	"AT-rich interaction domain 5A"	Q03989	2	96536743-96552634	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 137.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HDLM-2: 295.3;RPMI-8226: 117.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002860, HPA023879"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Nucleoli	"HPA002860: , HPA023879: AB_1845014"	"prognostic favorable (2.05e-6)"	"unprognostic (1.08e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.24e-8)"	"unprognostic (2.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	32.6	4.5	8.1	19.5	8.9	11.8	38.8	8.7	11.1	18.5	7.7	25.9	5.0	25.2	2.0	7.8	24.1	12.3	28.8	7.8	8.7	12.3	8.5	48.1	19.0	14.3	10.8	10.8	6.9	2.2	9.3	9.6	11.5	23.2	2.3	2.2	10.2	2.6	23.5	11.3	19.8	7.3	10.6	22.8	14.6	5.6	10.2	10.3	13.0	2.3	9.9	19.9	15.4	9.6	3.4	1.9	1.6	5.4	2.7	3.0	7.5	5.1	17.2	6.1	5.3	3.1	0.9	1.1	3.8	2.9	9.1	4.6	1.4	0.3	2.1	295.3	4.1	6.9	1.1	5.8	3.4	4.7	4.9	2.1	5.7	5.0	0.9	5.3	5.4	8.1	5.4	38.5	2.4	2.9	8.7	16.1	3.3	1.5	0.2	12.2	11.3	117.5	0.7	2.5	2.2	1.1	0.5	0.6	4.3	1.3	0.2	10.0	6.0	5.4	6.7	6.2	4.6	24.7	21.5	3.1	3.0	11.1	4.9	10.5	7.9	32.8	15.3	6.9	14.9	5.9	13.1	14.6	10.3	6.5	14.1	14.4	21.5	27.5	5.5	18.4	16.0	14.9	8.1	8.9	8.7	11.1	7.8	8.7	14.3	10.8	11.5	10.6	10.2	9.6	97.1	3.2	18.3	3.9	59.9	52.4	46.5	17.0	5.7	24.8	80.3	44.7	14.7	8.6	14.7	3.7	31.3	4.9	121.1	10.8	3.9	33.7	14.2	16.7	26.8	82.2	0.0	3.4	1.5	30.9	9.0	41.2	11.2	32.4	61.9	2.1	38.6	28.7	72.6	0.0	1.6	10.7	20.3	41.5	137.1	36.7	3.7	61.6	58.7	15.9	66.6	6.5	123.6	3.5	1.3	29.1	23.9	6.4	54.5	28.2	0.6	10.6	8.3	25.7	46.0	49.1	120.1	3.2	17.9	1.1	32.5	4.0	98.2	2.1	7.8	26.9
ARID5B	"FLJ21150, MRF2"	ENSG00000150347	"AT-rich interaction domain 5B"	Q14865	10	61901684-62096944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 968.2;Syncytiotrophoblasts: 920.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 115.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015037	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA015037: AB_1845015"	"unprognostic (3.31e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.75e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-2)"	50.0	8.1	2.9	21.2	5.8	6.9	34.3	3.2	11.3	37.2	20.7	17.5	10.2	39.0	4.6	20.2	20.6	39.3	18.3	4.4	1.6	21.4	8.3	18.3	18.8	7.8	6.9	17.5	6.2	13.3	10.0	21.0	11.4	18.3	11.7	4.1	15.8	10.2	87.2	18.1	14.2	42.5	0.9	16.9	11.5	6.9	9.0	13.1	7.8	11.9	16.7	30.9	19.6	9.7	2.2	0.9	6.0	14.7	13.0	34.0	1.2	42.9	115.2	29.9	23.3	52.7	2.3	3.9	10.1	41.4	4.3	14.3	20.6	6.5	36.0	13.7	6.1	2.1	10.4	13.5	23.9	0.6	25.2	43.3	3.4	17.6	20.2	26.2	3.9	7.5	1.9	5.7	9.9	7.7	14.4	1.1	1.1	10.2	13.5	17.7	9.8	1.1	20.1	23.9	3.3	4.4	19.2	10.6	12.8	13.1	8.7	0.7	3.3	16.5	22.0	25.1	10.9	0.4	0.0	11.4	14.3	0.8	5.4	9.6	1.2	0.8	13.3	2.8	1.8	37.5	19.7	11.8	2.2	41.2	12.8	8.4	2.2	12.3	8.2	1.0	30.9	5.4	2.9	5.8	3.2	11.3	4.4	1.6	7.8	6.9	11.4	0.9	9.0	9.7	86.2	131.4	70.7	54.5	199.8	968.2	453.9	111.3	105.9	54.4	112.8	96.6	72.8	27.1	96.3	51.5	0.0	187.8	89.1	7.5	99.7	56.1	31.7	164.7	231.0	134.1	36.4	5.2	167.8	14.6	150.7	343.6	21.4	457.7	24.6	37.6	119.2	7.4	51.0	74.0	181.9	18.7	22.4	44.1	162.4	20.1	151.6	43.6	138.7	34.7	39.0	17.2	58.7	74.4	155.8	41.1	25.2	60.5	234.5	193.7	5.4	304.8	38.4	3.6	131.5	496.3	463.9	8.2	5.8	65.7	477.8	920.4	178.2	24.3	41.7	233.9
ARMCX1	"ALEX1, GASP7"	ENSG00000126947	"Armadillo repeat containing X-linked 1"	Q9P291	X	101550547-101554700	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 7.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 74.9;ASC TERT1: 66.9;BJ hTERT+ SV40 Large T+ RasG12V: 78.2;LHCN-M2: 70.7;RH-30: 87.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000268, HPA005685, CAB020695"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	"Nucleoplasm, Cytosol"	"CAB020695: , HPA000268: , HPA005685: AB_10600781"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.32e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.09e-2)"	24.4	34.0	16.8	8.8	18.4	3.1	21.9	14.9	21.9	32.3	18.2	31.4	7.0	30.4	21.2	11.4	25.2	17.5	32.8	18.0	19.5	13.7	4.0	16.5	5.5	16.2	17.9	48.3	12.8	16.9	25.9	14.9	18.8	24.3	7.6	12.0	14.1	23.0	27.7	10.9	12.0	21.2	15.6	14.1	14.8	5.9	17.7	6.3	16.4	25.5	3.4	23.2	21.7	17.9	2.1	0.6	16.0	0.0	74.9	66.9	0.2	25.5	49.7	31.4	78.2	0.0	0.4	0.0	21.3	39.3	34.2	2.1	0.0	3.7	17.7	0.1	0.0	14.9	5.1	0.0	39.6	0.0	0.2	56.5	4.8	23.8	0.0	25.9	19.2	0.0	0.3	0.3	70.7	1.0	0.0	0.1	23.1	0.0	0.2	0.0	87.8	0.1	21.6	0.0	15.8	13.1	0.0	0.3	45.9	4.4	2.5	11.0	25.6	18.9	10.0	55.5	0.3	0.0	0.3	0.0	18.6	0.0	12.1	0.0	3.3	0.4	0.0	3.1	0.5	0.0	0.4	0.3	7.7	0.2	1.1	2.7	0.1	1.8	0.9	4.0	0.8	1.6	16.8	18.4	14.9	21.9	18.0	19.5	16.2	17.9	18.8	15.6	17.7	17.9	27.6	25.6	7.4	8.5	0.7	33.1	22.9	5.0	18.2	32.2	19.1	17.4	59.7	7.2	4.1	23.9	6.2	1.6	3.7	0.6	13.7	21.1	0.3	10.4	23.2	29.9	5.4	4.2	9.5	7.1	2.6	53.2	9.2	11.2	24.1	20.0	20.7	0.8	27.9	21.9	11.8	2.2	2.0	9.5	33.4	2.0	47.2	17.5	58.7	4.7	5.7	36.0	0.0	11.1	8.4	5.6	0.1	44.4	0.4	20.6	0.6	13.6	3.6	13.9	46.0	60.6	39.9	1.6	0.7	3.8	21.7	2.6	2.3	35.6	2.5	7.5
ARMCX2	"ALEX2, GASP9, KIAA0512"	ENSG00000184867	"Armadillo repeat containing X-linked 2"	Q7L311	X	101655281-101659850	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 154.8"	"Cell type enhanced"	"Detected in many"		"Sertoli cells: 59.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 164.1;NTERA-2: 117.2;SuSa: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005761	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	Nucleoplasm	"HPA005761: AB_10600782"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.59e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.41e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (9.06e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.25e-1)"	17.0	46.2	28.7	11.5	29.1	0.5	17.6	22.8	29.7	36.9	26.5	25.4	5.4	30.6	154.8	9.2	28.8	20.6	33.2	29.1	31.6	28.3	3.2	16.8	8.5	25.9	26.2	47.8	18.9	71.2	78.3	26.3	27.5	28.3	7.9	15.3	44.5	67.9	6.2	6.5	13.0	32.3	23.4	21.3	16.3	5.8	28.1	7.7	59.7	7.5	6.5	26.9	20.1	25.4	0.0	0.0	50.8	0.4	43.6	39.4	0.4	56.0	70.4	1.4	1.4	0.0	21.8	0.0	0.0	74.6	0.0	1.5	0.0	1.3	0.6	0.0	2.0	0.2	60.9	0.0	46.4	0.4	0.1	63.7	17.6	43.5	0.4	68.3	59.7	0.0	0.2	0.3	164.1	0.0	0.0	0.6	117.2	3.4	0.3	14.5	88.9	0.3	2.8	0.0	20.4	36.6	0.0	0.2	1.7	90.3	25.9	0.1	13.0	61.9	65.1	38.8	0.4	0.0	0.0	0.2	55.7	0.1	1.2	0.0	0.4	0.0	1.0	0.9	0.4	2.8	0.9	0.9	0.7	4.0	2.4	2.5	0.0	2.8	0.6	0.9	0.7	1.1	28.7	29.1	22.8	29.7	29.1	31.6	25.9	26.2	27.5	23.4	28.1	25.4	10.4	16.0	6.4	8.5	8.2	4.2	16.4	5.8	21.1	12.5	18.0	20.8	28.7	5.7	11.4	33.1	8.4	1.2	2.4	0.1	3.9	9.6	0.2	11.2	23.4	13.3	9.1	3.2	15.4	2.0	0.7	28.4	4.6	15.2	2.5	18.1	19.2	0.7	3.8	1.7	14.3	3.0	2.0	2.4	6.5	1.3	24.2	7.4	5.4	11.2	7.1	9.3	0.0	16.1	14.0	2.2	0.1	24.5	2.8	16.5	0.3	4.3	4.9	11.3	59.2	31.8	23.9	1.4	1.9	3.8	3.0	5.1	2.5	4.6	1.6	7.2
AVPR1A	AVPR1	ENSG00000166148	"Arginine vasopressin receptor 1A"	P37288	12	63142759-63151201	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 56.6"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 24.1;Hepatocytes: 62.7;Sertoli cells: 78.9;Smooth muscle cells: 100.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"ASC diff: 5.6;Karpas-707: 13.1;U-266/84: 9.8"	"Group enriched"	"Detected in some"	5	"basal ganglia: 7.0;hypothalamus: 3.8"	"Low region specificity"	"Detected in all"									NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (1.49e-1)"	"unprognostic (2.82e-1)"	"unprognostic (9.90e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.43e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.58e-6)"	"unprognostic (1.45e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.38e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.66e-4)"	17.2	56.6	0.4	1.4	0.2	0.0	9.0	0.0	0.3	9.1	1.4	1.7	0.7	10.9	1.1	3.0	4.8	6.1	2.0	0.3	0.5	4.6	20.9	0.5	1.2	0.5	0.2	1.3	2.3	2.2	0.5	0.3	0.2	2.3	1.2	1.4	1.1	4.2	2.0	1.8	0.9	12.2	0.1	0.8	1.7	0.6	0.8	1.4	10.4	3.5	0.6	2.5	2.6	0.2	0.1	0.2	0.6	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.3	0.3	0.5	0.5	0.2	0.2	0.1	0.8	0.2	14.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.6	0.3	0.2	0.3	3.4	1.5	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	3.1	24.1	4.5	0.0	2.7	0.1	0.0	0.5	2.7	0.5	1.6	0.0	0.2	0.7	62.7	0.2	0.0	1.0	0.0	0.0	1.3	0.3	0.0	2.8	1.4	0.0	0.0	0.0	7.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	78.9	2.9	100.9	0.2	0.2	0.0	0.3	0.1	0.6	2.1	0.0	0.3
AXL	"ARK, JTK11, Tyro7, UFO"	ENSG00000167601	"AXL receptor tyrosine kinase"	P30530	19	41219223-41261766	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Differentiation, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Oncogene, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 147.2;Kupffer cells: 187.5;Langerhans cells: 185.5;Prostatic glandular cells: 123.4;Sertoli cells: 210.4;Smooth muscle cells: 171.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 11.1;plasmacytoid DC: 25.7"	"Group enriched"	"Detected in many"	12	"dendritic cells: 25.7;NK-cells: 11.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 501.2;U-251 MG: 540.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032501, HPA037422, HPA037423, HPA075217"	Uncertain		Supported	"Vesicles,Plasma membrane,Actin filaments"		NA	Yes	12100000	72000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Vesicles, Actin filaments"	"CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: AB_2675470, HPA075217: "	"unprognostic (2.20e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.79e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.57e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.53e-7)"	"unprognostic (1.16e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.83e-3)"	43.6	18.8	17.5	15.5	22.6	1.7	26.6	19.7	17.7	36.1	12.4	42.5	11.7	34.4	8.7	17.6	25.4	22.4	26.7	16.6	18.8	9.8	15.0	25.9	6.2	26.8	20.6	24.7	6.3	10.7	7.3	34.2	22.1	19.2	12.6	5.8	10.6	24.6	9.4	20.0	19.0	37.1	20.9	37.7	21.4	18.6	24.0	7.2	16.6	11.3	5.0	32.5	25.2	21.9	408.0	160.0	9.7	1.3	34.6	34.7	0.5	314.5	280.2	450.9	278.2	8.5	185.5	0.2	124.7	501.2	235.3	33.3	0.4	211.8	384.8	0.7	0.3	0.0	100.4	6.3	125.0	0.3	0.3	26.4	3.8	266.7	409.5	254.8	169.8	0.1	15.8	0.5	284.6	0.5	0.2	0.4	4.1	1.0	76.3	0.2	165.3	0.3	202.3	0.2	0.1	0.1	81.5	0.6	1.8	57.4	0.9	7.2	351.8	317.8	214.6	307.7	540.8	0.5	0.9	1.0	211.5	0.5	241.8	1.5	0.3	0.2	0.1	0.4	0.2	0.1	0.3	0.1	6.0	0.1	0.3	0.3	0.3	11.1	0.2	25.7	0.4	0.3	17.5	22.6	19.7	17.7	16.6	18.8	26.8	20.6	22.1	20.9	24.0	21.9	13.5	9.6	3.6	35.9	1.9	41.7	88.3	10.3	3.4	0.5	2.3	14.2	8.6	1.5	4.4	5.5	0.0	4.2	0.8	0.1	0.0	6.9	8.7	6.0	45.8	17.7	0.0	0.0	0.8	0.2	2.1	147.2	1.5	5.4	0.0	17.3	11.0	1.2	28.8	1.7	1.1	0.1	2.0	187.5	185.5	5.5	61.5	61.4	26.6	30.9	3.1	26.8	0.0	11.1	0.5	14.5	0.1	79.7	0.8	123.4	0.3	0.1	2.8	1.2	210.4	38.1	171.1	1.9	2.0	1.2	29.1	11.5	3.6	2.5	0.1	28.0
B3GNT2	"B3GN-T1, B3GN-T2, B3GNT-2, B3GNT1, BETA3GNT"	ENSG00000170340	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2"	Q9NY97	2	62196115-62224731	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 115.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005997	Approved		Approved	Vesicles		NA	NA		99000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 14: REH - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA005997: AB_1845234"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.63e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.25e-1)"	17.3	20.8	6.6	13.3	13.6	72.7	26.1	5.9	9.8	25.9	9.0	19.4	27.7	24.6	6.2	25.1	12.7	27.4	19.0	6.8	8.6	33.4	21.8	34.2	24.1	6.9	8.3	5.9	39.7	7.6	13.2	30.6	9.7	10.8	24.3	5.2	15.5	8.2	3.2	11.0	14.4	24.1	6.1	14.9	18.2	7.6	8.5	25.5	19.5	9.0	18.3	20.1	12.8	6.7	20.7	14.0	20.9	9.3	22.5	10.0	60.0	19.8	21.8	15.4	20.5	29.2	32.5	22.3	17.8	18.5	21.6	19.4	13.3	16.6	26.5	46.8	10.8	55.1	6.4	17.2	16.8	33.2	23.8	12.3	30.7	29.6	10.5	11.0	23.4	15.3	30.4	13.7	18.9	15.7	63.7	49.6	20.0	37.4	5.8	115.0	14.4	12.3	29.2	20.1	20.1	14.9	14.1	29.9	23.5	33.4	8.6	38.7	26.7	18.6	16.4	31.7	19.9	38.2	14.4	96.2	14.6	56.5	18.4	14.9	9.0	56.2	20.0	8.6	28.0	14.8	14.7	34.6	10.6	16.6	17.3	26.0	21.3	41.0	11.7	13.3	26.2	17.6	6.6	13.6	5.9	9.8	6.8	8.6	6.9	8.3	9.7	6.1	8.5	6.7	40.3	64.1	9.8	2.0	31.4	71.5	30.9	20.8	92.2	15.6	40.0	20.7	9.2	18.6	21.9	18.4	0.0	40.9	43.8	42.7	23.5	24.0	0.1	51.1	30.3	31.8	9.5	61.6	11.2	57.2	38.3	19.5	36.7	97.3	3.8	9.7	37.5	21.3	60.4	0.0	3.4	22.7	87.5	20.5	58.5	0.7	2.5	34.4	35.6	14.0	19.7	8.6	18.6	2.5	7.2	36.3	24.8	2.2	25.8	25.5	14.2	19.0	19.1	2.1	65.7	8.1	68.2	0.3	1.6	77.4	64.8	65.3	45.9	10.6	13.9	41.1
BARX1		ENSG00000131668	"BARX homeobox 1"	Q9HBU1	9	93951627-93955355	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"stomach 1: 166.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.0;Early spermatids: 2.6;Fibroblasts: 2.9;Smooth muscle cells: 1.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 19.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AN3-CA: 29.5;HMC-1: 69.8;NTERA-2: 20.7;THP-1: 28.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055858			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Vesicles	"HPA055858: AB_2682947"	"unprognostic (6.19e-4)"	"unprognostic (4.81e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (8.16e-6)"	"unprognostic (4.96e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.46e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.23e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (9.68e-13)"	"unprognostic (7.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.16e-2)"	17.1	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	2.9	0.0	0.3	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.6	15.1	1.5	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	166.5	3.9	0.0	0.0	1.0	0.5	0.4	0.0	0.0	0.0	0.0	2.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.6	0.0	4.3	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	69.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.4	20.7	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.3	5.8	0.0	28.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.9	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BGLAP	OCN	ENSG00000242252	"Bone gamma-carboxyglutamate protein"	P02818	1	156242184-156243317	"FDA approved drug targets, Predicted secreted proteins"	Biomineralization		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 19.9;choroid plexus: 10.8;intestine: 8.5"	"Cell type enhanced"	"Detected in some"		"Ionocytes: 4.1;Melanocytes: 3.6;Plasma cells: 2.8;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"NK-cell: 1.8;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	17	"dendritic cells: 1.6;NK-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 8.3;U-87 MG: 5.4"	"Region enriched"	"Detected in single"	9	"olfactory bulb: 7.8"	"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	15500000	2200000	"Cluster 40: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.50e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.82e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.44e-5)"	"unprognostic (2.63e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.53e-3)"	"unprognostic (4.70e-2)"	"unprognostic (9.67e-6)"	"unprognostic (3.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.64e-3)"	0.7	0.5	12.7	0.6	13.9	0.9	0.6	13.3	19.9	1.7	10.8	8.5	0.6	1.4	1.1	0.7	1.4	0.6	0.8	12.3	12.7	1.1	1.6	0.6	0.4	14.6	13.4	1.9	0.8	0.2	1.1	0.4	13.5	2.0	1.8	0.2	1.7	0.7	0.5	1.7	2.3	1.8	14.0	1.9	0.8	0.4	13.4	0.3	1.4	0.0	0.2	0.8	1.0	14.7	0.1	1.5	0.7	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.5	0.5	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.5	0.1	0.2	0.4	0.0	0.0	0.7	0.6	0.1	0.3	0.7	0.1	0.4	1.8	0.0	0.2	0.6	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.4	0.7	1.1	1.4	5.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.6	0.0	0.0	12.7	13.9	13.3	19.9	12.3	12.7	14.6	13.4	13.5	14.0	13.4	14.7	0.6	0.0	0.0	0.0	0.6	1.5	1.0	1.0	0.6	0.2	1.1	0.9	0.0	0.0	1.0	0.0	0.0	0.5	0.2	0.1	0.0	0.1	0.1	0.3	0.4	0.6	0.0	0.0	0.0	0.2	0.3	1.0	0.5	0.5	0.0	1.1	1.1	0.2	0.2	0.0	0.0	0.9	4.1	0.0	0.8	0.2	1.5	0.5	3.6	0.0	0.4	0.4	1.0	0.0	0.0	0.0	1.1	0.4	2.8	0.7	0.3	2.0	0.3	0.6	6.6	0.5	0.3	0.4	0.8	0.6	1.3	0.4	0.6	0.8	0.8	0.7
BGN	"DSPG1, SLRR1A"	ENSG00000182492	Biglycan	P21810	X	153494980-153509546	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Aortic aneurysm, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 795.8"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 223.5;Peritubular cells: 782.7;Sertoli cells: 1485.7;Smooth muscle cells: 401.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 312.6;BJ hTERT+: 400.8;fHDF/TERT166: 568.9;HSkMC: 283.9;hTEC/SVTERT24-B: 235.2;HUVEC TERT2: 561.2;U-138 MG: 249.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003157, CAB003678"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		3300000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB003678: AB_425325, HPA003157: AB_1078282"	"unprognostic (1.74e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.60e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (6.00e-8)"	"unprognostic (7.05e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.57e-3)"	165.8	213.0	54.1	93.1	57.6	0.3	118.0	51.2	91.5	371.0	69.5	69.3	22.0	234.4	83.7	45.8	143.7	326.1	795.8	56.1	48.7	396.5	347.9	477.3	42.4	50.6	50.8	94.9	67.9	26.6	144.1	199.1	53.2	184.2	24.8	1.1	107.7	135.5	32.4	118.9	48.8	213.2	45.5	352.1	51.6	69.9	64.6	15.9	250.0	46.7	35.9	126.8	180.0	65.4	0.0	0.0	29.7	0.1	31.5	70.5	1.1	312.6	400.8	56.7	18.6	39.5	0.0	0.0	56.9	568.9	2.0	0.1	0.0	0.0	10.2	0.0	0.0	0.0	0.6	3.9	27.0	0.0	0.2	283.9	2.2	235.2	10.7	29.0	561.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	1.5	0.3	0.2	0.0	0.1	0.0	0.6	0.4	0.0	0.0	1.1	11.8	1.3	0.0	120.0	249.5	2.3	1.0	1.5	0.9	0.1	0.0	0.1	0.3	114.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	57.6	51.2	91.5	56.1	48.7	50.6	50.8	53.2	45.5	64.6	65.4	30.5	3.2	5.6	5.9	0.6	104.1	1.3	7.3	5.7	0.2	1.2	5.6	16.1	4.3	2.5	9.2	0.0	15.5	0.7	0.0	1.9	2.7	1.8	1.4	28.3	45.2	0.0	5.3	0.1	0.2	50.0	180.0	7.7	1.1	3.8	8.4	223.5	1.6	4.4	3.3	0.1	0.0	0.0	4.0	43.6	13.5	147.9	3.0	35.6	25.3	2.0	0.1	0.0	20.6	0.0	1.2	0.0	782.7	0.0	3.0	0.0	0.8	1.6	0.2	1485.7	3.1	401.3	0.8	1.2	1.8	54.1	56.9	3.0	7.7	0.0	1.6
BRMS1L	"BRMS1, FLJ39177, MGC11296"	ENSG00000100916	"BRMS1 like transcriptional repressor"	Q5PSV4	14	35826338-35932325	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046623	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA046623: AB_2679724"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (2.56e-2)"	"unprognostic (2.02e-2)"	"unprognostic (8.04e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (6.55e-5)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (6.87e-6)"	6.2	10.1	8.3	3.8	9.0	2.6	6.2	7.6	11.2	6.0	5.4	5.1	3.2	6.3	5.5	6.4	5.1	4.2	11.6	8.9	7.8	8.9	6.1	4.8	3.0	7.4	8.2	7.2	3.0	9.8	4.4	7.3	7.9	6.5	3.6	8.2	4.2	6.2	13.6	5.9	3.1	7.0	7.7	3.5	4.3	5.3	8.2	3.5	7.2	13.7	3.9	5.8	5.4	9.4	10.1	10.1	17.1	9.9	15.2	19.1	25.5	10.3	9.9	15.7	15.3	6.5	8.3	8.1	10.3	14.4	7.4	12.6	13.7	18.7	22.3	9.0	16.8	7.4	10.1	28.6	10.7	3.7	5.9	13.4	12.5	12.1	10.2	8.2	11.4	4.7	3.6	6.3	17.7	13.5	4.3	6.0	6.8	14.2	14.8	4.4	19.1	6.2	12.7	11.4	5.1	13.1	12.0	13.7	12.2	13.0	15.7	5.2	7.0	14.9	9.1	8.6	10.2	5.8	8.2	5.0	3.7	8.1	9.2	0.0	0.5	0.3	1.0	1.2	0.8	0.7	1.0	1.3	0.3	0.5	1.4	1.2	0.0	0.4	1.4	0.9	1.4	0.7	8.3	9.0	7.6	11.2	8.9	7.8	7.4	8.2	7.9	7.7	8.2	9.4	11.6	9.6	13.9	13.7	10.5	18.6	10.2	10.4	19.9	18.5	8.4	7.1	19.2	2.8	10.6	7.3	4.2	19.3	15.7	2.3	7.9	4.9	3.5	6.7	13.0	11.2	4.8	1.3	21.2	6.9	15.4	15.3	6.1	6.3	14.7	6.9	6.8	6.3	5.1	16.8	22.3	3.8	12.2	2.8	9.5	3.2	11.1	3.9	8.8	6.5	6.6	21.4	3.1	20.6	26.2	4.4	3.0	9.8	8.8	14.0	1.7	19.2	6.7	17.5	19.7	17.5	20.0	6.5	16.6	12.6	16.2	22.4	11.4	11.8	3.7	7.1
C11orf96	AG2	ENSG00000187479	"Chromosome 11 open reading frame 96"	Q7Z7L8	11	43925342-43943878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 750.2;ovary: 721.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 796.5;Endometrial stromal cells: 906.3;Fibroblasts: 801.3;Granulosa cells: 982.4;Peritubular cells: 474.3;Smooth muscle cells: 1942.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"SH-SY5Y: 197.7"	"Low region specificity"	"Detected in all"							HPA038843	Uncertain		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		No	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Focal adhesion sites, Cytosol"		"HPA038843: AB_10673296"	"unprognostic (1.55e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.42e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.19e-2)"	478.3	199.0	28.7	39.2	24.3	4.9	203.5	26.1	34.2	305.0	18.4	151.0	19.7	283.4	8.7	44.8	750.2	61.1	269.3	24.8	44.4	226.8	179.2	377.9	6.8	93.8	42.4	721.3	60.7	3.2	126.5	15.4	38.5	157.3	8.4	1.3	22.2	14.3	110.8	97.2	130.3	28.4	35.1	54.4	240.2	67.8	44.5	5.0	119.4	10.3	0.7	176.3	148.1	21.0	0.0	0.0	0.0	0.0	4.0	2.0	1.1	0.3	1.3	0.0	0.1	0.1	0.0	0.0	0.5	0.5	2.1	0.1	0.4	0.0	0.0	0.0	2.9	6.2	0.1	0.0	0.8	0.5	0.6	0.3	0.1	1.4	0.0	0.0	1.2	2.1	2.3	0.0	0.0	0.0	2.4	2.7	1.7	0.0	0.9	10.3	0.7	4.7	0.0	0.0	2.2	197.7	0.0	0.0	19.4	5.5	0.0	2.3	2.7	9.2	3.8	2.3	0.2	22.5	0.2	3.2	7.1	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	24.3	26.1	34.2	24.8	44.4	93.8	42.4	38.5	35.1	44.5	21.0	796.5	6.4	139.9	0.0	1.9	92.9	15.2	1.6	5.2	15.4	8.2	13.7	6.0	0.0	1.9	0.0	2.1	1.5	13.7	0.3	0.0	4.5	4.3	34.1	906.3	260.3	0.0	2.7	0.0	0.6	4.4	801.3	4.1	183.3	13.9	982.4	172.7	6.4	3.8	1.7	0.0	0.2	0.0	8.4	171.8	13.9	215.6	27.1	174.3	0.0	0.1	2.7	0.0	0.0	0.0	1.9	0.0	474.3	9.4	73.6	0.0	0.0	0.9	9.3	302.4	173.2	1942.9	2.1	1.5	6.5	88.5	3.1	14.2	243.9	0.1	50.5
C12orf57	"C10, GRCC10"	ENSG00000111678	"Chromosome 12 open reading frame 57"	Q99622	12	6942978-6946003	"Disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046182, HPA059163, HPA066043"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"HPA046182: AB_2679572, HPA059163: AB_2683937, HPA066043: AB_2685603"	"unprognostic (5.89e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.20e-3)"	"unprognostic (8.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (8.74e-4)"	"unprognostic (4.25e-2)"	"prognostic unfavorable (2.32e-7)"	"unprognostic (1.47e-2)"	"unprognostic (3.26e-1)"	"unprognostic (6.81e-2)"	"unprognostic (8.39e-3)"	254.8	199.9	230.6	76.1	231.7	128.4	282.7	235.0	329.3	411.9	239.0	242.7	76.5	296.1	85.9	143.9	328.1	134.2	327.9	221.9	240.4	225.2	205.5	217.9	183.5	233.4	235.7	574.0	300.7	117.2	332.4	75.2	233.9	297.0	69.5	37.0	173.2	157.1	194.2	307.1	163.3	85.2	227.6	160.7	220.3	82.1	252.6	262.6	214.2	179.8	77.0	263.9	270.0	236.8	88.3	253.6	291.0	288.0	196.6	233.8	96.1	113.7	277.0	96.4	153.0	101.4	146.8	27.0	88.1	178.1	124.4	83.6	111.2	140.6	23.1	158.1	232.8	234.8	191.4	145.2	372.3	96.9	220.7	281.9	164.7	74.6	101.7	188.8	164.2	216.5	82.2	230.3	90.5	264.3	204.6	124.8	522.0	146.3	92.2	224.4	259.7	404.8	131.2	218.8	128.9	377.5	182.8	184.3	242.6	136.7	46.8	501.1	174.3	192.7	181.8	77.9	173.0	169.8	150.0	149.8	198.6	2.4	132.2	75.7	20.0	19.3	187.8	34.2	123.6	133.2	208.5	199.6	29.5	163.8	248.0	203.7	7.9	99.9	87.0	225.2	204.5	160.1	230.6	231.7	235.0	329.3	221.9	240.4	233.4	235.7	233.9	227.6	252.6	236.8	260.9	64.1	129.2	11.1	256.4	264.5	285.2	255.3	546.9	90.6	284.2	624.3	219.4	211.6	146.0	123.2	25.0	131.4	216.3	262.8	365.9	191.9	175.7	122.1	336.7	206.8	312.1	81.6	7.4	423.9	219.4	340.3	179.4	146.9	148.9	86.2	204.9	307.0	67.2	37.0	11.0	686.2	162.8	88.9	138.1	299.5	453.3	120.2	231.3	15.0	58.4	197.5	200.8	7.1	8.9	205.5	240.0	377.3	216.6	279.5	146.8	244.4	89.0	94.9	289.3	389.2	473.4	75.1	86.0	301.7	215.0	154.2	328.2	157.0	349.5	215.6
C1orf198	"DKFZp667D152, FLJ14525, FLJ16283, FLJ38847, MGC10710"	ENSG00000119280	"Chromosome 1 open reading frame 198"	Q9H425	1	230837119-230869589	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 131.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 192.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 13.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 13.1"	"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 138.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004798	Approved		Supported	Cytosol	"Intracellular and membrane"	NA	NA		80000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA004798: AB_1848722"	"unprognostic (7.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.50e-5)"	"unprognostic (3.53e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.77e-2)"	39.7	13.4	77.5	11.0	106.4	5.3	30.0	93.3	83.7	36.5	41.1	35.2	11.8	38.8	14.9	14.9	32.7	32.3	45.4	72.6	85.0	17.3	14.7	66.9	15.5	108.4	105.1	27.3	27.9	20.1	7.6	31.1	108.9	21.4	11.4	9.8	23.4	32.3	106.2	34.0	13.9	46.1	97.8	18.0	29.9	6.8	94.5	6.6	34.9	26.1	9.1	33.2	26.4	131.3	22.4	16.7	44.9	30.8	81.9	59.9	76.7	40.4	63.7	20.4	20.6	53.0	12.3	26.8	24.5	138.1	10.3	14.1	23.5	8.9	15.0	87.5	22.3	4.2	15.0	17.9	35.7	13.9	4.0	72.9	13.4	8.1	8.9	43.7	12.9	16.9	8.7	9.0	14.1	15.0	11.0	6.6	52.6	49.5	13.7	25.6	32.1	6.0	16.2	26.7	26.0	41.5	20.5	27.2	14.2	23.6	34.6	11.8	10.3	32.9	32.8	7.7	24.5	16.0	7.7	8.0	8.7	8.7	95.3	13.1	1.3	0.3	2.0	2.7	2.4	1.9	1.3	0.8	1.7	1.2	2.6	2.3	1.0	2.9	1.3	0.2	0.6	4.7	77.5	106.4	93.3	83.7	72.6	85.0	108.4	105.1	108.9	97.8	94.5	131.3	11.1	192.3	23.2	35.3	1.2	26.0	13.1	6.4	7.4	2.0	32.7	23.7	36.4	32.9	17.3	11.0	10.4	17.5	1.3	2.6	1.9	41.9	11.4	8.2	8.9	11.6	5.4	9.9	2.6	26.3	32.2	33.2	3.6	10.6	2.5	15.1	8.6	4.5	11.0	25.2	5.3	9.0	8.2	1.8	19.4	8.3	13.4	11.6	65.8	13.1	3.6	12.8	0.0	6.0	67.5	31.1	3.7	9.1	2.5	21.3	2.8	7.4	12.2	4.6	32.9	26.8	45.1	10.4	5.7	8.9	29.0	12.9	3.4	5.2	6.9	18.7
C1QTNF1	"CTRP1, FLJ90694, GIP, ZSIG37"	ENSG00000173918	"C1q and TNF related 1"	Q9BXJ1	17	79022814-79049788	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 214.2;heart muscle: 319.1"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 120.0;Sertoli cells: 105.2;Smooth muscle cells: 105.8;Syncytiotrophoblasts: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 313.5;BJ hTERT+: 72.9;HHSteC: 112.3;HSkMC: 61.3;U-87 MG: 66.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025429, HPA051101"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	314000000	40000	"Cluster 34: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"CAB025429: , HPA051101: AB_2681343"	"unprognostic (2.58e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.81e-3)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (9.09e-9)"	"unprognostic (1.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.95e-2)"	214.2	75.3	9.5	14.8	15.2	0.5	156.0	16.1	13.3	50.2	45.3	38.3	4.6	45.1	6.5	18.9	63.5	24.3	319.1	9.1	18.2	25.3	45.7	44.4	14.0	18.3	25.4	70.5	14.9	13.5	17.5	42.2	18.0	57.1	6.3	0.9	34.9	44.0	27.0	38.6	29.3	13.3	14.1	35.7	25.0	5.4	21.9	5.1	115.0	21.3	6.6	34.7	42.3	13.2	0.1	32.3	0.3	0.1	313.5	27.1	0.2	13.6	72.9	7.0	11.9	2.7	14.0	0.1	1.5	5.1	18.1	0.7	1.0	0.5	5.0	0.1	3.5	0.2	11.7	1.5	112.3	0.1	0.2	61.3	0.2	14.5	0.8	9.3	8.8	1.6	0.1	0.3	1.6	0.1	0.3	0.2	3.0	3.7	27.9	0.1	22.3	0.4	0.0	0.4	1.3	5.3	9.2	1.8	32.7	1.2	0.0	0.0	1.4	32.6	0.8	4.0	4.8	0.3	0.1	0.1	66.2	0.2	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.5	15.2	16.1	13.3	9.1	18.2	18.3	25.4	18.0	14.1	21.9	13.2	36.1	0.0	0.6	4.9	0.4	6.5	0.7	12.3	0.6	0.1	9.2	1.8	10.8	5.7	0.5	1.8	0.0	21.5	0.4	3.2	0.0	19.5	0.1	0.6	17.9	38.3	4.8	2.7	0.2	5.9	1.5	23.6	2.6	0.6	0.0	25.3	120.0	1.9	2.6	0.0	0.9	6.3	2.0	7.5	11.3	0.7	10.5	1.1	3.6	5.6	10.9	0.5	0.0	0.5	0.3	3.7	3.1	3.4	0.1	1.8	0.9	0.2	0.3	0.5	105.2	12.7	105.8	0.0	0.7	0.4	4.5	47.3	0.8	18.1	5.2	0.6
C20orf202		ENSG00000215595	"Chromosome 20 open reading frame 202"	A1L168	20	1203454-1208279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 3.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Early spermatids: 3.6;Late spermatids: 2.1;Paneth cells: 1.3;Proximal enterocytes: 1.2;Sertoli cells: 6.6;Smooth muscle cells: 1.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Daudi: 1.0"	"Group enriched"	"Detected in some"	15	"cerebellum: 8.0;olfactory bulb: 2.6"	"Low region specificity"	"Detected in many"			HPA042786	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 28: Placenta - Pregnancy"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA042786: AB_10795760"	"unprognostic (8.20e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.15e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.55e-2)"	"unprognostic (5.82e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.24e-3)"	0.6	0.1	0.5	0.1	0.5	0.0	0.3	1.0	0.9	0.2	0.3	0.3	0.3	0.1	0.0	0.3	0.4	0.7	0.6	0.4	0.5	0.4	0.1	1.3	0.2	0.5	0.5	0.1	0.3	0.4	0.2	3.3	0.6	0.1	0.3	0.4	0.4	0.6	0.5	0.5	1.1	0.2	0.5	0.2	0.3	0.6	0.7	0.1	0.2	0.3	0.1	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.5	1.0	0.9	0.4	0.5	0.5	0.5	0.6	0.5	0.7	0.6	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.1	0.0	1.2	0.1	0.0	0.0	6.6	0.1	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0
C20orf27	FLJ20550	ENSG00000101220	"Chromosome 20 open reading frame 27"	Q9GZN8	20	3753508-3767781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 178.7;Hofbauer cells: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 144.6;intermediate monocyte: 249.1;myeloid DC: 199.4;non-classical monocyte: 235.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 199.4;monocytes: 249.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047483	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		140000	"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA047483: AB_2680064"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.99e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (1.69e-5)"	"unprognostic (8.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	55.8	24.0	48.8	20.4	125.4	103.6	45.2	44.7	70.9	39.5	33.7	117.3	17.0	42.5	8.7	29.6	51.8	25.5	27.9	45.6	63.3	25.7	24.7	20.8	24.5	52.9	59.3	66.3	23.6	9.4	23.3	8.9	67.5	24.2	7.8	4.9	15.7	10.9	22.4	26.9	33.9	14.1	43.8	45.5	86.8	22.7	59.5	11.0	23.4	11.5	9.8	73.9	26.3	40.7	172.9	177.7	24.4	106.1	49.5	28.1	42.7	45.5	25.1	70.4	50.3	120.5	61.6	111.1	41.4	48.2	94.7	140.9	65.7	101.9	24.9	26.1	138.3	63.2	35.9	212.6	36.2	88.2	24.7	41.0	41.8	93.3	46.1	24.2	48.2	72.9	114.6	59.8	37.3	240.2	107.6	186.3	114.9	107.0	248.4	86.6	67.9	123.7	43.9	62.0	121.8	56.6	41.2	155.3	85.1	10.4	36.9	96.8	35.9	104.8	73.8	171.6	129.6	50.5	93.2	80.7	31.5	161.2	53.9	1.3	144.6	2.3	28.7	249.1	42.1	38.7	33.6	38.6	199.4	36.2	37.6	37.5	5.4	32.5	235.3	38.7	34.2	87.4	48.8	125.4	44.7	70.9	45.6	63.3	52.9	59.3	67.5	43.8	59.5	40.7	54.0	0.0	3.3	3.3	26.5	24.2	23.0	26.8	35.3	9.7	28.2	45.7	3.7	8.6	7.4	11.0	2.1	17.5	15.8	10.2	29.4	32.6	21.8	13.8	178.7	28.7	15.7	99.1	6.0	30.0	49.2	27.1	14.3	7.5	22.9	45.0	19.6	17.9	142.9	1.7	9.5	15.9	16.2	119.0	53.1	15.3	32.6	92.2	37.4	5.6	97.4	24.6	15.5	3.5	2.1	34.7	14.6	24.8	20.2	46.6	19.3	32.4	2.7	13.6	65.7	17.1	98.8	27.3	39.1	34.8	32.8	7.3	24.1	69.7	33.0	22.7
C4orf46	"LOC201725, RCDG1"	ENSG00000205208	"Chromosome 4 open reading frame 46"	Q504U0	4	158666675-158672255	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047287, HPA052670"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA047287: AB_2680011, HPA052670: "	"unprognostic (2.71e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.27e-5)"	"unprognostic (1.60e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.06e-3)"	2.5	2.4	1.9	4.1	2.4	14.5	2.9	2.4	2.8	2.7	1.3	3.3	3.0	5.0	2.1	2.9	2.4	2.8	3.7	1.9	1.9	1.9	1.5	2.6	6.0	2.3	2.2	4.2	2.4	1.7	1.1	4.5	2.3	2.4	4.2	9.4	1.7	2.2	2.1	2.9	2.8	4.0	2.1	3.2	2.6	12.8	2.0	10.2	4.3	6.0	5.4	2.6	2.0	2.9	16.6	9.9	23.7	35.0	10.3	10.6	11.8	27.5	18.9	31.5	27.4	8.9	14.6	29.3	4.3	14.0	11.6	9.0	20.6	14.2	40.3	40.5	10.7	44.5	10.4	11.9	3.5	33.9	23.7	6.2	5.0	25.6	11.2	10.4	22.7	29.3	19.7	72.1	43.2	8.9	65.8	29.7	16.3	10.6	13.0	47.0	13.5	13.0	9.6	8.1	12.8	38.5	12.1	10.9	10.1	11.9	9.3	26.9	12.0	48.0	22.1	27.0	23.2	16.5	22.3	37.0	12.1	29.8	18.9	2.4	1.9	1.7	1.9	1.6	1.4	1.7	1.5	1.9	2.1	1.4	2.1	2.3	0.6	3.4	2.2	1.8	1.8	1.3	1.9	2.4	2.4	2.8	1.9	1.9	2.3	2.2	2.3	2.1	2.0	2.9	10.3	3.2	1.8	1.3	7.8	24.1	5.1	5.8	14.2	7.5	6.5	5.2	7.6	1.5	3.2	1.8	4.2	9.8	8.2	2.9	7.9	3.6	0.8	7.6	10.8	6.9	7.7	11.2	1.2	3.0	11.8	14.5	4.6	15.0	7.0	8.7	5.0	2.0	9.7	10.1	1.8	5.1	6.1	10.3	25.8	1.8	4.7	7.6	19.6	0.0	18.9	6.5	5.2	1.0	6.2	3.8	3.1	6.0	18.1	6.6	3.2	2.8	3.3	28.2	6.6	7.7	10.6	49.1	15.2	30.1	15.6	3.3	9.6	2.5	5.8	7.2
CACNA1H	Cav3.2	ENSG00000196557	"Calcium voltage-gated channel subunit alpha1 H"	O95180	16	1153106-1221771	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 107.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 22.8;Late spermatids: 15.5;Peritubular cells: 25.9;Sertoli cells: 26.3;Smooth muscle cells: 22.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 17.9;AN3-CA: 25.4;MCF7: 48.3;OE19: 16.0;T-47d: 13.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039125	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Vesicles"		"HPA039125: AB_10795578"	"unprognostic (1.66e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (3.12e-5)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (1.93e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.55e-2)"	13.6	28.0	13.6	5.2	24.5	0.1	7.6	2.1	12.1	26.3	0.0	107.7	6.4	57.3	2.6	7.1	37.8	10.3	9.3	11.0	8.1	14.1	13.4	11.8	0.7	3.0	3.8	80.1	4.6	3.6	45.9	2.1	2.9	28.0	2.4	1.8	1.9	27.5	6.2	19.4	22.3	15.6	3.7	0.7	27.5	19.4	13.5	0.5	11.0	3.0	0.2	57.0	17.1	0.2	0.0	17.9	3.0	25.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	10.4	0.1	0.0	11.0	3.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	0.0	3.0	4.9	0.0	0.0	48.3	0.0	0.0	9.4	16.0	3.6	0.0	0.0	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.9	1.0	13.9	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	24.5	2.1	12.1	11.0	8.1	3.0	3.8	2.9	3.7	13.5	0.2	1.3	0.0	0.0	1.0	0.0	1.5	0.1	0.0	0.0	22.8	0.3	0.1	2.7	4.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	3.7	7.2	0.2	5.3	2.2	10.8	0.0	2.6	0.0	0.1	1.3	0.5	0.2	4.5	0.0	0.4	7.8	0.1	0.0	0.7	1.0	2.0	0.0	0.3	15.5	8.4	0.2	0.0	0.0	0.0	0.8	0.0	0.5	0.1	0.4	0.4	25.9	0.0	7.2	0.0	0.7	0.0	1.5	26.3	0.4	22.4	3.4	5.1	0.0	3.4	0.0	0.2	0.3	0.1	1.3
CALD1	"CDM, H-CAD, L-CAD"	ENSG00000122786	"Caldesmon 1"	Q05682	7	134744252-134970729	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 916.1"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1190.3;Leydig cells: 1745.0;Peritubular cells: 2005.6;Sertoli cells: 2294.3;Smooth muscle cells: 2549.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 736.3;fHDF/TERT166: 1202.8;U-138 MG: 733.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000006, HPA008066, HPA017330"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		Yes	No		39000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Actin filaments"		"CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917"	"unprognostic (2.16e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (6.52e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	225.8	119.2	27.3	164.9	35.0	1.3	161.1	28.1	47.6	241.6	37.2	916.1	80.3	523.3	150.7	275.6	304.4	203.2	115.0	26.9	29.1	134.7	224.4	155.5	75.4	32.3	30.4	326.2	52.5	32.7	53.3	430.0	30.9	348.9	149.8	13.1	70.3	781.7	46.5	76.0	233.1	688.4	27.9	129.2	324.2	52.7	33.4	28.5	114.1	75.2	34.4	505.3	208.0	28.8	115.9	75.3	163.3	146.1	572.7	464.8	161.6	661.6	736.3	227.2	246.6	138.3	3.5	0.7	153.3	1202.8	148.1	26.9	106.0	202.3	308.4	1.5	38.9	4.0	87.8	94.7	375.6	1.5	0.8	360.9	153.6	252.8	147.4	343.6	193.0	0.0	0.6	1.6	338.7	0.3	0.6	3.2	197.7	0.1	25.6	1.4	146.6	2.3	46.9	32.2	29.0	72.1	235.3	31.7	90.0	491.0	7.2	1.4	508.5	733.2	130.0	143.8	230.3	0.9	1.1	1.3	259.0	0.8	573.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.9	0.2	0.0	0.0	0.0	2.9	27.3	35.0	28.1	47.6	26.9	29.1	32.3	30.4	30.9	27.9	33.4	28.8	400.6	22.4	17.6	43.1	7.3	420.4	379.6	218.8	164.4	172.0	115.5	466.1	456.5	228.8	33.5	44.1	6.2	202.7	5.0	0.3	23.5	392.6	61.0	89.4	1190.3	432.9	3.6	16.0	95.4	23.6	903.9	886.9	16.3	206.2	5.1	251.0	422.0	638.4	43.5	92.5	58.3	1.2	28.5	21.0	112.8	83.6	1745.0	38.8	336.2	94.6	8.4	140.6	6.2	98.5	158.8	146.0	0.2	2005.6	4.2	456.9	0.1	332.1	11.3	21.2	2294.3	326.1	2549.3	12.1	12.2	70.1	171.8	276.6	27.5	414.1	0.8	36.7
CBS	HIP4	ENSG00000160200	"Cystathionine beta-synthase"	P35520	21	43053191-43076943	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Allosteric enzyme, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 174.9;pancreas: 99.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.3;Cardiomyocytes: 4.9;Hepatocytes: 3.6;Ionocytes: 2.0;Melanocytes: 5.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	51	"neutrophil: 5.0"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 177.5;HAP1: 172.8;HHSteC: 224.1;MCF7: 197.7;RPMI-8226: 197.4"	"Low region specificity"	"Detected in all"							HPA001223	Supported		Approved	Nucleoli,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	Nucleoli	"HPA001223: AB_1846112"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.68e-4)"	"unprognostic (3.62e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	6.6	2.8	42.5	1.0	39.5	0.2	3.4	58.5	55.3	12.3	29.3	4.8	3.0	4.5	0.0	2.0	5.8	1.2	7.7	41.4	40.3	3.8	174.9	10.2	2.7	42.5	44.6	30.3	99.0	2.5	8.8	1.2	42.7	12.7	0.9	2.5	19.9	1.1	1.1	2.3	7.0	2.3	38.4	1.7	16.5	2.0	48.1	0.7	17.4	1.2	1.4	11.6	6.2	45.4	30.0	17.0	31.3	113.4	48.9	31.5	177.5	39.5	10.0	15.6	15.4	53.7	1.5	0.1	19.2	67.2	0.3	1.5	172.8	13.2	3.1	0.0	20.5	12.3	73.1	63.8	224.1	7.9	19.1	21.7	1.4	16.0	16.4	13.2	38.6	85.6	138.7	118.1	11.1	197.7	16.1	0.1	20.3	65.7	29.4	0.0	0.2	197.4	0.5	15.5	57.8	85.1	78.5	5.4	44.4	18.4	27.0	91.2	5.4	0.8	42.5	0.3	4.8	34.8	30.2	41.2	19.0	11.0	53.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	42.5	39.5	58.5	55.3	41.4	40.3	42.5	44.6	42.7	38.4	48.1	45.4	0.2	0.0	0.5	0.7	0.0	0.4	0.0	2.3	0.0	0.2	0.5	0.1	4.9	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.2	0.8	1.2	0.0	0.1	0.0	0.1	0.0	3.6	0.2	0.0	0.0	0.0	2.0	0.0	1.4	0.0	0.9	0.2	5.4	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.2	1.7	0.1	0.1	0.1	0.0	0.3	0.6	0.0	0.6	0.0	1.0	0.1	0.1	0.0	0.2	0.1
CBX6		ENSG00000183741	"Chromobox 6"	O95503	22	38861422-38872249	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048653	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Mitochondria"		"HPA048653: AB_2680479"	"unprognostic (1.65e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.90e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.97e-2)"	"prognostic favorable (2.46e-6)"	"unprognostic (2.75e-1)"	"unprognostic (1.27e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.26e-2)"	16.3	22.4	67.1	16.5	53.6	28.3	12.3	9.9	83.6	21.0	0.0	39.3	6.5	34.0	14.5	13.3	27.0	11.3	17.7	88.2	10.1	18.7	6.3	17.2	14.2	16.6	14.0	24.4	17.1	49.5	27.5	4.3	10.0	22.0	7.2	8.5	13.7	25.9	8.9	8.2	17.1	26.1	5.5	15.9	20.5	4.3	21.8	12.5	19.0	6.7	15.3	31.0	11.9	30.8	40.3	41.7	9.1	31.3	68.5	38.2	2.8	42.8	24.5	21.8	20.3	21.1	36.5	65.3	31.2	29.5	15.3	46.8	17.0	18.3	11.9	63.1	53.0	6.7	18.5	7.4	37.2	32.6	31.1	57.0	9.1	49.7	23.5	30.1	24.9	18.4	14.9	32.2	15.1	45.5	20.2	9.5	8.1	23.1	31.9	29.9	30.5	25.9	31.3	37.4	44.3	9.8	27.5	36.4	23.7	3.2	25.0	19.3	32.7	18.9	57.9	33.2	29.6	32.9	34.1	23.5	37.0	33.6	40.1	2.2	9.1	4.7	18.6	12.4	15.3	6.7	12.6	13.1	9.1	7.7	10.3	12.6	4.0	9.1	12.5	46.1	8.0	20.0	67.1	53.6	9.9	83.6	88.2	10.1	16.6	14.0	10.0	5.5	21.8	30.8	30.5	16.0	14.7	9.8	25.1	33.9	47.4	18.4	16.5	100.4	42.6	31.6	27.5	52.9	22.1	73.5	39.6	12.4	83.0	9.6	35.2	102.6	1.1	6.9	46.0	36.4	122.7	17.7	28.9	50.1	2.0	48.5	3.1	17.5	6.3	18.7	46.8	32.4	19.8	124.5	27.3	3.2	30.5	40.8	121.1	2.9	74.3	33.2	81.8	14.0	91.1	91.2	57.7	15.1	23.3	46.9	9.1	80.9	24.5	58.9	0.1	51.7	18.0	59.4	72.3	54.4	85.1	4.2	6.8	10.4	34.0	4.7	35.8	40.9	0.9	82.6
CCDC102B	"ACY1L, AN, C18orf14, FLJ23594, HsT1731"	ENSG00000150636	"Coiled-coil domain containing 102B"	Q68D86	18	68715209-69055189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 28.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 72.8;Early spermatids: 138.2;Excitatory neurons: 80.8;Late spermatids: 83.3;Oligodendrocytes: 90.1;Sertoli cells: 78.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 9.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 14.2;BJ hTERT+: 29.0;fHDF/TERT166: 26.2;HSkMC: 15.4;Karpas-707: 10.2"									"HPA040623, HPA048194"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	Cytosol	"HPA040623: AB_10805715, HPA048194: AB_2680309"	"unprognostic (3.92e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.50e-3)"	"unprognostic (7.13e-2)"	"unprognostic (3.50e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.59e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (2.90e-6)"	"unprognostic (2.21e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.00e-3)"	"unprognostic (3.13e-3)"	7.1	2.9	1.5	3.7	1.8	0.7	2.7	0.6	3.5	2.8	0.0	3.8	1.5	1.7	1.1	3.4	1.8	13.6	3.2	1.3	2.0	4.3	1.7	14.3	8.6	2.6	1.6	0.9	1.5	2.6	0.9	28.4	3.1	1.2	4.5	2.2	1.3	1.3	0.6	1.0	2.6	3.7	2.0	2.2	3.6	2.0	2.3	1.5	5.2	1.1	2.0	10.6	1.5	3.6	0.0	0.0	4.0	0.3	3.6	14.2	0.2	0.8	29.0	0.3	0.5	0.1	0.4	0.1	0.6	26.2	0.5	0.4	0.1	0.2	0.4	1.2	0.4	0.8	0.0	1.3	7.0	0.1	0.4	15.4	0.6	0.4	3.5	0.6	0.2	2.0	0.0	10.2	2.4	0.0	0.6	0.3	0.8	0.2	0.5	1.3	0.2	0.5	0.1	0.0	1.7	1.5	0.1	0.0	0.1	1.6	0.3	1.3	4.0	0.6	0.2	0.2	0.3	4.4	0.3	0.8	2.1	1.7	2.5	0.0	0.1	0.3	1.0	0.2	0.9	0.5	0.6	0.8	0.2	0.6	1.8	1.1	0.0	1.0	0.2	9.1	0.3	0.3	1.5	1.8	0.6	3.5	1.3	2.0	2.6	1.6	3.1	2.0	2.3	3.6	11.5	0.0	2.2	72.8	4.4	0.6	0.8	0.8	0.6	6.4	2.7	2.9	10.0	0.0	2.1	3.7	6.2	0.8	12.4	0.4	5.9	0.7	138.2	2.9	6.7	6.8	0.0	3.0	80.8	1.8	0.6	15.3	0.0	1.1	2.5	5.7	8.6	0.8	3.2	6.7	33.6	0.2	0.0	1.9	1.8	83.3	32.3	3.3	0.0	44.0	2.1	11.9	7.2	36.2	90.1	0.2	2.6	9.1	2.2	0.4	0.3	5.3	1.5	13.4	78.9	3.8	37.3	1.9	5.7	0.7	0.6	0.3	3.8	3.7	0.4	0.6
CCDC3	DKFZp761F241	ENSG00000151468	"Coiled-coil domain containing 3"	Q9BQI4	10	12896625-13099652	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 132.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 50.1;Excitatory neurons: 100.2;Inhibitory neurons: 41.3;Peritubular cells: 60.5;Smooth muscle cells: 119.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 10.4;HAP1: 19.1;HDLM-2: 32.4;hTERT-RPE1: 14.8;U-2 OS: 20.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 20.8"	HPA062425			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA062425: AB_2684759"	"unprognostic (2.26e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.54e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.88e-2)"	91.8	11.0	32.9	5.9	35.2	0.1	37.2	17.9	40.2	48.1	17.8	10.1	6.6	25.0	41.3	60.4	56.7	70.7	21.9	37.1	20.1	19.0	20.6	21.0	12.4	18.6	19.1	86.2	6.5	4.9	10.2	22.2	19.6	35.2	7.4	1.6	7.1	22.0	30.7	132.2	14.3	24.2	19.8	24.7	13.1	11.6	21.7	42.0	20.0	13.3	4.2	23.2	27.4	30.5	0.0	0.2	1.7	9.4	0.0	0.0	0.1	0.0	0.0	0.7	0.0	2.5	0.0	0.0	0.7	0.0	10.4	1.9	19.1	3.6	0.6	32.4	8.1	0.0	0.2	0.0	0.7	0.0	0.0	2.3	2.3	0.4	0.0	14.8	0.9	0.8	0.0	0.2	1.0	0.2	0.0	5.4	1.5	0.0	0.1	0.0	4.1	0.3	0.0	0.0	3.6	1.6	7.0	1.0	0.0	4.4	0.0	0.0	0.0	0.0	20.0	1.2	0.3	0.0	0.0	0.0	0.1	0.0	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	32.9	35.2	17.9	40.2	37.1	20.1	18.6	19.1	19.6	19.8	21.7	30.5	12.4	0.0	0.0	10.1	0.1	50.1	6.4	26.3	13.6	1.2	0.9	4.7	7.9	1.5	2.1	0.0	0.0	0.3	1.3	0.1	1.9	0.0	0.2	0.1	0.7	27.2	0.0	0.0	100.2	0.0	0.2	16.0	0.5	0.4	0.0	16.4	8.2	0.2	0.3	0.0	41.3	0.1	0.0	0.0	6.4	1.5	22.4	0.6	14.2	3.7	0.0	0.3	0.0	22.6	23.2	0.1	2.5	60.5	0.0	3.0	0.3	0.4	1.1	2.1	32.9	7.9	119.4	0.0	5.7	2.1	37.2	0.3	1.0	6.0	0.3	1.3
CCER2		ENSG00000262484	"Coiled-coil glutamate rich protein 2"	I3L3R5	19	38908980-38912158	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"Melanocytes: 617.2"	"Group enriched"	"Detected in many"	5	"glioma: 5.1;testis cancer: 1.9;urothelial cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.4;THP-1: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069716	Uncertain				"Secreted - unknown location"	NA	NA		8800		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA069716: AB_2686183"	"unprognostic (6.58e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.01e-9)"	"unprognostic (1.75e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.32e-4)"	0.5	0.6	2.2	0.2	2.4	0.7	0.8	2.3	3.4	1.2	1.8	0.9	0.3	0.7	0.3	1.2	1.1	0.1	0.9	2.3	2.2	1.8	2.9	0.5	0.3	2.9	2.2	0.7	0.5	0.2	2.5	0.1	2.4	1.4	0.1	1.0	0.9	0.2	2.3	4.2	0.9	0.1	2.1	1.1	0.6	4.9	2.2	0.4	1.2	0.0	0.1	0.9	0.8	2.4	0.1	1.4	0.3	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.6	0.5	0.1	0.2	0.1	0.0	0.0	0.0	0.9	0.2	0.9	0.0	0.9	0.2	0.4	0.3	0.0	0.2	0.7	0.1	0.2	0.1	0.6	0.4	0.2	0.1	0.1	0.0	0.1	1.0	1.4	0.0	0.0	0.7	0.0	0.0	0.6	0.5	0.2	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.4	2.3	3.4	2.3	2.2	2.9	2.2	2.4	2.1	2.2	2.4	0.1	3.2	0.0	3.9	0.1	76.9	0.1	0.1	0.0	2.5	0.4	0.5	0.4	1.5	0.1	1.8	4.2	0.4	0.4	0.3	0.0	0.0	1.4	0.3	0.2	0.6	1.2	0.4	2.3	0.0	0.1	0.8	0.0	0.5	0.0	0.3	0.0	0.6	0.2	0.0	3.3	0.2	0.0	0.3	7.2	4.9	0.3	0.2	617.2	0.0	0.0	1.3	0.0	3.5	2.2	0.1	0.2	0.0	0.0	0.1	0.2	0.2	0.4	3.8	0.0	0.4	0.7	1.1	2.1	0.0	3.0	0.3	0.4	0.2	0.6	0.1
CCL1	"I-309, P500, SCYA1, SISe, TCA3"	ENSG00000108702	"C-C motif chemokine ligand 1"	P22362	17	34360328-34363233	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 2.2;lymphoid tissue: 1.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.2;granulocytes: 8.9;Late spermatids: 1.6;T-cells: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	38	"HMC-1: 702.6"									HPA049861	Uncertain				"Secreted to blood"	NA	NA	84400		"Cluster 25: Monocytes - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA049861: AB_2680919"		"unprognostic (6.52e-2)"				"unprognostic (4.81e-3)"		"unprognostic (5.84e-2)"	"unprognostic (5.01e-1)"	"unprognostic (6.04e-1)"				"unprognostic (2.71e-1)"	"unprognostic (1.37e-1)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	702.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.4	0.8	0.5	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0
CCL19	"CKb11, ELC, exodus-3, MIP-3b, SCYA19"	ENSG00000172724	"C-C motif chemokine ligand 19"	Q99731	9	34689570-34691276	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 632.5"	"Group enriched"	"Detected in some"	12	"Basal keratinocytes: 74.7;Basal respiratory cells: 56.9;Fibroblasts: 59.6;Langerhans cells: 111.9;Melanocytes: 92.5;monocytes: 107.1;Smooth muscle cells: 150.9;Suprabasal keratinocytes: 54.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 118.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;HDLM-2: 3.2;TIME: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067758	Enhanced				"Secreted to blood"	NA	NA	195000	63000	"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA067758: AB_2685897"	"prognostic favorable (2.88e-5)"	"prognostic favorable (9.91e-6)"	"unprognostic (8.25e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.36e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (8.63e-7)"	"unprognostic (7.98e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.87e-1)"	133.1	3.4	3.0	609.4	3.6	0.0	43.6	2.6	8.2	27.7	5.5	34.3	7.9	5.4	3.8	55.6	14.1	69.3	40.8	2.5	2.8	47.7	49.1	48.7	632.5	4.5	3.8	2.4	4.8	0.3	7.9	0.0	4.2	34.3	70.2	0.1	49.5	2.0	0.4	42.8	146.4	32.5	2.9	59.6	68.8	4.0	3.4	526.3	51.6	2.2	603.0	108.4	9.1	2.9	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.6	2.6	8.2	2.5	2.8	4.5	3.8	4.2	2.9	3.4	2.9	3.3	0.0	0.0	0.0	0.8	74.7	0.0	56.9	0.0	0.0	0.4	1.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	7.3	0.0	0.0	0.0	0.2	0.0	59.6	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	1.3	111.9	0.2	0.0	3.7	92.5	1.0	107.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	150.9	0.7	0.6	0.9	54.0	0.0	6.6	0.0	0.0	0.5
CCL2	"GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF"	ENSG00000108691	"C-C motif chemokine ligand 2"	P13500	17	34255218-34257203	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 756.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 1152.5;Ductal cells: 3382.2;Exocrine glandular cells: 919.2;Prostatic glandular cells: 889.0;Skeletal myocytes: 994.7;Smooth muscle cells: 1507.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 7.5;eosinophil: 3.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.0;monocytes: 7.5"	"Group enriched"	"Detected in many"	4	"BJ hTERT+: 1902.2;HMC-1: 2427.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"midbrain: 9.9;spinal cord: 39.4"	"CAB013676, HPA019163"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	323000		"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	Vesicles	"CAB013676: , HPA019163: AB_1846179"	"unprognostic (6.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.37e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.33e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.92e-2)"	390.9	129.8	15.6	167.2	15.1	96.5	76.8	14.7	26.8	20.4	24.4	169.5	41.2	30.2	15.0	47.1	85.6	256.5	305.8	16.0	21.1	229.5	161.1	405.1	78.4	32.7	16.5	19.3	141.6	34.6	70.5	39.1	21.9	153.1	103.5	11.5	47.0	45.4	19.6	40.3	80.3	150.7	21.4	73.2	121.2	12.1	43.3	142.7	84.4	47.0	16.6	756.1	36.3	25.3	0.1	15.3	40.4	0.0	110.7	94.5	0.3	116.6	1902.2	243.3	516.8	7.1	0.2	0.3	90.4	27.6	3.8	64.0	4.3	0.1	122.9	0.6	0.9	0.2	13.5	0.0	3.5	0.4	2427.9	105.9	0.0	50.6	2.9	162.6	112.4	0.0	6.5	20.2	0.0	0.0	0.7	19.6	5.8	0.0	0.4	0.6	3.3	20.9	354.7	0.0	0.1	8.1	0.3	6.0	3.3	108.4	4.6	2.5	6.4	129.0	5.7	3.6	0.7	1.2	0.5	0.1	75.7	37.6	84.3	0.0	7.5	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	1.6	15.6	15.1	14.7	26.8	16.0	21.1	32.7	16.5	21.9	21.4	43.3	25.3	218.3	182.7	126.5	2.0	3.6	568.6	866.2	595.3	1152.5	0.1	23.5	50.9	29.5	92.9	120.7	138.0	0.0	2.7	2.2	0.0	0.0	3382.2	0.0	8.4	37.8	577.2	0.0	0.0	0.7	919.2	3.6	840.5	5.6	11.4	353.0	0.1	50.3	0.4	439.1	0.0	0.1	0.0	6.1	8.9	408.5	0.4	12.2	593.1	213.5	8.4	37.8	13.8	0.0	0.0	0.1	781.2	0.0	1.5	2.9	889.0	0.0	67.7	27.7	0.7	131.5	994.7	1507.0	0.4	0.3	13.0	222.8	4.5	44.3	1.7	0.1	40.6
CCL26	"eotaxin-3, IMAC, MIP-4a, MIP-4alpha, SCYA26, TSC-1"	ENSG00000006606	"C-C motif chemokine ligand 26"	Q9Y258	7	75769533-75789896	"Human disease related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 20.4;pituitary gland: 16.4"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 7.1;Intestinal goblet cells: 7.7;Leydig cells: 16.8;Sertoli cells: 13.1;Smooth muscle cells: 20.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 14.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 11.2;hTEC/SVTERT24-B: 14.8;PC-3: 51.1;U-2 OS: 13.7"					"Region enriched"	"Detected in single"	16	"spinal cord: 1.7"						"Secreted to blood"	NA	NA	117000		"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (1.14e-1)"	"unprognostic (4.17e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.02e-1)"	"unprognostic (8.71e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.05e-11)"	"unprognostic (2.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.73e-1)"	"unprognostic (6.29e-3)"	2.7	3.1	1.5	0.6	1.7	0.0	1.9	1.6	3.7	3.1	10.1	0.8	0.3	1.2	1.9	1.8	2.7	1.4	3.9	1.5	1.5	1.7	0.4	1.9	3.4	1.7	1.5	20.4	0.4	3.2	16.4	0.4	1.6	1.0	7.2	2.5	0.7	0.3	0.4	1.9	1.0	1.4	1.7	0.4	0.9	1.2	1.9	0.3	0.6	0.1	0.2	3.6	4.3	1.5	0.2	11.2	0.0	0.0	1.3	1.7	0.0	0.6	5.2	4.3	7.3	0.3	3.2	0.0	7.2	3.5	0.3	2.1	0.0	0.0	5.8	0.0	0.5	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.6	14.8	0.1	2.3	0.0	0.0	5.2	0.0	2.2	0.7	0.0	0.0	8.4	0.5	51.1	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.6	0.1	0.0	2.2	0.0	0.0	0.3	8.2	13.7	4.2	2.7	0.0	0.0	0.0	2.5	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.6	3.7	1.5	1.5	1.7	1.5	1.6	1.7	1.9	1.5	0.5	0.0	0.0	0.0	0.0	1.1	3.5	1.8	0.0	0.5	0.1	0.1	0.4	0.0	0.7	0.0	4.2	0.0	0.0	2.3	0.0	0.0	0.5	0.1	1.1	0.6	0.0	0.0	0.1	0.0	0.0	7.1	0.5	0.1	0.0	0.1	1.1	0.0	0.0	0.0	0.1	7.7	0.0	3.2	1.4	0.9	16.8	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.1	4.9	0.0	0.6	0.1	0.0	0.2	2.2	13.1	0.9	20.2	0.1	0.4	0.6	1.8	0.0	0.2	2.5	1.6	2.6
CCL8	"HC14, MCP-2, SCYA8"	ENSG00000108700	"C-C motif chemokine ligand 8"	P80075	17	34319435-34321402	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Smooth muscle cells: 104.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	6	"classical monocyte: 3.4"	"Lineage enriched"	"Detected in single"	6	"monocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.1;BJ hTERT+ SV40 Large T+ RasG12V: 1.0;EFO-21: 2.1;HSkMC: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	32000		"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (7.51e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (1.05e-7)"	"unprognostic (1.39e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.41e-2)"	17.5	4.7	0.4	5.1	0.4	1.8	6.2	0.4	0.9	1.5	0.5	18.1	14.1	7.3	1.9	3.5	1.3	8.8	2.7	0.4	0.4	7.7	3.2	7.1	3.9	0.6	0.4	1.4	1.1	4.8	0.5	7.1	0.6	2.2	16.4	0.0	1.9	1.3	0.4	0.5	17.0	9.3	1.8	2.9	2.9	3.1	1.1	12.5	2.3	7.0	0.5	13.7	0.3	0.6	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.4	0.9	0.4	0.4	0.6	0.4	0.6	1.8	1.1	0.6	21.5	0.0	0.0	0.0	0.1	4.2	0.3	0.5	0.0	0.0	0.9	1.1	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	10.5	0.9	7.5	9.6	0.0	0.0	0.0	2.0	0.0	16.4	0.0	1.6	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	3.5	18.6	2.2	0.0	12.7	5.4	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.3	104.3	0.0	0.0	0.0	5.4	0.1	0.8	0.7	0.0	0.1
CDS2		ENSG00000101290	"CDP-diacylglycerol synthase 2"	O95674	20	5126879-5197887	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 160.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019698	Approved		Approved	"Endoplasmic reticulum"		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"		"HPA019698: AB_1846464"	"unprognostic (4.59e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.53e-9)"	"unprognostic (8.89e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.44e-1)"	14.3	13.8	30.0	9.1	32.4	13.0	10.6	22.9	28.6	10.5	2.1	13.0	5.2	11.5	8.2	9.2	10.7	8.9	24.8	30.3	34.6	14.6	12.8	13.4	8.8	27.2	36.1	9.3	6.5	17.3	14.4	9.9	37.4	13.4	10.7	31.5	7.6	16.7	9.7	5.9	10.1	18.0	18.8	9.4	10.6	11.7	42.5	13.3	12.5	12.7	12.6	10.8	7.7	21.7	25.4	27.4	28.1	13.7	16.4	14.9	11.7	13.9	28.5	22.7	32.2	17.8	23.8	19.8	6.8	26.4	41.1	36.5	23.1	29.5	23.9	18.4	6.8	23.5	7.9	27.0	15.3	13.9	8.1	12.8	16.1	29.8	11.5	20.3	30.7	26.5	11.6	23.9	21.4	4.6	30.1	5.7	12.1	12.4	7.6	25.0	22.5	9.4	14.5	25.0	11.4	15.5	15.3	26.2	34.6	33.8	16.4	6.7	25.4	15.6	11.6	14.1	14.0	20.8	160.2	15.9	7.4	11.7	8.1	55.3	17.3	21.2	15.2	14.7	16.6	12.1	15.6	17.3	13.8	11.4	12.0	11.8	49.7	12.0	13.4	10.9	19.5	23.7	30.0	32.4	22.9	28.6	30.3	34.6	27.2	36.1	37.4	18.8	42.5	21.7	43.3	19.2	15.7	36.9	36.2	17.6	30.3	33.0	14.2	60.1	17.7	14.4	55.2	18.6	19.6	33.1	95.9	22.2	29.6	15.3	5.9	33.1	71.6	20.1	14.0	42.3	10.7	14.9	39.3	22.7	40.0	17.9	15.3	21.5	21.0	20.5	27.8	21.7	60.8	43.7	52.0	12.4	12.2	36.6	26.1	33.3	16.1	31.5	32.0	21.5	38.7	21.9	28.8	28.6	56.1	31.7	20.3	24.8	48.9	23.1	15.7	13.2	23.5	65.5	19.7	19.7	52.1	26.8	34.7	14.8	15.3	16.3	36.7	13.0	13.1	29.1
CLEC11A	"CLECSF3, LSLCL, P47, SCGF"	ENSG00000105472	"C-type lectin domain containing 11A"	Q9Y240	19	50723364-50725718	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 132.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 119.3;Fibroblasts: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"HEL: 363.0;HMC-1: 637.3;NB-4: 901.1;THP-1: 694.7;U-937: 358.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042690	Approved		Approved	Centrosome	"Secreted in other tissues"	NA	NA		1300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Centrosome		"HPA042690: AB_10795511"	"unprognostic (9.33e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (6.91e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (6.09e-2)"	"unprognostic (8.66e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.57e-2)"	17.5	17.5	5.0	7.0	5.6	132.6	14.1	7.9	9.1	44.4	2.9	12.0	4.8	31.9	1.6	8.4	37.5	6.2	16.3	4.4	7.2	21.1	12.1	15.0	2.7	10.2	7.9	31.5	7.5	2.4	22.3	5.5	8.1	22.5	1.9	0.7	6.9	4.8	4.4	16.8	9.7	8.1	7.2	14.0	8.0	9.1	6.2	2.6	12.8	1.0	0.8	19.2	28.2	6.0	2.6	3.5	0.0	2.9	33.7	45.3	79.2	139.3	37.9	15.6	15.7	0.1	0.0	0.4	1.7	70.2	0.8	1.6	0.4	0.2	10.7	0.6	22.9	363.0	0.1	0.0	21.3	0.2	637.3	33.7	0.2	1.9	2.3	0.1	17.9	16.1	4.1	2.2	29.0	2.6	3.1	901.1	1.6	0.3	4.6	30.7	0.2	0.2	0.8	0.4	0.0	3.8	4.2	0.0	58.1	0.0	0.9	694.7	100.3	1.1	41.6	0.7	0.7	2.1	2.2	0.5	47.3	358.7	44.2	1.4	24.3	0.4	0.9	11.5	0.1	0.6	0.3	0.2	17.7	0.4	2.0	4.5	1.6	5.7	5.6	4.8	0.2	8.2	5.0	5.6	7.9	9.1	4.4	7.2	10.2	7.9	8.1	7.2	6.2	6.0	12.4	3.2	5.4	10.4	3.9	32.0	32.2	2.9	27.3	20.5	30.8	31.9	3.4	8.6	4.0	29.5	10.4	8.6	5.0	1.7	119.3	11.0	6.5	17.0	70.7	16.9	26.5	36.4	9.0	3.1	72.4	107.2	4.1	14.1	5.7	18.9	51.4	6.3	49.4	21.9	8.3	4.5	10.2	21.5	73.3	19.9	70.8	29.6	78.2	9.4	11.2	70.4	14.4	8.0	12.9	3.1	1.7	67.4	0.9	21.4	0.5	13.7	5.0	20.7	65.7	20.2	59.2	17.2	21.7	26.3	45.9	18.3	5.8	56.7	3.5	17.8
CLEC12B		ENSG00000256660	"C-type lectin domain family 12 member B"	Q2HXU8	12	10010627-10018796	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 5.1;skin 1: 4.2;testis: 13.1"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 80.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"GAMG: 2.8;U-937: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.08e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.60e-1)"		"unprognostic (1.81e-1)"	"unprognostic (3.76e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.14e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.02e-5)"	"unprognostic (1.41e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.48e-1)"	"unprognostic (8.95e-4)"	0.4	0.0	0.0	0.5	0.1	5.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.8	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	4.2	0.1	0.1	0.0	1.6	0.1	13.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	15.4	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.8	9.5	0.3	2.2	80.0	0.0	2.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.0	0.9	0.0	0.1	0.0	0.0	0.0
CLIC4	"CLIC4L, DKFZP566G223, H1, huH1, P64H1"	ENSG00000169504	"Chloride intracellular channel 4"	Q9Y696	1	24745382-24844321	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 346.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 13.4;naive B-cell: 11.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008019, HPA060804"	Enhanced		Supported	"Plasma membrane,Centrosome"		NA	NA		5800000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Centrosome"		"HPA008019: AB_1846946, HPA060804: AB_2684370"	"unprognostic (7.35e-3)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (5.54e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.01e-2)"	"prognostic favorable (1.48e-5)"	"unprognostic (2.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.82e-3)"	154.0	58.6	51.8	97.7	70.2	32.3	88.1	61.8	82.7	165.4	39.4	136.3	32.4	201.5	84.6	119.3	103.0	106.5	197.2	50.8	66.5	256.8	72.3	114.6	51.0	73.6	68.0	46.0	49.7	29.3	14.1	120.6	67.0	112.8	66.8	53.1	49.4	152.8	30.7	33.6	54.2	280.4	62.4	43.1	80.0	34.2	88.9	59.6	47.6	53.2	56.4	156.1	73.4	91.4	219.3	25.3	222.7	176.8	299.1	645.6	116.7	561.0	571.4	253.9	304.2	48.3	114.1	129.8	320.1	799.2	77.0	76.8	155.0	151.5	635.7	33.3	64.9	50.0	60.8	88.3	417.3	17.5	6.3	299.3	256.8	363.0	365.1	417.3	427.0	76.0	40.4	138.2	739.0	38.4	34.8	28.5	212.6	50.4	101.8	83.5	247.3	51.5	260.0	58.4	38.9	101.3	144.7	68.4	453.7	228.3	60.0	116.1	601.0	452.2	168.8	199.4	230.1	75.4	111.7	108.6	333.8	151.1	140.5	0.8	5.4	2.5	0.4	4.4	0.0	13.4	0.3	0.2	5.6	11.9	0.1	0.2	1.2	0.0	4.0	1.7	0.0	3.5	51.8	70.2	61.8	82.7	50.8	66.5	73.6	68.0	67.0	62.4	88.9	91.4	178.7	16.0	30.5	24.8	50.8	61.6	50.4	79.8	37.0	3.7	49.9	33.0	172.5	21.5	35.2	14.7	10.4	71.5	2.2	18.1	41.1	39.2	44.9	20.9	103.0	177.1	9.6	40.8	1.5	43.1	211.4	120.5	21.4	53.6	40.0	10.2	88.5	34.4	39.3	1.7	4.2	22.6	20.3	28.2	100.2	27.3	28.6	52.6	129.9	75.9	50.8	13.0	4.1	41.7	196.9	54.7	10.6	87.6	171.2	114.5	0.1	346.1	16.7	26.5	46.0	87.9	162.5	44.0	29.1	29.3	52.0	177.0	8.1	46.5	2.6	49.1
COCH	"COCH-5B2, DFNA31, DFNA9"	ENSG00000100473	Cochlin	O43405	14	30874514-30895065	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"pancreas: 502.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 63.0;Horizontal cells: 84.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 71.3"	"Group enriched"	"Detected in some"	12	"memory B-cell: 38.3;naive B-cell: 17.7"	"Lineage enriched"	"Detected in many"	17	"B-cells: 38.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 95.7;Hep G2: 63.8;K-562: 129.1;NB-4: 105.5;SCLC-21H: 111.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 50.8"	HPA065086			Supported	Vesicles	"Secreted in other tissues"	NA	NA		160000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA065086: "	"unprognostic (8.36e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	3.2	3.7	7.3	2.8	71.3	4.0	3.4	1.4	20.9	17.4	19.0	3.2	0.8	0.6	2.2	0.9	6.2	2.9	1.9	5.6	8.0	5.2	0.5	0.6	11.0	2.9	7.9	0.8	502.0	3.4	10.1	1.9	3.7	48.3	2.2	12.1	3.6	73.4	1.3	15.2	2.6	1.1	6.2	2.6	1.7	5.2	12.5	1.3	1.3	5.0	7.7	2.0	23.0	1.7	0.0	35.3	3.1	0.0	0.6	0.1	21.8	0.2	0.0	6.4	17.1	20.9	1.2	0.4	1.7	0.0	1.3	0.1	22.2	0.0	10.6	0.0	95.7	18.1	7.6	63.8	0.0	1.8	7.3	1.3	0.0	0.6	0.0	0.0	0.3	39.9	129.1	5.1	1.6	0.8	9.2	105.5	11.9	0.1	3.7	26.7	0.0	0.9	1.1	3.4	111.8	30.4	2.6	0.6	0.2	12.1	0.0	48.7	0.9	0.0	0.0	0.3	0.1	5.7	15.8	11.2	0.0	0.0	4.7	0.0	0.6	0.0	0.0	0.0	0.0	38.3	0.3	0.0	0.1	17.7	0.0	0.1	0.2	0.0	0.0	0.0	2.2	1.0	7.3	71.3	1.4	20.9	5.6	8.0	2.9	7.9	3.7	6.2	12.5	1.7	2.0	0.0	0.5	3.6	13.4	19.1	2.3	0.3	0.0	2.7	7.9	1.5	0.8	2.8	0.9	0.0	4.2	6.5	1.3	0.6	1.9	0.5	1.5	2.2	0.8	3.1	17.0	7.4	14.3	63.0	14.3	22.0	1.1	1.0	1.3	1.8	5.0	5.0	3.8	84.1	24.2	0.3	6.1	5.0	25.2	2.0	1.5	2.4	19.6	7.5	2.8	14.5	0.0	6.0	16.5	3.7	4.3	6.0	10.0	3.5	0.2	11.7	0.5	4.0	0.0	2.8	9.0	22.1	20.3	0.1	13.5	6.6	3.3	0.1	0.6	1.7
COL13A1		ENSG00000197467	"Collagen type XIII alpha 1 chain"	Q5TAT6	10	69801880-69964275	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Osteogenesis"	"Developmental protein, Heparin-binding"	"Congenital myasthenic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 30.4"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 10.1;granulocytes: 20.3;Melanocytes: 5.4;Microglial cells: 6.5;NK-cells: 9.2;Smooth muscle cells: 5.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 63.6;BJ hTERT+: 61.6;hTERT-RPE1: 83.7;HUVEC TERT2: 102.2;PC-3: 93.1;TIME: 137.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA050392	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA050392: AB_2681110"	"unprognostic (2.79e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.67e-4)"	"unprognostic (3.13e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.43e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.36e-5)"	"unprognostic (2.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.93e-2)"	1.2	1.9	1.5	2.6	1.7	0.3	2.0	9.5	3.3	5.7	1.9	4.6	2.9	1.8	30.4	1.9	2.8	2.4	3.4	1.4	1.5	2.0	0.8	10.9	0.9	1.6	1.6	0.9	2.1	0.8	3.7	1.7	1.8	13.6	3.4	0.0	0.7	8.0	0.9	5.2	3.8	2.9	1.6	8.0	6.2	0.7	1.7	0.3	1.5	1.4	0.8	3.8	1.8	1.5	1.5	0.6	22.1	0.0	0.1	4.3	0.1	63.6	61.6	10.9	5.5	0.0	1.4	0.2	10.5	30.1	1.0	2.3	0.0	0.2	18.9	0.0	1.6	0.0	0.0	0.0	2.9	0.0	0.1	9.8	0.1	27.5	9.0	83.7	102.2	0.0	0.0	0.1	10.4	0.4	0.0	0.2	5.3	0.0	93.1	0.1	0.0	10.3	0.4	0.0	2.4	0.0	0.0	0.2	3.4	0.9	0.0	0.2	137.4	0.3	17.1	5.7	45.7	13.4	0.0	0.1	37.2	0.1	51.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.5	1.7	9.5	3.3	1.4	1.5	1.6	1.6	1.8	1.6	1.7	1.5	0.9	0.0	0.6	0.3	0.0	3.4	0.3	0.3	0.6	0.2	0.1	2.0	2.1	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	1.3	0.0	0.0	0.2	3.4	0.0	0.0	1.4	0.0	0.0	10.1	0.0	0.1	20.3	1.8	1.1	0.0	0.1	0.0	0.3	0.0	0.0	0.3	2.3	0.0	0.0	0.3	5.4	6.5	0.0	0.1	9.2	0.0	0.3	0.1	0.0	0.4	0.3	0.5	0.9	0.0	0.1	0.0	0.0	1.1	5.6	0.5	0.5	0.2	3.0	0.1	0.6	0.5	0.1	0.1
COL18A1	"KNO, KNO1, KS"	ENSG00000182871	"Collagen type XVIII alpha 1 chain"	P39060	21	45405165-45513720	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 561.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 479.6;Sertoli cells: 223.5;Smooth muscle cells: 268.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 139.0;EFO-21: 309.4;NTERA-2: 170.6;RPTEC TERT1: 131.6;TIME: 186.0"	"Region enriched"	"Detected in all"	6	"cerebellum: 22.1"	"Low region specificity"	"Detected in all"			"HPA030933, HPA036104"	Supported		Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		290000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"HPA030933: , HPA036104: AB_2674943"	"unprognostic (4.32e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.55e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (4.23e-3)"	"unprognostic (9.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.10e-3)"	"unprognostic (2.25e-3)"	136.4	87.6	14.5	33.9	22.3	15.9	97.1	26.4	21.8	229.4	34.4	91.2	30.4	135.6	35.4	50.1	118.3	28.9	122.2	15.7	18.1	218.2	561.9	83.2	19.8	43.7	28.6	257.3	102.3	7.9	106.5	40.7	39.1	91.0	5.5	5.4	35.8	46.8	26.5	77.8	65.7	28.5	26.6	86.8	44.5	30.0	27.0	9.0	101.1	7.4	7.2	109.8	112.2	45.4	10.5	84.0	20.6	18.0	38.6	31.9	3.3	82.0	139.0	39.1	10.5	48.8	28.9	1.5	309.4	82.8	21.6	37.9	4.6	5.0	7.4	0.7	20.0	47.9	1.4	69.6	37.3	0.7	4.4	37.6	3.3	3.8	4.5	8.5	121.3	0.5	49.6	0.3	14.4	16.7	0.8	3.2	170.6	3.2	30.7	0.7	12.6	4.0	131.6	1.3	22.8	16.3	7.6	7.8	26.6	73.0	7.5	9.9	186.0	0.5	11.4	0.4	17.7	0.4	0.8	1.5	0.1	1.7	32.7	0.8	0.1	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.2	3.2	0.0	0.0	0.1	0.0	0.1	14.5	22.3	26.4	21.8	15.7	18.1	43.7	28.6	39.1	26.6	27.0	45.4	156.9	0.0	4.1	6.5	3.9	67.7	15.5	19.0	67.7	13.5	9.3	32.1	15.7	61.5	5.0	112.2	4.2	1.9	3.4	0.1	9.8	117.5	1.5	58.3	99.5	91.2	0.0	33.0	4.9	5.8	1.1	101.1	3.6	144.2	57.8	6.6	75.0	479.6	2.4	0.0	15.8	0.1	4.1	12.1	32.5	6.7	79.9	6.5	49.8	82.4	3.2	141.9	7.2	4.0	28.0	9.9	0.0	126.0	4.6	14.0	0.0	72.9	0.7	6.3	223.5	138.2	268.6	4.1	6.0	7.9	28.6	2.5	15.3	47.5	0.4	2.6
COL27A1	"FLJ11895, KIAA1870, MGC11337"	ENSG00000196739	"Collagen type XXVII alpha 1 chain"	Q8IZC6	9	114155537-114312511	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 93.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 60.1;Extravillous trophoblasts: 75.5;Gastric mucus-secreting cells: 43.8;Hepatocytes: 43.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 29.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 54.8;Hep G2: 48.7"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in all"	19	"cerebellum: 71.0"	"HPA021884, HPA048471"	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA021884: AB_2670857, HPA048471: AB_2680407"	"unprognostic (4.45e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (7.11e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.31e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.97e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.50e-3)"	9.2	8.7	4.0	3.5	3.4	0.3	9.1	29.6	4.8	93.7	3.0	11.2	3.9	39.7	16.1	8.1	16.7	7.9	10.9	3.6	4.7	33.1	42.7	7.0	3.1	7.0	7.9	27.6	21.2	1.0	4.1	11.7	6.5	22.5	1.4	1.5	5.4	13.7	5.8	15.7	6.9	10.5	4.9	4.7	11.9	6.4	6.4	9.2	13.5	2.8	2.2	8.1	37.7	4.3	3.8	7.8	17.9	6.6	1.3	1.9	54.8	8.7	5.9	6.3	5.2	8.1	0.2	0.0	2.1	4.3	4.7	9.2	6.2	8.1	3.4	0.0	0.7	0.0	7.5	48.7	1.9	0.0	19.8	4.9	2.3	7.6	3.4	3.6	9.4	7.4	0.0	1.9	3.6	1.8	0.1	3.5	6.5	15.1	2.1	25.9	18.1	3.7	14.6	4.2	0.3	0.2	0.4	0.2	1.1	6.8	1.6	5.8	8.9	5.5	11.1	0.7	13.9	1.0	0.0	0.0	4.5	0.1	8.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	3.4	29.6	4.8	3.6	4.7	7.0	7.9	6.5	4.9	6.4	4.3	2.9	3.2	23.0	15.0	0.8	27.1	4.9	14.2	18.2	1.2	24.3	22.1	34.4	60.1	6.1	9.2	6.2	1.0	2.0	0.5	3.9	12.8	3.7	3.3	25.3	7.1	4.8	0.0	11.0	5.1	75.5	15.0	43.8	11.5	0.0	6.9	3.6	43.6	6.5	1.7	4.6	1.8	0.0	1.0	4.1	1.6	19.3	0.8	23.2	8.4	0.1	5.6	0.0	25.6	0.8	4.7	2.5	4.5	0.4	10.6	0.3	9.8	0.6	1.4	26.3	4.9	40.1	0.5	2.0	5.8	22.4	2.3	1.4	23.8	2.4	3.2
COL4A1		ENSG00000187498	"Collagen type IV alpha 1 chain"	P02462	13	110148963-110307157	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 900.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 401.4;Endometrial stromal cells: 312.2;Endothelial cells: 385.9;Extravillous trophoblasts: 672.4;Sertoli cells: 506.2;Smooth muscle cells: 415.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 501.6;EFO-21: 915.3;TIME: 331.3"	"Low region specificity"	"Detected in all"							CAB001695	Approved				"Secreted to extracellular matrix"	NA	NA		75000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 28: Placenta - Pregnancy"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB001695: "	"unprognostic (3.82e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.47e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.16e-2)"	348.4	33.6	10.8	135.9	5.2	0.4	130.4	3.7	9.0	65.7	8.9	108.5	24.8	105.3	14.8	40.8	64.1	116.8	81.9	12.6	5.2	53.4	22.1	137.0	27.7	9.1	7.0	27.0	36.0	36.3	12.8	900.3	7.5	53.6	30.4	1.8	19.0	85.6	40.1	25.2	43.4	312.7	6.8	76.3	50.1	10.7	13.7	10.7	54.7	47.0	11.1	120.8	38.2	6.9	40.0	15.2	195.9	0.3	501.6	148.9	274.9	246.2	59.5	134.0	65.3	4.2	0.8	0.1	915.3	46.2	59.7	26.8	0.0	55.8	30.3	1.3	29.5	0.2	28.2	0.0	142.8	0.0	0.4	49.7	8.9	132.8	59.4	212.8	207.7	0.1	0.3	0.2	31.1	0.1	0.1	0.8	28.1	0.2	3.6	0.4	58.6	0.1	278.8	0.0	1.4	29.8	0.1	0.4	61.0	192.4	0.1	13.9	331.3	39.9	121.4	1.0	97.4	0.3	1.8	3.9	0.4	0.7	297.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.0	10.8	5.2	3.7	9.0	12.6	5.2	9.1	7.0	7.5	6.8	13.7	6.9	401.4	41.7	8.9	5.2	1.9	14.0	9.7	8.5	2.8	1.0	3.5	16.5	41.1	10.0	0.9	23.9	0.0	49.7	0.5	0.1	1.9	22.6	0.7	19.8	312.2	385.9	0.0	0.0	10.5	0.2	672.4	211.8	1.5	48.7	1.3	215.8	134.6	1.3	27.7	0.0	18.9	0.5	0.0	4.4	19.2	2.8	38.5	4.2	30.2	36.5	0.6	2.5	0.0	1.0	0.9	0.6	0.1	109.4	0.5	6.2	0.5	26.7	2.8	0.4	506.2	142.8	415.1	1.2	5.0	0.8	15.2	45.0	4.2	45.9	0.6	2.2
COL4A2	"DKFZp686I14213, FLJ22259"	ENSG00000134871	"Collagen type IV alpha 2 chain"	P08572	13	110305812-110513209	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 474.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 313.6;Endometrial stromal cells: 308.3;Endothelial cells: 278.2;Extravillous trophoblasts: 512.9;Granulosa cells: 223.8;Sertoli cells: 374.7;Smooth muscle cells: 338.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 1041.3;WM-115: 428.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010751, HPA029118, HPA069337"	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		2700000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"CAB010751: AB_476828, HPA029118: , HPA069337: "	"unprognostic (2.43e-1)"	"unprognostic (4.13e-3)"	"unprognostic (8.04e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.49e-5)"	"unprognostic (1.33e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (9.25e-4)"	240.5	51.2	15.1	103.5	2.3	0.6	153.5	1.7	5.9	111.6	3.4	282.0	29.5	219.4	10.4	51.8	122.9	84.2	113.0	19.3	1.8	71.7	19.1	181.7	22.8	4.3	7.8	51.9	32.6	25.6	17.5	474.0	6.0	121.3	18.9	2.8	35.0	95.8	44.7	45.2	84.1	226.8	2.6	121.5	96.4	15.7	11.5	7.9	74.9	21.5	7.1	186.2	74.4	2.9	88.9	45.7	218.7	0.6	213.7	99.0	312.8	307.9	97.4	167.3	76.1	2.5	0.7	0.6	1041.3	60.0	75.0	85.4	0.1	82.4	27.3	28.1	46.3	0.2	76.6	0.7	150.5	0.5	1.0	42.8	4.5	114.8	71.2	193.5	158.5	0.0	1.3	0.9	25.4	0.3	0.3	12.1	34.2	0.8	11.7	0.6	87.8	0.4	125.6	0.0	6.4	35.4	0.3	0.9	81.2	84.7	0.6	6.7	327.7	94.9	237.9	2.3	161.9	0.6	3.0	7.4	5.8	0.4	428.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	2.3	1.7	5.9	19.3	1.8	4.3	7.8	6.0	2.6	11.5	2.9	313.6	83.3	5.8	17.9	2.9	9.6	8.0	16.3	1.8	2.4	7.0	56.8	31.8	20.0	1.8	53.3	0.0	77.4	0.1	10.0	1.9	39.0	1.7	19.4	308.3	278.2	0.0	8.0	17.7	4.4	512.9	159.1	5.6	50.1	1.3	223.8	102.1	1.8	30.9	0.0	44.0	7.0	2.0	3.3	13.3	3.4	60.6	3.8	39.2	46.9	2.0	7.3	0.0	5.5	1.1	2.8	1.4	176.0	1.5	12.3	23.9	32.7	2.1	0.3	374.7	64.7	338.9	0.9	8.5	0.7	7.0	67.2	3.6	49.4	5.4	2.4
COL6A5	"COL29A1, FLJ35880, VWA4"	ENSG00000172752	"Collagen type VI alpha 5 chain"		3	130345516-130484844	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	5	"lung: 5.6;skin 1: 6.2"	"Group enriched"	"Detected in some"	6	"Basal keratinocytes: 3.4;Early spermatids: 5.6;Erythroid cells: 3.8;Fibroblasts: 5.5;Langerhans cells: 5.2;Late spermatids: 3.0;Suprabasal keratinocytes: 3.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"midbrain: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	64	"HDLM-2: 15.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA043138	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA043138: AB_10796687"	"unprognostic (3.45e-2)"	"unprognostic (4.08e-2)"	"unprognostic (6.01e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-6)"		"unprognostic (8.44e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.71e-1)"		"unprognostic (7.58e-8)"	"unprognostic (3.85e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.79e-2)"	0.0	0.0	0.0	0.1	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.2	0.7	0.0	0.0	0.0	1.0	0.8	0.1	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.3	0.0	3.8	0.2	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.2	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	3.4	0.0	0.2	0.0	0.0	0.0
COX4I2	"COX4-2, COX4B, COX4L2, COXIV-2, dJ857M17.2"	ENSG00000131055	"Cytochrome c oxidase subunit 4I2"	Q96KJ9	20	31637912-31645006	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 49.1;placenta: 115.4"	"Group enriched"	"Detected in some"	5	"Sertoli cells: 414.2;Smooth muscle cells: 191.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"SH-SY5Y: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.64e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.51e-2)"	"prognostic favorable (6.04e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (9.78e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.59e-2)"	19.1	1.1	6.7	1.7	6.7	0.0	15.9	6.5	9.1	4.8	6.1	4.7	1.9	7.5	3.9	5.4	4.9	10.6	39.7	6.5	6.7	10.9	1.1	49.1	4.7	6.8	7.0	2.9	2.3	9.3	2.2	115.4	7.0	10.1	2.7	1.1	3.6	4.7	8.7	4.9	5.8	7.1	6.6	1.7	4.2	1.5	7.0	1.8	14.7	19.4	3.0	7.7	6.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	6.7	6.5	9.1	6.5	6.7	6.8	7.0	7.0	6.6	7.0	6.6	55.0	0.0	0.0	0.0	0.5	6.4	0.3	0.0	2.2	0.4	0.9	1.9	2.7	0.0	0.0	0.0	0.0	1.1	0.3	0.1	0.0	0.0	0.2	0.1	0.7	23.5	0.0	0.0	0.0	0.0	0.3	9.5	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	7.5	0.7	3.7	0.5	8.8	2.8	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.7	414.2	4.6	191.6	0.1	1.0	0.8	6.7	2.5	1.0	1.0	0.0	0.3
CPE		ENSG00000109472	"Carboxypeptidase E"	P16870	4	165361194-165498547	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 643.3;retina: 741.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 727.4;Bipolar cells: 569.1;Cone photoreceptor cells: 621.3;Enteroendocrine cells: 587.4;Leydig cells: 500.8;Muller glia cells: 530.9;Peritubular cells: 621.0;Rod photoreceptor cells: 803.3;Sertoli cells: 854.6;Smooth muscle cells: 519.4"	"Cancer enhanced"	"Detected in all"		"glioma: 240.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 311.6;SCLC-21H: 418.2;SiHa: 629.0;SuSa: 342.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003819, CAB024907"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		600000		"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Centrosome	"Nucleoplasm, Vesicles"	"CAB024907: , HPA003819: AB_2667054"	"unprognostic (1.84e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.91e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.56e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (4.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.12e-4)"	138.1	151.7	554.8	20.5	593.0	1.8	97.5	550.9	604.0	53.9	311.9	44.6	22.0	67.7	404.6	74.8	88.6	65.7	100.7	584.3	643.3	68.4	26.7	50.1	37.5	417.0	494.2	104.0	170.4	89.9	328.4	7.7	456.2	295.1	36.8	741.7	104.5	84.7	56.2	45.1	30.7	83.3	448.3	11.6	80.2	146.2	578.2	68.8	179.7	47.5	35.2	33.8	73.4	446.2	0.2	8.4	54.4	10.5	41.4	4.5	2.4	0.1	21.5	8.1	16.5	0.0	0.5	0.0	15.8	0.6	1.9	1.2	20.4	4.4	4.7	0.3	78.6	0.0	21.6	311.6	3.0	0.3	0.5	102.3	21.5	0.3	0.4	104.0	0.2	0.0	0.1	2.1	11.2	15.4	0.4	2.7	34.4	0.2	12.1	0.3	0.2	1.1	0.7	3.4	418.2	138.0	629.0	77.9	0.0	342.6	46.7	1.9	0.0	16.7	42.5	1.5	1.5	23.5	0.6	2.2	15.5	0.7	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	554.8	593.0	550.9	604.0	584.3	643.3	417.0	494.2	456.2	448.3	578.2	446.2	87.1	0.0	5.6	727.4	0.6	26.1	81.7	10.3	66.0	569.1	25.6	52.1	54.5	54.3	5.0	22.0	621.3	0.6	1.4	2.9	0.0	19.7	6.7	2.2	12.1	130.4	587.4	2.7	234.8	1.8	0.3	249.0	31.6	1.3	0.0	8.6	274.2	15.1	1.0	70.7	129.0	16.2	38.7	5.4	41.2	23.3	500.8	6.3	87.2	94.6	1.0	530.9	0.0	211.6	23.0	12.4	3.7	621.0	0.7	434.6	10.2	12.7	1.2	803.3	854.6	14.1	519.4	19.7	13.3	14.0	20.9	0.8	5.5	15.4	4.0	18.9
CRIM1	S52	ENSG00000150938	"Cysteine rich transmembrane BMP regulator 1"	Q9NZV1	2	36355778-36551135	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 163.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 262.9;Hepatic stellate cells: 207.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 466.5;fHDF/TERT166: 462.5;TIME: 651.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000556	Enhanced				"Intracellular and membrane"	NA	NA		170000	"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA000556: AB_1078567"	"unprognostic (2.15e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.11e-3)"	"unprognostic (8.19e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (9.51e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.67e-2)"	88.3	14.6	27.0	18.8	28.1	3.5	58.9	9.4	23.5	26.7	51.4	28.7	14.9	26.6	16.7	30.5	34.4	32.2	34.5	20.3	28.8	70.0	16.0	50.1	14.8	23.5	21.9	36.9	23.5	29.2	7.4	163.8	21.2	25.8	23.2	29.5	31.1	32.6	50.1	27.2	18.2	35.7	22.1	47.1	17.5	12.4	36.1	9.9	33.8	36.5	8.7	38.9	22.2	17.1	100.9	75.4	15.2	17.5	69.1	78.0	125.0	466.5	244.7	255.4	133.4	95.3	34.2	0.2	297.9	462.5	166.1	42.8	11.4	75.2	206.5	1.1	8.7	3.2	96.7	55.5	221.5	2.2	0.6	110.1	55.2	102.4	182.4	238.4	361.9	1.9	4.7	0.7	271.6	9.2	0.2	1.2	11.9	5.2	22.1	5.4	19.6	15.5	159.8	41.1	1.8	0.2	81.5	26.4	3.4	56.2	72.3	2.0	651.1	321.7	116.1	40.4	229.1	25.5	0.5	0.9	94.7	0.4	100.8	1.4	0.1	0.5	0.6	0.0	0.4	0.3	0.2	0.3	0.1	0.2	0.0	0.3	0.2	0.4	0.6	2.1	0.2	0.0	27.0	28.1	9.4	23.5	20.3	28.8	23.5	21.9	21.2	22.1	36.1	17.1	262.9	12.8	43.3	100.2	5.4	66.0	38.5	30.1	43.9	12.0	55.6	72.9	34.4	47.1	26.5	132.4	2.1	111.9	27.1	49.5	3.9	33.5	1.0	37.1	27.7	159.8	31.8	10.7	85.1	2.6	40.6	41.0	10.2	75.9	1.3	27.4	207.1	3.6	27.7	0.0	57.5	37.7	36.7	7.7	32.5	2.0	19.0	8.2	39.2	135.9	7.1	18.5	6.2	65.9	17.2	26.5	30.9	19.9	6.9	75.5	11.5	38.4	28.9	42.5	46.0	18.4	164.6	2.1	9.4	22.0	30.1	173.5	17.1	5.7	33.2	58.3
CRISPLD2	"DKFZP434B044, LCRISP2, LGL1"	ENSG00000103196	"Cysteine rich secretory protein LCCL domain containing 2"	Q9H0B8	16	84819985-84920768	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 137.3;Fibroblasts: 185.5;Leydig cells: 271.5;Peritubular cells: 265.9;Skeletal myocytes: 146.2;Smooth muscle cells: 341.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 87.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 87.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 43.7;BEWO: 69.2;HHSteC: 161.4;HSkMC: 68.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 15.6"	"HPA030054, HPA030055"	Approved		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	No	219000000000		"Cluster 1: Neutrophils - Mixed function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nucleoli"		"HPA030054: AB_2732452, HPA030055: AB_10611821"	"unprognostic (8.91e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (7.35e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.15e-3)"	113.4	29.0	3.3	46.6	4.9	8.1	64.2	3.9	4.6	112.9	2.6	88.9	10.8	115.7	20.3	39.9	129.0	104.0	36.6	3.7	5.2	40.9	17.1	92.7	7.3	5.9	5.5	80.7	23.5	2.5	19.3	122.7	5.9	98.9	18.1	2.4	18.1	27.7	15.0	36.7	58.5	95.0	4.4	24.9	65.9	21.5	4.3	8.2	47.9	12.2	3.7	119.9	69.8	5.7	0.9	2.2	0.6	6.0	43.7	16.2	69.2	34.5	30.4	27.2	19.1	4.7	2.9	0.1	3.0	30.5	8.0	1.0	0.1	0.1	27.3	0.0	0.2	0.5	0.9	0.1	161.4	0.0	0.3	68.0	0.1	8.0	0.1	9.0	0.2	0.0	0.3	0.3	3.1	1.4	0.3	1.7	2.0	4.6	2.0	0.1	0.3	0.4	0.2	5.5	6.7	0.5	8.1	3.5	0.7	9.4	13.7	0.9	3.8	0.4	1.8	28.3	1.0	0.4	0.1	5.8	0.2	0.5	4.1	14.8	20.2	0.7	0.0	1.2	0.0	0.1	0.2	0.0	1.3	0.0	0.1	0.0	87.2	0.0	0.0	0.1	0.0	4.2	3.3	4.9	3.9	4.6	3.7	5.2	5.9	5.5	5.9	4.4	4.3	5.7	5.9	3.2	2.3	0.7	0.7	46.1	8.6	0.6	9.6	0.5	3.9	7.6	8.6	2.8	1.6	0.0	0.0	7.4	0.8	1.8	0.0	1.4	12.6	7.0	137.3	21.7	3.0	0.0	2.2	0.5	42.4	185.5	27.0	6.3	7.0	11.5	38.6	0.8	4.7	1.7	1.5	4.1	0.0	36.6	39.6	19.6	271.5	14.8	48.0	9.4	41.5	5.1	3.1	54.3	0.6	0.9	0.3	265.9	0.9	17.1	0.2	0.1	0.9	0.7	92.1	146.2	341.2	1.0	1.9	3.7	42.8	9.0	5.4	5.7	2.2	6.5
CRTAP	"CASP, LEPREL3, P3H5"	ENSG00000170275	"Cartilage associated protein"	O75718	3	33114014-33147773	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Disease variant, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 377.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 306.9;monocytes: 377.6"	"Cell line enhanced"	"Detected in all"		"ASC diff: 795.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043598, HPA044150"	Approved		Approved	"Intermediate filaments,Actin filaments,Cytosol"	"Secreted to blood"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Intermediate filaments, Actin filaments, Cytosol"		"HPA043598: AB_10960991, HPA044150: AB_10959594"	"unprognostic (5.29e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.85e-3)"	"unprognostic (7.36e-2)"	"unprognostic (4.73e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.28e-3)"	157.2	106.5	65.2	38.7	69.2	43.2	123.9	51.9	54.8	211.2	52.9	145.1	35.0	170.1	57.1	58.7	138.3	80.5	83.9	49.6	64.9	67.9	44.6	92.3	37.3	65.2	62.4	131.4	36.0	45.7	22.8	69.9	63.9	90.7	51.6	19.3	54.0	106.5	54.4	84.1	65.6	115.0	67.5	48.2	78.9	25.0	65.3	23.7	77.2	68.9	38.1	142.7	135.8	69.5	64.1	123.3	37.8	119.2	795.0	516.6	219.0	136.1	294.0	160.6	151.9	42.1	35.1	44.4	147.6	259.3	129.9	80.2	68.0	103.9	115.5	110.1	106.0	69.2	87.6	43.7	237.4	45.4	54.8	415.3	208.5	145.0	183.2	311.7	172.0	27.0	60.3	82.1	164.6	54.7	16.5	46.3	45.5	67.5	165.7	59.4	111.0	86.1	127.8	42.0	7.9	61.0	92.0	79.8	201.1	87.3	85.9	109.3	113.0	209.1	89.1	115.4	145.9	59.0	214.3	6.7	164.3	89.7	117.1	13.4	377.6	28.5	35.8	147.7	52.5	39.9	51.4	40.2	306.9	39.2	29.2	27.8	30.5	42.1	46.0	82.5	74.0	200.5	65.2	69.2	51.9	54.8	49.6	64.9	65.2	62.4	63.9	67.5	65.3	69.5	74.0	9.6	42.8	15.3	29.0	60.4	41.1	39.5	150.8	17.9	32.7	43.7	34.7	25.8	22.0	38.6	8.4	49.0	37.1	14.8	11.7	25.0	1.2	17.4	135.7	72.7	6.0	46.0	10.0	32.0	81.6	142.3	29.0	31.2	48.1	58.4	122.4	53.2	107.0	35.3	14.5	26.0	10.2	181.1	91.1	6.3	142.9	108.6	80.0	10.3	134.1	15.9	22.6	17.1	11.6	18.4	16.3	144.8	58.1	24.5	24.4	52.7	6.8	10.1	111.7	78.4	120.9	1.6	15.9	95.1	46.7	28.0	26.5	89.9	36.1	30.0
CSPG4	"CSPG4A, HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2"	ENSG00000173546	"Chondroitin sulfate proteoglycan 4"	Q6UVK1	15	75674322-75712848	"Predicted membrane proteins"	"Angiogenesis, Differentiation, Tissue remodeling"	"Developmental protein, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 55.4"	"Group enriched"	"Detected in some"	5	"Oligodendrocyte precursor cells: 57.3;Sertoli cells: 118.3;Smooth muscle cells: 47.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 74.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 64.7;SK-MEL-30: 146.1;U-138 MG: 92.1;WM-115: 138.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001933, HPA002951, CAB016189, HPA042785, HPA050008"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		48000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Nucleoplasm	"CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: AB_2680991"	"unprognostic (5.21e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (7.60e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (4.93e-5)"	29.6	1.8	9.0	7.3	7.1	0.0	18.5	6.6	9.3	16.0	1.8	55.4	2.8	34.5	1.4	8.3	15.0	5.6	14.6	7.5	8.2	4.9	0.9	19.4	0.4	11.7	7.8	8.9	2.1	1.2	2.2	15.5	9.7	14.4	2.2	0.1	4.7	11.2	39.6	7.8	15.3	22.7	6.7	5.6	19.1	1.3	7.7	0.6	5.6	10.0	0.3	30.3	12.6	9.8	11.9	0.1	1.0	7.1	1.6	9.8	0.1	64.7	28.6	44.4	28.8	0.1	45.0	0.0	1.5	45.4	6.2	0.6	0.1	0.3	13.6	0.6	0.2	0.0	19.2	0.0	10.0	0.0	0.1	4.8	0.1	13.5	1.5	16.5	0.0	0.0	0.1	0.1	7.6	0.1	0.0	0.2	1.2	0.0	0.3	0.1	4.0	0.1	0.0	0.0	0.1	0.2	1.7	0.1	146.1	1.2	0.9	1.2	0.1	92.1	17.9	3.6	0.8	0.0	0.2	0.0	20.3	0.5	138.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.0	7.1	6.6	9.3	7.5	8.2	11.7	7.8	9.7	6.7	7.7	9.8	4.9	0.0	0.0	1.0	0.0	2.8	0.7	4.7	0.0	1.4	0.1	0.8	11.4	0.0	0.8	1.8	0.0	0.2	0.5	0.1	0.0	0.0	0.6	0.7	0.7	2.7	0.0	0.0	0.4	0.0	0.6	5.9	1.5	0.4	0.0	1.8	1.1	0.2	1.1	0.0	0.2	0.0	0.0	0.0	3.2	0.0	0.3	0.3	12.4	3.7	0.0	0.0	0.0	57.3	0.1	0.0	0.0	0.4	0.0	4.3	0.0	0.1	1.0	0.2	118.3	3.1	47.1	0.0	1.3	0.1	1.8	0.3	0.3	0.1	0.0	0.4
CSRP1	"CSRP, CYRP, D1S181E"	ENSG00000159176	"Cysteine and glycine rich protein 1"	P21291	1	201483530-201509456	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 2743.3;seminal vesicle: 2571.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 341.2;Breast myoepithelial cells: 737.5;Extravillous trophoblasts: 388.5;Smooth muscle cells: 419.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045617	Uncertain					NA	NA		11000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA045617: AB_2679391"	"unprognostic (7.08e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.96e-3)"	344.5	127.2	713.6	224.5	871.4	41.0	321.8	742.5	717.3	542.4	467.6	2743.3	180.6	1904.4	308.4	884.1	1025.6	152.7	194.2	647.3	735.1	192.5	114.7	386.0	64.9	840.1	837.4	319.0	114.6	188.0	117.0	118.3	719.0	947.2	432.0	24.2	250.1	2571.3	64.0	219.8	503.6	2009.6	713.5	165.6	748.3	44.2	848.5	48.0	186.4	53.8	65.7	1494.5	469.1	766.6	83.0	195.3	52.0	116.4	83.2	107.7	273.6	605.7	514.3	455.3	360.9	211.1	57.7	78.7	36.1	325.0	96.7	144.7	32.7	120.3	321.2	169.5	29.3	90.7	220.1	30.7	387.4	72.1	10.2	99.3	105.3	373.0	163.1	253.1	508.1	34.9	4.5	71.9	302.1	232.9	46.6	11.8	0.8	99.0	73.2	18.3	304.9	266.8	212.6	129.7	27.1	22.5	238.0	503.8	163.9	25.6	87.0	74.3	610.6	303.7	195.7	206.6	250.6	40.5	82.6	30.6	303.5	137.6	202.6	75.5	49.8	65.6	37.4	49.3	36.9	25.0	35.8	34.9	65.0	18.1	20.5	25.2	5.0	34.3	54.2	5.2	54.1	46.5	713.6	871.4	742.5	717.3	647.3	735.1	840.1	837.4	719.0	713.5	848.5	766.6	151.8	38.5	47.8	86.5	21.8	49.2	341.2	24.6	207.7	3.4	123.7	737.5	24.8	21.5	36.9	47.8	0.0	88.8	23.3	96.6	49.0	165.1	21.5	30.1	73.6	86.9	57.9	19.1	2.4	171.7	388.5	86.7	36.7	38.9	27.9	13.9	91.1	28.3	66.0	0.0	2.1	80.0	14.2	29.1	55.8	44.9	41.0	37.0	126.3	10.3	73.5	137.4	15.5	6.6	114.8	140.5	71.4	292.3	61.5	113.8	97.2	28.4	25.2	3.1	144.7	37.7	419.9	2.4	3.2	75.3	34.9	160.9	31.2	30.4	69.7	103.6
CYB5R3	DIA1	ENSG00000100243	"Cytochrome b5 reductase 3"	P00387	22	42617840-42649392	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 830.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001566	Approved		Supported	"Endoplasmic reticulum"		NA	NA		1500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"		"HPA001566: AB_1078601"	"unprognostic (4.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (2.45e-1)"	"unprognostic (8.22e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.24e-2)"	404.4	310.5	147.1	87.4	152.9	82.7	272.2	145.7	189.9	237.3	115.0	192.4	94.8	248.4	58.8	152.4	174.0	139.5	374.3	138.7	163.9	182.9	279.4	201.3	76.3	194.7	174.2	218.3	89.1	62.0	137.4	107.8	169.9	181.4	74.9	27.3	149.8	239.3	203.0	233.6	138.1	200.2	154.8	101.4	182.0	142.7	156.7	54.0	157.8	140.5	72.3	216.7	210.0	160.2	125.5	78.6	126.6	78.6	830.9	654.7	74.4	359.2	330.0	262.2	232.4	104.0	95.6	58.8	156.6	668.8	113.8	112.4	85.3	178.0	133.7	63.9	187.3	83.6	127.3	202.4	211.0	118.4	149.5	397.4	138.1	188.9	124.5	190.8	220.0	74.0	73.5	296.3	361.9	137.9	116.8	108.4	51.0	129.2	142.7	84.9	153.8	131.3	202.0	90.6	56.1	73.2	118.6	113.2	134.0	92.6	90.6	112.0	340.9	282.0	175.3	192.3	137.9	78.3	91.2	72.4	328.8	67.8	237.9	126.3	104.0	300.3	75.9	135.3	76.6	110.1	72.8	83.9	154.0	102.7	50.8	54.0	53.8	63.5	176.7	140.8	95.0	86.4	147.1	152.9	145.7	189.9	138.7	163.9	194.7	174.2	169.9	154.8	156.7	160.2	238.5	86.6	62.2	17.0	51.7	110.1	95.5	184.8	27.3	16.7	52.3	73.2	106.4	105.8	100.9	60.7	4.2	110.0	37.0	90.5	49.0	216.4	4.8	51.4	82.9	161.5	83.7	113.9	12.3	107.0	199.3	183.4	38.2	65.4	62.8	57.8	180.2	230.4	108.3	16.8	16.1	45.8	142.4	50.6	112.0	17.0	253.9	67.7	176.1	25.3	112.5	91.0	33.0	7.1	26.4	156.8	85.6	280.6	36.7	82.3	116.9	110.8	53.3	18.4	190.7	62.5	202.5	23.8	45.5	57.5	112.7	117.9	43.0	233.1	55.2	96.4
CYCS	"CYC, HCS"	ENSG00000172115	"Cytochrome c, somatic"	P99999	7	25118656-25125260	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Electron transport, Respiratory chain, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 799.8"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1663.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004222, CAB005126, CAB018597"	Enhanced		Supported	Mitochondria		NA	NA		170000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria		"CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383"	"unprognostic (3.06e-2)"	"unprognostic (3.39e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.81e-4)"	"unprognostic (4.44e-2)"	"unprognostic (7.04e-3)"	"unprognostic (5.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.30e-5)"	"unprognostic (1.18e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (7.04e-2)"	86.0	115.6	65.8	89.2	70.4	85.0	59.2	79.8	101.7	45.3	87.6	263.6	150.1	42.3	41.5	105.9	43.0	52.9	476.8	72.1	82.8	174.6	115.7	54.3	63.8	71.0	72.9	48.1	38.5	226.2	57.0	43.0	69.4	54.3	238.8	153.9	58.0	60.1	483.7	47.6	120.1	91.1	70.2	48.0	108.1	61.1	83.4	74.0	74.6	799.8	89.4	119.8	60.1	71.7	336.4	185.1	195.0	273.7	108.7	83.1	199.6	314.4	128.0	229.2	264.5	307.4	222.2	383.8	152.9	138.5	678.3	385.8	396.5	295.0	401.2	115.0	179.1	318.6	208.9	218.7	170.2	739.0	271.1	111.2	257.5	230.9	492.9	99.4	209.5	232.2	597.1	397.9	246.0	155.1	408.6	284.4	365.1	746.3	343.0	282.1	235.3	364.5	360.9	322.5	392.6	190.3	164.5	689.0	267.9	338.7	359.5	436.6	152.8	209.3	383.3	329.8	591.8	401.4	507.3	860.5	281.0	526.4	606.7	65.3	56.2	42.8	68.0	106.0	82.5	102.5	62.2	71.6	105.7	90.0	58.6	70.2	8.2	73.3	96.8	81.5	87.5	83.0	65.8	70.4	79.8	101.7	72.1	82.8	71.0	72.9	69.4	70.2	83.4	71.7	244.3	83.3	118.6	42.4	337.6	689.8	818.3	698.5	237.9	163.1	210.6	179.6	770.0	144.4	314.2	183.9	77.2	192.6	304.4	827.5	1663.0	278.3	496.4	154.8	120.2	183.3	384.9	162.6	53.2	216.0	351.0	257.3	287.5	197.5	212.6	68.7	81.0	210.8	353.0	132.9	64.6	522.5	502.5	141.5	715.2	161.8	90.1	329.2	590.5	16.9	245.8	220.9	197.8	17.1	24.2	303.8	570.5	93.6	358.7	551.9	392.8	638.6	146.1	195.2	138.1	294.7	962.3	423.1	211.1	402.7	715.2	349.3	349.7	146.9	600.2	884.1
CYP26B1	P450RAI-2	ENSG00000003137	"Cytochrome P450 family 26 subfamily B member 1"	Q9NR63	2	72129238-72147862	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9;skin 1: 31.4"	"Group enriched"	"Detected in many"	4	"Leydig cells: 75.8;Peritubular cells: 229.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 9.8;HaCaT: 14.8;RH-30: 18.4;U-2 OS: 19.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012567	Uncertain		Approved	Cytosol	"Intracellular and membrane"	No	No				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA012567: AB_1847429"	"unprognostic (1.70e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.19e-4)"	"unprognostic (3.46e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.17e-4)"	"unprognostic (8.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.04e-2)"	26.2	4.3	12.0	1.9	3.3	0.1	15.0	12.3	7.0	5.0	0.4	3.2	3.7	2.5	1.5	3.9	5.5	1.1	8.5	6.7	1.3	8.8	1.0	2.7	4.9	48.0	10.4	4.5	0.6	0.8	9.3	3.3	49.9	2.6	1.2	4.2	9.9	7.3	5.9	31.4	4.7	1.6	0.0	3.5	1.2	13.8	0.7	19.3	14.4	2.3	2.9	3.2	4.2	3.5	0.6	5.9	0.0	0.1	9.8	4.0	5.9	0.9	0.1	0.2	0.2	1.8	0.5	0.0	0.5	0.7	3.0	14.8	8.5	0.0	0.1	0.0	2.7	0.0	7.0	0.9	0.2	0.0	0.3	0.0	0.5	0.0	0.3	3.0	1.1	4.0	0.6	0.1	0.9	2.9	0.0	0.1	0.0	0.1	1.0	0.1	18.4	0.0	0.0	1.3	0.6	0.1	3.0	0.0	3.5	1.2	0.3	0.9	0.0	1.6	19.3	9.0	3.0	0.1	1.2	0.0	6.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	3.3	12.3	7.0	6.7	1.3	48.0	10.4	49.9	0.0	0.7	3.5	2.4	0.0	0.0	2.0	1.2	14.7	1.1	0.8	0.6	0.2	2.3	0.8	1.4	4.3	0.2	0.0	0.0	0.1	0.0	1.1	0.0	0.2	4.1	0.2	0.2	19.0	1.8	5.3	5.3	0.0	0.9	15.6	0.0	0.3	0.0	1.5	34.6	0.8	0.1	0.0	0.7	0.0	0.0	6.1	19.1	9.6	75.8	0.4	7.2	0.0	0.0	7.4	0.0	2.0	0.5	0.4	1.5	229.9	0.0	0.5	0.2	0.1	0.2	0.3	0.0	5.7	20.7	1.5	3.8	1.6	9.7	0.1	0.8	7.5	0.1	0.4
DACT3	"DAPPER3, MGC15476, RRR1"	ENSG00000197380	"Dishevelled binding antagonist of beta catenin 3"	Q96B18	19	46647551-46661182	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.9;Oligodendrocytes: 27.2;Smooth muscle cells: 22.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 10.5;SH-SY5Y: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043053	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	Nucleoplasm	"HPA043053: AB_10794769"	"unprognostic (2.35e-1)"	"unprognostic (3.08e-1)"	"unprognostic (5.30e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.03e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (7.97e-8)"	"unprognostic (1.59e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (6.66e-4)"	9.1	3.3	42.1	5.9	42.0	1.4	5.4	41.1	54.4	34.7	3.6	53.9	3.9	48.2	14.3	7.4	37.4	7.2	27.5	48.6	33.4	5.9	2.6	14.0	1.1	45.4	40.1	17.0	1.1	1.9	4.1	1.7	39.9	19.7	6.7	5.8	1.7	24.6	2.2	4.1	13.0	31.6	34.7	6.8	18.0	18.7	46.3	0.5	4.8	2.9	0.9	39.0	15.9	58.0	0.2	0.2	5.6	5.3	1.9	1.5	0.5	3.1	5.2	1.0	1.5	0.2	0.3	0.5	2.0	10.5	1.0	0.3	3.6	0.1	1.0	0.3	1.9	1.2	0.8	0.2	2.7	0.1	2.1	4.9	0.1	1.3	0.1	0.6	0.4	0.7	1.8	1.8	0.9	0.4	0.2	1.4	2.2	0.0	0.8	4.6	1.3	0.3	0.2	0.3	2.1	24.6	0.4	0.2	0.4	5.7	0.4	0.5	0.4	2.6	3.2	2.6	0.5	1.6	0.5	0.8	0.5	0.8	1.9	2.6	0.3	0.3	0.2	0.1	0.1	0.3	0.2	0.2	0.1	0.5	0.2	0.2	1.6	0.7	0.2	0.3	0.2	0.1	42.1	42.0	41.1	54.4	48.6	33.4	45.4	40.1	39.9	34.7	46.3	58.0	1.9	6.4	5.5	13.7	0.2	2.3	1.5	0.0	0.0	16.5	1.0	2.4	17.8	1.5	0.7	0.0	2.1	5.4	0.5	0.3	0.0	0.0	23.9	0.4	9.3	3.1	1.8	0.0	9.2	0.0	2.6	7.4	0.0	0.8	6.3	0.5	1.8	0.2	1.1	1.7	16.7	0.2	2.0	1.6	9.2	8.6	7.8	1.4	3.6	7.5	1.2	9.2	2.1	15.1	27.2	0.1	1.2	14.7	0.1	1.0	0.2	0.3	0.2	6.3	6.6	2.3	22.9	2.3	2.5	0.4	3.3	9.9	1.0	4.3	0.2	1.0
DCBLD1	"dJ94G16.1, MGC46341"	ENSG00000164465	"Discoidin, CUB and LCCL domain containing 1"	Q8N8Z6	6	117453817-117569858	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA059667	Approved		Approved	Cytosol		NA	NA		22000000	"Cluster 32: T-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA059667: AB_2684099"	"unprognostic (1.00e-1)"	"prognostic unfavorable (6.44e-5)"	"unprognostic (1.08e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.74e-2)"	"unprognostic (8.99e-2)"	"unprognostic (5.69e-3)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (8.57e-8)"	"unprognostic (6.99e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.36e-1)"	8.3	3.5	3.7	6.0	4.6	0.6	5.7	3.5	4.9	9.1	2.6	6.6	6.5	5.1	3.3	5.4	2.5	9.1	6.0	5.5	2.7	4.8	9.6	9.9	3.4	3.5	3.6	1.9	6.3	6.8	8.3	8.7	3.7	2.6	6.1	1.0	4.8	2.8	5.5	2.9	8.1	3.8	3.4	3.8	7.6	5.6	3.0	1.2	5.9	5.1	2.5	6.3	5.8	4.3	8.0	17.9	6.3	7.0	10.8	13.5	17.9	45.1	58.1	36.9	27.8	37.9	16.7	0.0	21.8	19.1	45.9	17.9	12.1	19.9	38.7	3.5	9.4	6.8	18.5	62.3	46.7	10.0	5.7	15.4	45.5	33.6	31.4	42.5	52.3	6.7	14.8	6.7	48.9	6.4	0.1	6.7	4.7	21.4	7.4	0.0	1.3	4.7	8.2	9.4	19.0	0.3	33.0	3.6	5.3	9.0	4.7	13.1	38.9	0.0	44.1	12.6	19.8	18.9	5.4	5.3	18.7	9.6	16.5	0.0	0.2	0.0	0.6	0.2	0.1	0.0	0.8	1.2	0.2	0.0	1.0	1.3	0.0	0.4	0.1	0.4	0.9	0.5	3.7	4.6	3.5	4.9	5.5	2.7	3.5	3.6	3.7	3.4	3.0	4.3	16.0	16.0	18.8	5.2	3.0	5.2	3.7	12.3	0.6	8.4	4.8	3.6	5.3	12.8	14.4	5.5	6.2	31.5	4.9	9.5	1.9	7.0	33.0	5.3	15.1	11.0	4.2	3.2	20.8	4.8	6.1	6.6	13.7	7.9	1.3	13.9	17.2	9.6	5.8	5.0	3.3	8.5	6.1	7.0	15.0	10.9	0.9	5.8	8.8	13.1	2.5	1.1	6.2	12.1	11.6	10.4	7.7	0.4	1.6	3.0	11.1	2.7	5.7	3.5	13.1	5.1	27.6	2.2	10.6	6.8	6.0	18.2	5.1	2.1	11.1	5.4
DCD	"AIDD, DCD-1, DSEP, HCAP, PIF"	ENSG00000161634	Dermcidin	P81605	12	54644589-54648493	"Plasma proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 2476.8"	"Cell type enriched"	"Detected in some"	355	"Melanocytes: 8167.8"	"Cancer enriched"	"Detected in some"	9	"breast cancer: 91.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"									HPA063967	Enhanced				"Secreted in other tissues"	NA	NA		410000000	"Cluster 42: Non-specific - Transcription"	"Cluster 61: Skin - Cornification"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA063967: AB_2685163"	"unprognostic (3.55e-2)"													"unprognostic (1.61e-1)"				100.2	0.4	3.5	0.3	3.3	1.1	354.3	3.4	5.4	0.3	3.8	0.7	0.2	0.7	0.9	0.5	0.2	0.8	1.3	3.5	3.3	0.2	0.9	0.6	0.2	3.3	3.6	0.4	1.0	0.0	0.5	0.1	3.5	0.4	0.2	0.5	0.5	0.1	14.0	2476.8	0.7	0.1	3.0	0.4	0.7	1.1	3.2	0.3	0.5	0.0	0.2	0.2	0.7	4.1	0.2	0.3	0.4	0.4	0.3	0.4	0.4	0.5	0.1	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.4	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.5	0.2	0.0	0.2	0.1	0.3	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	1.9	0.4	0.5	0.4	0.3	0.6	0.5	0.4	0.3	0.2	0.4	0.5	0.5	1.1	0.9	0.7	0.5	0.6	0.2	3.5	3.3	3.4	5.4	3.5	3.3	3.3	3.6	3.5	3.0	3.2	4.1	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.1	0.0	0.0	8167.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.4	0.2	0.0	23.0	0.0	1.0	0.0	0.0	0.0
DCT	TYRP2	ENSG00000080166	"Dopachrome tautomerase"	P40126	13	94436811-94479682	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Melanin biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"skin 1: 107.4"	"Cell type enriched"	"Detected in some"	23	"Melanocytes: 3552.1"	"Cancer enriched"	"Detected in some"	215	"melanoma: 155.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	272	"SK-MEL-30: 257.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA010742, HPA010743, HPA010800, CAB017634"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Vesicles	"CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.06e-2)"	"unprognostic (6.18e-5)"	"unprognostic (6.97e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.42e-1)"	0.4	0.4	0.6	0.0	1.0	0.1	3.0	0.4	0.7	0.2	0.2	0.3	0.0	0.3	0.9	0.0	0.9	0.1	0.1	0.6	0.6	0.2	0.2	0.1	0.0	0.6	0.6	0.4	0.4	0.0	1.6	0.0	0.5	0.3	0.0	0.9	1.5	0.3	0.4	107.4	0.1	0.1	0.6	0.1	0.1	0.6	0.6	0.5	0.2	0.1	0.0	0.2	0.3	0.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	257.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.2	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.4	0.7	0.6	0.6	0.6	0.6	0.5	0.6	0.6	0.5	0.0	0.0	0.0	23.5	0.0	152.3	0.1	0.0	0.0	1.0	0.3	0.5	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.5	0.1	1.2	0.0	0.0	16.1	0.2	0.0	1.4	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	25.5	23.8	0.9	0.0	3552.1	1.9	0.0	3.5	0.0	6.6	2.4	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.5	1.0	0.5	0.8	0.0	33.4	0.0	0.9	0.1	0.0	0.0
DMPK	"DM, DM1, DM1PK, DMK, MDPK, MT-PK"	ENSG00000104936	"DM1 protein kinase"	Q09013	19	45769709-45782552	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.1;Sertoli cells: 59.2;Smooth muscle cells: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 85.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 8.7"	"HPA007164, HPA008905"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	Vesicles	"HPA007164: AB_1078687, HPA008905: AB_1078685"	"unprognostic (7.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (9.39e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.24e-3)"	24.2	68.3	22.1	17.5	24.0	3.0	19.1	22.2	33.1	42.8	25.6	121.5	15.8	92.7	5.3	33.4	61.2	13.9	171.3	21.8	21.6	20.3	8.8	29.8	5.2	24.0	23.8	31.1	34.3	2.9	37.9	8.8	22.3	56.4	4.8	4.1	18.6	37.6	173.6	12.3	34.6	59.9	21.9	17.8	51.7	13.2	23.8	4.2	21.7	143.2	1.3	69.1	34.3	21.3	11.7	16.7	13.5	10.7	13.4	12.9	10.5	26.1	22.2	10.5	8.8	2.2	6.6	2.9	2.8	32.9	9.2	15.1	3.0	1.5	2.2	12.4	16.6	0.8	22.6	1.4	12.6	0.1	5.4	22.8	8.0	6.4	1.7	24.2	3.6	2.1	8.6	8.0	15.4	13.7	1.6	3.8	8.8	4.8	3.3	5.0	85.1	6.4	4.7	11.5	10.2	13.5	13.6	27.6	9.3	4.8	28.6	5.5	8.4	9.2	10.4	8.3	15.0	16.8	11.5	2.9	9.5	1.3	13.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	24.0	22.2	33.1	21.8	21.6	24.0	23.8	22.3	21.9	23.8	21.3	10.5	0.0	2.2	44.1	3.7	8.0	8.1	3.8	5.7	5.7	9.6	9.9	3.7	4.3	3.2	3.7	8.4	2.7	4.2	4.7	1.9	2.7	1.5	8.7	8.6	7.9	10.1	0.4	16.4	17.3	2.0	8.4	8.2	6.3	0.0	9.7	9.3	1.5	0.8	5.0	12.4	8.2	8.2	1.6	9.8	1.8	7.2	0.8	7.2	10.3	0.4	2.6	5.2	26.7	10.0	5.8	4.5	23.3	3.1	4.0	3.8	31.7	7.1	7.4	59.2	27.6	34.9	7.2	6.4	10.1	6.8	1.6	4.5	5.4	5.1	4.6
DSTN	"ACTDP, ADF"	ENSG00000125868	"Destrin, actin depolymerizing factor"	P60981	20	17570075-17609919	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 1690.3;SK-BR-3: 1421.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037094	Approved					NA	NA		3700000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB037094: AB_476911"	"unprognostic (1.05e-3)"	"unprognostic (1.61e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.89e-3)"	"unprognostic (6.05e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-3)"	306.9	232.5	134.0	136.7	150.8	53.3	287.0	144.0	178.0	336.8	144.5	1146.3	136.1	636.1	297.1	535.6	449.9	297.4	411.6	150.0	158.2	269.0	141.3	315.8	60.2	146.7	150.3	236.8	268.9	180.0	127.1	162.3	154.4	559.2	306.8	114.0	274.6	758.3	87.2	227.8	285.6	695.0	147.6	75.2	486.8	82.0	140.4	47.8	273.0	111.4	79.0	704.4	312.7	164.1	323.0	431.3	161.5	160.5	399.8	391.5	303.8	397.7	616.4	248.1	221.7	200.4	348.6	50.1	97.7	587.8	458.5	305.3	149.4	606.5	281.9	28.0	125.5	131.9	247.2	295.3	426.2	102.9	86.5	357.9	563.1	239.3	275.9	609.0	360.6	85.4	63.4	65.7	468.1	251.7	42.2	121.6	110.4	1690.3	322.3	28.9	248.4	103.5	686.4	291.9	244.6	72.9	363.0	1421.1	441.9	263.7	654.3	55.9	345.3	294.9	93.2	324.1	276.8	39.7	52.2	134.6	139.9	43.8	250.8	33.8	17.6	59.2	55.9	32.2	46.8	11.9	56.9	52.0	22.1	9.0	37.0	47.0	11.8	48.8	46.4	51.1	46.7	45.3	134.0	150.8	144.0	178.0	150.0	158.2	146.7	150.3	154.4	147.6	140.4	164.1	372.8	1442.3	667.9	25.1	84.9	1151.6	697.0	796.7	542.4	101.5	925.2	762.2	1131.3	739.2	696.8	678.6	50.1	576.4	336.9	549.2	1457.6	1022.2	295.0	558.3	447.3	481.7	546.5	83.1	54.7	1468.6	1165.0	533.5	275.7	540.2	183.8	199.4	425.9	602.4	222.2	176.7	43.1	643.2	533.0	147.8	361.5	111.2	496.8	133.0	610.1	57.1	191.7	779.1	224.6	30.7	44.0	1018.6	572.8	1266.8	172.4	640.3	304.4	1491.4	912.0	153.1	1216.2	271.1	1745.4	390.0	298.9	515.2	1043.5	549.5	161.6	252.0	545.8	680.2
DTX3	"FLJ34766, RNF154"	ENSG00000178498	"Deltex E3 ubiquitin ligase 3"	Q8N9I9	12	57604622-57609804	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 70.7"	"Cancer enriched"	"Detected in all"	4	"glioma: 54.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"NK-cells: 1.0;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 84.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059654	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA059654: AB_2684097"	"unprognostic (2.31e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.91e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.84e-1)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (8.62e-2)"	"unprognostic (5.44e-3)"	"unprognostic (7.99e-2)"	"unprognostic (8.81e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.48e-2)"	36.6	58.2	117.1	15.8	120.2	7.2	36.4	117.5	138.2	97.6	115.0	117.4	11.5	95.5	50.7	24.2	92.0	24.5	67.6	124.5	111.4	63.8	12.3	37.2	21.2	107.8	112.1	124.3	41.9	39.4	145.1	28.1	108.6	82.1	16.8	80.8	31.4	48.2	21.0	21.1	46.2	48.5	105.3	46.0	51.0	29.0	112.6	23.6	75.9	16.6	15.5	65.0	60.7	119.0	8.8	22.7	65.9	0.1	0.0	0.1	0.4	13.8	35.4	29.7	30.0	11.8	36.5	12.3	20.5	30.0	0.3	14.2	0.0	1.7	20.9	31.1	4.1	7.1	39.4	12.5	49.4	0.0	0.1	24.5	16.7	22.8	0.3	84.4	33.6	0.1	0.0	40.9	23.1	19.2	38.4	0.3	52.1	7.2	2.0	0.0	55.1	0.7	2.8	22.7	47.7	75.5	10.9	3.1	7.0	15.8	38.4	18.9	0.1	38.6	15.3	17.9	20.2	66.2	53.6	0.2	24.8	0.1	20.6	0.0	0.0	0.0	2.5	0.0	0.6	0.1	0.9	1.2	0.1	0.1	0.8	1.6	0.0	1.0	0.0	0.3	2.2	1.2	117.1	120.2	117.5	138.2	124.5	111.4	107.8	112.1	108.6	105.3	112.6	119.0	4.9	16.0	15.6	25.8	2.9	6.2	10.0	8.7	21.1	47.8	12.2	19.9	11.0	11.5	10.5	12.9	50.1	0.5	10.6	0.5	13.7	8.2	0.9	17.8	17.4	8.5	15.6	4.4	29.9	1.9	0.3	15.1	6.1	5.5	5.7	17.2	15.0	0.6	0.6	70.7	29.3	0.9	10.2	2.0	2.1	2.8	34.2	1.6	3.6	8.4	0.8	27.4	36.0	25.1	19.0	2.6	0.0	31.6	5.8	7.1	0.0	4.6	30.9	42.0	46.0	11.5	37.5	4.6	5.7	2.8	2.8	1.2	10.4	16.8	0.7	3.5
EDNRA	"ET-A, ETA-R, hET-AR"	ENSG00000151617	"Endothelin receptor type A"	P25101	4	147480917-147544954	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 113.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 117.1;Leydig cells: 43.8;Peritubular cells: 68.1;Sertoli cells: 52.6;Smooth muscle cells: 108.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 9.4;ASC TERT1: 18.2;HHSteC: 9.3;LHCN-M2: 22.7;SH-SY5Y: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013774, CAB018957"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"		"CAB018957: AB_2039838, HPA013774: AB_1847994"	"unprognostic (3.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (1.50e-7)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (6.20e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	14.0	5.5	2.1	3.3	2.8	0.0	8.3	2.7	4.2	57.0	2.1	3.2	3.4	44.7	23.3	4.4	18.4	12.7	26.0	2.2	2.2	4.2	3.1	22.7	3.8	2.9	3.1	37.5	1.1	3.4	2.8	12.1	2.9	30.7	3.4	0.3	6.4	113.9	4.0	4.6	2.9	45.1	2.5	8.4	5.4	6.2	2.9	4.9	6.8	5.5	2.6	11.8	24.0	3.0	0.0	1.2	5.2	0.0	9.4	18.2	0.0	2.9	3.8	0.4	0.1	0.2	0.0	0.0	0.0	0.9	0.6	0.0	0.4	0.7	0.2	0.0	1.9	0.0	2.8	0.0	9.3	0.0	0.0	6.9	0.6	0.5	0.0	3.4	0.0	0.0	0.0	1.4	22.7	0.3	0.0	0.1	1.5	0.0	1.1	0.0	0.9	0.1	1.3	1.0	0.0	16.3	0.0	0.0	0.0	3.4	0.0	0.0	0.0	3.6	0.7	0.0	0.0	1.3	0.4	0.0	7.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.8	2.7	4.2	2.2	2.2	2.9	3.1	2.9	2.5	2.9	3.0	7.7	3.2	5.3	1.0	0.0	3.1	0.8	1.7	27.3	0.1	0.8	5.2	24.9	0.0	4.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	2.9	3.4	117.1	8.0	0.0	0.0	5.3	0.0	0.1	15.9	0.0	2.7	0.0	14.3	0.0	0.0	0.6	0.0	22.5	0.0	0.0	0.0	3.9	3.5	43.8	0.8	3.6	9.4	0.0	0.1	0.0	2.0	1.0	0.2	0.0	68.1	0.0	1.4	0.0	0.5	0.0	0.5	52.6	0.6	108.6	0.7	0.7	7.1	2.7	0.1	0.9	0.3	0.0	0.4
EDNRB	"ETB, HSCR, HSCR2"	ENSG00000136160	"Endothelin receptor type B"	P24530	13	77895481-77975529	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Albinism, Deafness, Disease variant, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 127.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 120.5;Astrocytes: 126.3;Hepatic stellate cells: 112.5;Melanocytes: 110.3;Muller glia cells: 116.2;Sertoli cells: 216.9;Skeletal myocytes: 81.3;Smooth muscle cells: 102.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 127.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 68.0;ASC diff: 50.5;SK-MEL-30: 66.0;U-266/70: 40.7;WM-115: 131.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017842, HPA027546"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Cytosol	"CAB017842: , HPA027546: AB_2672327"	"unprognostic (7.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.59e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (4.17e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.01e-2)"	"prognostic favorable (7.20e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.77e-3)"	58.8	41.2	34.7	19.5	50.8	0.9	39.8	44.6	26.1	18.7	6.7	13.0	20.0	13.1	3.7	8.2	14.1	14.9	28.1	27.5	51.6	33.0	50.9	51.2	10.4	76.2	66.0	4.7	11.4	15.3	9.6	127.8	47.9	25.3	13.2	17.9	27.0	6.9	11.3	12.5	21.9	12.9	97.2	16.8	10.6	2.3	64.9	4.0	31.8	18.8	4.7	23.6	15.5	78.7	5.7	0.0	68.0	0.0	50.5	2.0	1.0	0.0	0.1	0.0	0.0	25.9	0.0	0.0	2.6	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.3	0.3	0.0	0.0	3.5	0.0	0.2	13.2	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.2	1.7	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.1	0.5	0.1	0.0	66.0	8.9	0.0	0.3	0.3	0.6	0.1	0.0	0.4	40.7	24.9	0.1	1.2	0.0	131.8	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	34.7	50.8	44.6	26.1	27.5	51.6	76.2	66.0	47.9	97.2	64.9	78.7	120.5	12.8	51.0	126.3	0.2	14.8	1.0	0.0	1.2	5.8	1.2	2.8	10.8	0.0	2.5	0.0	6.2	14.7	0.3	0.1	0.0	0.0	2.9	2.9	20.7	73.3	0.0	0.0	1.3	0.0	13.9	51.1	1.1	35.9	6.3	2.1	112.5	1.1	13.4	0.0	1.6	0.0	0.0	18.7	10.6	2.2	79.9	5.2	110.3	6.5	0.1	116.2	0.0	48.2	0.9	0.1	0.0	2.6	0.1	2.6	0.0	0.1	1.5	4.4	216.9	81.3	102.1	0.4	2.1	0.2	7.2	5.7	1.6	2.5	0.0	1.5
EGFLAM	"AGRINL, AGRNL, FLJ39155, PIKA"	ENSG00000164318	"EGF like, fibronectin type III and laminin G domains"	Q63HQ2	5	38258409-38465480	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 121.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 120.9;Early spermatids: 50.7;Late spermatids: 49.1;Leydig cells: 155.4;Sertoli cells: 85.5;Smooth muscle cells: 70.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 6.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 10.2;HBEC3-KT: 12.6;hTERT-HME1: 16.4;HUVEC TERT2: 16.1;LHCN-M2: 37.0;U-2 OS: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA066577	Approved				"Secreted - unknown location"	NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA066577: "	"unprognostic (2.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.63e-3)"	"unprognostic (6.31e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (7.02e-6)"	"unprognostic (2.60e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.04e-2)"	41.7	19.8	2.0	2.8	2.5	0.2	47.1	1.9	2.3	15.6	3.5	6.1	1.9	5.6	6.8	4.0	8.2	4.9	26.2	1.5	2.4	6.9	4.7	2.9	14.2	3.2	4.2	23.7	3.1	4.0	5.8	51.6	3.6	14.2	3.2	66.7	6.9	20.6	72.0	5.9	4.7	6.7	1.6	9.8	3.4	15.0	3.6	20.4	9.0	121.2	9.1	7.7	13.0	2.5	3.2	0.0	6.5	0.2	0.8	0.2	0.0	2.9	0.0	0.5	0.1	0.0	0.0	0.1	10.2	0.1	0.1	0.0	0.0	12.6	0.0	0.0	1.6	0.0	6.1	0.0	2.8	0.0	0.1	5.4	0.0	0.1	16.4	0.0	16.1	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	3.9	0.0	3.7	0.1	1.3	0.0	0.2	0.0	0.1	15.6	0.6	0.2	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.5	1.9	2.3	1.5	2.4	3.2	4.2	3.6	1.6	3.6	2.5	11.4	0.0	0.0	0.3	0.0	2.7	0.3	0.0	0.0	1.3	2.4	9.8	2.6	0.0	0.0	0.0	120.9	0.3	0.4	0.0	3.9	0.5	50.7	0.2	3.2	5.4	0.0	0.0	0.6	1.0	0.5	17.8	0.0	0.3	0.0	1.6	1.4	0.0	0.7	0.0	0.9	0.0	0.0	0.0	4.2	49.1	155.4	0.6	5.4	1.9	0.0	3.4	0.0	1.0	0.1	1.3	0.0	30.9	0.0	0.2	0.0	6.5	0.0	33.1	85.5	22.0	70.9	9.8	3.3	0.3	2.0	0.5	0.4	23.5	0.0	0.3
EHD2	PAST2	ENSG00000024422	"EH domain containing 2"	Q9NZN4	19	47713422-47743134	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 161.9;Leydig cells: 99.1;Peritubular cells: 107.2;Sertoli cells: 236.7;Smooth muscle cells: 139.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 312.2;BJ: 238.5;fHDF/TERT166: 258.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047394, HPA049890, HPA049986, HPA066751"	Approved		Supported	"Plasma membrane"		NA	NA		1500000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"HPA047394: AB_2680026, HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.33e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.70e-3)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (5.49e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (6.59e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.06e-3)"	195.0	59.9	18.4	32.8	17.6	0.4	133.9	16.5	21.2	110.3	11.9	116.1	14.3	119.9	13.2	53.5	75.4	31.2	85.9	15.9	17.1	24.4	14.4	102.8	9.1	23.3	19.3	68.3	28.2	6.2	12.6	50.3	20.0	62.2	14.7	3.0	34.2	51.1	39.6	54.7	54.5	79.6	17.2	40.3	56.3	11.2	24.1	5.1	49.5	28.2	8.3	112.3	88.8	15.8	62.7	142.7	0.1	1.7	312.2	236.0	0.2	238.5	114.0	86.0	70.0	9.3	31.2	0.0	0.3	258.6	20.3	78.1	1.5	126.5	51.9	0.1	0.8	8.4	78.4	0.7	197.0	0.0	16.6	230.1	109.5	72.5	70.6	113.7	168.4	0.7	26.6	0.2	91.7	11.4	13.3	0.7	1.8	9.2	25.9	1.4	10.0	0.2	69.5	2.9	0.1	0.8	212.5	8.2	6.2	19.1	20.2	4.3	192.6	128.0	27.8	112.5	52.2	0.2	0.2	0.2	119.3	3.3	27.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	18.4	17.6	16.5	21.2	15.9	17.1	23.3	19.3	20.0	17.2	24.1	15.8	161.9	60.9	20.6	10.7	0.3	20.3	29.4	31.0	12.5	5.5	7.3	10.8	11.6	10.0	22.5	5.5	0.0	1.1	0.8	0.1	0.0	21.2	0.6	3.4	60.5	75.4	0.0	8.6	4.0	14.1	1.6	55.8	5.1	4.5	2.5	24.7	48.9	3.1	1.9	0.0	0.9	0.0	2.0	1.3	8.8	4.3	99.1	1.6	8.8	7.5	0.6	1.8	0.0	3.5	0.3	31.1	0.0	107.2	0.1	28.8	0.0	0.1	5.5	0.8	236.7	24.8	139.4	0.9	3.0	15.8	13.5	1.5	1.5	27.2	0.0	33.4
EPB41L1	"4.1N, KIAA0338"	ENSG00000088367	"Erythrocyte membrane protein band 4.1 like 1"	Q9H4G0	20	36091504-36232799	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 156.4;Inhibitory neurons: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 1.0"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 1.0"	"Cell line enhanced"	"Detected in many"		"A549: 163.5;HaCaT: 237.9;OE19: 192.9;SK-BR-3: 185.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054104, HPA056817"	Enhanced		Supported	"Plasma membrane"		NA	NA		33000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"HPA054104: AB_2682380, HPA056817: AB_2683244"	"unprognostic (2.01e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (9.30e-4)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.39e-10)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.26e-2)"	55.1	122.1	68.6	8.1	73.8	0.4	25.7	66.0	97.2	37.7	0.0	31.2	13.8	27.9	31.0	46.3	45.3	40.3	21.3	64.7	81.7	64.7	8.9	30.1	4.4	101.5	80.3	41.8	29.3	37.0	21.1	21.8	94.0	26.9	20.9	39.5	56.6	42.6	12.0	14.2	16.7	27.2	53.0	8.1	64.2	18.3	75.0	4.5	24.8	15.4	14.0	40.7	31.7	79.9	53.5	163.5	57.7	21.5	36.8	22.8	53.8	16.8	37.7	35.1	27.9	108.7	93.7	3.0	26.4	52.7	71.7	237.9	26.7	19.6	26.2	0.5	14.9	0.4	52.7	107.6	11.3	0.2	19.4	19.9	9.4	32.9	2.7	44.7	8.6	13.0	2.7	41.5	30.5	34.2	1.8	0.9	21.4	192.9	49.9	2.6	16.0	66.3	30.5	84.6	20.1	24.5	74.9	185.6	6.4	43.9	45.8	2.4	7.3	40.9	43.0	20.8	3.7	50.3	19.0	0.6	71.2	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	68.6	73.8	66.0	97.2	64.7	81.7	101.5	80.3	94.0	53.0	75.0	79.9	14.5	16.0	22.1	27.7	0.4	2.9	5.0	11.1	30.7	31.9	12.8	9.4	8.5	28.6	16.5	47.8	156.4	1.5	0.8	23.8	19.6	22.2	2.9	10.6	8.7	9.2	15.5	0.0	56.8	10.8	0.5	11.0	50.4	7.5	52.5	13.3	10.0	3.7	6.9	32.0	75.7	6.0	4.1	1.3	2.2	2.7	15.8	6.0	3.6	3.7	0.0	22.7	0.0	24.6	73.1	31.6	15.7	42.2	2.1	5.1	8.0	37.1	21.9	8.7	32.9	6.8	35.1	4.6	7.1	43.2	1.7	1.1	0.8	7.1	13.2	18.0
EVA1B	"C1orf78, FAM176B, FLJ10647"	ENSG00000142694	"Eva-1 homolog B"	Q9NVM1	1	36322031-36324154	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 143.9;Extravillous trophoblasts: 250.3;Syncytiotrophoblasts: 161.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 23.3;BJ: 29.0;BJ hTERT+: 22.4;HSkMC: 20.4;NB-4: 41.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041928, HPA043537"	Approved		Approved	Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA041928: AB_2677752, HPA043537: AB_2678538"	"prognostic favorable (4.58e-4)"	"unprognostic (5.66e-3)"	"unprognostic (1.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.22e-2)"	"unprognostic (4.00e-3)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (4.79e-5)"	"unprognostic (1.87e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.02e-1)"	26.8	19.4	5.5	3.4	5.4	2.0	35.8	5.5	6.4	41.8	7.5	19.8	2.5	34.0	0.6	12.2	21.9	1.3	19.9	5.0	5.9	39.2	8.5	26.1	1.9	6.8	6.4	30.2	7.8	1.9	9.4	9.0	6.0	29.0	0.4	0.0	28.7	2.9	5.7	24.0	15.8	1.6	7.0	37.6	14.2	7.5	6.6	0.5	33.9	1.0	0.5	22.0	30.1	5.7	0.7	2.7	1.6	3.0	7.9	23.3	6.8	29.0	22.4	5.4	6.3	0.2	2.1	0.0	8.5	9.2	1.0	0.2	0.2	1.1	1.1	3.3	6.0	3.6	0.6	1.3	17.4	0.1	0.6	20.4	0.0	6.9	0.3	0.9	8.7	0.1	1.4	1.0	3.6	0.2	0.1	41.7	1.7	0.0	10.4	1.5	0.3	7.1	4.6	0.0	0.1	3.9	2.8	1.1	13.3	1.1	0.0	2.7	12.7	7.9	0.0	10.5	2.7	0.3	0.0	0.1	2.9	1.8	7.1	4.0	0.9	0.0	0.2	0.3	0.6	0.0	0.3	0.5	0.5	0.0	0.0	0.0	1.7	1.6	0.1	0.0	1.2	0.1	5.5	5.4	5.5	6.4	5.0	5.9	6.8	6.4	6.0	7.0	6.6	5.7	82.8	0.0	0.0	2.3	6.2	16.2	19.3	7.3	0.0	0.0	143.9	90.6	2.2	1.5	5.1	7.3	0.0	54.7	8.4	0.3	1.9	20.2	7.1	9.4	88.4	53.9	0.0	0.8	0.0	15.2	250.3	56.6	0.0	15.2	4.5	15.7	84.9	0.9	48.7	0.0	0.0	0.1	6.1	41.3	28.8	24.8	50.7	30.4	12.4	5.6	10.2	14.1	4.1	0.0	0.1	28.9	1.1	48.5	7.9	56.6	0.4	7.7	5.6	0.9	26.3	7.8	98.4	8.4	3.3	0.7	12.4	161.3	9.7	58.2	0.5	30.3
EXOC1	"BM-102, FLJ10893, SEC3, SEC3L1, Sec3p"	ENSG00000090989	"Exocyst complex component 1"	Q9NV70	4	55853648-55905086	"Predicted intracellular proteins, Transporters"	"Antiviral defense, Exocytosis, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037706, HPA044873"	Uncertain		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Microtubules, Cytosol"	"HPA037706: AB_10670525, HPA044873: AB_2679125"	"unprognostic (7.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (8.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (2.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.24e-2)"	"prognostic favorable (5.50e-5)"	19.7	16.5	18.1	17.3	20.4	12.7	20.0	20.4	20.0	18.9	18.7	18.0	16.8	16.6	20.4	29.3	16.5	15.5	16.5	18.3	20.0	15.9	10.2	17.4	18.3	21.1	19.2	15.1	12.9	20.5	14.5	20.8	20.3	14.3	19.1	18.5	17.4	12.8	13.6	28.1	16.2	15.7	20.4	20.8	15.6	16.9	20.1	13.9	16.3	13.5	20.0	16.2	20.1	25.1	21.8	12.4	21.9	25.3	36.9	45.9	14.6	30.2	30.1	24.1	25.1	8.6	37.1	20.9	20.6	32.6	29.1	25.4	18.0	23.9	34.5	11.1	12.4	19.4	14.8	10.1	34.7	21.3	26.4	37.4	32.1	25.1	27.6	31.2	39.9	16.0	28.3	20.1	53.0	13.8	15.6	21.5	13.9	31.2	23.4	18.0	16.4	17.1	26.9	23.6	16.2	28.7	18.0	29.2	25.5	18.5	18.6	22.6	48.5	29.7	24.2	25.8	26.3	23.9	12.7	18.4	38.6	23.4	28.8	21.3	14.6	13.1	6.5	19.0	8.8	8.4	9.2	9.5	14.3	8.3	8.3	6.0	19.5	12.5	23.6	6.4	11.6	7.9	18.1	20.4	20.4	20.0	18.3	20.0	21.1	19.2	20.3	20.4	20.1	25.1	44.7	41.7	38.0	77.4	24.5	34.8	14.8	34.0	22.2	48.8	26.4	21.2	29.1	17.2	35.6	22.0	31.3	60.8	21.4	38.3	19.6	23.6	45.3	41.0	47.5	39.0	22.2	19.6	72.6	20.0	31.6	28.9	22.4	37.2	36.7	35.5	40.0	12.3	40.9	28.6	86.5	28.8	24.4	37.7	47.4	16.7	21.5	37.8	40.9	56.2	38.7	40.3	22.6	73.4	138.0	36.2	32.4	23.7	19.0	17.4	37.6	21.9	44.7	32.5	32.9	25.9	27.9	47.6	31.6	42.5	39.9	51.2	27.8	44.6	28.7	26.8
F2RL2	PAR3	ENSG00000164220	"Coagulation factor II thrombin receptor like 2"	O00254	5	76615482-76623413	"G-protein coupled receptors, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.9;gallbladder: 6.8"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 2.3;Fibroblasts: 3.9;Hepatic stellate cells: 10.0;Rod photoreceptor cells: 5.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 9.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	9	"basophil: 10.4"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 10.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 53.5;HBF TERT88: 33.8;HEL: 78.4;hTEC/SVTERT24-B: 34.8;hTERT-RPE1: 73.2;U-138 MG: 54.0;WM-115: 69.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (1.35e-3)"	"unprognostic (5.71e-3)"	"prognostic favorable (4.69e-4)"	"unprognostic (6.71e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.56e-2)"	"unprognostic (9.71e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.24e-8)"	"unprognostic (7.64e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	0.3	0.4	1.2	1.8	1.5	0.3	3.8	4.4	0.2	1.3	0.1	3.5	1.6	2.3	0.1	0.8	0.3	6.8	1.8	0.2	4.4	0.3	2.0	0.6	0.1	3.9	4.7	0.1	1.0	0.3	0.4	0.2	2.9	0.3	1.7	5.0	3.7	0.1	0.0	2.3	2.3	3.8	2.3	0.3	1.3	0.0	6.9	0.8	0.2	0.5	0.3	1.0	0.3	0.5	0.0	2.0	0.2	0.2	2.3	12.1	0.0	31.3	53.5	8.3	30.0	0.0	0.1	0.0	1.8	0.2	24.8	0.1	0.0	0.2	33.8	0.0	0.1	78.4	0.7	0.2	4.7	0.1	0.1	6.7	0.2	34.8	0.1	73.2	2.9	0.2	0.0	0.1	3.0	0.0	0.0	0.0	2.8	0.0	0.3	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	54.0	16.2	2.4	0.4	2.7	0.0	0.0	6.4	0.0	69.8	10.4	0.4	0.1	0.7	0.2	0.6	0.1	0.7	0.4	0.1	0.1	0.3	0.7	0.9	1.1	0.1	1.1	0.9	0.0	1.2	1.5	4.4	0.2	0.2	4.4	3.9	4.7	2.9	2.3	6.9	0.5	0.0	0.0	0.0	0.3	0.3	0.9	0.1	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	1.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	2.3	1.0	0.0	0.0	0.2	0.0	0.0	3.9	1.1	0.3	0.0	0.0	10.0	0.3	0.1	0.0	0.3	0.0	0.0	1.2	1.1	0.0	0.0	0.3	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.5	0.0	0.0	0.1	0.6	0.0	0.9	0.0	0.0	0.1
F8A2		ENSG00000274791	"Coagulation factor VIII associated 2"	P23610	X	155382115-155383230	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	114	"brain: 11.4"	"Cell type enhanced"	"Detected in single"		"Melanocytes: 1.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	10	"medulla oblongata: 11.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 48: Smooth muscle cells - ECM organization"								"unprognostic (2.04e-2)"					"unprognostic (5.07e-1)"				"unprognostic (8.70e-2)"				0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	11.4	0.9	0.3	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
FAM162B	"bA86F4.2, C6orf189"	ENSG00000183807	"Family with sequence similarity 162 member B"	Q5T6X4	6	116752197-116765719	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 65.2"	"Group enriched"	"Detected in some"	4	"Adipocytes: 34.6;Sertoli cells: 65.7;Smooth muscle cells: 105.1"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 32.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 8.7;BJ hTERT+: 23.5;BJ hTERT+ SV40 Large T+ RasG12V: 22.1;HHSteC: 6.3;HSkMC: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036112, HPA060342"	Enhanced					NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA036112: AB_10696649, HPA060342: AB_2684258"	"unprognostic (1.81e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.86e-5)"	"unprognostic (8.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.32e-2)"	"unprognostic (6.27e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-3)"	"unprognostic (4.34e-2)"	14.7	14.9	3.3	0.8	4.4	0.0	10.9	1.9	7.0	13.2	2.5	3.3	0.9	5.8	7.5	4.4	10.1	5.2	9.1	4.6	2.7	4.5	0.9	17.9	1.5	3.0	2.5	5.7	1.7	3.7	6.6	65.2	2.7	6.2	2.1	0.2	8.2	13.4	5.4	3.0	2.3	3.7	2.7	0.1	3.5	2.5	2.8	1.8	9.7	10.6	1.2	7.9	9.9	4.7	0.0	0.0	0.0	0.0	2.3	0.1	0.0	8.7	23.5	3.7	22.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.4	1.9	7.0	4.6	2.7	3.0	2.5	2.7	2.7	2.8	4.7	34.6	0.0	0.0	1.3	0.0	1.3	0.1	0.0	1.2	0.0	0.9	0.8	0.9	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	16.9	0.7	15.7	13.7	0.0	0.0	14.8	0.0	0.2	14.1	0.0	0.4	0.0	0.1	3.6	0.0	0.5	0.0	6.9	0.0	0.0	0.0	2.1	2.2	2.1	0.7	1.8	3.7	0.0	0.0	0.0	6.6	0.5	0.2	0.0	5.3	0.0	0.2	0.0	0.1	0.0	0.1	65.7	2.2	105.1	10.3	5.9	0.6	0.9	0.5	2.3	0.1	0.0	0.0
FBXL22	"Fbl22, FLJ39626"	ENSG00000197361	"F-box and leucine rich repeat protein 22"	Q6P050	15	63597353-63602428	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 60.4;intestine: 60.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MCF7: 4.9;SCLC-21H: 5.3;U-937: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA047624, HPA054627"	Uncertain		Uncertain	Nucleoli,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoli, Cytosol"		"HPA047624: AB_2680107, HPA054627: AB_2682548"	"unprognostic (2.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	3.6	0.9	1.9	2.8	1.7	0.3	1.8	2.7	2.0	15.7	0.2	60.1	2.9	60.4	3.6	7.0	21.2	8.8	17.2	1.6	1.3	1.0	0.5	1.1	0.9	0.8	1.1	4.5	0.7	0.6	0.7	0.9	0.9	16.9	4.8	0.6	3.2	29.4	4.9	1.4	7.3	28.9	0.5	0.6	11.1	3.0	1.8	0.4	1.5	1.8	0.2	26.3	10.1	1.0	0.7	1.2	0.2	0.8	0.5	0.5	0.1	0.2	0.0	0.3	0.0	0.8	0.9	0.3	0.7	0.2	0.4	0.8	0.6	0.4	0.0	0.8	0.6	0.3	1.1	2.2	0.1	0.4	0.1	0.2	0.2	0.1	0.5	0.1	0.2	2.2	0.0	1.1	0.0	4.9	0.7	0.7	1.7	0.8	0.4	0.7	0.0	2.4	0.3	0.3	5.3	0.2	0.6	1.0	0.3	0.0	1.9	0.6	0.8	0.3	1.0	0.5	0.2	0.7	1.5	0.8	0.5	3.7	0.8	0.2	0.0	0.0	0.5	0.0	0.5	0.6	0.6	0.6	0.0	0.4	1.0	0.4	0.1	0.7	0.0	1.6	0.0	0.2	1.9	1.7	2.7	2.0	1.6	1.3	0.8	1.1	0.9	0.5	1.8	1.0	1.4	0.0	0.0	1.0	3.4	0.1	1.8	0.4	0.6	10.1	4.7	8.6	7.7	2.8	0.7	7.3	4.2	0.7	2.7	2.3	9.8	1.2	0.9	3.2	5.8	1.3	4.9	2.5	1.5	1.1	1.2	3.4	7.7	5.8	0.0	0.9	3.9	4.0	0.7	0.0	1.8	6.1	0.0	1.6	0.4	0.5	0.3	1.7	0.0	0.0	0.7	10.6	2.1	1.5	0.5	0.8	3.0	11.3	9.1	1.7	1.9	4.0	0.1	3.8	0.0	6.2	8.1	3.8	3.2	4.4	0.9	0.5	4.4	2.7	4.0	0.8
FBXO17	"FBG4, Fbx17, FBXO26, FLJ11798, FLJ25205, MGC9379"	ENSG00000269190	"F-box protein 17"	Q96EF6	19	38941401-38975742	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 67.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 56.7;Hepatocytes: 58.5;Leydig cells: 83.0;Peritubular cells: 74.1;Proximal tubular cells: 70.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 18.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 37.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (1.68e-1)"	"unprognostic (2.62e-2)"	"unprognostic (6.97e-3)"	"prognostic unfavorable (5.67e-4)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.56e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (5.34e-2)"	"unprognostic (4.06e-4)"	"unprognostic (2.77e-3)"	22.9	5.2	5.7	1.7	5.1	0.4	17.5	7.7	5.5	28.1	4.6	18.7	2.1	25.1	5.9	7.3	20.8	4.7	12.8	4.9	4.7	42.8	67.9	10.3	1.5	4.3	4.3	33.6	11.7	4.8	9.1	2.9	4.4	18.5	1.5	3.8	7.1	7.6	3.1	13.9	6.9	9.2	3.9	4.4	10.2	4.4	5.6	0.8	5.5	1.9	1.2	18.1	18.8	4.0	19.7	37.3	0.1	23.4	16.7	11.7	0.5	7.7	7.8	9.8	11.8	17.0	0.3	0.4	6.3	12.6	19.2	5.3	4.2	5.5	8.9	0.1	14.9	0.1	2.8	19.5	10.9	0.2	0.6	10.2	4.6	16.5	7.7	18.9	13.1	0.1	21.5	0.1	10.1	9.8	0.1	0.3	7.9	0.0	0.1	0.0	0.1	0.1	11.8	0.1	0.2	15.3	10.9	0.0	9.1	5.4	9.5	0.3	3.9	24.4	17.8	10.1	10.5	0.3	1.1	0.1	21.7	0.1	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	5.7	5.1	7.7	5.5	4.9	4.7	4.3	4.3	4.4	3.9	5.6	4.0	5.3	0.0	1.1	15.0	0.2	18.7	11.3	9.9	33.0	4.1	3.0	14.4	3.1	17.2	5.4	14.7	35.5	6.9	0.2	0.1	56.7	6.7	4.1	0.6	29.6	8.1	0.0	0.0	14.5	2.0	5.4	34.1	0.0	0.5	0.0	20.1	14.6	58.5	38.8	5.0	19.2	0.0	8.2	0.8	8.5	3.4	83.0	1.9	19.6	13.1	0.0	10.2	0.0	16.1	2.0	2.0	0.0	74.1	1.2	15.8	0.0	70.3	2.0	13.0	52.6	20.6	19.8	0.7	4.4	10.0	17.5	5.1	0.9	16.1	0.0	4.1
FERMT2	"KIND2, mig-2, PLEKHC1, UNC112B"	ENSG00000073712	"Fermitin family member 2"	Q96AC1	14	52857268-52952435	"Predicted intracellular proteins"	"Cell adhesion, Cell shape, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040505, HPA072965"	Uncertain		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		230000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Focal adhesion sites"	"Nucleoplasm, Cytosol"	"HPA040505: AB_10673300, HPA072965: "	"unprognostic (4.38e-2)"	"unprognostic (4.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.96e-3)"	"unprognostic (7.69e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.73e-3)"	148.4	21.2	28.7	38.8	31.6	0.5	57.6	29.0	37.3	44.7	18.0	104.3	13.1	105.1	26.3	46.8	55.7	65.7	66.9	31.0	27.4	55.4	108.3	47.9	15.3	35.7	29.1	43.6	20.6	18.4	13.1	116.5	33.5	69.1	33.3	29.5	22.6	117.9	48.8	13.4	29.3	155.6	30.6	37.6	46.4	15.5	27.6	6.9	35.9	69.6	6.6	77.7	29.1	38.1	22.8	18.9	101.6	46.8	163.7	133.7	84.6	148.4	95.2	172.3	107.9	34.1	17.6	0.1	49.4	153.1	33.8	9.6	80.1	11.1	128.3	0.2	22.6	31.9	83.1	40.3	209.6	0.4	12.6	129.4	23.5	95.3	125.4	78.5	91.2	16.8	0.6	153.4	131.7	28.0	7.7	0.5	64.3	0.2	51.3	3.9	103.8	0.4	60.9	20.6	6.2	130.5	157.8	35.0	37.7	103.3	30.1	1.1	115.2	134.5	92.4	108.2	56.0	22.6	29.4	0.6	30.9	0.2	33.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	31.6	29.0	37.3	31.0	27.4	35.7	29.1	33.5	30.6	27.6	38.1	152.7	76.9	42.0	116.5	1.0	18.6	150.6	15.5	13.6	39.5	33.8	41.4	65.8	24.3	25.6	40.5	37.5	74.8	2.3	0.2	31.3	48.5	68.2	20.1	141.7	110.4	0.0	2.7	13.7	33.2	178.1	103.9	3.6	40.2	58.3	31.6	110.3	82.3	10.4	15.2	16.1	0.5	4.1	8.9	19.5	27.9	74.9	4.4	46.2	29.0	4.8	52.3	1.0	41.2	92.0	27.6	0.1	174.9	4.5	40.0	0.0	44.7	10.1	56.0	151.2	83.4	174.1	4.1	16.2	2.2	8.1	102.6	7.9	12.3	0.4	37.0
FKBP1C	bA184C23.2	ENSG00000198225	"FKBP prolyl isomerase 1C"		6	63211446-63213024	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 9.9;Cardiomyocytes: 11.7;Langerhans cells: 12.0;Melanocytes: 8.8;Suprabasal keratinocytes: 15.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.0;granulocytes: 4.4;monocytes: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA051798	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"		"Cluster 48: Smooth muscle cells - ECM organization"			"HPA051798: AB_2681615"	"unprognostic (6.64e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.91e-5)"	"unprognostic (4.78e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.79e-2)"	"unprognostic (8.54e-2)"	"unprognostic (9.95e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.73e-1)"	1.5	0.9	0.0	0.2	0.0	0.0	1.0	0.0	0.1	0.4	0.0	0.7	0.0	0.8	0.0	0.8	0.5	0.0	0.9	0.0	0.0	0.8	0.4	1.3	0.0	0.0	0.0	0.6	0.5	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.7	0.6	0.5	0.0	0.0	0.8	0.6	0.2	0.0	0.0	1.0	0.0	0.0	0.5	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	0.4	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.2	0.8	0.0	0.1	0.1	0.4	0.4	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	1.3	3.3	4.4	0.4	5.1	0.4	0.6	0.5	0.5	3.0	0.6	0.6	0.7	2.7	0.7	4.7	1.2	1.0	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.3	9.9	3.1	3.4	0.0	0.0	0.1	0.0	11.7	1.5	0.9	1.8	0.0	1.5	0.0	1.0	0.0	0.1	1.2	0.2	0.5	6.1	0.0	0.0	0.0	0.0	3.3	3.3	0.0	0.3	1.3	0.1	3.3	0.6	3.9	0.0	0.0	0.0	6.1	3.1	12.0	1.8	0.9	1.5	8.8	0.0	1.4	0.0	1.0	0.0	0.0	0.2	2.4	0.4	0.0	2.0	0.5	0.6	2.5	0.0	0.0	1.0	3.9	3.0	2.1	0.0	15.9	0.8	0.6	0.3	0.4	2.0
FLNA	"ABP-280, FLN, FLN1, OPD1, OPD2"	ENSG00000196924	"Filamin A"	P21333	X	154348524-154374634	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation"	Actin-binding	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 1203.7;intestine: 1462.2"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 500.6;Sertoli cells: 420.7;Smooth muscle cells: 459.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000356, HPA000368, HPA001016, HPA001115, HPA002925"	Enhanced	Approved	Enhanced	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		730000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Actin filaments, Cytosol"		"CAB000356: , HPA000368: AB_2797215, HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869"	"unprognostic (1.39e-1)"	"unprognostic (9.40e-3)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (5.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.88e-4)"	267.4	55.9	14.4	223.2	18.5	157.9	164.2	15.2	43.0	392.1	54.7	1462.2	89.9	1203.7	35.5	454.7	609.4	137.9	108.4	14.8	23.0	70.5	21.2	238.9	65.0	39.9	19.9	236.7	50.5	13.4	30.5	79.2	24.4	369.2	86.9	9.0	80.3	617.2	49.7	124.7	354.6	706.6	21.1	102.7	508.0	33.7	34.0	48.1	85.6	31.2	38.1	1053.9	286.4	21.5	947.2	719.2	246.7	316.1	209.8	278.4	400.9	614.0	680.1	552.5	489.8	469.2	169.4	80.5	1551.4	966.4	970.1	528.3	224.0	538.1	152.7	333.6	77.8	262.2	914.9	159.7	375.9	309.3	324.9	266.1	126.1	825.5	327.0	533.8	417.1	94.9	74.7	538.7	401.3	210.7	148.5	93.1	258.3	97.9	470.9	147.8	221.2	71.6	197.2	193.4	52.9	119.7	515.8	80.2	381.1	187.3	79.1	96.3	1016.6	625.2	586.8	640.0	1147.1	333.7	212.8	162.3	580.3	202.4	638.7	7.6	24.9	11.8	32.6	23.1	21.2	10.2	15.6	29.2	22.4	4.6	6.0	14.3	3.6	10.5	34.2	2.7	20.7	56.2	14.4	18.5	15.2	43.0	14.8	23.0	39.9	19.9	24.4	21.1	34.0	21.5	105.1	57.7	38.7	30.0	76.9	124.3	85.9	127.8	85.4	3.5	40.9	153.5	34.5	38.6	26.1	35.0	0.0	24.6	257.7	2.6	1.9	272.0	2.1	33.8	186.3	107.0	1.8	39.7	11.8	133.1	90.9	137.9	13.3	55.8	26.0	334.5	81.8	4.3	120.3	11.8	8.6	2.5	22.4	141.0	263.0	13.7	122.4	227.7	88.9	30.9	207.9	39.4	270.8	8.0	2.6	347.4	1.5	500.6	98.7	96.1	1.9	3.0	9.1	4.3	420.7	118.3	459.3	4.1	8.9	48.8	73.6	20.0	172.3	134.7	3.3	35.3
FOXC2	"FKHL14, MFH-1"	ENSG00000176692	"Forkhead box C2"	Q99958	16	86566829-86569728	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 5.6"	"Group enriched"	"Detected in some"	4	"Peritubular cells: 30.9;Sertoli cells: 19.7;Smooth muscle cells: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 25.2;HUVEC TERT2: 19.5;LHCN-M2: 31.2;TIME: 36.0;U-138 MG: 18.4;U-2197: 31.5;U-87 MG: 24.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"spinal cord: 42.7"	HPA056302			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nuclear bodies"		"HPA056302: AB_2683093"	"unprognostic (3.17e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.57e-7)"	"unprognostic (1.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.84e-4)"	2.4	1.5	0.5	0.3	1.1	0.0	1.8	0.9	1.6	2.2	3.2	0.5	0.1	0.8	0.6	0.5	2.0	1.3	5.6	0.4	0.4	5.4	0.1	2.1	0.4	0.5	0.5	1.1	0.2	0.1	2.4	0.1	0.5	1.0	0.1	0.1	2.4	0.6	0.7	0.8	0.4	0.4	0.7	0.0	0.4	1.9	0.7	0.1	2.0	0.5	0.1	0.8	1.5	0.3	0.0	0.0	0.0	0.0	5.8	7.8	0.0	11.3	14.3	8.0	1.5	0.0	0.0	0.0	1.5	1.4	11.2	0.0	0.2	3.3	7.0	0.0	0.6	0.0	7.9	0.0	2.7	0.0	0.0	1.3	3.4	25.2	7.9	14.5	19.5	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	1.7	0.0	0.1	0.1	0.0	0.0	1.8	0.0	0.0	5.9	0.0	0.0	36.0	18.4	0.0	31.5	0.0	0.0	0.0	0.0	24.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.9	1.6	0.4	0.4	0.5	0.5	0.5	0.7	0.7	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.8	2.1	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	5.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.6	1.5	0.1	1.8	1.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	30.9	1.2	0.8	0.0	0.0	0.0	0.1	19.7	0.6	33.2	0.2	5.0	0.5	0.0	0.0	0.0	0.0	0.1	1.4
FOXF1	"FKHL5, FREAC1"	ENSG00000103241	"Forkhead box F1"	Q12946	16	86510527-86515422	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 61.2;urinary bladder: 49.9"	"Group enriched"	"Detected in some"	4	"Endothelial cells: 17.1;Fibroblasts: 46.3;Smooth muscle cells: 18.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BJ: 12.8;BJ hTERT+: 27.9;HHSteC: 26.5;U-2197: 11.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028886			Approved	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA028886: AB_10601652"	"unprognostic (7.91e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.62e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.20e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.44e-1)"	3.6	0.2	6.0	10.2	5.3	0.0	1.2	4.8	5.4	16.2	2.9	61.2	8.9	2.7	1.1	10.1	1.8	15.0	0.8	4.5	4.8	2.1	3.2	34.1	3.2	5.9	5.2	0.7	1.3	1.1	0.4	23.1	6.0	25.8	10.8	0.2	1.2	5.4	0.2	0.3	21.2	11.7	5.1	0.6	26.3	0.7	7.0	0.1	5.4	1.4	1.5	49.9	11.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.8	27.9	3.8	1.3	0.0	0.1	0.0	0.0	1.2	2.6	0.0	2.2	0.0	3.3	0.0	1.5	0.0	2.1	0.0	26.5	0.0	2.3	2.8	0.0	4.5	0.5	0.4	4.7	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	4.4	0.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	1.9	11.9	0.0	0.0	0.0	0.0	2.5	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	5.3	4.8	5.4	4.5	4.8	5.9	5.2	6.0	5.1	7.0	5.1	2.0	0.0	0.6	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.4	0.3	17.1	0.0	0.0	0.0	0.0	0.4	46.3	1.1	0.2	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.2	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.0	0.0	0.0	0.0	0.4	0.0	0.1	18.7	0.0	1.3	0.6	0.3	1.2	0.1	0.1	0.0	0.6
FOXF2	"FKHL6, FREAC2"	ENSG00000137273	"Forkhead box F2"	Q12947	6	1389576-1395603	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.2"	"Cell type enhanced"	"Detected in some"		"Endothelial cells: 5.2;Fibroblasts: 7.9;Microglial cells: 19.7;Smooth muscle cells: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 70.4;HEK 293: 24.3;U-2197: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.53e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.76e-2)"	"unprognostic (8.75e-7)"	"unprognostic (1.03e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.29e-2)"	1.8	0.4	8.1	1.8	6.0	0.0	2.4	5.5	10.3	1.0	5.1	40.2	6.0	0.2	0.8	9.6	0.5	1.5	0.7	6.1	5.2	0.2	0.1	17.8	0.4	10.1	6.0	0.1	1.0	0.6	7.6	9.1	10.0	10.8	9.3	0.1	1.3	0.6	1.0	1.4	18.7	3.5	5.1	0.0	17.8	0.9	7.1	0.0	3.7	3.5	1.8	11.1	2.1	6.9	1.6	3.4	1.0	0.8	3.2	4.9	0.1	15.6	70.4	6.3	2.9	0.3	0.0	0.0	3.3	4.6	6.8	11.9	12.2	0.6	2.8	0.0	24.3	0.0	5.7	0.0	6.1	0.0	0.4	0.8	5.0	0.0	5.9	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.1	0.1	0.0	0.0	0.0	6.9	0.2	0.0	3.7	0.0	5.2	1.3	0.0	0.2	0.0	5.8	11.0	28.7	2.8	0.3	0.0	0.0	0.0	4.7	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	6.0	5.5	10.3	6.1	5.2	10.1	6.0	10.0	5.1	7.1	6.9	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.0	5.2	0.0	0.0	1.1	0.0	1.5	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.4	2.5	0.1	1.8	19.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	5.5	0.2	1.5	0.3	0.1	0.1	0.1	0.0	0.0	0.0
FOXL1	"FKH6, FKHL11, FREAC7"	ENSG00000176678	"Forkhead box L1"	Q12952	16	86576368-86583478	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Pancreatic endocrine cells: 10.4;Peritubular cells: 7.9;Sertoli cells: 6.6;Smooth muscle cells: 4.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 8.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.4;CAPAN-2: 31.9;hTEC/SVTERT24-B: 21.2;PC-3: 46.7;REH: 27.9;U-87 MG: 86.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"spinal cord: 5.0"							NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.21e-1)"	"unprognostic (3.31e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.79e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.36e-8)"	"unprognostic (1.50e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.17e-3)"	1.4	0.4	0.4	0.7	0.6	0.0	0.7	0.3	0.6	0.9	0.9	2.0	2.5	0.6	0.3	0.2	1.0	4.2	2.3	0.3	0.4	1.9	0.2	1.5	0.1	0.4	0.4	0.5	0.1	0.0	0.6	0.0	0.4	1.0	1.9	0.0	0.6	0.3	2.7	0.5	2.6	0.3	0.3	0.0	2.7	1.0	0.5	0.1	0.6	1.3	0.0	3.5	0.9	0.3	2.0	0.2	0.1	0.0	3.1	10.5	0.0	7.9	24.4	6.2	2.3	0.0	31.9	0.0	1.9	2.0	3.0	0.9	0.0	2.3	7.4	0.0	0.1	0.0	7.5	0.0	3.0	0.0	0.0	2.5	0.8	21.2	5.3	2.5	3.1	0.0	0.0	0.1	3.1	0.0	0.1	0.0	0.3	0.7	46.7	27.9	1.7	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	5.7	11.3	0.0	17.6	4.7	0.0	0.0	2.2	86.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.3	0.6	0.3	0.4	0.4	0.4	0.4	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	7.9	0.0	0.2	0.0	0.0	0.1	0.0	6.6	0.4	4.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3
FOXS1	"FKHL18, FREAC10"	ENSG00000179772	"Forkhead box S1"	O43638	20	31844303-31845604	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Peritubular cells: 56.8;Sertoli cells: 131.5;Smooth muscle cells: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.2;hTERT-RPE1: 13.1;RH-30: 10.9;U-2 OS: 14.1;U-251 MG: 4.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA042475	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA042475: AB_10964265"	"unprognostic (2.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (1.09e-3)"	"unprognostic (2.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.00e-2)"	4.5	1.6	2.4	1.4	2.4	0.0	2.8	2.6	3.8	3.7	1.7	1.4	0.3	3.9	2.4	1.0	1.9	2.0	9.7	2.2	2.3	5.4	0.8	5.3	2.5	2.6	2.5	2.0	0.9	0.6	2.3	4.8	2.7	2.4	0.6	0.0	1.1	3.1	1.7	1.5	1.4	1.2	2.2	3.0	1.2	5.5	2.6	1.0	3.5	1.7	0.9	2.6	2.4	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.9	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.1	0.0	14.1	0.0	4.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.4	2.6	3.8	2.2	2.3	2.6	2.5	2.7	2.2	2.6	2.3	4.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.2	0.0	1.1	2.6	0.0	0.0	0.0	0.5	0.0	7.2	0.0	0.1	0.0	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.9	4.9	5.0	0.2	1.8	8.4	0.0	0.0	0.0	0.0	0.0	5.7	0.0	56.8	0.0	0.1	0.0	0.0	0.0	0.1	131.5	0.4	31.5	0.6	0.5	0.1	0.3	0.3	0.1	6.6	0.0	0.1
FRMD3	"EPB41L4O, MGC20553"	ENSG00000172159	"FERM domain containing 3"	A2A2Y4	9	83242990-83538546	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 85.0;skeletal muscle: 81.2;tongue: 74.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 108.6;Cardiomyocytes: 73.7;Cone photoreceptor cells: 79.2;Early spermatids: 121.9;Horizontal cells: 101.0;Late spermatids: 122.8;Sertoli cells: 72.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 27.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.0;intermediate monocyte: 3.4;neutrophil: 2.5;non-classical monocyte: 1.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 2.5;monocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"HEL: 24.0;OE19: 49.2;RPMI-8226: 79.6;SCLC-21H: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017285	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	"Plasma membrane"	"HPA017285: AB_2669569"	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.87e-2)"	"prognostic favorable (7.24e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.68e-3)"	9.4	7.3	6.6	2.0	5.5	5.4	6.7	4.3	6.8	3.0	12.0	5.5	2.9	2.7	15.7	2.5	2.2	2.5	85.0	6.3	7.7	14.9	0.7	4.0	1.3	10.1	8.5	1.4	1.6	20.6	4.2	14.8	7.3	2.8	6.6	21.6	2.9	7.8	81.2	2.1	6.7	3.5	7.6	7.2	2.8	9.9	9.9	1.1	7.1	74.7	0.5	4.6	2.6	5.4	0.0	4.3	3.8	0.3	0.7	0.2	0.3	4.1	0.3	0.1	0.0	0.5	5.2	0.9	4.7	1.9	0.9	0.2	0.2	0.0	0.0	0.2	0.2	24.0	4.8	2.8	0.2	0.0	0.3	1.0	0.1	0.0	0.2	0.2	2.7	0.1	0.1	0.1	4.9	0.7	0.0	0.1	0.4	49.2	7.2	0.1	3.0	79.6	6.2	10.1	28.4	13.8	1.4	0.3	0.9	0.6	1.7	0.8	4.4	0.2	0.6	0.1	2.9	0.4	0.3	0.0	0.9	7.6	2.8	0.0	2.0	0.0	0.2	3.4	0.4	0.3	0.1	0.0	0.2	0.4	0.0	0.0	2.5	0.3	1.5	0.4	0.0	6.0	6.6	5.5	4.3	6.8	6.3	7.7	10.1	8.5	7.3	7.6	9.9	5.4	38.4	22.4	1.1	6.2	0.4	1.0	1.0	0.6	0.6	108.6	2.6	1.9	73.7	15.7	1.8	1.8	79.2	0.4	0.2	28.9	17.6	2.8	121.9	2.8	1.4	25.8	1.2	0.8	37.9	2.0	1.2	8.8	2.0	3.9	0.0	0.4	4.2	0.3	0.8	101.0	70.0	38.3	0.0	4.4	0.6	122.8	2.1	8.3	0.0	27.2	4.2	3.9	1.0	10.1	16.0	2.3	10.0	4.9	0.0	1.6	43.6	12.4	3.2	7.0	72.3	66.6	50.7	4.1	1.4	0.2	1.3	0.1	0.9	29.8	2.4	2.3
FXYD6		ENSG00000137726	"FXYD domain containing ion transport regulator 6"	Q9H0Q3	11	117836976-117877486	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 163.9;Leydig cells: 237.9;Muller glia cells: 128.7;Peritubular cells: 363.8;Sertoli cells: 355.0;Theca cells: 141.8"	"Cancer enriched"	"Detected in all"	6	"glioma: 71.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"classical monocyte: 37.7"	"Lineage enriched"	"Detected in many"	6	"monocytes: 37.7"	"Cell line enhanced"	"Detected in some"		"AF22: 136.0;HAP1: 92.9;RH-30: 57.1;SCLC-21H: 204.5;SH-SY5Y: 114.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041334, HPA042284"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA041334: AB_10970752, HPA042284: AB_2677931"	"unprognostic (2.18e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.31e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (3.44e-2)"	"prognostic favorable (4.38e-5)"	"unprognostic (4.64e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.60e-4)"	58.4	116.3	230.8	30.1	258.5	9.8	39.5	82.5	293.2	112.3	28.1	371.1	22.2	321.5	61.0	29.8	181.6	93.1	117.1	244.3	187.3	70.6	32.8	86.6	30.0	91.8	173.6	281.1	30.1	9.8	175.0	16.7	149.5	107.8	35.9	47.1	29.5	73.2	37.3	22.2	104.6	197.6	71.4	151.9	98.9	86.6	136.4	31.2	66.5	78.3	18.9	202.9	80.4	179.3	0.3	0.9	136.0	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.6	0.1	4.8	0.7	92.9	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.3	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.2	2.6	0.0	1.7	6.3	0.5	27.2	0.0	0.0	0.1	57.1	1.0	3.5	0.1	204.5	114.0	0.0	0.5	5.1	36.9	2.4	2.4	0.0	0.0	30.0	0.5	0.0	0.4	0.3	0.1	1.0	0.4	0.4	0.0	37.7	0.0	0.0	9.4	0.6	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.9	0.0	0.1	0.6	0.0	9.9	230.8	258.5	82.5	293.2	244.3	187.3	91.8	173.6	149.5	71.4	136.4	179.3	72.2	6.4	2.2	0.0	1.1	6.6	2.4	1.1	0.6	3.5	2.1	21.5	9.3	1.5	0.7	0.0	2.1	0.8	1.0	0.0	1.9	6.4	3.6	0.6	23.9	71.8	12.5	10.7	0.0	0.4	1.1	78.6	0.5	1.0	0.0	29.7	163.9	1.6	72.7	1.7	0.0	0.2	6.1	32.4	9.6	14.3	237.9	18.7	16.0	0.0	9.8	128.7	1.0	0.0	0.0	0.4	0.0	363.8	1.2	4.9	0.0	0.1	1.7	4.4	355.0	49.6	79.6	4.6	3.5	1.4	3.8	1.4	1.4	141.8	0.0	1.7
FZD10	CD350	ENSG00000111432	"Frizzled class receptor 10"	Q9ULW2	12	130162459-130165740	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 16.7;skin 1: 9.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 8.4;Basal squamous epithelial cells: 12.5;Fibroblasts: 8.4;Skeletal myocytes: 13.1;Smooth muscle cells: 9.3;Squamous epithelial cells: 25.5;Suprabasal keratinocytes: 8.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 5.5;BEWO: 6.4;hTCEpi: 3.7;RPTEC TERT1: 1.9;RT4: 3.2"	"Region enhanced"	"Detected in many"		"thalamus: 6.9"	"Low region specificity"	"Detected in many"			"HPA014484, HPA014485"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA014484: AB_1849132, HPA014485: AB_1849134"	"unprognostic (2.41e-3)"	"unprognostic (3.29e-1)"	"unprognostic (4.74e-2)"	"prognostic favorable (5.05e-7)"	"unprognostic (2.81e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.62e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.66e-9)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.07e-1)"	0.7	0.1	0.7	0.1	0.6	0.0	0.8	1.2	0.6	6.5	0.2	0.3	0.1	2.8	0.9	16.7	1.4	1.6	0.2	0.6	0.6	0.6	0.0	0.8	0.4	1.2	1.0	2.9	0.1	0.0	0.9	2.3	1.1	2.9	0.2	0.4	4.2	1.5	1.0	9.4	0.4	0.4	0.7	0.0	0.4	0.1	2.7	0.3	1.0	0.8	0.7	2.6	6.8	1.1	0.0	0.0	5.5	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	1.0	0.5	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	3.2	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	1.2	0.6	0.6	0.6	1.2	1.0	1.1	0.7	2.7	1.1	0.4	0.0	0.5	0.0	0.0	8.4	4.7	0.1	12.5	0.1	0.6	0.8	0.6	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.5	2.1	2.1	0.0	0.0	0.0	0.2	0.6	8.4	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.4	0.0	13.1	9.3	0.0	0.4	25.5	8.5	0.8	0.1	0.0	0.0	1.8
GEM	KIR	ENSG00000164949	"GTP binding protein overexpressed in skeletal muscle"	P55040	8	94249253-94262350	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 229.6"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 721.1;Fibroblasts: 395.9;Langerhans cells: 155.5;Smooth muscle cells: 359.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"myeloid DC: 1.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 83.0;U-266/70: 140.6;U-87 MG: 104.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"spinal cord: 24.3"	HPA024798	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA024798: AB_10602137"	"unprognostic (1.24e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.76e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.04e-2)"	"unprognostic (7.92e-2)"	"unprognostic (9.15e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (1.65e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (4.29e-4)"	"unprognostic (2.93e-3)"	56.1	58.4	10.9	35.6	9.6	2.6	36.7	8.3	12.3	57.9	38.7	105.7	16.6	97.2	9.7	59.5	39.0	229.6	63.4	11.0	20.8	32.3	20.2	33.1	23.8	12.7	12.2	19.9	15.7	2.9	27.3	7.3	11.0	31.7	35.9	44.4	13.1	16.8	4.2	10.9	31.1	77.3	8.4	21.9	48.0	3.8	12.2	12.6	23.6	10.8	14.2	90.6	33.6	12.3	1.6	6.1	2.7	0.6	22.9	30.4	0.4	16.1	83.0	21.4	29.8	2.3	4.1	0.0	1.0	6.1	40.1	0.5	2.7	1.4	28.0	12.2	1.4	0.0	0.6	0.0	3.0	0.0	26.3	13.1	0.1	34.1	18.9	24.4	0.9	1.4	0.7	2.7	12.7	0.8	1.0	0.2	4.0	3.4	18.3	0.0	4.9	0.1	7.8	0.0	20.4	12.1	0.0	0.1	2.8	3.4	2.0	0.1	1.2	29.4	8.1	19.2	33.4	140.6	0.9	0.1	104.7	0.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	10.9	9.6	8.3	12.3	11.0	20.8	12.7	12.2	11.0	8.4	12.2	12.3	18.4	6.4	25.4	22.2	8.9	68.1	85.7	9.6	721.1	26.8	8.6	35.1	90.8	4.3	4.0	1.8	18.8	0.4	4.1	8.2	0.0	7.3	4.7	26.0	49.2	19.0	25.0	0.0	0.7	0.4	1.4	395.9	54.0	50.3	13.4	1.0	7.1	0.1	2.8	30.3	3.4	2.6	2.0	0.6	155.5	0.3	3.4	43.3	92.5	0.0	0.8	41.9	0.0	0.0	0.3	2.7	17.2	5.7	46.5	20.2	2.1	2.6	1.2	21.4	32.9	55.5	359.5	1.3	1.1	24.1	49.9	3.4	33.4	0.9	4.2	10.6
GGT5	"GGT-REL, GGTLA1"	ENSG00000099998	"Gamma-glutamyltransferase 5"	P36269	22	24219654-24245108	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Glutathione biosynthesis, Leukotriene biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endothelial cells: 42.8;Fibroblasts: 58.3;Leydig cells: 36.4;Sertoli cells: 184.1;Smooth muscle cells: 85.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.3;eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 164.9;ASC TERT1: 124.4;HHSteC: 234.7;HSkMC: 271.7;TIME: 110.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008121, CAB032489"	Uncertain		Approved	"Nucleoli fibrillar center"	"Intracellular and membrane"	NA	NA		22000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoli fibrillar center"		"CAB032489: AB_2111010, HPA008121: AB_1078965"	"unprognostic (8.14e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (6.36e-5)"	"prognostic unfavorable (4.06e-4)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.33e-2)"	137.6	60.5	39.0	18.6	39.3	1.4	90.6	37.6	41.7	73.2	32.8	27.8	19.4	54.4	12.9	19.6	70.6	37.2	93.4	35.0	45.1	78.2	55.2	37.7	48.0	52.2	46.3	26.6	25.8	13.2	41.1	11.9	46.9	49.3	12.0	2.1	37.1	20.9	23.1	40.1	40.8	32.2	41.9	36.1	40.0	9.6	45.3	10.4	110.2	16.6	18.3	45.1	64.2	38.2	0.0	1.8	0.6	0.0	164.9	124.4	1.1	2.9	0.2	0.1	0.0	0.1	0.1	0.2	3.4	0.2	0.3	0.3	0.1	0.1	0.0	2.2	0.9	6.7	1.0	24.1	234.7	3.0	6.4	271.7	0.1	3.4	3.2	0.4	45.8	0.7	0.4	1.2	44.1	0.4	0.0	22.4	3.6	1.1	0.0	0.1	4.0	1.0	6.1	0.0	0.4	5.9	0.1	7.3	0.1	22.7	1.0	1.7	110.8	0.1	2.3	0.1	0.0	0.3	1.5	0.2	3.9	5.7	0.2	2.3	0.5	4.5	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.2	39.0	39.3	37.6	41.7	35.0	45.1	52.2	46.3	46.9	41.9	45.3	38.2	27.2	3.2	16.0	1.0	0.3	7.0	3.3	3.2	0.0	0.0	7.2	4.2	4.4	0.0	17.9	0.0	0.0	0.2	0.4	0.0	0.0	0.6	0.8	0.3	8.3	42.8	0.0	2.7	0.1	0.2	0.2	58.3	1.1	0.4	1.3	0.0	33.5	0.1	2.1	0.0	0.1	0.0	0.0	1.0	12.5	3.3	36.4	1.8	3.6	22.5	3.3	0.3	0.0	0.5	0.0	0.4	0.0	23.7	0.3	2.2	0.0	0.1	2.2	1.0	184.1	33.9	85.6	0.6	0.4	0.3	4.4	0.3	1.1	2.1	0.0	1.4
GJA4	CX37	ENSG00000187513	"Gap junction protein alpha 4"	P35212	1	34792999-34795747	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Hepatic stellate cells: 234.2;Sertoli cells: 664.0;Smooth muscle cells: 306.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 74.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047981	Approved					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA047981: AB_2680228"	"unprognostic (2.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.48e-1)"	"unprognostic (5.24e-3)"	"prognostic favorable (3.28e-4)"	"unprognostic (2.01e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.17e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.82e-3)"	"unprognostic (7.96e-3)"	79.4	20.4	10.1	9.3	11.0	0.3	61.5	9.8	15.1	26.6	9.0	14.7	2.8	33.8	5.5	7.5	40.0	17.3	83.6	10.5	9.6	35.8	17.3	40.7	11.3	10.3	10.2	18.0	7.0	10.6	6.4	61.6	10.6	18.8	3.8	0.8	10.1	10.7	34.7	14.8	13.9	15.2	10.2	9.9	12.9	5.4	10.2	2.7	39.8	35.2	5.4	28.1	22.4	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.1	11.0	9.8	15.1	10.5	9.6	10.3	10.2	10.6	10.2	10.2	9.9	90.4	0.0	0.0	0.3	0.6	9.7	1.9	0.2	1.2	0.2	1.1	1.5	9.0	1.5	0.6	3.7	0.0	0.2	0.7	0.0	0.0	11.0	0.1	3.1	0.5	81.4	15.6	2.7	0.0	0.0	0.1	7.7	2.6	4.9	0.0	0.5	234.2	1.8	0.3	0.0	0.0	0.0	0.0	6.3	10.7	1.1	0.9	2.2	19.6	1.0	0.6	0.1	0.0	0.0	0.0	1.0	0.0	12.8	0.2	3.0	0.0	0.1	1.2	0.7	664.0	4.4	306.3	0.2	1.2	0.7	8.7	0.0	1.3	1.6	0.1	5.2
GJC1	"CX45, GJA7"	ENSG00000182963	"Gap junction protein gamma 1"	P36383	17	44798448-44830816	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 40.0"	"Group enriched"	"Detected in many"	4	"Sertoli cells: 157.8;Smooth muscle cells: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071788			Uncertain	"Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli	"Cell Junctions, Cytosol"	"HPA071788: "	"unprognostic (1.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.55e-8)"	"unprognostic (5.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (7.83e-4)"	9.5	0.7	3.1	3.6	2.8	0.8	5.2	10.1	3.8	9.2	5.5	28.6	1.6	24.7	2.9	2.7	5.3	5.4	11.8	2.3	1.4	2.2	0.7	7.2	2.7	2.1	2.9	2.2	1.4	3.4	0.6	40.0	2.6	8.9	2.9	1.0	1.1	18.6	4.6	2.0	5.3	32.7	1.3	0.7	7.6	8.8	4.0	1.6	6.7	5.9	2.0	11.4	6.1	3.0	44.5	21.9	62.0	18.9	8.3	10.6	20.5	50.3	36.6	50.0	52.6	12.4	24.7	0.5	2.3	46.4	69.9	10.1	29.2	13.7	70.8	0.5	19.8	0.4	12.1	1.6	3.8	0.3	1.7	8.8	1.6	37.0	11.8	20.4	17.1	9.6	1.8	0.5	31.4	0.4	6.7	4.3	29.5	0.1	16.2	39.5	73.8	0.3	11.4	16.8	10.2	21.5	4.6	0.5	16.2	41.3	10.9	8.0	12.3	43.8	39.3	22.2	38.9	0.4	11.3	32.5	15.9	0.3	40.7	2.0	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.2	0.2	0.2	1.0	0.5	0.1	0.2	0.1	0.1	3.1	2.8	10.1	3.8	2.3	1.4	2.1	2.9	2.6	1.3	4.0	3.0	11.7	0.0	0.0	0.7	0.2	2.0	1.7	0.5	0.0	3.4	0.6	1.4	25.1	0.0	0.2	1.8	2.1	0.5	0.4	0.1	0.0	1.5	1.5	1.4	14.9	19.5	0.0	0.0	8.1	0.0	2.6	6.3	0.0	3.0	0.0	9.4	4.2	0.3	1.5	13.5	1.4	0.0	0.0	0.3	4.2	0.3	1.5	1.2	3.6	1.0	0.6	0.2	0.0	0.0	0.3	0.6	0.0	2.2	0.0	1.4	0.0	0.3	0.2	0.9	157.8	4.8	101.1	15.6	28.4	0.6	3.0	0.5	0.8	7.8	0.1	1.3
GJD3	"Cx30.2, CX31.9, GJA11, GJC1"	ENSG00000183153	"Gap junction protein delta 3"	Q8N144	17	40360652-40364737	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 28.3;MCF7: 10.6;T-47d: 10.2"	"Not detected"	"Not detected"													NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 48: Smooth muscle cells - ECM organization"					"unprognostic (5.54e-4)"	"unprognostic (4.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.84e-2)"	"unprognostic (8.01e-3)"	"unprognostic (3.75e-3)"		"unprognostic (7.89e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.43e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.73e-4)"	1.9	1.0	0.3	2.4	0.3	0.3	0.4	0.1	0.3	1.3	0.0	2.0	2.4	1.4	1.3	3.4	1.8	2.8	2.4	0.3	0.7	1.4	1.4	3.8	2.3	0.4	0.4	0.5	1.7	0.4	0.0	0.8	0.6	2.5	0.9	0.1	1.6	3.4	1.7	2.7	2.5	1.5	0.1	8.1	2.3	0.8	0.8	1.7	4.3	1.5	0.6	2.3	0.2	0.1	2.4	6.0	0.6	2.2	0.0	0.0	8.9	2.7	0.1	0.4	1.2	0.4	1.2	0.0	2.1	1.5	0.1	8.0	0.0	0.0	0.0	2.5	4.6	0.5	0.8	6.5	28.3	1.2	3.3	1.7	0.0	0.1	0.0	2.3	0.0	1.8	5.2	0.0	0.0	10.6	0.7	3.5	0.7	0.8	1.4	2.9	0.0	0.4	0.1	8.7	0.6	2.4	4.0	0.3	1.2	0.7	10.2	3.9	3.1	0.1	0.2	2.0	0.0	0.7	0.0	1.1	0.6	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.3	0.3	0.7	0.4	0.4	0.6	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
GPR20		ENSG00000204882	"G protein-coupled receptor 20"	Q99678	8	141356470-141367286	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 72.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"intermediate monocyte: 2.6;non-classical monocyte: 4.3"	"Lineage enriched"	"Detected in single"	22	"monocytes: 4.3"	"Cell line enriched"	"Detected in single"	6	"EFO-21: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071337			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Cytosol	"HPA071337: "	"unprognostic (4.47e-2)"	"unprognostic (2.64e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.41e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.23e-2)"	"unprognostic (4.07e-1)"	0.8	0.2	0.0	0.2	0.0	0.0	0.6	0.0	0.4	2.0	0.0	1.4	0.4	1.9	0.7	0.6	1.5	0.7	1.1	0.0	0.0	0.6	0.2	1.5	0.0	0.0	0.0	1.2	0.2	0.1	0.2	1.2	0.1	0.9	0.3	0.0	0.2	0.8	0.3	0.4	2.1	1.8	0.0	0.2	1.7	0.1	0.0	0.0	0.5	0.4	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.1	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.3	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.2	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	72.3	0.3	16.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1
GPR21		ENSG00000188394	"G protein-coupled receptor 21"	Q99679	9	123033667-123035665	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"brain: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA041651	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 48: Smooth muscle cells - ECM organization"			"HPA041651: AB_10794673"													"unprognostic (9.22e-3)"			"unprognostic (1.46e-1)"		0.9	0.0	0.2	0.5	1.0	0.1	0.3	0.0	2.1	0.6	0.0	0.2	0.1	0.9	0.2	0.5	0.4	0.5	0.3	0.8	0.0	0.2	0.0	0.2	0.9	0.0	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.1	0.5	0.4	0.1	0.2	0.1	0.2	0.1	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	2.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR4		ENSG00000177464	"G protein-coupled receptor 4"	P46093	19	45589764-45602212	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 26.7;Endothelial cells: 26.4;Hepatic stellate cells: 24.7;Sertoli cells: 6.6;Smooth muscle cells: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HUVEC TERT2: 18.7;TIME: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014278	Uncertain					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA014278: AB_1849300"	"unprognostic (2.49e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (9.19e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (6.46e-3)"	"unprognostic (1.93e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.49e-3)"	40.6	6.9	7.0	3.3	6.2	0.5	22.1	6.0	8.8	4.9	6.2	4.2	0.9	7.4	0.7	2.6	6.0	3.3	23.8	5.6	5.9	24.6	3.6	28.6	0.9	8.0	7.5	3.5	3.7	1.4	5.9	4.0	8.6	5.8	0.7	0.9	2.9	0.9	5.7	2.9	5.1	2.5	6.5	4.1	5.6	1.7	10.7	0.5	18.2	2.5	0.6	7.0	4.9	6.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.7	1.1	0.0	0.1	0.0	2.0	0.1	0.0	0.1	0.0	0.1	1.3	0.2	0.1	0.0	0.1	0.0	0.5	0.0	0.8	0.0	0.0	0.3	0.3	0.0	18.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	31.3	0.1	1.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.0	6.2	6.0	8.8	5.6	5.9	8.0	7.5	8.6	6.5	10.7	6.3	26.7	0.0	0.5	0.7	0.1	2.4	0.2	0.0	1.2	0.1	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.1	0.3	26.4	0.0	0.0	0.1	0.0	0.0	1.5	2.0	0.2	0.0	0.0	24.7	0.1	0.3	0.0	0.2	0.0	0.0	1.2	1.6	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	6.6	0.6	16.8	0.0	0.2	0.1	1.3	0.0	0.1	0.3	0.0	0.3
GUCY1A1	"GC-SA3, GUC1A3, GUCY1A3"	ENSG00000164116	"Guanylate cyclase 1 soluble subunit alpha 1"	Q02108	4	155666726-155737059	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 38.4;Alveolar cells type 2: 56.1;Breast glandular cells: 37.4;Breast myoepithelial cells: 24.9;Distal tubular cells: 19.6;Ductal cells: 21.8;Smooth muscle cells: 49.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 8.2;non-classical monocyte: 10.1;plasmacytoid DC: 11.5"	"Group enriched"	"Detected in many"	35	"dendritic cells: 11.5;monocytes: 10.1;NK-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.8;HEK 293: 5.5;Karpas-707: 9.7;MOLT-4: 18.5;RPTEC TERT1: 12.1;RT4: 14.2;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010887, HPA056004, HPA058617"	Uncertain		Supported	Nucleoplasm		NA	NA		7100	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: AB_2732624"	"unprognostic (4.81e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.85e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-3)"	14.4	7.8	10.1	17.0	24.1	1.2	15.4	2.8	14.0	14.5	0.1	27.1	8.7	16.1	6.2	7.5	9.5	12.6	33.7	12.7	8.0	15.6	8.0	21.0	8.5	5.3	10.0	5.6	13.1	31.4	3.9	25.9	4.5	25.8	10.3	17.0	5.3	13.9	5.1	2.5	9.2	28.9	8.7	14.1	8.6	1.2	10.2	7.5	7.2	18.7	9.2	7.3	6.6	8.5	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	6.8	0.0	0.0	0.0	5.5	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	3.6	0.0	9.7	0.0	0.0	18.5	0.0	0.0	0.0	0.2	4.1	0.0	3.0	12.1	14.2	2.5	8.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.0	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.1	8.2	10.1	11.5	0.0	1.0	10.1	24.1	2.8	14.0	12.7	8.0	5.3	10.0	4.5	8.7	10.2	8.5	38.4	9.6	56.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	37.4	24.9	0.0	0.0	6.8	11.0	0.0	0.4	1.7	0.0	19.6	21.8	0.0	5.5	9.7	10.9	0.0	0.0	0.0	2.0	0.3	8.3	0.0	15.2	3.8	3.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	12.9	2.2	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0
GUCY1B1	"GC-S-beta-1, GC-SB3, GUC1B3, GUCY1B3"	ENSG00000061918	"Guanylate cyclase 1 soluble subunit beta 1"	Q02153	4	155758992-155807811	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.2;Ductal cells: 22.9;Glandular and luminal cells: 15.5;Proximal tubular cells: 22.2;Smooth muscle cells: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"intermediate monocyte: 7.2;non-classical monocyte: 23.9"	"Lineage enriched"	"Detected in many"	13	"monocytes: 23.9"	"Cell line enhanced"	"Detected in many"		"HEL: 46.0;Karpas-707: 23.7;MOLT-4: 29.9;RPTEC TERT1: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010890, HPA020870"	Approved		Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB010890: AB_259911, HPA020870: AB_1850444"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.69e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (7.35e-3)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.14e-1)"	"unprognostic (6.36e-3)"	13.8	7.1	23.6	15.6	30.0	2.2	10.0	5.3	36.6	12.6	0.0	28.9	5.8	16.4	6.0	8.1	13.7	13.3	18.7	30.1	28.2	13.2	7.7	16.5	10.4	9.8	13.9	5.8	10.9	50.3	6.0	43.6	22.8	13.6	8.7	34.7	5.5	12.2	5.9	3.5	11.1	25.0	6.4	11.0	13.8	2.4	14.8	7.2	7.3	14.9	7.3	10.0	11.1	17.0	0.0	0.5	6.5	0.0	2.2	11.4	0.0	2.0	3.6	0.2	0.1	0.0	0.0	0.0	3.0	1.1	5.0	0.1	13.6	0.3	0.8	0.0	4.6	46.0	0.0	0.0	1.2	0.0	0.0	5.1	0.4	0.0	0.2	4.2	0.1	10.2	0.0	23.7	3.0	2.1	29.9	0.1	0.4	0.0	3.2	3.5	0.9	0.7	42.9	4.4	0.7	7.8	0.0	0.2	0.0	6.4	0.0	0.0	0.0	7.3	1.6	12.4	9.5	0.3	0.0	0.0	15.6	0.0	0.0	1.4	0.5	0.5	0.0	7.2	0.0	0.1	0.0	0.0	1.8	0.2	0.0	0.0	0.5	1.3	23.9	1.6	0.0	5.8	23.6	30.0	5.3	36.6	30.1	28.2	9.8	13.9	22.8	6.4	14.8	17.0	20.2	6.4	7.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	2.2	0.0	0.0	0.0	9.2	0.0	1.1	1.1	0.0	5.9	22.9	0.0	3.7	4.3	3.4	0.0	0.0	0.0	4.2	0.2	5.4	0.0	15.5	1.3	4.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	22.2	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.7	0.4	0.7	0.0	0.0
HES4	bHLHb42	ENSG00000188290	"Hes family bHLH transcription factor 4"	Q9HCC6	1	998962-1000172	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 345.1;Paneth cells: 397.4;Prostatic glandular cells: 286.6;Smooth muscle cells: 385.7;Urothelial cells: 494.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"eosinophil: 12.4"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 12.4"	"Cell line enriched"	"Detected in many"	7	"HEK 293: 198.1"					"Low region specificity"	"Detected in all"			HPA062465			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Vesicles, Cytosol"	"HPA062465: AB_2684771"	"unprognostic (6.23e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.07e-2)"	"prognostic favorable (3.85e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (6.25e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.77e-1)"	"unprognostic (7.76e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.08e-3)"	10.5	1.9	12.9	0.7	15.3	0.5	9.1	8.1	34.3	9.2	0.9	11.0	1.2	10.5	0.4	7.5	10.3	0.1	22.6	6.8	17.9	13.6	3.0	10.8	0.2	22.3	15.8	3.9	5.6	0.9	8.4	1.5	17.0	11.4	0.3	0.8	7.7	2.2	4.0	8.4	3.9	1.2	6.0	4.4	5.6	2.6	24.0	1.4	6.0	0.9	0.3	10.0	8.4	4.0	14.3	1.6	1.5	0.2	0.2	0.1	17.6	8.6	1.0	5.2	5.4	2.3	4.5	0.0	20.0	0.7	2.3	25.3	2.1	0.3	0.2	0.1	198.1	0.1	2.4	2.9	1.7	0.0	1.7	0.1	2.0	0.3	0.4	0.7	0.6	2.5	4.1	0.3	0.0	7.6	11.7	0.6	0.2	3.1	19.2	0.2	1.9	4.4	2.0	0.0	1.1	4.6	5.8	14.3	29.1	0.7	10.5	0.0	1.1	1.6	0.6	0.0	4.0	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.0	12.4	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	12.9	15.3	8.1	34.3	6.8	17.9	22.3	15.8	17.0	6.0	24.0	4.0	90.1	0.0	0.0	18.6	15.3	52.1	345.1	1.7	6.8	8.9	158.9	149.4	13.3	20.0	4.0	58.8	0.0	1.5	22.3	88.3	31.3	44.1	1.0	74.7	30.0	63.4	10.7	2.7	12.9	2.9	43.9	65.5	11.2	153.3	53.5	3.1	37.5	0.8	4.8	0.0	25.9	25.4	4.1	10.0	120.5	1.5	7.5	70.8	115.6	11.2	5.2	129.7	12.3	8.5	1.7	10.7	397.4	15.4	2.3	286.6	1.5	0.8	1.1	11.3	164.3	157.8	385.7	3.2	29.6	43.0	82.7	3.4	27.4	2.0	56.9	494.9
HES7	bHLHb37	ENSG00000179111	"Hes family bHLH transcription factor 7"	Q9BYE0	17	8120592-8124106	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.1"	"Cell type enhanced"	"Detected in some"		"Melanocytes: 3.6;Smooth muscle cells: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.0;Daudi: 6.0;HAP1: 8.3;HDLM-2: 6.5;HeLa: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA072105	Uncertain		Approved	Nucleoplasm,Nucleoli		No	NA				"Cluster 43: Testis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Nucleoli	"HPA072105: AB_2686488"	"unprognostic (1.98e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.99e-2)"		"unprognostic (2.84e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.22e-5)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.55e-1)"	0.3	0.1	0.2	0.0	0.2	0.0	0.3	1.7	1.6	0.7	0.0	0.3	0.0	0.7	0.0	0.3	0.5	0.1	0.9	0.5	0.2	2.1	0.0	0.9	0.1	0.2	0.0	0.9	0.1	0.4	0.4	0.6	0.2	0.4	0.0	0.5	0.6	0.0	0.2	0.5	0.2	0.0	0.3	0.4	0.2	1.1	0.2	0.0	0.5	0.0	0.1	0.2	0.7	0.4	6.0	0.4	0.5	1.8	0.1	0.2	0.2	0.3	0.5	0.5	2.2	0.1	0.3	6.0	0.1	0.0	1.0	0.7	8.3	0.7	0.0	6.5	3.9	0.2	13.9	0.1	0.7	0.7	0.8	0.1	1.1	1.8	4.4	1.0	0.1	1.0	0.2	2.9	0.2	0.1	0.1	0.3	0.2	0.5	1.5	0.6	0.3	1.2	0.2	0.0	0.3	2.9	0.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	1.3	1.4	2.1	3.9	0.9	0.4	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.7	1.6	0.5	0.2	0.2	0.0	0.2	0.3	0.2	0.4	0.9	0.0	0.0	1.0	0.2	2.2	1.0	0.3	1.2	2.3	2.3	1.7	1.3	0.0	0.1	1.8	0.0	0.0	0.8	0.2	0.0	0.1	1.7	0.2	0.1	1.7	0.0	0.0	1.1	0.0	0.0	1.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	2.0	0.3	1.8	0.0	0.0	0.5	3.6	0.0	0.6	0.9	0.0	1.0	0.0	0.0	0.0	0.4	0.1	1.6	0.0	0.1	0.2	0.7	0.0	1.5	5.9	0.1	0.6	1.0	1.6	0.3	0.3	0.0	0.2	0.2
HEYL	"bHLHb33, HESR3, HEY3"	ENSG00000163909	"Hes related family bHLH transcription factor with YRPW motif like"	Q9NQ87	1	39623435-39639643	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 69.5"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 17.5;Leydig cells: 26.1;Peritubular cells: 56.8;Sertoli cells: 52.6;Skeletal myocytes: 33.4;Smooth muscle cells: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 8.0;LHCN-M2: 20.8;RH-30: 26.5;THP-1: 6.2;U-266/84: 7.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001438, HPA076960"	Approved		Approved	Mitochondria,Cytosol		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	Cytosol	"HPA001438: AB_1079052, HPA076960: AB_2732326"	"unprognostic (1.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.19e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (2.26e-6)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.63e-5)"	17.9	12.4	9.5	5.6	12.0	0.1	9.3	10.5	6.9	18.5	4.1	7.2	1.9	27.9	5.7	4.8	17.4	8.0	57.0	5.4	15.0	9.5	4.2	23.5	1.7	11.3	15.6	13.4	69.5	2.4	15.3	29.5	12.9	17.0	3.4	6.7	2.7	14.4	6.0	2.9	4.9	25.0	7.3	6.3	6.0	16.0	17.1	1.3	20.4	5.4	2.0	8.7	11.3	8.3	0.0	2.8	4.8	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.1	2.0	0.3	0.0	1.6	0.5	0.0	0.0	2.8	0.0	0.3	0.0	3.2	5.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	8.0	0.5	0.7	20.8	1.9	0.0	0.1	0.0	0.2	0.1	1.4	26.5	0.2	0.0	0.5	0.6	0.0	0.0	0.1	0.0	1.1	0.0	6.2	0.0	0.0	0.2	0.0	0.0	0.7	7.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	12.0	10.5	6.9	5.4	15.0	11.3	15.6	12.9	7.3	17.1	8.3	1.3	0.0	0.0	0.7	0.0	0.9	0.1	0.0	0.0	0.9	0.1	0.0	3.6	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	1.0	5.4	1.3	4.0	1.9	0.0	0.0	0.1	3.5	0.3	13.3	2.0	2.4	0.0	0.7	1.4	0.0	0.3	1.7	0.2	0.2	0.0	0.0	2.3	17.5	26.1	0.4	5.4	4.7	0.1	0.4	0.0	0.0	2.4	2.8	0.3	56.8	0.0	0.2	0.0	0.1	0.0	3.9	52.6	33.4	29.5	0.4	2.0	0.1	0.1	0.3	0.3	1.9	0.4	0.2
HIGD1B	"CLST11240, CLST11240-15"	ENSG00000131097	"HIG1 hypoxia inducible domain family member 1B"	Q9P298	17	44846353-44850476	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 114.6;choroid plexus: 65.0;placenta: 105.2"	"Group enriched"	"Detected in some"	5	"Sertoli cells: 762.6;Smooth muscle cells: 209.3"	"Cancer enhanced"	"Detected in all"		"glioma: 9.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA079501			Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA079501: "	"unprognostic (6.85e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.07e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.98e-3)"	"unprognostic (3.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.19e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.23e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.52e-2)"	11.7	0.5	71.0	0.7	71.0	0.5	8.8	70.3	114.6	8.3	65.0	3.7	2.1	9.9	11.6	5.0	5.3	11.3	46.4	68.8	71.4	11.5	0.6	38.6	2.6	71.4	70.9	2.9	3.1	8.0	1.4	105.2	72.4	9.5	1.1	2.3	1.4	6.4	14.5	2.0	4.3	11.3	68.9	0.1	3.7	1.5	73.0	1.8	5.0	30.8	1.4	4.3	4.4	69.1	0.2	0.6	0.0	0.7	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.3	0.2	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.7	0.1	0.8	0.5	0.0	0.9	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.7	0.5	0.0	0.3	0.7	0.7	0.4	0.3	0.3	0.8	0.4	1.0	0.0	0.5	0.7	0.3	0.2	0.0	0.1	0.0	0.3	0.3	0.0	0.6	0.2	0.4	0.5	0.4	1.2	0.6	0.5	1.1	0.7	1.7	0.6	0.2	1.2	1.0	0.4	0.2	0.7	0.9	1.2	0.3	0.9	0.7	0.0	0.7	0.1	0.3	0.8	0.5	71.0	71.0	70.3	114.6	68.8	71.4	71.4	70.9	72.4	68.9	73.0	69.1	88.9	0.0	0.5	0.0	0.3	3.4	0.6	0.3	0.0	0.5	1.2	2.8	11.0	0.0	1.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.2	0.2	0.7	70.2	0.0	0.0	0.7	0.0	0.2	4.4	0.0	0.3	0.0	0.0	0.7	0.1	0.8	1.7	0.6	0.0	0.0	0.0	3.9	0.6	0.3	1.6	0.0	2.8	0.0	1.0	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.9	762.6	9.5	209.3	0.0	0.3	0.7	2.4	0.3	0.8	32.3	0.0	0.7
HNRNPA0	HNRPA0	ENSG00000177733	"Heterogeneous nuclear ribonucleoprotein A0"	Q13151	5	137745651-137754363	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036569, HPA059404"	Enhanced		Enhanced	Nucleoplasm		No	No		150000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA036569: AB_10670840, HPA059404: AB_2684004"	"unprognostic (5.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.78e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.86e-2)"	"prognostic favorable (1.99e-4)"	"unprognostic (2.34e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.39e-2)"	21.9	23.8	11.1	14.5	10.9	32.1	19.2	14.8	12.1	22.3	8.3	19.0	13.7	28.5	10.7	20.1	23.2	10.2	18.1	10.8	13.4	14.8	14.8	19.1	15.7	10.9	10.4	30.3	17.5	12.3	15.5	15.6	10.9	15.2	10.7	10.9	14.5	11.9	18.1	19.8	19.1	16.1	10.2	18.0	19.4	12.9	12.6	28.7	17.6	12.8	14.6	19.1	19.1	11.8	36.9	36.2	68.6	69.7	33.1	20.9	70.3	27.6	22.7	24.2	27.8	67.8	28.3	66.3	38.9	23.7	26.6	33.1	37.4	42.8	29.4	33.6	52.1	42.9	22.5	41.6	30.4	39.8	43.9	34.0	29.6	19.2	22.0	26.6	34.0	59.0	35.7	43.2	24.7	47.8	75.0	53.2	53.7	17.3	26.1	88.6	50.0	33.8	24.2	41.7	86.6	70.5	35.6	24.5	49.1	74.8	31.1	45.6	33.4	38.6	32.8	21.6	53.3	43.4	37.6	46.8	25.0	45.4	38.9	2.7	1.4	4.6	2.9	2.1	3.4	2.1	2.8	3.0	2.3	2.5	3.0	3.2	1.3	4.4	2.5	3.2	1.7	1.1	11.1	10.9	14.8	12.1	10.8	13.4	10.9	10.4	10.9	10.2	12.6	11.8	151.5	86.6	53.6	7.2	251.2	550.9	436.4	290.2	390.9	85.1	197.5	136.1	36.1	155.8	138.6	101.2	37.5	347.9	234.6	88.8	172.1	257.5	25.5	108.6	172.1	204.4	236.4	179.6	11.3	146.5	478.1	237.2	141.7	126.8	95.8	162.4	192.1	77.0	191.7	84.1	11.5	181.2	229.9	142.3	416.4	44.9	157.8	142.4	281.1	11.2	228.6	137.1	213.1	15.6	16.8	201.6	157.2	150.8	138.9	313.1	147.3	146.9	65.3	62.9	85.5	271.8	221.9	144.0	72.8	247.6	484.3	365.7	267.5	155.8	242.0	401.0
HOXC11	HOX3H	ENSG00000123388	"Homeobox C11"	O43248	12	53973126-53977643	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 1.8;skin 1: 5.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 7.5;Distal tubular cells: 1.9;Melanocytes: 3.6;Proximal enterocytes: 3.7;Spermatocytes: 3.5;Suprabasal keratinocytes: 3.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 34.7;BJ hTERT+: 17.5;HaCaT: 15.4;HeLa: 12.4;T-47d: 27.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"spinal cord: 1.3"	HPA038291	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA038291: AB_10674552"	"unprognostic (1.50e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"		"unprognostic (6.90e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.41e-3)"	"unprognostic (4.46e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-1)"		"unprognostic (1.82e-1)"	1.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.6	1.8	5.0	1.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	9.3	1.1	0.0	34.7	3.2	4.9	0.0	5.1	17.5	7.4	5.3	0.3	1.3	0.0	0.3	4.8	0.0	15.4	6.6	0.0	3.3	1.0	0.1	0.2	12.4	0.0	0.0	0.1	0.1	0.9	1.4	0.0	0.4	0.0	0.0	0.3	1.5	0.0	4.8	2.2	0.0	0.1	0.0	10.1	0.1	0.0	0.6	0.0	0.7	1.2	0.0	0.2	3.2	7.8	3.1	0.3	27.4	0.0	0.0	0.0	5.8	0.4	0.3	0.0	0.0	0.0	0.0	0.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.7	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.9	0.0	0.0	0.0	1.0	1.0	3.5	0.9	0.0	3.8	0.0	0.1	0.0	0.2	0.0
HSPB6	"FLJ32389, Hsp20, PPP1R91"	ENSG00000004776	"Heat shock protein family B (small) member 6"	O14558	19	35754566-35758079	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 2969.8;tongue: 1759.1"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 165.7;Fibroblasts: 125.2;Leydig cells: 271.8;Peritubular cells: 220.4;Smooth muscle cells: 102.6;Theca cells: 311.0"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 93.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1774.3;ASC TERT1: 742.0;HHSteC: 599.9;HSkMC: 700.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001974, HPA044153, HPA054811"	Enhanced		Supported	"Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		310000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Nucleoli, Golgi apparatus"	"CAB001974: , HPA044153: AB_2678836, HPA054811: AB_2682610"	"unprognostic (3.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.21e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (3.32e-2)"	"unprognostic (6.65e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (1.43e-6)"	650.0	414.0	37.3	45.4	40.6	0.4	394.9	32.5	49.2	581.9	26.1	699.9	28.1	565.1	101.6	112.3	495.1	97.9	1463.9	30.0	43.6	69.0	42.3	126.6	5.7	76.7	48.5	455.2	50.5	4.2	17.5	40.2	73.7	271.2	44.0	21.1	115.9	194.7	2969.8	39.1	180.0	278.2	50.8	15.7	362.1	60.6	53.8	6.2	99.5	1759.1	2.7	537.3	290.6	49.3	0.6	0.7	2.1	2.5	1774.3	742.0	1.2	83.0	1.3	4.9	9.3	1.1	0.4	0.7	0.6	252.4	0.0	0.2	0.4	0.7	3.9	0.9	0.5	0.4	1.3	0.5	599.9	0.2	0.9	700.3	0.0	19.1	0.9	2.2	5.4	0.3	0.5	1.0	0.2	0.3	0.4	1.9	1.2	2.3	0.6	1.5	0.5	0.7	0.0	0.1	0.8	0.7	0.1	0.2	0.7	0.3	0.3	0.5	0.1	153.2	0.9	17.3	0.6	1.0	2.8	0.3	20.5	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	40.6	32.5	49.2	30.0	43.6	76.7	48.5	73.7	50.8	53.8	49.3	11.1	3.2	0.6	1.6	0.1	1.8	0.4	0.0	3.4	7.8	0.5	0.5	29.7	0.0	0.0	0.0	0.0	2.5	0.1	0.1	0.0	0.1	27.0	4.9	165.7	3.6	0.0	5.2	0.2	0.0	2.5	125.2	4.1	3.5	0.0	3.6	17.5	0.3	5.0	0.0	0.5	0.0	0.0	0.3	3.6	18.9	271.8	2.7	1.8	0.0	0.6	44.5	0.0	0.0	0.1	0.2	0.0	220.4	0.1	0.4	0.0	0.4	0.0	2.8	26.3	38.0	102.6	2.3	1.4	1.9	2.0	4.8	1.8	311.0	0.0	0.5
ID4	bHLHb27	ENSG00000172201	"Inhibitor of DNA binding 4, HLH protein"	P47928	6	19837370-19842197	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 274.7"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 246.6;Endometrial ciliated cells: 438.4;Endometrial stromal cells: 362.6;Glandular and luminal cells: 335.3;Muller glia cells: 391.8;Smooth muscle cells: 368.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 111.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 45.0;AN3-CA: 50.7;EFO-21: 105.1;HEK 293: 66.0;SCLC-21H: 117.0;SuSa: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075639			Supported	Nucleoplasm		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA075639: "	"unprognostic (3.25e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.65e-2)"	"prognostic favorable (2.49e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.57e-3)"	74.6	5.0	50.1	7.5	47.6	0.2	41.7	33.6	55.4	41.0	22.8	9.8	7.2	30.0	9.4	21.7	70.3	10.2	75.7	48.0	59.6	30.8	4.4	27.8	5.0	42.8	60.8	48.4	19.1	2.5	36.4	22.2	42.2	29.7	6.7	19.4	27.1	44.0	3.6	107.8	11.9	21.0	43.6	20.2	19.8	23.0	58.5	2.0	274.7	3.1	2.1	31.4	33.1	40.2	0.0	0.6	45.0	50.7	1.2	0.1	0.1	5.8	0.1	0.4	0.0	0.0	0.0	0.0	105.1	14.1	0.2	20.3	0.0	0.0	0.4	0.0	66.0	0.0	0.0	0.5	0.3	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	8.1	6.3	0.0	0.0	0.0	0.2	7.6	14.2	117.0	1.5	0.0	1.8	7.2	37.6	3.2	0.0	0.0	0.2	5.6	0.1	1.6	0.0	0.1	1.1	1.6	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.1	47.6	33.6	55.4	48.0	59.6	42.8	60.8	42.2	43.6	58.5	40.2	31.8	96.1	53.0	229.9	1.9	83.1	190.8	16.7	232.8	11.2	143.8	246.6	42.5	7.2	19.6	68.0	2.1	9.9	2.9	15.6	50.9	18.0	2.1	438.4	362.6	19.9	91.6	0.0	1.8	3.3	9.5	83.9	118.3	335.3	0.0	17.6	23.9	0.0	2.7	3.3	1.2	23.4	22.4	0.6	24.8	7.9	8.1	5.3	88.9	2.8	0.0	391.8	0.0	0.5	0.3	1.4	27.1	0.0	1.4	93.6	8.2	76.0	8.4	13.7	0.0	76.3	368.8	1.2	44.9	119.6	78.6	5.9	6.1	0.7	7.8	42.4
IFI27L2	"FAM14A, TLH29"	ENSG00000119632	"Interferon alpha inducible protein 27 like 2"	Q9H2X8	14	94127779-94130253	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 446.8"									HPA049588			Approved	Nucleoli,Cytosol	"Intracellular and membrane"	No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	Nucleoli	"HPA049588: "	"unprognostic (9.70e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.76e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.79e-3)"	"unprognostic (3.96e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.88e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.52e-2)"	47.8	114.5	148.9	42.4	157.0	46.6	43.1	159.2	207.3	76.4	142.8	57.3	22.5	51.5	14.5	73.9	54.1	46.4	108.2	149.3	169.0	68.2	10.2	60.0	57.9	162.6	152.7	78.8	27.8	55.0	83.3	10.7	162.3	35.8	20.4	51.6	26.7	21.6	8.8	52.5	52.8	25.6	160.9	72.2	35.5	31.1	160.1	46.9	35.1	9.9	50.5	41.6	72.1	171.9	61.5	39.3	10.8	90.8	70.1	166.5	7.6	118.1	129.9	92.3	99.6	12.1	28.0	29.0	128.3	134.2	59.1	81.6	8.8	150.5	36.8	185.4	3.0	44.0	41.0	4.6	98.5	53.2	116.7	163.1	55.8	50.5	39.0	162.6	49.1	108.5	3.8	446.8	107.5	128.3	32.3	33.9	16.4	41.9	49.2	1.9	40.2	42.2	137.8	25.2	24.1	28.7	3.8	0.0	78.4	22.9	146.4	87.6	65.9	61.5	35.0	79.5	30.1	171.8	164.4	10.4	201.7	124.1	39.2	167.4	238.3	48.0	153.4	167.9	99.4	214.2	140.6	168.4	184.2	201.3	104.2	134.9	37.6	44.3	121.5	153.5	203.5	217.4	148.9	157.0	159.2	207.3	149.3	169.0	162.6	152.7	162.3	160.9	160.1	171.9	86.5	38.5	50.9	10.1	71.8	92.8	73.1	218.3	111.0	27.2	47.9	103.6	162.8	50.1	55.8	178.4	20.9	2.3	79.3	58.2	178.1	159.2	8.2	78.1	113.7	70.1	99.6	20.6	1.6	29.1	2.7	133.0	43.8	11.6	90.7	64.8	121.1	4.2	190.8	23.5	3.6	193.8	57.0	163.7	107.6	31.1	183.0	119.1	236.5	0.0	134.7	181.0	137.0	5.5	13.9	68.1	150.2	115.5	104.4	23.7	125.6	113.3	61.8	113.3	124.9	70.4	87.7	8.3	22.1	105.2	66.9	2.9	92.2	92.7	82.8	55.9
IFITM5	"BRIL, DSPA1, fragilis4, Hrmp1"	ENSG00000206013	"Interferon induced transmembrane protein 5"	A6NNB3	11	298200-299526	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Mineral balance"	"Developmental protein"	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 4.9;pancreas: 7.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	8	"cerebral cortex: 4.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA039258			Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA039258: AB_10673608"	"unprognostic (9.84e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.46e-2)"		"unprognostic (4.20e-2)"	"unprognostic (4.42e-2)"		"unprognostic (8.31e-2)"	"unprognostic (7.99e-3)"		"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"		"unprognostic (4.90e-2)"	0.1	0.0	0.0	0.1	0.0	0.7	0.2	0.0	4.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.4	0.1	0.1	0.1	0.0	7.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGFBP5		ENSG00000115461	"Insulin like growth factor binding protein 5"	P24593	2	216672105-216695549	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 1492.5;ovary: 1323.4"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 1104.1;Ionocytes: 980.6;Leydig cells: 1828.2;Peritubular cells: 981.7;Sertoli cells: 1275.3;Skeletal myocytes: 2750.9;Smooth muscle cells: 1376.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 831.3;BJ hTERT+: 2192.6;T-47d: 531.7;U-138 MG: 710.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059827, HPA070407"		Supported	Approved	"Nuclear bodies,Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	110000000	380000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus, Vesicles"	"Nuclear bodies"	"HPA059827: AB_2732640, HPA070407: "	"unprognostic (7.69e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (4.58e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.04e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.91e-3)"	375.1	221.8	35.6	178.2	35.1	0.7	354.6	21.9	30.9	1492.5	46.9	232.3	35.0	837.7	121.3	166.4	953.0	129.3	155.0	50.4	41.8	479.1	34.2	78.2	71.3	36.3	37.9	1323.4	30.7	30.7	272.8	290.7	31.5	241.4	66.2	105.4	111.0	121.8	470.9	129.0	139.3	621.2	28.1	38.7	323.5	28.8	43.8	95.0	326.2	292.9	45.9	259.2	382.9	62.4	0.0	0.0	210.6	0.9	237.1	7.5	0.8	831.3	2192.6	108.8	10.4	0.0	1.0	0.1	3.3	2.3	0.0	0.1	26.2	0.0	5.6	0.1	8.2	218.1	4.4	0.2	103.1	0.1	1.8	33.1	0.0	14.7	0.1	24.8	0.1	0.2	0.7	0.1	0.5	70.9	0.9	1.2	2.3	0.0	3.4	0.3	0.8	1.2	70.3	249.1	14.5	8.5	14.6	100.4	0.0	12.8	531.7	0.1	80.3	710.2	42.2	109.3	41.0	0.7	0.1	0.1	1.4	0.1	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.6	35.1	21.9	30.9	50.4	41.8	36.3	37.9	31.5	28.1	43.8	62.4	237.3	3.2	4.4	40.1	20.6	102.5	13.5	211.0	25.0	8.7	73.9	199.9	92.0	5.7	251.6	112.2	6.2	3.9	1.7	0.0	5.9	10.3	8.4	140.2	250.7	120.8	0.0	0.0	6.0	0.0	4.5	1104.1	30.5	128.5	2.5	11.4	49.6	1.4	8.7	3.3	13.7	0.0	980.6	0.6	189.7	39.9	1828.2	18.4	101.4	29.0	0.6	674.4	0.0	5.5	0.4	2.2	0.0	981.7	5.5	17.0	0.0	1.1	120.9	18.7	1275.3	2750.9	1376.0	2.2	3.0	17.7	67.9	5.6	18.4	124.7	0.1	16.8
IGFBP7	"FSTL2, IGFBP-7, MAC25, PSF"	ENSG00000163453	"Insulin like growth factor binding protein 7"	Q16270	4	57030773-57110385	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 11440.4;Peritubular cells: 11731.6;Sertoli cells: 8184.6;Smooth muscle cells: 4434.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 21.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 693.6;BJ hTERT+: 643.1;hTERT-RPE1: 1471.3;RPTEC TERT1: 682.7;TIME: 1009.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002196, CAB020668"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	30300000	190000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"CAB020668: , HPA002196: AB_1079107"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.97e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.55e-2)"	833.0	374.9	99.4	151.1	124.0	44.2	583.2	112.7	149.7	640.3	1299.1	473.1	105.6	653.2	260.4	115.3	618.1	405.7	1117.2	132.7	143.8	1298.6	283.2	532.4	133.1	185.2	138.7	359.1	270.1	77.2	246.0	66.6	146.4	506.0	83.2	4.7	193.7	659.0	185.6	193.6	259.6	334.9	136.8	436.9	267.4	259.2	187.9	48.9	995.3	91.8	81.9	546.4	494.0	132.6	1.3	4.8	1.1	0.0	134.8	50.4	4.7	693.6	643.1	59.2	19.0	2.8	0.1	0.3	433.7	33.5	35.3	70.2	0.7	111.1	15.7	1.3	5.4	2.5	78.7	0.5	207.7	17.1	17.9	234.7	55.8	96.8	26.2	1471.3	138.2	0.6	0.5	0.9	142.8	0.0	0.5	74.5	5.9	0.0	1.3	13.4	0.4	2.8	682.7	0.0	1.0	1.8	130.2	9.5	0.0	276.3	1.8	64.6	1009.4	60.5	46.4	7.8	114.8	41.1	0.4	1.4	159.2	58.3	1.8	2.0	3.9	21.7	0.1	4.1	0.1	0.0	0.0	0.0	10.7	0.0	0.0	0.1	0.3	10.8	4.5	0.4	0.1	1.7	99.4	124.0	112.7	149.7	132.7	143.8	185.2	138.7	146.4	136.8	187.9	132.6	2254.8	112.2	20.2	164.9	16.2	238.5	127.2	300.5	24.5	5.9	27.7	53.5	148.2	20.0	90.6	2087.4	22.9	6.6	76.9	1.4	516.5	2455.3	75.9	1235.5	702.2	2740.1	1.2	82.7	0.7	15.1	8.3	1435.9	29.0	381.3	15.8	1205.0	3079.4	16.4	26.5	0.0	3.7	1.0	61.1	101.9	375.7	335.4	11440.4	70.4	944.5	151.8	41.8	17.1	345.0	11.6	0.8	84.6	1.5	11731.6	11.0	113.3	0.0	692.2	731.0	12.5	8184.6	155.0	4434.0	36.6	38.6	9.9	179.1	5.7	51.3	759.1	2.5	64.0
IGLL5		ENSG00000254709	"Immunoglobulin lambda like polypeptide 5"	B9A064	22	22887780-22896111	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 408.3;lymphoid tissue: 674.1;stomach 1: 308.1"	"Cell type enriched"	"Detected in some"	55	"Melanocytes: 93931.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	226	"memory B-cell: 515.9;naive B-cell: 615.5"	"Lineage enriched"	"Detected in many"	246	"B-cells: 615.5"	"Group enriched"	"Detected in some"	7	"Daudi: 637.2;U-266/70: 386.4;U-698: 441.1"														"Secreted to blood"	NA	NA		53000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"				"prognostic favorable (6.10e-4)"	"unprognostic (7.64e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.82e-2)"	"prognostic favorable (3.41e-5)"	"unprognostic (1.76e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (5.94e-8)"	"unprognostic (1.85e-1)"	"unprognostic (4.63e-1)"	"unprognostic (8.52e-2)"	"unprognostic (6.50e-2)"	16.3	25.1	0.3	164.8	0.2	94.4	139.3	0.1	1.2	32.8	0.4	405.6	408.3	7.8	0.0	50.4	14.7	67.3	11.2	0.1	0.1	17.0	15.9	65.7	308.5	0.4	0.1	18.6	11.0	1.5	1.5	0.2	0.2	8.3	249.4	0.1	279.3	22.2	0.5	2.7	181.5	8.8	0.4	458.8	308.1	4.3	0.2	123.6	26.2	0.2	674.1	223.5	10.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	637.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	3.6	0.9	0.0	0.0	0.6	1.0	0.4	0.0	0.1	0.0	0.0	0.9	1.4	0.0	1.9	0.1	0.2	386.4	68.5	441.1	0.0	0.3	0.0	0.4	0.7	0.2	0.3	0.1	0.2	515.9	0.2	0.2	0.8	615.5	0.1	0.2	1.0	0.2	0.4	2.5	0.3	68.1	0.3	0.2	0.1	1.2	0.1	0.1	0.4	0.1	0.2	0.4	0.2	0.5	0.0	3.2	30.9	0.0	222.5	108.6	0.0	0.0	0.0	0.0	1.4	0.1	0.0	1.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.7	0.0	0.0	12.7	1.2	5.7	0.0	0.0	0.0	7.7	3.1	0.0	11.4	0.1	1.1	4.2	0.0	0.0	0.0	0.1	0.0	0.8	113.1	3.8	0.0	0.9	93931.2	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1680.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	93.5	0.0	49.3	0.0	2.4	0.0
IL17B	"IL-17B, IL-20, MGC138900, MGC138901, NIRF, ZCYTO7"	ENSG00000127743	"Interleukin 17B"	Q9UHF5	5	149371324-149404202	"Cancer-related genes, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 44.8;Peritubular cells: 13.2;Sertoli cells: 26.3;Smooth muscle cells: 7.6;Theca cells: 9.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"basophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"HEL: 1.3;Karpas-707: 1.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042441	Uncertain				"Secreted to blood"	NA	NA	75000		"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 36: HEL - Hemostasis"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA042441: AB_10797014"	"unprognostic (2.83e-4)"	"unprognostic (2.71e-2)"	"unprognostic (4.90e-3)"	"unprognostic (9.22e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (9.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.54e-2)"	"unprognostic (9.30e-3)"	"unprognostic (3.22e-1)"	"unprognostic (6.98e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.10e-1)"	1.4	2.2	0.0	1.0	0.0	0.2	2.9	0.5	0.1	3.2	0.0	3.1	0.3	4.3	0.0	1.5	1.1	0.4	1.1	0.0	0.0	0.7	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.1	2.4	0.1	0.4	2.8	2.1	0.3	0.9	1.3	2.2	0.0	0.6	0.8	3.7	0.0	0.0	0.1	0.2	0.0	1.4	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.8	44.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.6	1.3	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	1.0	1.1	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.6	7.6	0.1	0.1	0.0	0.3	0.0	0.0	9.9	0.0	0.1
IL24	"C49A, FISP, IL-24, IL10B, mda-7, Mob-5, ST16"	ENSG00000162892	"Interleukin 24"	Q13007	1	206897443-206904139	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 15.2;lymphoid tissue: 25.5;urinary bladder: 14.6"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 6.8;Basal prostatic cells: 2.9;Fibroblasts: 11.6;Smooth muscle cells: 7.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 9.9"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 5.4;T-cells: 3.6"	"Cell line enriched"	"Detected in some"	9	"BJ hTERT+: 172.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025972	Uncertain				"Secreted to blood"	NA	NA	140000		"Cluster 21: B-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB025972: "	"prognostic favorable (5.09e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.09e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.63e-2)"	"unprognostic (3.43e-4)"	"unprognostic (5.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.33e-2)"	3.5	0.1	0.1	3.6	0.1	1.5	0.7	0.1	0.2	0.4	0.2	1.3	0.0	1.0	0.0	0.9	1.0	1.3	0.8	0.1	0.3	0.8	1.2	1.8	5.8	0.2	0.4	0.2	0.2	0.0	0.5	0.9	0.3	1.0	0.0	0.0	1.1	0.0	3.8	0.2	15.2	0.1	0.1	25.5	0.6	0.1	0.3	0.0	1.0	0.0	0.2	14.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	172.7	0.0	0.4	0.0	0.5	0.2	0.1	0.0	3.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.2	2.5	18.7	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	16.7	0.7	0.0	0.0	0.0	2.3	1.2	7.4	0.5	2.5	0.8	0.3	1.4	0.0	0.2	0.0	0.0	0.0	0.8	0.0	1.9	5.4	1.7	2.7	0.0	5.0	3.6	2.9	0.4	0.4	0.0	0.0	1.9	0.8	0.1	0.1	0.1	0.2	0.1	0.3	0.2	0.4	0.3	0.1	0.3	0.1	0.2	0.0	1.3	0.0	1.8	6.8	2.9	0.5	0.0	0.0	0.4	0.3	1.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.1	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	7.9	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.1	0.7
IL34	"C16orf77, IL-34, MGC34647"	ENSG00000157368	"Interleukin 34"	Q6ZMJ4	16	70579895-70660682	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 106.3;skin 1: 62.0"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 18.3;Peritubular cells: 40.6;Sertoli cells: 19.7;Suprabasal keratinocytes: 20.5;Theca cells: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	13	"eosinophil: 18.5"	"Lineage enriched"	"Detected in single"	185	"granulocytes: 18.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.1;Hep G2: 2.7;HSkMC: 2.4;NTERA-2: 5.3;U-138 MG: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	57100		"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.76e-3)"	"prognostic favorable (7.41e-4)"	"unprognostic (5.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-2)"	"prognostic favorable (9.69e-4)"	"unprognostic (8.19e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.83e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (3.52e-8)"	"unprognostic (6.47e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.37e-2)"	4.4	22.9	17.1	3.9	18.1	0.1	8.6	8.5	23.3	9.6	23.1	4.0	5.1	2.9	1.0	25.5	3.2	6.7	4.4	22.5	14.5	5.7	2.5	5.0	9.1	13.0	11.7	1.6	1.9	1.0	12.5	0.5	14.1	6.2	2.2	1.2	16.0	3.8	9.6	62.0	6.4	2.5	10.1	106.3	2.4	3.5	19.0	3.9	5.1	2.5	5.0	4.8	13.4	11.6	0.0	0.6	0.1	0.1	0.2	2.1	0.2	0.1	1.8	0.2	0.2	0.4	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.9	0.0	1.6	2.4	0.1	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.3	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.3	0.0	0.0	0.0	3.6	0.1	0.1	0.1	0.2	0.0	0.0	0.3	0.7	0.1	1.4	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	18.1	8.5	23.3	22.5	14.5	13.0	11.7	14.1	10.1	19.0	11.6	2.8	0.0	1.8	2.9	0.1	8.3	1.6	3.4	2.2	1.2	15.7	14.7	0.4	1.5	4.9	0.0	4.2	0.1	0.5	0.0	0.0	7.4	0.2	0.5	0.3	6.1	0.0	0.0	12.7	2.0	0.9	9.0	0.0	0.1	0.0	0.0	3.6	0.1	3.8	5.0	11.4	0.1	2.0	0.0	4.2	0.3	18.3	0.4	12.4	5.6	0.0	15.2	0.0	1.5	1.0	0.8	0.1	40.6	0.1	2.4	0.2	0.3	1.2	0.8	19.7	2.0	8.1	0.1	0.4	7.8	20.5	0.8	0.3	18.8	0.5	1.9
IL6	"BSF2, HGF, HSF, IFNB2, IL-6"	ENSG00000136244	"Interleukin 6"	P05231	7	22725884-22732002	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 217.6;urinary bladder: 281.3"	"Group enriched"	"Detected in many"	4	"Adipocytes: 188.5;Endometrial ciliated cells: 163.9;Endothelial cells: 287.4;Fibroblasts: 593.3;Glandular and luminal cells: 322.2;Smooth muscle cells: 449.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	44	"memory B-cell: 3.9;naive B-cell: 4.8"	"Lineage enriched"	"Detected in single"	48	"B-cells: 4.8"	"Group enriched"	"Detected in many"	4	"BJ hTERT+: 2214.7;GAMG: 1447.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB023406, CAB072821"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	5700		"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"CAB023406: AB_617317, CAB072821: "	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (1.10e-11)"	"unprognostic (2.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.31e-2)"	"unprognostic (7.80e-2)"	217.6	13.9	3.6	30.8	3.8	46.8	31.3	3.7	6.0	4.7	9.2	22.1	1.9	5.7	0.0	34.9	18.9	41.6	55.1	3.8	3.8	17.7	13.0	114.9	9.1	4.0	4.3	6.2	19.5	10.0	38.3	11.3	4.9	16.5	17.3	1.4	12.0	2.0	7.8	7.6	8.3	19.5	3.9	7.0	18.0	1.2	4.7	6.3	14.2	4.1	3.7	281.3	5.7	4.1	0.1	0.0	0.0	0.0	0.7	2.2	7.5	8.9	2214.7	43.2	151.0	0.0	0.6	0.2	71.6	15.2	1447.6	1.7	0.0	0.3	59.9	94.2	0.2	0.0	3.7	0.0	47.3	0.0	0.6	5.6	0.0	413.8	63.1	44.2	18.2	0.0	10.6	0.5	1.9	0.1	0.0	0.3	1.6	0.7	0.5	0.0	0.0	0.0	124.2	0.0	0.0	0.0	144.5	0.1	0.6	7.9	0.1	0.1	14.5	15.2	1.4	28.2	4.7	0.0	27.8	0.4	98.5	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	3.8	3.7	6.0	3.8	3.8	4.0	4.3	4.9	3.9	4.7	4.1	188.5	6.4	22.7	0.0	27.0	44.6	3.4	28.5	1.8	0.1	1.4	1.1	1.4	0.0	17.7	3.7	0.0	1.1	0.4	0.1	0.0	9.8	0.4	163.9	44.6	287.4	0.0	0.0	0.0	2.8	4.0	593.3	0.0	322.2	6.3	0.0	3.6	0.1	4.1	0.0	0.0	0.0	0.0	9.3	76.5	0.2	0.0	27.4	40.9	2.8	4.2	0.0	0.0	0.0	0.1	4.3	0.1	0.0	0.9	16.4	0.0	0.0	8.1	0.0	0.0	28.9	449.0	0.0	0.1	0.4	33.4	1.4	8.6	0.2	0.0	20.6
INHBA		ENSG00000122641	"Inhibin subunit beta A"	P08476	7	41667168-41705834	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 21.6"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 94.4;Langerhans cells: 68.0;Leydig cells: 137.6;Smooth muscle cells: 218.3;Syncytiotrophoblasts: 178.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 75.9;hTEC/SVTERT24-B: 227.0;hTERT-HME1: 92.9;hTERT-RPE1: 139.2;TIME: 120.1;U-138 MG: 174.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		210000		"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (4.11e-3)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (4.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.18e-2)"	"prognostic unfavorable (4.34e-4)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (7.91e-8)"	"unprognostic (6.22e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.18e-3)"	2.3	1.5	2.1	5.1	2.0	10.4	0.9	2.3	7.8	1.5	0.7	1.0	0.8	17.3	3.7	2.1	1.2	21.6	5.4	8.7	3.3	2.8	9.5	11.0	1.2	4.3	8.1	6.8	0.6	0.5	0.5	10.9	3.4	3.2	0.6	2.3	5.4	5.0	0.5	2.0	0.5	4.3	4.5	0.5	0.8	1.7	3.0	0.2	1.2	4.6	0.4	10.3	1.1	3.4	4.2	0.0	0.4	0.1	3.3	7.1	0.0	18.2	1.9	9.9	3.3	0.0	0.4	0.0	1.1	6.9	11.6	15.3	0.0	75.9	9.6	5.1	0.0	0.0	0.0	0.0	13.9	0.0	0.2	7.0	4.2	227.0	92.9	139.2	8.2	0.0	0.5	0.0	23.0	0.2	0.0	0.3	1.5	0.0	10.5	0.0	0.0	0.0	0.0	0.1	0.1	5.7	11.1	0.6	0.0	6.2	0.1	0.2	120.1	174.7	49.7	18.9	19.0	0.0	0.0	0.0	6.7	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	2.1	2.0	2.3	7.8	8.7	3.3	4.3	8.1	3.4	4.5	3.0	3.4	0.7	3.2	15.7	0.0	0.9	17.3	10.8	13.5	2.2	0.1	3.5	6.5	6.0	0.0	4.4	0.0	0.0	1.4	0.3	0.1	0.0	23.6	0.6	1.4	4.1	5.9	0.0	0.0	2.4	2.0	4.6	42.0	0.0	2.6	7.6	94.4	0.7	18.5	1.5	0.0	0.2	0.2	4.1	1.4	68.0	5.9	137.6	55.8	14.2	0.0	27.0	16.1	0.0	4.0	0.3	11.1	0.1	23.3	0.0	12.5	0.0	0.1	2.8	1.3	0.0	4.9	218.3	0.7	0.3	1.4	8.9	178.4	1.7	18.8	0.2	2.3
INPP5A	5PTASE	ENSG00000068383	"Inositol polyphosphate-5-phosphatase A"	Q14642	10	132537787-132783480	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"basophil: 6.7"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 6.7"	"Low cell line specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 250.8"	"Low region specificity"	"Detected in all"			HPA012285	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Plasma membrane"	"HPA012285: AB_1851802"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.35e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.70e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.91e-3)"	"unprognostic (8.66e-2)"	22.5	16.9	26.8	12.0	85.5	9.5	17.3	56.9	30.4	29.6	10.9	54.2	19.2	49.5	19.5	29.6	30.7	15.2	75.0	20.4	21.3	14.1	14.6	25.1	8.4	20.5	37.7	19.5	12.8	12.2	14.7	28.8	20.4	24.5	16.7	16.9	13.5	23.6	75.4	22.9	23.4	42.1	17.5	13.9	27.6	22.9	50.5	6.8	14.1	50.3	7.3	35.5	22.7	27.0	35.4	13.7	22.6	21.9	33.8	23.7	18.4	36.4	27.9	23.3	15.4	32.6	14.0	3.1	13.7	38.8	15.1	19.5	24.8	15.2	27.9	10.8	14.4	5.1	17.3	44.7	24.3	12.9	11.9	16.0	14.9	15.0	28.2	18.6	16.3	6.6	7.6	18.2	12.6	28.3	3.6	40.9	10.5	21.0	24.3	7.6	14.9	5.6	19.4	19.9	5.4	18.5	18.3	26.5	22.6	20.5	17.2	30.4	13.7	14.9	17.2	20.1	21.6	3.6	18.4	11.0	14.4	8.6	6.5	6.7	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.3	26.8	85.5	56.9	30.4	20.4	21.3	20.5	37.7	20.4	17.5	50.5	27.0	14.7	9.6	19.7	14.7	4.5	5.4	4.4	1.9	0.0	10.5	7.1	5.3	10.1	4.3	6.4	7.3	0.0	3.9	5.0	24.8	0.0	6.5	12.3	2.8	22.8	10.0	6.1	3.2	33.5	9.2	3.7	5.6	6.6	5.9	8.8	8.6	15.0	17.9	2.9	8.4	25.2	9.9	2.0	7.2	12.0	17.0	7.2	6.9	1.8	19.7	4.1	9.6	0.0	18.1	29.2	12.1	11.5	11.7	2.5	6.5	13.8	4.3	2.5	5.2	6.6	6.5	24.3	6.3	7.3	2.8	5.8	2.5	2.7	10.7	13.9	8.6
ITGA7		ENSG00000135424	"Integrin subunit alpha 7"	Q13683	12	55684568-55716043	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Cell shape"	"Integrin, Receptor"	"Congenital muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 262.3"	"Group enriched"	"Detected in many"	6	"Astrocytes: 87.5;Cardiomyocytes: 124.5;Sertoli cells: 164.3;Skeletal myocytes: 65.8;Smooth muscle cells: 110.6"	"Cancer enhanced"	"Detected in all"		"glioma: 35.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"hTERT-RPE1: 309.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008427	Uncertain		Approved	"Nuclear speckles,Vesicles,Plasma membrane"		NA	NA		1200000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Nuclear speckles, Vesicles"	"HPA008427: AB_1851823"	"unprognostic (4.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.02e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (2.85e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (9.59e-5)"	133.4	8.2	18.5	18.5	21.2	1.8	69.0	15.9	30.2	28.7	16.1	97.8	17.7	45.5	12.3	23.9	56.1	30.8	157.9	34.5	17.8	11.5	10.2	15.5	6.4	21.2	21.1	19.1	5.1	6.1	12.6	1.9	20.3	33.9	8.9	2.4	14.9	37.3	262.3	16.0	27.4	95.2	16.4	10.2	35.2	8.9	23.8	3.4	26.1	154.1	3.3	46.5	25.5	21.0	0.2	4.1	7.5	12.3	66.5	13.4	0.7	5.4	8.7	11.7	11.8	8.4	6.5	2.3	7.4	3.4	0.9	1.1	5.1	0.3	10.0	0.2	3.8	0.8	2.8	3.2	0.5	0.3	2.7	19.1	0.2	64.2	0.3	309.1	0.2	2.2	0.9	1.6	37.8	5.3	0.3	3.1	20.9	1.7	0.4	0.1	28.7	0.6	0.2	0.2	0.9	2.8	0.6	0.2	48.0	4.0	0.9	13.9	0.0	1.3	12.4	0.8	8.4	3.2	2.2	0.9	57.8	8.2	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.5	21.2	15.9	30.2	34.5	17.8	21.2	21.1	20.3	16.4	23.8	21.0	11.9	0.0	0.0	87.5	0.3	1.9	0.5	0.1	0.6	2.4	1.2	3.4	124.5	2.8	0.0	1.8	4.2	0.0	0.3	0.7	0.0	0.3	0.3	1.1	1.2	9.5	7.7	0.4	17.6	0.0	0.1	5.0	0.5	1.1	0.0	6.2	0.7	1.4	0.6	0.0	9.4	1.8	0.0	1.9	2.7	0.1	6.5	2.2	3.6	9.4	0.0	3.4	0.0	6.6	3.7	0.3	0.1	6.4	0.1	0.8	2.6	0.8	0.1	0.6	164.3	65.8	110.6	4.1	2.9	0.7	2.3	0.1	0.5	0.3	0.9	0.3
ITGB1	"CD29, FNRB, GPIIA, MDF2, MSK12"	ENSG00000150093	"Integrin subunit beta 1"	P05556	10	32887273-33005792	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 1206.9;Pancreatic endocrine cells: 1393.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 2711.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003434, HPA059297, HPA069003"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Focal adhesion sites"		NA	NA		270000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Focal adhesion sites"	"Endoplasmic reticulum"	"CAB003434: AB_303570, HPA059297: AB_2732634, HPA069003: AB_2732125"	"unprognostic (3.07e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.67e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.36e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.68e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.08e-2)"	491.9	179.3	61.5	241.5	78.2	81.5	216.2	75.0	90.9	259.2	68.3	265.3	147.4	330.4	171.7	168.6	172.0	347.4	390.3	60.2	74.3	180.4	287.1	233.6	118.0	88.4	80.6	157.1	135.3	145.4	59.8	459.5	88.9	248.1	223.6	27.7	130.7	427.7	157.9	92.2	150.8	710.0	76.6	204.7	160.1	91.2	86.4	77.5	161.5	194.5	106.2	357.4	119.1	88.9	638.0	907.0	495.4	559.6	1183.4	1019.5	398.1	2063.9	1239.6	999.0	903.9	215.9	1478.2	164.5	354.1	1830.9	638.0	438.9	149.1	1204.1	1122.0	163.1	112.7	195.8	416.3	253.6	826.4	48.3	195.5	1027.7	658.2	1040.8	426.0	2711.1	1263.6	81.0	136.6	76.5	1700.8	109.0	80.1	46.7	107.4	200.6	428.2	52.0	357.0	30.9	1454.8	186.2	108.0	271.4	649.9	114.6	498.2	813.7	153.9	175.0	1362.6	1280.0	712.2	904.2	719.7	64.7	14.8	91.2	956.6	198.2	518.5	7.5	35.1	16.1	83.4	69.8	22.8	109.6	191.8	138.7	33.9	40.3	24.9	68.4	9.0	90.3	108.2	11.4	266.8	117.2	61.5	78.2	75.0	90.9	60.2	74.3	88.4	80.6	88.9	76.6	86.4	88.9	631.5	342.9	143.8	26.4	118.0	546.7	435.5	531.6	208.3	32.8	147.1	307.5	210.8	241.6	268.1	226.2	31.3	210.3	217.8	179.8	13.7	1206.9	6.6	194.6	437.9	421.1	193.3	153.0	37.2	411.3	515.2	374.7	95.8	406.5	88.7	561.8	375.9	268.1	179.8	38.7	52.4	97.4	213.6	170.1	206.7	18.3	254.5	217.8	343.3	67.5	119.4	72.0	111.2	42.7	66.8	1393.7	128.5	601.8	181.2	412.5	75.6	68.7	171.5	45.5	637.7	236.3	724.0	10.1	76.0	84.4	170.5	219.7	211.3	225.6	127.0	296.1
KBTBD13	"hCG_1645727, NEM6"	ENSG00000234438	"Kelch repeat and BTB domain containing 13"	C9JR72	15	65076746-65079948	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 30.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062737	Uncertain					NA	NA				"Cluster 33: Striated muscle - Muscle contraction"		"Cluster 48: Smooth muscle cells - ECM organization"			"HPA062737: AB_2684856"										"unprognostic (1.18e-1)"		"unprognostic (7.88e-2)"			"unprognostic (6.07e-2)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.2	0.5	0.1	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNE4	MiRP3	ENSG00000152049	"Potassium voltage-gated channel subfamily E regulatory subunit 4"	Q8WWG9	2	223051814-223198399	"Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 37.5"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 32.3;Melanocytes: 32.0;Sertoli cells: 118.3;Smooth muscle cells: 128.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 20.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 164.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA011420	Approved		Approved	"Nuclear bodies,Microtubules"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Microtubules	"Nuclear bodies"	"HPA011420: AB_1079170"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (9.42e-5)"	"unprognostic (2.17e-2)"	"unprognostic (7.56e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.89e-2)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (4.70e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.24e-3)"	"unprognostic (9.08e-3)"	13.3	3.4	7.7	11.0	6.9	0.5	6.9	6.0	11.2	5.0	5.8	8.0	1.3	30.7	2.3	5.1	7.9	20.3	13.5	8.0	6.9	7.5	5.1	3.1	5.7	9.5	8.1	12.3	10.3	1.8	10.3	6.7	9.3	4.4	2.0	3.3	2.7	5.5	5.4	3.2	3.6	37.5	6.9	4.5	12.5	1.1	7.5	0.7	9.4	3.2	1.1	10.7	3.8	8.0	0.0	0.8	0.0	164.3	36.6	3.7	0.2	4.0	3.8	0.8	1.8	0.0	0.2	0.0	0.0	2.5	5.8	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.0	4.5	0.0	0.1	6.3	0.0	5.5	0.0	0.0	0.0	0.1	0.0	0.2	6.7	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.4	0.1	0.1	0.4	6.4	0.1	12.1	0.7	0.1	0.0	0.0	3.8	0.1	3.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.7	6.9	6.0	11.2	8.0	6.9	9.5	8.1	9.3	6.9	7.5	8.0	8.2	0.0	2.2	4.2	0.0	3.8	0.4	0.2	0.0	0.1	1.8	0.4	4.9	0.0	1.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.8	16.3	19.8	4.8	0.0	0.0	0.0	0.2	32.3	9.2	0.6	3.8	0.4	3.9	0.2	0.1	3.3	0.3	0.0	2.0	0.0	5.8	0.3	21.1	1.0	32.0	5.6	0.0	6.1	0.0	1.0	0.0	0.4	0.1	17.0	0.4	1.4	0.0	0.0	3.7	0.7	118.3	1.7	128.3	0.1	0.2	0.4	3.1	0.3	0.6	0.1	0.2	1.8
KCNJ8	Kir6.1	ENSG00000121361	"Potassium inwardly rectifying channel subfamily J member 8"	Q15842	12	21764955-21775600	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 71.3"	"Group enriched"	"Detected in many"	4	"Sertoli cells: 197.2;Smooth muscle cells: 61.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"BJ: 11.1;CACO-2: 58.4;SH-SY5Y: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA031066	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA031066: AB_10602240"	"unprognostic (8.12e-3)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (7.81e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.66e-3)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (4.70e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.54e-3)"	28.6	17.3	4.9	3.2	5.4	0.0	22.1	4.8	5.7	17.0	11.6	15.6	1.2	18.8	0.7	3.6	14.8	1.8	71.3	4.7	5.0	13.9	41.9	13.8	2.5	5.2	5.3	16.8	42.4	1.8	7.8	3.0	5.1	13.0	0.3	0.8	6.4	8.4	17.1	5.8	5.9	5.5	5.2	8.0	12.7	1.0	7.2	0.6	16.1	4.5	0.4	15.1	11.5	4.7	0.0	0.1	0.9	0.0	1.4	3.2	0.0	11.1	4.4	6.5	1.9	58.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.1	0.0	4.3	2.9	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.2	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	6.6	2.7	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	5.4	4.8	5.7	4.7	5.0	5.2	5.3	5.1	5.2	7.2	4.7	18.7	3.2	29.5	2.9	0.0	1.3	0.4	0.0	0.6	0.0	9.2	3.0	28.3	0.0	0.6	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.7	10.8	12.8	1.2	0.0	3.6	1.3	0.0	9.8	0.0	0.9	0.0	1.0	2.9	23.0	0.3	0.0	0.2	0.0	0.0	0.8	1.5	0.1	0.3	0.3	1.8	0.0	0.0	13.2	0.0	0.5	0.4	1.2	0.0	0.7	0.1	0.4	0.0	0.0	0.0	2.0	197.2	3.3	61.6	0.0	1.0	0.1	0.9	0.3	0.3	0.5	0.2	0.6
KCNMB1	hslo-beta	ENSG00000145936	"Potassium calcium-activated channel subfamily M regulatory beta subunit 1"	Q16558	5	170374671-170389634	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 59.2;intestine: 75.1;smooth muscle: 53.1"	"Cell type enriched"	"Detected in many"	6	"Peritubular cells: 354.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.7;monocytes: 5.9"	"Cell line enhanced"	"Detected in some"		"REH: 8.8;SK-BR-3: 2.1;U-937: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 14: REH - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.06e-2)"	"unprognostic (2.70e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.13e-6)"	"unprognostic (1.08e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.04e-2)"	5.7	1.8	2.7	10.5	2.3	1.7	6.9	2.5	2.7	16.8	1.4	75.1	4.3	59.2	6.2	16.6	20.6	7.3	4.2	2.1	2.4	1.4	0.7	4.0	1.7	5.9	4.0	4.0	0.7	0.3	0.5	1.1	6.2	24.5	8.9	1.1	6.8	50.6	1.0	2.9	14.3	53.1	3.4	2.3	21.5	2.7	4.2	1.0	1.4	1.1	1.3	32.6	11.2	3.9	0.1	0.1	1.5	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.3	0.1	1.0	0.1	0.4	0.1	0.0	0.0	0.0	0.3	0.1	1.2	0.6	0.2	0.0	0.4	0.2	0.2	0.0	0.1	0.2	0.1	0.1	0.4	0.3	0.7	0.1	0.7	0.0	0.8	0.3	0.0	0.1	8.8	0.0	0.2	0.0	0.2	0.4	0.2	0.1	2.1	0.0	0.7	0.1	1.0	0.5	0.2	0.3	0.3	0.0	0.4	0.2	0.1	0.1	3.8	0.1	1.3	3.3	0.3	0.1	5.9	0.1	0.2	0.2	0.1	5.7	0.3	0.1	0.1	0.9	0.4	5.1	2.0	0.2	1.0	2.7	2.3	2.5	2.7	2.1	2.4	5.9	4.0	6.2	3.4	4.2	3.9	1.3	0.0	6.3	0.3	1.2	2.0	1.2	0.4	0.0	1.6	2.5	55.1	3.7	4.3	4.5	1.8	6.2	0.5	1.7	0.1	0.0	0.1	0.6	0.6	14.4	3.6	0.0	1.3	0.1	0.4	0.6	9.8	0.0	0.6	19.7	0.4	1.8	0.4	7.4	1.7	0.3	0.2	0.0	18.9	10.9	4.5	38.5	15.6	3.6	4.7	27.8	0.6	2.1	0.0	0.1	0.0	0.0	354.3	0.3	1.3	0.0	0.1	4.5	2.3	46.0	2.2	43.6	0.7	1.2	0.1	1.7	0.5	1.7	1.4	0.0	0.7
KLHL23	"FLJ37812, MGC22679, MGC2610"	ENSG00000213160	"Kelch like family member 23"	Q8NBE8	2	169694488-169776989	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 132.5;Cone photoreceptor cells: 89.6;Sertoli cells: 170.9;Smooth muscle cells: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 83.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047593			Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Actin filaments"		"HPA047593: "	"unprognostic (4.77e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.48e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.09e-1)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.87e-3)"	6.9	2.1	8.1	6.1	9.6	1.7	6.2	13.2	9.9	9.6	0.2	20.8	11.1	25.6	4.0	12.0	8.9	6.7	8.0	9.8	7.2	6.6	5.9	5.9	3.1	3.7	5.8	17.9	7.2	6.4	3.3	12.8	4.6	13.6	13.9	13.6	8.0	12.5	12.0	1.6	11.8	25.0	4.0	2.8	5.1	10.9	7.6	11.1	8.1	16.3	2.9	8.7	3.9	6.3	17.0	8.6	64.5	18.3	3.6	1.3	43.7	8.0	6.1	14.4	15.8	18.0	14.4	10.6	6.7	0.8	20.9	2.6	67.7	5.8	21.9	37.7	33.2	31.3	16.9	29.9	5.4	44.2	4.7	2.5	4.7	6.0	10.2	9.3	11.2	38.3	43.5	1.4	4.8	8.2	65.0	17.9	52.7	9.0	6.7	20.7	55.1	1.1	13.1	49.9	83.4	57.1	12.7	1.2	7.8	20.3	10.6	14.2	4.2	5.8	18.6	5.7	13.6	4.9	4.9	47.3	4.5	13.0	9.0	0.0	0.0	0.0	0.7	0.0	0.9	0.3	0.6	0.5	0.1	0.3	1.0	1.0	0.0	3.4	0.0	0.9	0.8	0.3	8.1	9.6	13.2	9.9	9.8	7.2	3.7	5.8	4.6	4.0	7.6	6.3	13.7	3.2	8.7	0.0	1.1	1.5	6.9	2.8	7.4	132.5	15.0	17.1	52.9	14.3	6.7	0.0	89.6	5.6	3.8	14.6	3.9	15.6	4.6	2.4	12.8	12.6	31.8	9.7	0.0	30.5	9.6	11.2	4.1	5.5	0.0	27.5	7.5	11.8	0.9	40.4	0.0	21.2	28.5	0.8	1.9	3.7	2.5	1.3	0.0	0.0	0.2	14.6	5.2	0.0	0.0	16.1	13.6	8.6	0.4	17.2	9.7	16.9	4.9	34.8	170.9	11.4	102.6	3.4	20.9	4.7	1.0	1.2	5.5	13.8	20.9	4.1
KRTAP4-3	KAP4.3	ENSG00000196156	"Keratin associated protein 4-3"	Q9BYR4	17	41167231-41168221	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	179	"skin 1: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HDLM-2: 1.1"	"Not detected"	"Not detected"													NA	NA		1400000		"Cluster 61: Skin - Cornification"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LBH		ENSG00000213626	"LBH regulator of WNT signaling pathway"	Q53QV2	2	30231534-30323730	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 210.6;Pancreatic endocrine cells: 298.9;Smooth muscle cells: 435.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 112.4;MAIT T-cell: 110.2;memory B-cell: 92.0;memory CD4 T-cell: 83.8;memory CD8 T-cell: 86.1;naive B-cell: 123.0;naive CD4 T-cell: 140.2;naive CD8 T-cell: 124.6;T-reg: 89.2"	"Group enriched"	"Detected in all"	7	"B-cells: 123.0;T-cells: 140.2"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 302.4;hTERT-RPE1: 150.6;U-2 OS: 95.1"	"Low region specificity"	"Detected in all"							HPA034669	Approved		Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA034669: AB_10600820"	"unprognostic (2.13e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.77e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.25e-2)"	"unprognostic (7.91e-3)"	"unprognostic (1.67e-1)"	35.2	10.3	8.4	57.4	7.9	28.6	32.0	13.7	22.4	45.6	18.4	27.4	14.4	83.0	27.0	17.0	41.7	44.9	119.3	15.2	33.9	39.3	15.0	130.7	117.8	23.0	17.4	63.3	14.4	84.8	16.7	54.5	18.4	27.3	18.1	70.8	63.9	26.3	14.3	30.3	41.2	48.2	11.2	83.5	22.8	9.8	14.4	125.7	68.9	20.4	100.9	35.5	22.7	11.8	0.1	11.4	14.0	2.5	3.6	2.2	1.1	14.5	19.1	3.8	0.6	59.4	15.2	28.6	33.3	302.4	3.8	19.5	81.1	0.8	0.6	41.3	3.4	4.6	12.2	0.2	10.9	0.4	4.0	13.0	1.1	5.0	0.3	150.6	0.7	19.0	14.6	0.2	14.2	0.2	32.3	0.4	84.6	2.6	0.6	33.1	75.4	9.7	2.6	5.0	3.9	10.0	23.7	2.3	1.0	49.7	0.1	1.2	18.9	26.8	95.1	52.0	1.8	53.8	3.3	2.7	11.9	1.8	8.4	0.7	0.7	1.1	112.4	1.2	110.2	92.0	83.8	86.1	0.8	123.0	140.2	124.6	4.0	18.9	3.2	12.1	89.2	110.4	8.4	7.9	13.7	22.4	15.2	33.9	23.0	17.4	18.4	11.2	14.4	11.8	46.9	109.0	20.0	0.7	167.3	12.4	64.5	51.7	16.5	41.2	13.0	125.0	65.1	12.8	40.8	25.8	210.6	18.3	152.2	6.0	13.7	85.4	39.4	110.5	18.0	81.8	23.8	85.9	2.2	56.9	10.8	54.7	23.4	45.2	15.8	2.3	23.6	1.2	33.2	8.4	16.4	9.3	30.5	10.0	23.1	144.5	10.5	14.3	23.2	14.0	6.7	13.1	163.7	9.5	0.7	298.9	8.7	26.7	26.3	95.3	0.7	21.7	67.8	45.4	177.5	36.3	435.6	0.7	6.6	9.1	10.7	9.3	205.3	8.8	6.3	56.8
LDOC1	"BCUR1, Mar7, Mart7, RTL7, SIRH7"	ENSG00000182195	"LDOC1 regulator of NFKB signaling"	O95751	X	141111605-141177129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 123.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 43.0;Proximal tubular cells: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 24.7;MCF7: 31.9;PC-3: 34.3;U-251 MG: 21.9"	"Region enriched"	"Detected in many"	5	"cerebellum: 19.2"					"HPA051768, HPA061842"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nucleoli"		"HPA051768: AB_2681599, HPA061842: AB_2684624"	"unprognostic (4.09e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.76e-2)"	32.3	34.0	4.7	0.9	5.5	0.1	28.0	2.9	8.5	45.8	0.2	18.8	0.9	53.9	1.8	21.4	48.5	1.6	15.1	6.2	5.8	33.2	4.8	19.6	0.8	5.3	5.0	46.8	19.3	10.5	123.3	0.0	5.0	34.3	0.3	3.4	55.1	5.9	5.5	31.5	12.5	2.0	1.2	14.2	18.4	10.8	5.0	0.9	53.7	0.4	0.7	33.1	30.6	6.0	0.0	24.7	3.0	8.4	5.0	6.2	0.0	5.0	5.8	6.3	8.8	0.0	8.0	0.0	4.2	7.7	6.1	10.4	3.4	7.1	4.5	0.0	6.6	0.0	11.7	0.0	2.0	0.0	1.9	10.9	3.6	5.5	2.9	5.1	5.7	0.0	0.1	0.0	5.7	31.9	0.0	0.0	3.3	0.0	34.3	0.0	2.7	0.0	7.7	4.7	0.0	3.2	0.0	4.0	0.0	1.6	5.1	0.0	11.9	0.0	6.8	0.0	21.9	0.0	0.0	0.0	3.5	0.0	0.0	3.1	0.0	0.0	1.2	0.0	0.8	0.9	2.5	0.8	0.2	2.1	2.2	1.4	0.0	6.4	0.0	1.4	2.6	1.0	4.7	5.5	2.9	8.5	6.2	5.8	5.3	5.0	5.0	1.2	5.0	6.0	8.6	0.0	5.3	4.2	4.9	6.0	16.8	4.6	16.5	29.3	23.8	20.2	2.2	30.0	8.2	23.9	8.4	2.8	5.7	0.1	43.0	13.8	0.7	7.8	13.5	12.8	5.4	0.8	9.4	14.0	1.8	16.1	3.6	6.0	2.5	8.8	12.8	0.1	0.9	20.2	9.9	0.4	8.2	0.3	1.8	1.1	22.1	1.0	3.6	7.5	0.3	21.2	5.2	7.1	15.0	13.7	0.2	38.7	0.9	11.9	0.0	43.8	4.6	13.0	13.1	15.3	26.2	0.9	7.6	16.7	6.8	1.5	5.2	13.5	0.3	15.0
LGI4		ENSG00000153902	"Leucine rich repeat LGI family member 4"	Q8N135	19	35124513-35142451	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.7;Distal enterocytes: 33.1;Muller glia cells: 95.5;Sertoli cells: 78.9;Smooth muscle cells: 104.4"	"Group enriched"	"Detected in many"	6	"glioma: 4.5;melanoma: 11.5;renal cancer: 13.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	27	"WM-115: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042116, HPA043556"	Approved		Approved	"Golgi apparatus"	"Secreted in brain"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"HPA042116: AB_2677855, HPA043556: AB_2678550"	"unprognostic (3.79e-1)"	"unprognostic (6.13e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.84e-7)"	"unprognostic (1.71e-2)"	"unprognostic (4.47e-1)"	"unprognostic (7.73e-2)"	"unprognostic (7.13e-2)"	77.6	5.4	71.2	4.1	72.3	0.2	36.1	70.3	98.4	99.9	52.1	100.5	3.6	35.5	2.3	15.0	43.7	5.0	39.4	67.8	61.3	4.7	8.0	14.3	2.1	86.5	68.4	13.3	6.4	1.4	4.4	3.6	70.1	37.2	3.7	7.2	12.2	13.3	39.1	21.2	35.1	4.8	72.8	1.9	27.0	2.7	72.0	0.5	19.1	5.4	0.5	33.5	79.3	81.4	0.1	0.0	0.0	0.0	0.1	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.1	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	71.2	72.3	70.3	98.4	67.8	61.3	86.5	68.4	70.1	72.8	72.0	81.4	13.3	0.0	0.0	74.7	0.2	2.5	0.6	0.3	3.4	0.8	1.5	1.5	17.1	0.0	0.8	1.8	2.1	0.0	0.2	33.1	0.0	0.0	0.1	0.2	2.8	5.4	1.8	0.0	21.9	0.0	0.3	12.7	0.0	0.2	0.0	0.0	7.9	2.0	0.1	0.0	2.2	0.9	0.0	0.0	4.6	0.3	14.6	0.7	10.6	5.6	0.1	95.5	0.0	2.0	9.2	0.1	21.8	7.2	0.3	1.2	1.1	0.1	0.9	3.1	78.9	7.9	104.4	2.8	2.8	0.8	2.4	0.0	0.7	0.0	0.7	1.1
LINC00514		ENSG00000262152	"Long intergenic non-protein coding RNA 514"		16	2988256-3002016	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	7	"brain: 3.2;lymphoid tissue: 2.5;skin 1: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 3.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8;HaCaT: 3.8;hTCEpi: 2.6;MCF7: 2.0;OE19: 3.1;SCLC-21H: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA					"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (1.19e-1)"	"unprognostic (8.43e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.16e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.65e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0		0.1	0.2	0.3	0.1	0.1	0.4	0.0	0.0	3.7	0.1	0.0	0.0	0.0	0.2	0.1	0.1	2.5	0.0	0.0	0.1	0.0		0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.1	0.2	0.0	1.8	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	2.0	0.0	0.1	0.0	3.1	0.0	0.0	0.5	0.0	0.0	0.0	2.5	0.0	0.2	1.1	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.4	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
LIX1L	MGC46719	ENSG00000271601	"Limb and CNS expressed 1 like"	Q8IVB5	1	145933423-145958017	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063598			Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA063598: AB_2685055"	"unprognostic (5.21e-2)"	"unprognostic (4.09e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.85e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (9.81e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (2.10e-3)"	"unprognostic (4.95e-1)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (5.27e-4)"	21.0	19.0	14.6	15.2	15.1	6.4	16.0	13.8	13.1	27.1	15.6	23.0	6.7	27.6	11.1	9.8	21.1	15.6	16.3	12.9	13.5	9.8	10.2	15.6	20.4	15.0	15.2	36.9	5.8	7.5	16.3	16.2	14.0	16.2	9.2	19.0	9.4	20.8	34.8	8.1	13.3	25.7	13.9	20.8	11.3	6.6	15.8	16.6	10.8	31.5	20.8	21.1	16.9	15.0	7.3	10.3	31.0	34.5	63.4	53.5	0.4	16.3	29.4	24.8	18.1	0.8	6.7	19.6	17.5	33.1	9.3	0.4	14.6	13.6	23.3	18.2	4.5	10.9	11.0	10.4	20.8	26.2	24.8	32.9	6.2	20.3	29.3	39.9	48.7	25.8	16.4	30.6	39.9	0.2	34.6	21.8	9.0	0.1	13.2	23.2	15.6	32.4	25.7	0.2	11.1	31.6	33.5	0.1	24.9	12.8	1.2	20.3	38.0	41.9	11.5	27.6	27.8	24.5	18.7	19.9	29.5	21.4	20.7	4.0	2.2	3.9	5.7	2.2	7.0	3.0	6.6	5.8	2.1	3.1	6.1	8.0	3.7	3.8	3.8	3.3	5.4	2.6	14.6	15.1	13.8	13.1	12.9	13.5	15.0	15.2	14.0	13.9	15.8	15.0	29.7	0.0	5.8	11.1	23.1	11.3	10.6	10.8	11.4	17.1	3.8	7.5	17.5	14.3	4.9	11.0	8.4	1.4	18.6	2.8	3.9	9.6	10.4	2.3	21.6	36.7	12.6	23.5	5.1	10.0	4.3	28.4	2.6	3.5	5.1	10.8	45.7	19.6	21.1	13.5	6.1	1.4	8.2	24.3	43.8	3.6	35.8	18.8	28.4	15.9	27.4	28.1	35.0	8.5	7.0	11.0	1.2	56.4	17.8	7.5	0.1	7.7	3.0	13.6	26.3	16.8	37.9	24.1	4.7	3.1	7.7	0.8	37.4	21.4	2.1	4.2
LMOD1	"1D, 64kD, D1"	ENSG00000163431	"Leiomodin 1"	P29536	1	201896456-201946588	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 513.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5;Leydig cells: 125.6;Peritubular cells: 275.3;Rod photoreceptor cells: 70.2;Sertoli cells: 197.2;Smooth muscle cells: 224.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 43.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 15.8;BJ: 21.3;BJ hTERT+: 34.4;fHDF/TERT166: 17.4;HSkMC: 14.5;hTERT-RPE1: 54.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028325, HPA028435, HPA030097"	Enhanced		Approved	Cytosol		No	No				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223"	"unprognostic (3.84e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.64e-1)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.15e-2)"	157.7	52.5	7.8	28.5	9.7	0.0	75.4	5.7	9.1	161.9	5.5	513.9	25.1	309.5	49.7	135.8	194.7	85.5	31.7	6.2	8.0	11.8	5.1	44.3	7.3	13.6	6.5	72.2	8.4	18.2	5.8	35.3	6.8	165.2	46.9	48.0	21.2	242.5	137.5	43.2	115.5	206.6	5.4	18.5	218.6	17.9	9.1	2.5	39.8	45.7	1.6	368.7	111.9	7.2	0.0	0.1	0.4	1.2	15.8	2.0	1.3	21.3	34.4	1.3	1.5	0.1	0.2	0.0	0.7	17.4	0.2	0.3	0.5	0.0	0.4	0.0	1.4	0.0	0.1	0.0	1.5	0.1	0.1	14.5	0.0	1.0	0.0	54.4	0.1	0.0	0.2	0.2	0.7	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.5	0.1	0.4	0.1	0.3	0.0	0.5	0.4	9.5	0.7	0.0	0.0	0.1	0.8	0.3	0.0	0.7	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	9.7	5.7	9.1	6.2	8.0	13.6	6.5	6.8	5.4	9.1	7.2	16.1	0.0	1.1	8.5	0.3	1.3	1.0	0.3	0.0	4.8	1.6	40.8	25.1	0.0	0.0	0.0	135.5	1.7	0.0	0.1	0.0	0.0	2.1	2.6	64.5	5.8	0.0	0.0	0.5	0.6	0.3	20.4	0.5	1.2	0.0	0.7	9.3	0.4	1.0	3.3	1.0	0.0	0.0	0.0	2.3	8.2	125.6	0.9	3.6	3.7	0.0	7.3	0.0	4.0	1.0	0.0	0.0	275.3	0.0	0.9	0.0	0.1	0.9	70.2	197.2	5.2	224.3	1.2	0.5	0.8	2.3	1.2	1.3	2.1	0.0	0.4
LZTS1	FEZ1	ENSG00000061337	"Leucine zipper tumor suppressor 1"	Q9Y250	8	20246165-20303963	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 14.8;parathyroid gland: 54.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 17.6;Excitatory neurons: 26.2;Horizontal cells: 20.2;Melanocytes: 19.6;Rod photoreceptor cells: 18.5;Sertoli cells: 65.7;Smooth muscle cells: 15.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 59.2"	"Group enriched"	"Detected in many"	5	"amygdala: 13.1;basal ganglia: 11.6;cerebral cortex: 14.8;hippocampal formation: 14.5;white matter: 9.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 19.7;SK-MEL-30: 75.0;U-698: 23.2;WM-115: 50.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"amygdala: 23.2;basal ganglia: 66.8;cerebral cortex: 45.5;hippocampal formation: 36.3;olfactory bulb: 26.7"	"HPA006294, HPA022046"	Approved		Approved	"Nucleoli,Plasma membrane"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Nucleoli	"HPA006294: AB_1079288, HPA022046: AB_1853455"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.06e-3)"	"unprognostic (6.81e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (9.28e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.82e-3)"	3.7	1.7	13.1	1.5	11.6	0.1	3.0	0.0	14.8	2.0	0.0	1.3	0.5	2.9	0.9	5.3	1.6	3.5	5.0	14.5	0.6	4.7	0.7	7.0	1.1	0.0	0.1	1.2	1.5	54.2	2.2	6.5	0.3	2.8	0.4	3.5	1.4	1.1	1.9	4.6	0.9	2.5	0.0	0.5	1.4	7.5	2.3	1.9	2.7	2.0	0.5	2.3	1.7	9.2	0.1	0.0	9.7	8.3	0.0	0.0	1.2	5.0	0.1	4.3	3.7	0.3	0.1	11.1	3.5	3.1	1.6	0.2	0.5	0.2	2.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	1.7	0.9	0.1	1.8	0.0	0.6	0.0	11.7	0.0	0.1	14.4	0.0	19.7	0.1	12.2	0.0	0.0	0.0	15.6	0.0	2.7	0.4	14.8	12.9	0.0	0.0	75.0	8.2	0.1	0.4	0.0	5.1	3.5	0.1	1.5	0.1	0.1	23.2	0.1	1.1	50.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.1	11.6	0.0	14.8	14.5	0.6	0.0	0.1	0.3	0.0	2.3	9.2	3.9	0.0	0.0	1.6	0.0	1.3	0.8	1.0	17.6	1.8	0.3	11.3	4.6	0.0	0.1	0.0	4.2	7.1	0.4	0.0	1.9	0.0	0.5	0.6	1.3	3.2	0.0	0.0	26.2	0.0	2.3	2.4	0.0	0.5	0.0	3.5	0.0	0.0	0.9	20.2	2.9	0.0	2.0	0.0	0.0	0.8	1.2	0.2	19.6	1.9	0.0	0.9	0.0	6.0	0.8	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.0	18.5	65.7	1.1	15.4	0.2	1.1	7.3	0.1	0.8	1.4	2.5	0.0	0.0
MAP1B	"MAP5, PPP1R102"	ENSG00000131711	"Microtubule associated protein 1B"	P46821	5	72107234-72209565	"Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 431.3;retina: 154.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 717.2;Excitatory neurons: 571.8;Horizontal cells: 647.8;Rod photoreceptor cells: 562.1;Sertoli cells: 769.2;Smooth muscle cells: 461.2"	"Cancer enriched"	"Detected in all"	5	"glioma: 48.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 301.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009792, HPA022275"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		180000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB009792: AB_2137420, HPA022275: AB_1853944"	"unprognostic (9.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (8.22e-5)"	30.2	19.4	135.6	10.9	127.6	0.1	17.8	181.9	299.9	14.9	0.0	16.9	2.1	16.6	9.5	13.0	11.5	11.0	25.8	138.9	310.5	4.0	2.2	7.1	2.2	392.1	297.1	7.0	3.6	2.5	16.4	10.0	431.3	20.1	5.3	154.9	7.7	25.4	6.0	13.3	7.1	26.4	222.4	1.3	15.3	12.0	332.9	1.5	8.3	9.6	1.3	26.7	11.4	272.0	1.4	62.8	133.5	48.7	80.9	140.1	0.2	32.6	22.7	29.0	34.5	0.5	1.7	0.1	71.8	108.2	87.9	0.6	73.2	2.8	43.3	0.2	12.3	6.7	22.3	18.3	43.6	0.0	5.1	142.1	9.3	116.7	42.8	25.9	91.6	0.2	10.6	0.3	49.5	0.6	0.1	0.0	36.5	0.0	21.3	0.4	16.4	0.1	2.5	0.1	89.9	63.0	28.9	0.3	14.9	109.7	0.2	6.1	301.6	90.7	44.6	69.4	140.3	8.0	0.4	0.2	98.5	0.1	72.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	135.6	127.6	181.9	299.9	138.9	310.5	392.1	297.1	431.3	222.4	332.9	272.0	45.6	0.0	2.0	85.5	1.5	31.6	71.3	2.3	5.2	240.3	14.3	34.3	366.0	2.8	11.5	9.2	717.2	1.6	0.6	0.0	0.0	12.9	13.2	75.4	116.8	97.8	77.6	0.0	571.8	3.4	1.4	220.6	6.6	27.7	1.3	25.3	42.1	0.8	6.4	647.8	350.7	0.7	18.3	1.3	28.4	23.4	309.7	10.1	80.0	91.8	0.0	406.1	0.0	131.2	269.3	7.1	0.0	384.8	0.5	22.1	0.1	0.9	48.6	562.1	769.2	85.4	461.2	8.9	8.0	1.9	50.6	4.0	4.2	269.9	0.2	20.0
MATN3	"EDM5, HOA"	ENSG00000132031	"Matrilin 3"	O15232	2	19992052-20012668	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 13.2;placenta: 11.3"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 38.5;Sertoli cells: 26.3"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 13.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"Hep G2: 143.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 1.7"	HPA051250			Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		440000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum, Golgi apparatus"		"HPA051250: AB_2681406"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (7.57e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.62e-5)"	"unprognostic (1.27e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (2.51e-1)"	"unprognostic (7.04e-2)"	"unprognostic (3.15e-2)"	2.2	0.6	5.1	0.5	3.2	0.0	2.7	3.4	5.7	2.5	2.5	0.6	0.4	2.1	0.9	0.5	1.9	2.1	0.4	3.4	3.9	1.9	0.0	13.2	0.3	5.2	6.0	0.7	0.4	0.4	0.3	11.3	5.2	1.6	0.5	0.3	0.6	4.6	0.3	0.8	0.4	1.7	4.7	0.3	1.8	0.9	7.6	0.1	1.3	0.6	0.3	0.8	1.2	3.6	6.4	4.9	16.1	0.1	4.5	9.7	1.0	2.0	1.1	6.5	8.2	4.7	2.7	0.0	0.8	1.7	6.2	1.1	0.4	12.7	9.2	0.0	0.4	0.0	1.1	143.4	1.1	0.0	0.0	21.3	0.7	7.1	1.7	4.5	8.7	0.0	0.0	0.0	13.8	2.5	0.0	0.0	5.0	0.2	2.4	0.0	0.0	0.0	19.5	4.5	0.1	2.1	10.6	1.8	6.5	27.1	19.2	0.1	4.9	9.5	11.4	0.4	1.2	0.1	0.0	0.0	1.6	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	3.2	3.4	5.7	3.4	3.9	5.2	6.0	5.2	4.7	7.6	3.6	1.6	38.5	2.2	0.0	0.0	0.3	0.3	2.6	0.0	0.0	5.4	1.3	0.3	0.0	2.3	1.8	0.0	0.1	0.1	0.0	0.0	0.4	0.4	0.3	0.8	2.8	0.0	0.0	0.1	0.2	1.9	1.9	0.0	0.5	0.0	4.4	0.0	0.0	0.1	0.0	0.2	0.0	4.1	0.0	0.3	0.4	1.5	0.1	3.6	4.7	0.0	0.0	0.0	0.5	0.2	1.1	0.0	4.5	0.0	0.3	0.0	0.8	1.6	0.0	26.3	0.8	6.8	0.0	1.3	0.0	0.1	0.1	0.1	6.3	0.0	0.2
MATR3	"KIAA0723, MGC9105, MPD2, VCPDM"	ENSG00000015479	"Matrin 3"	P43243	5	139293674-139331677	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"	RNA-binding	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 155.9;Inhibitory neurons: 160.2;Langerhans cells: 122.3;Oligodendrocyte precursor cells: 117.6;Oligodendrocytes: 162.4;Respiratory ciliated cells: 127.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB033552, HPA036564, HPA036565"	Supported		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		260000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB033552: AB_2281755, HPA036564: AB_10669907, HPA036565: AB_10673623"	"unprognostic (9.33e-2)"	"unprognostic (6.57e-2)"	"unprognostic (8.37e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.86e-2)"	"unprognostic (7.90e-2)"	112.9	127.9	145.2	93.6	156.1	323.5	161.0	172.2	224.5	144.1	109.6	106.3	76.9	166.6	124.0	103.3	131.1	115.3	111.4	158.4	146.1	150.1	112.9	115.2	157.9	126.2	132.1	199.3	102.8	168.6	95.1	122.9	131.4	130.2	106.5	223.4	93.5	133.2	119.6	82.0	90.0	142.4	144.8	124.5	89.1	114.9	139.3	221.7	190.5	114.0	170.2	133.5	91.2	156.3	209.0	191.1	559.5	260.7	192.4	212.5	283.2	172.2	300.9	300.4	347.5	273.1	208.8	351.2	236.8	244.1	284.8	135.8	376.8	269.6	403.0	278.4	189.1	236.5	205.0	285.0	183.2	262.5	174.4	222.5	203.7	247.4	226.3	247.1	296.1	219.4	216.9	170.3	313.8	186.7	496.0	285.8	303.6	205.2	182.6	304.7	416.4	217.8	278.0	316.5	279.5	348.7	248.3	176.7	264.6	426.3	194.4	254.5	192.2	272.0	177.7	180.6	246.3	171.0	300.4	423.0	189.8	226.5	268.0	187.0	71.2	116.3	109.6	82.2	134.8	116.3	114.3	124.6	92.6	97.7	124.4	116.5	34.7	150.9	106.7	50.7	136.1	159.8	145.2	156.1	172.2	224.5	158.4	146.1	126.2	132.1	131.4	144.8	139.3	156.3	0.1	44.8	50.2	83.6	17.6	114.6	0.8	99.2	15.9	1.8	0.3	0.3	0.7	0.0	92.0	0.0	2.1	1.2	0.0	27.6	0.0	0.0	0.3	0.2	0.2	13.6	83.5	15.5	155.9	0.0	1.0	17.5	5.1	0.4	100.3	0.1	0.0	0.0	1.3	1.7	160.2	35.3	87.5	0.0	122.3	0.6	0.6	4.7	103.2	60.9	0.1	0.7	0.0	117.6	162.4	0.1	12.4	0.7	7.3	0.7	0.8	0.2	127.9	1.3	0.0	1.0	33.3	1.1	0.5	15.1	111.2	0.8	21.8	0.5	41.9	1.0
MBOAT1	"dJ434O11.1, LPEAT1, MGC44669, OACT1"	ENSG00000172197	"Membrane bound O-acyltransferase domain containing 1"	Q6ZNC8	6	20099684-20212469	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 18.8;Langerhans cells: 25.2;Oligodendrocytes: 41.5;Respiratory ciliated cells: 19.1;Suprabasal keratinocytes: 15.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 42.2;HEL: 40.6;T-47d: 31.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (1.26e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.85e-3)"	"unprognostic (3.88e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.62e-3)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (2.90e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.24e-2)"	7.3	3.3	1.4	6.0	3.6	11.1	12.5	4.6	2.4	13.3	1.9	19.2	13.8	14.2	5.8	10.5	21.7	8.4	5.9	1.1	2.1	6.1	4.5	7.4	5.4	7.4	3.8	12.5	5.8	5.7	2.4	4.0	6.3	9.3	18.9	1.2	8.1	5.3	1.9	6.8	16.4	8.4	4.6	7.3	15.2	1.4	4.1	2.7	7.6	2.2	5.2	8.6	10.9	9.4	4.5	4.7	8.3	6.6	0.9	2.7	0.6	7.1	2.0	4.4	5.1	2.3	19.0	0.0	14.5	6.8	3.9	42.2	7.6	3.6	6.3	11.3	4.5	40.6	7.9	0.1	5.5	10.6	11.9	1.2	3.6	1.9	8.1	2.3	2.4	7.1	5.4	7.2	1.0	4.7	6.3	10.1	2.1	4.4	2.3	2.0	9.1	25.0	5.9	8.7	0.4	5.3	1.4	8.6	9.0	15.9	31.2	5.3	2.0	6.0	4.2	3.6	3.4	9.7	20.9	0.1	0.6	7.9	7.9	39.9	27.6	66.8	3.9	33.3	20.2	2.6	9.1	7.2	15.1	1.6	2.6	2.6	34.4	4.4	41.1	18.5	13.5	7.9	1.4	3.6	4.6	2.4	1.1	2.1	7.4	3.8	6.3	4.6	4.1	9.4	1.3	3.2	0.5	0.3	1.7	11.0	0.9	3.5	4.6	0.0	2.4	1.3	0.4	0.0	6.6	0.0	0.0	0.1	3.7	3.5	1.9	2.7	0.0	4.7	3.1	2.5	0.0	8.4	1.1	1.2	0.1	6.4	18.8	7.5	0.0	1.9	1.1	0.0	1.5	0.0	0.5	2.0	2.0	1.0	25.2	0.0	0.3	4.4	8.8	6.5	4.5	1.3	0.0	0.0	41.5	1.5	7.7	0.0	1.5	0.8	5.5	0.0	19.1	0.1	0.0	1.0	3.6	0.0	0.1	5.4	15.5	0.3	6.4	10.4	3.0	1.8
MCAM	"CD146, HEMCAM, MelCAM, METCAM, MUC18"	ENSG00000076706	"Melanoma cell adhesion molecule"	P43121	11	119308529-119321521	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 128.5;Endothelial cells: 153.5;Muller glia cells: 89.8;Sertoli cells: 322.1;Smooth muscle cells: 384.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 83.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HUVEC TERT2: 1121.0;TIME: 1107.4;WM-115: 869.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002147, HPA008848"	Enhanced		Approved	"Plasma membrane"		NA	NA		1900000000	"Cluster 13: T-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"CAB002147: AB_563499, HPA008848: AB_1078445"	"unprognostic (6.45e-2)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (7.03e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.42e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (8.75e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.79e-3)"	332.7	30.0	36.6	68.4	46.1	1.2	180.6	45.7	45.3	96.6	25.3	166.3	29.2	175.8	47.0	89.2	136.4	66.8	118.0	35.3	44.7	42.0	10.5	116.4	19.6	59.4	43.1	60.9	22.0	93.9	17.8	168.0	52.2	78.1	32.2	12.2	39.5	148.0	40.7	50.9	73.0	160.9	36.2	35.4	97.7	9.7	50.2	15.5	58.7	37.4	15.4	174.5	79.8	44.8	0.7	5.1	4.7	0.3	21.5	0.3	23.2	3.2	0.3	29.9	13.3	17.9	0.9	1.2	94.5	10.7	44.7	3.2	38.3	8.1	15.0	56.9	14.5	1.2	102.4	19.8	51.0	0.1	0.4	15.2	0.3	40.8	18.7	1.1	1121.0	7.1	38.7	1.5	6.1	0.0	1.2	9.3	19.9	0.2	4.4	0.9	147.8	32.9	27.1	0.0	12.5	3.9	87.1	2.1	249.2	46.2	4.3	0.9	1107.4	3.1	156.7	0.2	89.1	2.4	2.3	0.6	43.1	0.1	869.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	36.6	46.1	45.7	45.3	35.3	44.7	59.4	43.1	52.2	36.2	50.2	44.8	128.5	0.0	2.3	1.3	1.4	4.7	0.6	11.1	8.0	1.2	9.9	19.7	65.8	18.6	1.1	0.0	22.9	0.5	2.5	0.1	0.0	17.3	1.7	7.8	14.0	153.5	0.0	0.0	1.4	0.4	38.7	14.1	1.5	10.3	0.0	18.2	60.0	0.6	0.8	0.0	3.5	0.0	0.0	1.3	7.0	0.7	0.9	2.4	21.4	14.0	0.6	89.8	1.0	18.6	45.2	1.6	0.0	25.2	3.1	1.7	0.0	0.9	1.3	4.0	322.1	9.9	384.6	2.1	1.6	1.7	3.3	0.4	9.3	4.9	0.1	1.8
MED22	"Med24, SRB6, SURF5"	ENSG00000148297	"Mediator complex subunit 22"	Q15528	9	133338312-133348131	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020391, HPA063694"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA020391: AB_1857668, HPA063694: AB_2685093"	"unprognostic (2.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.56e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (4.99e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (6.46e-4)"	"unprognostic (3.99e-1)"	"prognostic favorable (3.76e-11)"	"unprognostic (9.25e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.62e-1)"	14.1	20.4	7.1	6.2	7.1	4.9	14.0	7.3	7.2	22.1	6.3	24.6	5.2	23.2	2.8	15.6	20.4	3.4	22.2	6.8	6.8	19.5	12.1	15.1	6.3	8.4	7.2	21.4	14.8	6.7	16.7	4.4	7.3	21.7	2.9	2.8	14.3	7.4	13.3	14.3	17.6	5.6	7.5	21.9	15.7	10.2	6.9	4.6	19.2	3.3	5.0	23.2	16.2	7.1	10.0	11.5	17.7	12.7	3.8	6.5	20.5	11.9	8.3	14.5	9.6	25.4	9.1	20.0	6.9	8.5	12.6	19.4	13.3	11.5	6.0	15.7	7.7	10.6	28.8	6.9	6.4	13.7	10.5	5.0	9.0	13.0	8.6	6.8	7.0	11.5	15.7	9.3	6.9	13.8	19.5	11.4	24.8	12.4	13.8	26.4	14.1	18.4	6.0	7.2	14.3	11.6	13.8	17.4	10.4	7.1	19.7	4.7	9.5	18.7	13.0	13.0	15.8	6.4	9.4	19.4	10.8	10.6	15.8	1.1	1.5	2.6	0.7	1.2	0.9	1.1	0.8	0.9	1.1	1.5	0.9	0.7	2.3	0.6	2.2	1.5	0.7	1.1	7.1	7.1	7.3	7.2	6.8	6.8	8.4	7.2	7.3	7.5	6.9	7.1	6.4	22.4	11.7	4.6	8.3	8.3	10.6	4.0	4.0	13.6	6.9	5.2	9.9	7.2	3.1	16.5	0.0	6.1	12.8	8.8	3.9	5.8	1.9	3.7	6.7	8.4	6.7	3.8	3.0	5.3	5.1	11.2	6.1	6.2	7.6	8.4	6.4	4.3	7.8	13.5	3.3	6.5	4.1	7.2	8.3	2.8	11.8	8.3	1.8	3.7	5.6	9.6	5.2	3.0	5.3	8.1	2.1	16.6	6.8	8.4	8.3	5.2	1.7	12.1	26.3	14.8	15.2	13.2	13.7	5.2	6.5	5.5	5.8	5.9	5.9	4.7
MLANA	MART1	ENSG00000120215	Melan-A	Q16655	9	5890889-5910606	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 42.9"	"Cell type enriched"	"Detected in some"	23	"Melanocytes: 1718.2"	"Cancer enriched"	"Detected in single"	556	"melanoma: 277.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	406	"SK-MEL-30: 703.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000057, HPA048662"	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB000057: AB_442107, HPA048662: AB_2680485"	"unprognostic (2.52e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.53e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.71e-3)"	"unprognostic (3.60e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.01e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.43e-2)"	0.1	0.2	0.3	0.4	0.5	0.7	1.4	2.0	0.6	0.1	5.9	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.3	0.4	0.1	0.4	0.5	0.3	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.3	1.1	0.0	0.3	42.9	0.1	0.0	0.1	0.2	0.2	0.3	0.6	0.1	0.2	0.0	0.0	0.2	0.3	0.8	0.8	0.6	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.8	0.2	0.0	0.2	0.1	0.0	0.0	0.0	1.0	0.2	1.7	1.3	1.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.9	0.0	0.3	0.1	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.1	0.4	0.1	703.0	0.1	0.1	0.3	0.6	0.2	0.4	0.1	0.7	0.2	0.7	0.3	0.2	0.4	0.1	0.8	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.3	0.1	0.2	0.4	0.2	0.1	0.2	0.1	0.0	0.3	0.5	2.0	0.6	0.2	0.1	0.5	0.3	0.5	0.1	0.6	0.8	0.0	0.0	0.0	0.3	0.0	73.7	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.9	0.0	0.0	1.3	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	15.5	0.9	0.0	0.2	1718.2	0.0	0.0	0.0	0.0	1.5	1.8	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.3	14.5	0.0	0.5	0.1	0.0	0.0
MOB2	HCCA2	ENSG00000182208	"MOB kinase activator 2"	Q70IA6	11	1469457-1501247	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046313	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA046313: AB_10959882"	"unprognostic (5.02e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.24e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.80e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.67e-1)"	"unprognostic (8.56e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.15e-1)"	32.3	19.6	34.7	19.2	36.3	24.2	28.3	37.8	39.7	27.4	36.2	61.1	18.0	30.7	36.5	51.9	34.4	27.8	43.5	35.3	36.5	18.6	20.0	24.7	26.8	36.1	36.8	28.1	32.8	34.9	11.2	25.7	36.5	32.5	34.8	14.6	35.2	42.3	50.9	50.0	28.6	49.0	36.1	25.1	27.9	14.2	37.1	34.1	24.2	70.4	27.0	39.9	31.6	37.8	29.3	31.2	18.3	15.7	44.2	30.8	17.1	22.5	30.9	40.4	31.8	20.1	39.0	20.9	16.7	50.6	26.0	34.8	28.1	48.6	24.3	28.8	44.3	16.0	11.7	26.2	30.2	21.2	24.2	25.1	57.9	21.9	25.3	32.7	43.6	27.0	26.3	21.2	20.7	20.6	27.4	37.7	23.0	54.3	29.4	19.9	19.0	22.2	34.4	26.9	34.6	37.3	27.3	34.0	27.9	23.0	15.9	21.3	37.7	25.6	13.1	8.3	14.5	21.6	22.3	21.8	17.9	20.3	19.8	9.7	8.7	11.9	16.2	9.2	13.6	8.1	14.1	13.7	10.6	11.0	11.6	10.2	7.1	12.1	13.4	7.5	15.3	10.6	34.7	36.3	37.8	39.7	35.3	36.5	36.1	36.8	36.5	36.1	37.1	37.8	84.8	6.4	10.0	6.5	20.2	82.2	30.1	39.4	12.0	18.4	27.8	33.3	14.8	12.8	18.4	7.3	12.5	31.1	64.5	58.6	27.4	33.5	24.3	18.9	17.7	58.2	20.9	36.2	15.2	38.5	31.0	23.3	16.8	29.2	24.8	20.3	33.9	9.0	26.4	43.7	10.9	32.8	32.6	18.2	39.3	12.1	23.9	28.1	56.9	11.2	29.4	21.5	81.4	6.6	14.8	39.6	63.2	51.1	17.0	48.6	54.3	23.9	12.9	21.4	85.5	20.8	68.3	29.8	41.1	13.7	82.0	59.4	36.4	20.2	27.7	37.6
MPRIP	"M-RIP, p116Rip, RHOIP3"	ENSG00000133030	"Myosin phosphatase Rho interacting protein"	Q6WCQ1	17	17042457-17217679	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 60.9"	"Lineage enriched"	"Detected in all"	6	"T-cells: 60.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022034, HPA022901"	Enhanced		Supported	"Actin filaments,Cytosol"		NA	NA		29000	"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments"	Cytosol	"HPA022034: AB_1854093, HPA022901: AB_2297761"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.81e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	126.1	110.0	166.8	74.9	213.0	68.1	102.7	165.7	184.3	128.6	113.4	128.4	78.6	172.7	83.7	151.7	120.5	73.8	245.6	184.5	142.9	156.8	129.1	144.5	80.4	165.5	157.1	90.3	137.5	96.7	116.0	70.5	170.7	113.0	59.9	59.0	83.2	91.8	168.3	96.2	103.3	133.6	145.0	102.2	141.2	99.2	173.6	89.7	139.4	84.6	76.9	133.0	135.3	168.2	328.5	241.7	103.6	85.1	107.2	79.3	146.0	155.2	117.6	131.9	96.9	189.2	242.3	129.3	151.0	251.4	108.9	292.1	133.4	227.3	139.3	127.7	69.8	70.3	216.9	68.6	72.3	38.6	49.4	76.8	133.4	149.9	114.0	189.8	138.9	97.9	43.5	73.1	213.3	113.0	158.1	131.9	46.6	324.2	275.9	127.6	162.4	48.9	101.6	155.3	57.3	94.4	174.7	144.2	81.4	414.0	68.8	60.3	130.8	118.4	128.0	321.3	280.2	51.6	45.0	61.1	221.3	69.1	297.7	2.4	2.5	3.5	8.5	1.9	18.3	9.3	34.8	14.4	2.4	6.9	24.8	12.1	1.1	4.5	1.8	10.0	60.9	9.9	166.8	213.0	165.7	184.3	184.5	142.9	165.5	157.1	170.7	145.0	173.6	168.2	75.9	32.1	48.0	87.1	22.2	27.0	27.9	22.7	12.5	104.6	26.2	29.2	59.9	31.5	30.6	25.8	81.3	25.9	32.9	46.9	3.9	31.8	28.5	43.7	47.4	62.1	22.7	25.0	94.0	28.7	36.2	39.7	72.4	79.4	16.5	51.3	37.9	21.7	12.3	97.6	75.6	17.3	26.4	14.3	18.6	32.4	29.2	17.7	32.0	43.1	13.5	31.3	17.5	73.4	84.4	92.4	26.4	43.2	19.0	40.2	27.9	9.2	30.6	49.3	78.9	71.0	110.4	24.3	31.4	22.4	27.4	31.7	35.0	49.4	27.1	103.0
MPZ	"CMT1, CMT1B, CMT2I, CMT2J, HMSNIB, P0"	ENSG00000158887	"Myelin protein zero"	P25189	1	161304735-161309968	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Deafness, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 6.6;Skeletal myocytes: 9.3"	"Cancer enriched"	"Detected in many"	11	"melanoma: 83.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"WM-115: 139.3"	"Group enriched"	"Detected in some"	4	"olfactory bulb: 2.9;pons and medulla: 1.3"	"Region enriched"	"Detected in some"	10	"spinal cord: 2142.4"	HPA068925	Enhanced					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA068925: AB_2732123"	"unprognostic (6.77e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.88e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.62e-8)"	"unprognostic (6.75e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.32e-2)"	19.1	6.9	2.1	2.1	3.0	1.1	12.6	2.5	2.7	8.3	1.4	22.3	1.6	2.0	2.0	4.4	5.3	2.4	15.2	1.9	3.9	6.3	5.4	2.9	1.1	3.0	2.2	3.1	2.3	0.6	6.2	0.6	9.9	12.2	2.7	1.2	15.8	8.0	5.1	9.1	8.5	0.8	3.3	4.4	7.6	2.4	2.0	1.4	3.7	18.4	0.9	9.5	15.9	2.2	0.4	0.0	0.3	0.1	2.7	1.3	0.3	0.3	0.5	0.1	1.6	0.0	0.1	2.3	1.5	0.4	0.5	0.1	1.8	0.6	0.1	1.1	0.0	1.0	0.4	31.0	1.2	4.7	3.7	4.2	0.0	6.2	0.3	0.0	2.8	1.9	9.9	0.0	4.3	0.0	0.7	7.6	1.4	0.0	0.0	0.3	0.2	1.4	0.3	0.1	2.0	0.3	0.0	0.0	14.0	0.8	0.1	9.5	2.7	0.3	0.4	2.7	0.2	0.9	0.9	1.2	4.8	17.5	139.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	3.0	2.5	2.7	1.9	3.9	3.0	2.2	9.9	3.3	2.0	2.2	1.7	3.2	0.6	1.0	2.1	0.5	3.1	0.4	4.0	2.5	0.4	1.3	0.7	0.0	0.5	3.7	2.1	0.5	1.6	0.1	0.0	0.2	5.5	0.3	0.2	1.5	1.8	1.3	1.7	1.2	0.7	2.5	0.0	0.1	0.0	0.8	1.8	1.0	1.6	1.7	2.2	0.7	2.0	1.9	0.8	1.8	1.5	2.0	3.6	1.0	3.8	0.5	0.0	0.5	1.6	0.1	0.1	0.4	1.4	0.9	0.3	1.0	0.6	1.1	6.6	9.3	3.9	0.4	0.6	1.1	0.4	0.3	1.6	0.4	0.4	2.0
MRGPRF	"GPR140, GPR168, MGC21621, mrgF"	ENSG00000172935	"MAS related GPR family member F"	Q96AM1	11	69004395-69013382	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 171.2;intestine: 159.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 33.3;Leydig cells: 66.2;Peritubular cells: 100.8;Sertoli cells: 52.6;Smooth muscle cells: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 67.6;ASC TERT1: 30.0;BJ: 39.5;BJ hTERT+: 99.1;BJ hTERT+ SV40 Large T+: 36.8;fHDF/TERT166: 30.8;U-2197: 46.8"	"Region enriched"	"Detected in many"	5	"cerebellum: 14.8"	"Region enhanced"	"Detected in some"		"spinal cord: 4.8"	HPA028811	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear membrane, Plasma membrane"		"HPA028811: AB_10603875"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.55e-7)"	"unprognostic (2.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.62e-3)"	41.7	3.8	2.6	12.8	2.9	0.0	32.5	12.0	3.9	103.6	5.5	159.2	9.3	171.2	14.2	16.2	98.0	16.7	13.7	2.4	3.1	17.1	7.0	18.7	4.5	4.7	2.8	37.0	3.4	0.5	4.1	11.6	3.3	48.3	8.9	0.2	10.8	45.6	5.1	15.2	38.3	59.3	2.8	13.4	44.1	7.3	2.8	0.7	10.7	3.0	1.3	75.2	65.6	2.5	0.0	0.1	0.1	0.0	67.6	30.0	1.4	39.5	99.1	36.8	24.3	0.0	1.8	0.0	0.8	30.8	0.1	0.1	0.1	0.0	6.8	0.0	0.0	0.0	2.8	0.0	8.5	0.0	0.0	22.1	0.0	23.5	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	2.9	1.5	0.8	0.1	0.0	3.4	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	2.5	0.0	0.0	0.0	22.4	0.0	46.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.9	12.0	3.9	2.4	3.1	4.7	2.8	3.3	2.8	2.8	2.5	3.2	0.0	0.0	0.0	0.6	5.0	0.2	0.0	1.2	0.0	0.3	2.3	0.6	2.8	0.0	11.0	0.0	0.7	0.1	0.0	0.0	0.0	4.9	1.1	20.6	2.3	0.0	0.0	1.1	0.0	0.6	33.3	0.5	0.8	0.0	0.0	3.9	3.8	1.1	0.0	0.2	0.0	0.0	0.0	7.3	7.9	66.2	0.2	7.2	3.7	0.0	3.0	0.0	0.0	0.2	0.1	0.0	100.8	0.1	0.3	0.0	0.9	0.0	0.3	52.6	19.1	63.7	1.3	0.5	0.4	3.8	1.1	0.6	0.6	0.0	0.4
MSC	"ABF-1, bHLHa22"	ENSG00000178860	Musculin	O60682	8	71841560-71844412	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 40.9;Fibroblasts: 31.4;Leydig cells: 42.6;Melanocytes: 26.6;monocytes: 50.7;Pancreatic endocrine cells: 27.5;Peritubular cells: 41.3;Sertoli cells: 26.3;Skeletal myocytes: 70.0;Smooth muscle cells: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory CD8 T-cell: 25.8"	"Group enriched"	"Detected in many"	37	"B-cells: 6.9;dendritic cells: 6.4;T-cells: 25.8"	"Cell line enriched"	"Detected in many"	15	"HDLM-2: 819.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"cerebral cortex: 16.3;hippocampal formation: 13.2"	HPA062878			Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA062878: AB_2684891"	"unprognostic (2.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-3)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (3.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.07e-13)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.40e-2)"	13.3	8.9	2.5	11.4	1.2	3.9	7.0	0.4	4.5	6.7	0.9	3.0	2.2	4.8	0.9	3.1	4.2	11.1	19.9	5.9	0.6	6.3	3.6	9.5	12.1	3.1	0.7	5.1	5.2	0.3	3.3	16.3	1.0	5.5	1.1	0.0	4.3	3.1	3.0	3.5	5.3	2.3	0.6	6.4	5.4	3.0	0.7	1.6	4.4	2.4	3.5	20.5	6.5	2.8	0.1	6.2	0.0	0.0	28.1	4.9	0.0	1.2	23.8	0.5	1.3	0.0	0.0	0.0	0.3	4.8	28.5	1.3	0.0	1.5	0.0	819.3	0.3	0.0	0.0	0.0	49.8	0.0	2.8	11.1	0.0	49.2	30.1	11.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	6.7	0.0	0.0	0.0	55.3	0.0	0.0	0.0	2.4	0.0	0.1	0.0	44.9	0.5	0.0	5.5	0.0	0.2	0.1	7.8	0.3	5.0	0.2	0.1	20.4	0.1	34.5	0.0	0.1	0.0	5.2	0.1	7.2	6.9	9.2	25.8	0.1	6.2	0.2	8.7	0.2	0.0	0.3	6.4	13.0	3.2	2.5	1.2	0.4	4.5	5.9	0.6	3.1	0.7	1.0	0.6	0.7	2.8	1.2	0.0	0.0	0.0	2.7	5.1	0.2	0.4	0.0	0.0	0.2	0.3	1.9	0.0	0.0	1.8	0.0	0.1	4.3	0.0	0.0	16.1	0.6	0.3	1.0	4.5	0.0	0.0	1.1	40.9	0.1	31.4	1.5	0.1	0.0	0.0	3.9	0.0	1.8	0.0	0.1	0.0	0.0	0.3	8.9	1.5	42.6	5.8	26.6	0.0	50.7	0.0	0.0	0.0	0.2	27.5	0.0	41.3	7.0	0.7	0.0	1.2	0.0	0.0	26.3	70.0	27.8	0.4	0.3	0.3	3.3	0.0	10.0	8.1	0.0	0.3
MT1A	"MT1, MT1S"	ENSG00000205362	"Metallothionein 1A"	P04731	16	56638666-56640087	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 488.0;liver: 430.8"	"Group enriched"	"Detected in many"	6	"Adipocytes: 797.9;Fibroblasts: 244.1;Hepatocytes: 343.8;Skeletal myocytes: 561.9;Smooth muscle cells: 889.5"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 33.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.4;ASC TERT1: 27.9;HHSteC: 19.7;HMC-1: 29.5;hTEC/SVTERT24-B: 80.2;NTERA-2: 40.1"					"Low region specificity"	"Detected in single"			"CAB002161, CAB013056"	Approved					NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB002161: AB_563878, CAB013056: "	"unprognostic (1.36e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.26e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (6.67e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.35e-2)"	488.0	64.3	9.8	10.8	12.3	0.0	208.1	9.8	14.1	62.0	8.2	28.9	7.7	13.6	1.3	33.4	68.7	30.2	63.3	9.3	10.7	136.8	430.8	115.2	0.6	10.6	10.8	19.8	90.3	2.1	25.9	0.7	11.7	33.1	13.1	4.4	18.9	2.9	100.0	26.1	23.4	16.9	11.5	3.4	42.9	8.4	10.8	6.1	67.7	6.1	0.7	34.0	22.6	9.7	0.0	6.2	0.0	0.1	18.4	27.9	0.4	1.9	7.9	1.2	1.5	2.3	4.8	0.0	2.4	1.1	0.0	0.5	0.0	0.4	2.9	0.0	0.0	0.0	2.5	9.9	19.7	0.2	29.5	8.2	0.0	80.2	0.0	0.0	7.7	0.0	0.7	0.0	5.5	0.0	0.0	0.1	40.1	0.0	0.0	0.0	0.0	3.6	0.5	0.0	0.3	0.1	0.0	0.3	0.0	0.9	0.0	0.3	6.3	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	9.8	12.3	9.8	14.1	9.3	10.7	10.6	10.8	11.7	11.5	10.8	9.7	797.9	9.6	1.7	0.7	1.8	27.4	11.3	1.9	5.7	0.0	11.7	15.4	5.4	8.6	5.1	0.0	0.0	1.1	1.0	11.1	13.7	2.7	0.1	11.9	6.9	63.2	3.6	29.5	0.0	1.8	12.8	244.1	5.1	23.8	3.8	0.3	15.7	343.8	0.3	0.0	0.0	32.3	0.0	10.4	39.6	0.7	55.0	12.4	33.8	0.0	0.0	0.0	0.0	0.0	0.0	3.0	18.6	12.8	1.2	27.9	86.5	16.1	3.0	0.0	26.3	561.9	889.5	0.0	0.3	2.1	19.5	0.5	6.6	0.4	34.7	13.7
MTHFD2		ENSG00000065911	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase"	P13995	2	74186172-74217565	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 243.6;monocytes: 184.1;Smooth muscle cells: 239.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003684, HPA049657"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria		"CAB003684: AB_425867, HPA049657: AB_2680842"	"unprognostic (1.82e-3)"	"unprognostic (4.60e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (2.07e-5)"	"prognostic favorable (1.01e-4)"	"unprognostic (3.10e-3)"	"unprognostic (2.24e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.76e-3)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (3.66e-2)"	"unprognostic (6.52e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.34e-3)"	40.0	12.3	11.2	54.5	13.0	25.8	34.8	12.7	14.7	28.5	11.2	30.6	18.6	21.5	14.5	23.0	34.2	20.1	19.6	10.0	16.6	19.6	7.3	23.0	45.6	16.6	15.8	11.7	65.9	9.8	18.0	17.7	17.1	16.3	33.7	2.9	17.7	16.7	36.7	11.8	16.0	27.3	14.8	19.0	36.1	17.7	13.1	28.5	18.5	55.3	57.8	48.0	20.5	15.7	197.4	107.8	89.2	235.6	90.0	113.9	186.1	286.2	185.2	156.2	216.7	242.8	81.8	391.0	65.4	154.2	167.5	70.7	296.7	142.0	314.9	248.9	100.9	424.6	55.4	181.9	319.8	360.1	234.8	202.9	423.4	188.5	794.4	74.8	99.0	636.5	192.2	548.0	157.5	159.6	209.5	261.0	161.1	293.3	95.8	222.6	266.3	339.4	72.0	80.8	198.2	143.8	97.4	238.3	549.7	56.9	208.5	324.4	52.9	39.1	359.9	97.7	286.5	484.5	257.6	379.2	111.4	304.1	132.5	43.9	24.0	31.1	8.5	56.6	13.0	13.4	15.2	10.1	34.9	12.2	11.5	7.9	3.2	29.3	57.0	13.0	36.8	22.0	11.2	13.0	12.7	14.7	10.0	16.6	16.6	15.8	17.1	14.8	13.1	15.7	19.7	16.0	20.2	0.3	49.7	89.3	58.8	54.1	27.3	0.0	53.2	38.0	11.5	4.3	28.2	1.8	0.0	31.5	48.2	19.9	3.9	55.7	3.9	9.7	104.7	35.1	19.1	104.1	1.0	107.9	56.9	45.6	68.8	21.7	53.3	8.7	19.2	0.8	66.2	0.0	3.7	64.0	38.7	61.6	243.6	3.8	22.7	100.6	71.2	12.2	184.1	0.0	27.8	6.6	1.1	81.2	7.5	21.1	141.2	95.7	3.3	3.3	8.5	0.0	138.1	126.3	239.0	36.5	54.9	42.0	74.6	14.0	71.4	21.6	34.0	64.2
MTRF1L	"HMRF1L, mtRF1a"	ENSG00000112031	"Mitochondrial translational release factor 1 like"	Q9UGC7	6	152987362-153002709	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036367	Uncertain					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA036367: AB_10670715"	"prognostic unfavorable (4.82e-4)"	"unprognostic (4.64e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.56e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.80e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.84e-1)"	6.8	6.2	8.4	5.8	10.3	7.1	4.6	12.6	10.3	4.8	13.0	7.6	8.2	4.0	5.9	5.4	3.6	5.1	11.4	8.3	9.6	10.1	7.7	4.6	6.6	9.7	9.5	4.2	6.2	8.6	3.8	5.5	11.0	5.1	6.2	10.3	5.5	5.5	17.9	7.7	6.2	6.7	9.4	5.4	5.7	4.6	9.7	4.8	7.6	21.9	5.8	6.0	3.5	10.7	7.8	8.9	14.8	20.4	16.1	8.5	14.7	13.9	13.4	12.8	18.6	15.4	6.1	14.0	10.7	14.3	22.0	11.7	21.3	12.3	18.5	16.0	14.7	14.0	12.8	20.9	13.9	14.3	14.4	13.4	14.1	16.2	17.9	12.4	18.4	15.3	22.4	8.8	15.4	12.8	10.8	12.1	8.9	17.2	13.1	10.3	11.0	11.2	19.2	13.7	15.6	19.6	18.1	12.9	10.3	16.4	8.6	15.6	12.8	10.2	16.3	17.3	18.2	15.6	15.7	14.8	19.6	10.7	13.1	10.3	3.5	7.1	3.2	5.2	2.8	3.3	3.4	2.9	3.7	2.4	3.1	3.5	3.4	3.3	6.9	2.7	4.0	4.0	8.4	10.3	12.6	10.3	8.3	9.6	9.7	9.5	11.0	9.4	9.7	10.7	29.9	12.8	16.4	11.8	19.9	33.9	24.2	14.5	20.5	0.0	13.8	11.4	28.0	8.6	13.7	18.4	0.0	15.7	15.7	26.3	25.4	34.1	59.8	15.2	22.8	34.5	17.3	14.9	13.0	26.7	24.3	23.6	14.3	20.3	18.4	17.7	62.8	17.6	17.1	0.0	13.2	12.9	12.2	21.2	15.4	54.5	20.2	23.5	16.0	9.4	31.2	0.0	21.6	11.1	11.8	34.0	22.9	25.6	24.0	21.2	27.9	39.2	6.8	0.0	39.5	23.7	30.0	43.4	13.8	29.1	32.7	19.7	16.5	33.8	17.9	23.4
MUC7	"FLJ27047, MG2"	ENSG00000171195	"Mucin 7, secreted"	Q8TAX7	4	70430492-70482997	"Disease related genes, Predicted secreted proteins"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	875	"salivary gland: 26019.1"	"Cell type enriched"	"Detected in some"	12	"Melanocytes: 12.4"	"Group enriched"	"Detected in some"	12	"head and neck cancer: 8.1;melanoma: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA006411	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 48: Smooth muscle cells - ECM organization"			"HPA006411: AB_1854204"	"unprognostic (5.49e-2)"					"unprognostic (3.20e-1)"			"unprognostic (1.06e-1)"									1.2	5.3	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.7	0.0	1.0	0.0	0.1	0.0	2.1	0.0	0.0	6.6	0.0	0.0	1.0	3.7	0.6	0.0	0.0	0.7	6.5	29.7	0.0	1.9	3.2	0.0	0.8	0.0	0.0	26019.1	0.0	2.6	3.6	1.5	0.0	0.0	1.0	1.1	1.5	0.2	0.0	1.3	0.1	0.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.4	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MUSTN1	Mustang	ENSG00000272573	"Musculoskeletal, embryonic nuclear protein 1"	Q8IVN3	3	52833114-52835019	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 1689.2"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 1.3;Skeletal myocytes: 1.0;Smooth muscle cells: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.7;Hep G2: 8.0;HSkMC: 4.8;RH-30: 4.4"															NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.79e-2)"	"unprognostic (3.73e-2)"			"unprognostic (4.11e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.34e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-3)"	"unprognostic (6.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.88e-2)"	86.1	10.1	107.0	9.3	118.7	6.5	46.4	106.9	177.9	89.1	105.7	27.2	8.4	44.6	49.0	44.9	52.1	42.5	142.5	104.2	105.8	17.5	12.5	31.0	5.4	107.2	107.4	37.6	6.6	1.6	12.1	4.5	110.3	43.8	21.2	0.8	26.3	59.3	1689.2	28.7	26.7	30.6	99.9	10.9	22.1	4.3	118.5	5.7	31.1	305.6	3.9	54.5	65.7	105.1	0.0	0.0	4.7	0.0	0.5	2.1	1.9	0.0	0.5	0.2	0.5	0.0	0.5	0.0	0.0	1.4	0.2	0.4	0.6	1.3	0.4	0.1	0.5	0.0	1.4	8.0	0.3	1.0	0.4	4.8	1.0	0.6	0.7	0.9	1.2	0.9	0.0	0.0	0.3	0.1	0.4	1.6	0.1	0.6	1.0	0.3	4.4	0.0	0.9	0.0	0.2	0.3	0.3	0.4	0.4	2.0	0.1	2.6	0.0	0.6	0.2	1.0	0.2	0.0	0.0	0.3	0.5	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	107.0	118.7	106.9	177.9	104.2	105.8	107.2	107.4	110.3	99.9	118.5	105.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYH11	"SMHC, SMMHC"	ENSG00000133392	"Myosin heavy chain 11"	P35749	16	15703135-15857028	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Aortic aneurysm, Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 3322.6;seminal vesicle: 1665.5;urinary bladder: 2048.3"	"Group enriched"	"Detected in many"	8	"Peritubular cells: 1669.7;Sertoli cells: 624.5;Smooth muscle cells: 964.6"	"Group enriched"	"Detected in many"	5	"prostate cancer: 173.2;stomach cancer: 125.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;RPMI-8226: 1.4;U-698: 7.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"midbrain: 39.8"	"CAB002302, HPA014539, HPA015310"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		23000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"		"CAB002302: AB_563902, HPA014539: AB_1234906, HPA015310: AB_1854261"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.21e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (1.10e-5)"	"unprognostic (1.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.45e-3)"	172.9	38.6	5.0	109.1	17.2	0.2	78.4	5.5	14.5	372.3	11.1	3322.6	95.4	1074.6	219.7	759.7	606.1	250.6	74.8	5.3	5.2	27.9	9.2	108.9	9.5	9.0	7.0	144.0	10.7	2.8	11.6	68.2	7.1	762.7	293.2	0.4	83.3	1665.5	41.2	68.5	487.4	1053.2	5.8	46.0	832.5	60.9	7.2	2.9	46.0	34.6	5.3	2048.3	314.2	6.3	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.9	0.0	0.2	0.2	7.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	5.0	17.2	5.5	14.5	5.3	5.2	9.0	7.0	7.1	5.8	7.2	6.3	7.6	0.0	1.8	0.0	4.4	13.3	2.1	1.7	5.7	2.7	5.3	122.3	40.5	0.0	1.9	0.0	8.4	0.3	3.4	0.4	0.0	0.2	50.2	4.7	19.5	12.8	1.2	0.8	0.8	0.4	0.3	22.2	0.0	3.4	0.0	27.3	6.4	0.1	1.1	0.0	5.2	0.5	0.0	2.2	17.3	46.2	42.9	2.8	12.4	15.9	3.7	0.3	3.1	1.5	10.7	0.4	0.2	1669.7	2.4	5.6	0.1	0.2	2.5	1.9	624.5	4.3	964.6	3.1	8.8	3.5	18.6	0.0	5.7	34.7	0.4	2.6
MYL9	"LC20, MLC2, MRLC1, MYRL2"	ENSG00000101335	"Myosin light chain 9"	P24844	20	36541497-36551447	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 8015.9"	"Group enriched"	"Detected in many"	4	"Breast myoepithelial cells: 860.2;Cardiomyocytes: 1856.1;Peritubular cells: 1891.9;Sertoli cells: 2143.1;Smooth muscle cells: 2525.7;Theca cells: 881.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.2;neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 783.3;BJ: 1047.3;fHDF/TERT166: 844.3;hTERT-RPE1: 645.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 76.1"	"HPA039262, HPA045244, HPA059197"	Supported					NA	NA		34000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944"	"unprognostic (1.15e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.67e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.17e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (7.92e-7)"	"unprognostic (1.90e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-2)"	944.6	948.6	61.6	347.0	76.7	5.2	649.5	63.3	132.2	1083.0	104.6	8015.9	270.5	2897.3	238.2	999.8	1643.3	364.3	2294.5	61.4	63.1	352.2	116.6	617.9	56.4	66.3	66.3	717.2	82.0	45.4	91.2	160.3	66.1	2347.4	345.8	22.8	200.7	2248.7	164.3	289.2	1287.7	2107.8	62.0	274.3	1946.4	260.7	66.5	27.4	431.7	111.4	23.2	4176.1	943.6	63.3	79.4	1.3	60.3	1.2	783.3	298.6	264.5	1047.3	450.9	541.3	349.9	612.3	9.1	0.2	535.6	844.3	120.6	29.4	0.2	2.4	125.7	0.9	0.2	16.7	114.4	57.3	500.4	0.4	17.7	420.8	54.4	359.9	1.6	645.9	19.2	0.0	2.4	28.0	461.7	0.2	0.3	7.8	24.0	16.1	5.6	0.4	0.0	5.8	4.6	5.8	0.6	4.1	11.1	26.6	0.6	257.5	232.9	15.6	137.0	510.9	220.1	75.5	1.0	0.8	4.0	2.3	194.3	0.8	0.6	0.0	0.1	2.2	0.0	0.0	0.0	0.9	0.0	0.1	0.3	0.2	0.0	0.0	1.9	0.2	0.0	0.4	0.0	7.2	61.6	76.7	63.3	132.2	61.4	63.1	66.3	66.3	66.1	62.0	66.5	63.3	325.3	394.2	52.3	0.0	6.6	60.7	320.2	167.1	21.6	1.4	36.8	860.2	1856.1	24.3	50.8	90.1	0.0	37.0	6.3	0.1	27.4	310.3	9.3	13.1	419.9	179.7	0.0	5.7	0.2	116.0	78.3	410.4	10.2	9.3	15.2	234.3	169.9	2.7	32.0	1.7	0.1	1.2	14.2	5.0	76.6	55.4	331.8	111.7	72.9	30.9	19.4	230.4	6.2	0.0	0.5	47.9	2.5	1891.9	6.4	156.9	105.5	42.1	31.8	6.1	2143.1	65.9	2525.7	16.3	9.5	6.5	53.4	26.8	14.7	881.1	2.0	61.9
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	"Myosin light chain kinase"	Q15746	3	123610049-123884332	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 1700.3;smooth muscle: 2137.7"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 728.5;Hepatocytes: 208.7;Peritubular cells: 690.5;Sertoli cells: 276.1;Smooth muscle cells: 448.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 200.0;BJ hTERT+: 298.2;fHDF/TERT166: 260.2;hTERT-RPE1: 202.7;RPTEC TERT1: 291.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		NA	NA		1500000	"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments"	"Plasma membrane"	"CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543"	"unprognostic (2.80e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.26e-3)"	"unprognostic (9.60e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.46e-4)"	143.6	57.4	37.6	188.7	64.8	3.3	163.4	72.1	42.4	281.3	14.1	551.5	110.9	669.2	232.9	420.6	289.8	250.4	33.6	33.6	46.7	64.4	67.2	85.2	33.6	104.6	64.8	95.9	15.3	11.6	2.6	70.2	99.3	907.6	299.1	13.6	140.1	1700.3	10.0	20.1	125.1	2137.7	55.6	89.5	122.7	50.5	52.2	8.0	22.2	14.9	19.1	505.7	84.8	112.1	14.4	38.4	10.8	7.8	10.8	1.9	4.7	200.0	298.2	137.3	92.1	8.1	7.4	0.6	42.5	260.2	67.0	4.8	5.2	1.8	149.0	0.2	0.7	102.4	0.9	28.9	56.1	0.6	9.8	36.9	3.5	24.4	34.4	202.7	8.9	1.3	1.2	0.5	90.9	1.7	0.2	2.5	12.0	0.5	5.1	13.5	6.8	36.7	291.9	8.5	1.4	6.4	21.8	1.9	3.1	25.0	1.0	0.3	33.4	39.5	13.9	10.3	30.7	3.4	4.2	0.3	104.0	1.0	9.6	7.4	1.6	0.4	0.1	0.2	0.0	0.2	0.0	0.0	3.5	0.1	0.2	0.1	5.0	0.0	0.0	3.3	0.2	20.9	37.6	64.8	72.1	42.4	33.6	46.7	104.6	64.8	99.3	55.6	52.2	112.1	45.9	16.0	38.3	43.4	2.5	20.5	27.2	24.8	1.2	2.9	19.9	728.5	25.2	37.1	5.7	27.6	125.1	0.8	3.5	88.1	3.9	6.0	40.7	45.9	46.6	56.9	11.4	3.2	25.2	3.9	0.8	40.1	3.1	54.4	2.5	3.2	45.3	208.7	4.9	3.3	3.4	3.9	8.2	7.9	37.0	33.8	104.7	20.8	19.6	8.4	1.2	4.7	0.0	5.5	37.0	4.0	18.7	690.5	3.3	8.6	14.2	17.2	17.6	19.9	276.1	5.6	448.7	4.7	4.6	1.3	20.2	2.5	3.2	4.5	4.2	3.7
MYOCD	MYCD	ENSG00000141052	Myocardin	Q8IZQ8	17	12665890-12768949	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.2"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 47.3;Endometrial stromal cells: 48.5;Peritubular cells: 100.8;Sertoli cells: 26.3;Smooth muscle cells: 32.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 6.5;BJ hTERT+: 6.4;HBF TERT88: 10.4;hTEC/SVTERT24-B: 11.7;REH: 8.4;SuSa: 12.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 4.1"	"CAB046485, HPA071528, HPA072582"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB046485: AB_10600720, HPA071528: , HPA072582: "	"unprognostic (2.82e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.79e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.15e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (2.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.91e-2)"	3.2	1.0	0.4	4.3	0.7	0.0	1.2	0.3	0.8	9.4	1.6	24.2	2.6	13.0	2.4	13.1	8.5	4.6	14.2	0.4	0.4	0.7	0.2	2.7	0.1	0.5	0.5	4.4	0.3	0.1	0.2	3.4	0.8	8.8	4.9	0.0	0.2	20.7	0.5	1.3	5.1	15.8	0.5	0.6	6.1	2.1	0.8	0.1	0.7	0.8	0.1	17.2	4.4	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.5	6.4	2.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.4	1.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	12.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.3	0.8	0.4	0.4	0.5	0.5	0.8	0.5	0.8	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	47.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	2.0	48.5	1.2	7.8	0.0	1.2	0.2	0.1	3.6	0.0	1.0	0.0	8.4	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	1.0	0.5	0.6	0.2	0.0	9.4	0.0	0.0	0.0	1.0	0.3	0.0	0.0	100.8	0.0	0.1	0.0	0.1	0.0	0.0	26.3	0.2	32.9	0.3	0.8	0.1	0.9	0.5	0.4	6.0	0.0	0.1
NAB2	MADER	ENSG00000166886	"NGFI-A binding protein 2"	Q15742	12	57089043-57095476	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 98.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004510, HPA027464"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"CAB004510: AB_627982, HPA027464: AB_10601138"	"prognostic favorable (7.41e-4)"	"unprognostic (4.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.43e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.38e-6)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (5.67e-3)"	"unprognostic (6.19e-3)"	21.8	16.1	25.2	9.9	26.8	6.8	14.2	30.3	31.0	33.7	24.0	29.8	10.1	32.3	21.0	24.5	31.0	17.4	20.5	28.3	25.0	20.1	22.3	24.0	12.0	23.2	23.1	51.1	10.2	19.5	35.4	11.1	22.1	25.4	5.0	10.7	11.6	16.6	7.6	33.4	15.7	13.4	21.6	16.9	15.9	16.8	25.4	17.4	20.7	9.9	10.4	27.7	33.8	24.8	15.2	9.8	49.2	45.2	43.3	56.7	5.5	44.1	40.8	28.0	23.1	15.6	8.7	9.6	17.6	44.4	8.1	27.0	16.9	34.0	14.3	4.0	4.5	11.4	8.1	16.6	33.2	9.1	26.5	64.4	36.1	32.6	10.9	43.7	7.5	7.2	26.5	9.6	32.4	73.4	14.0	44.5	9.9	12.9	16.6	10.4	64.1	5.1	11.8	6.0	5.5	13.1	21.9	12.5	98.3	12.3	28.0	20.0	8.4	40.7	34.1	28.8	13.2	22.7	6.0	5.1	39.5	5.9	25.1	0.0	1.1	0.2	0.5	2.7	0.6	0.9	0.9	0.7	0.6	2.3	1.1	1.1	0.4	0.4	2.9	0.0	1.0	0.6	25.2	26.8	30.3	31.0	28.3	25.0	23.2	23.1	22.1	21.6	25.4	24.8	7.6	12.8	13.0	5.9	11.6	29.6	19.5	23.4	39.3	20.3	17.3	13.8	2.9	2.8	13.6	9.2	2.1	3.7	4.9	1.1	7.9	7.4	0.6	22.9	21.2	13.7	6.6	4.8	11.4	1.4	10.5	19.7	8.6	25.4	17.1	7.8	18.2	17.1	11.2	10.1	5.4	1.1	10.2	16.3	43.7	2.9	19.6	14.3	21.4	8.4	1.6	7.9	1.0	1.0	1.9	4.1	0.0	18.8	8.7	12.9	8.7	5.6	5.9	4.4	19.7	9.8	16.3	2.6	18.7	23.4	32.5	56.2	10.7	2.5	1.5	8.6
NBPF10	AG1	ENSG00000271425	"NBPF member 10"		1	146064711-146229000	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Alveolar cells type 2: 46.1;Basal keratinocytes: 57.0;Langerhans cells: 100.9;Suprabasal keratinocytes: 105.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (2.05e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.84e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.16e-3)"	"unprognostic (3.26e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.49e-2)"	"unprognostic (6.64e-5)"	"unprognostic (1.60e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.68e-2)"	3.7	1.1	3.4	2.8	2.8	7.6	4.3	2.2	6.4	4.9	7.4	2.8	1.1	3.5	3.8	2.8	3.0	2.2	1.3	3.6	2.2	1.9	3.2	3.3	2.5	3.8	3.1	5.4	3.3	3.2	0.3	2.5	2.9	2.7	2.8	4.6	2.0	3.0	1.0	7.4	1.2	3.4	1.7	4.4	1.8	3.3	4.5	2.7	2.3	2.2	2.4	2.2	1.4	4.1	6.4	1.7	3.6	2.4	11.3	13.6	3.0	3.3	4.5	3.3	3.3	1.5	3.0	2.7	0.7	6.4	3.2	3.0	4.0	4.5	6.7	3.4	3.0	6.3	5.0	0.8	4.5	2.7	1.9	12.4	4.1	9.2	8.8	10.6	3.9	1.7	2.0	8.7	7.1	7.3	1.1	2.4	1.5	1.6	4.7	1.4	2.6	3.6	2.3	4.5	0.4	0.4	5.1	4.9	1.8	5.8	4.2	3.6	12.3	3.2	2.9	2.9	4.4	5.8	2.3	3.4	2.9	2.9	2.7	2.2	2.0	2.7	0.3	1.0	0.4	1.5	0.3	0.3	0.8	1.5	0.3	0.2	5.6	0.3	2.3	2.2	0.3	0.1	3.4	2.8	2.2	6.4	3.6	2.2	3.8	3.1	2.9	1.7	4.5	4.1	0.5	76.9	46.1	13.7	12.8	57.0	4.9	15.4	5.2	0.5	3.7	2.0	8.4	2.8	22.0	0.0	0.0	0.7	9.2	1.5	0.0	5.3	15.1	2.8	2.8	3.4	0.0	10.5	0.8	2.7	5.0	18.2	3.1	6.1	20.2	6.4	0.7	1.8	1.4	0.0	1.1	2.7	14.2	5.0	100.9	3.3	6.5	17.7	30.2	4.7	14.2	2.0	9.2	5.0	0.1	5.5	25.3	8.2	5.7	2.1	2.2	0.2	19.6	2.0	0.0	7.6	9.9	9.9	5.4	23.8	105.8	0.5	6.6	1.4	3.4	4.5
NDN	"HsT16328, PWCR"	ENSG00000182636	"Necdin, MAGE family member"	Q99608	15	23685400-23687305	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 236.4;Peritubular cells: 207.6;Theca cells: 121.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 55.0;ASC diff: 52.9;HSkMC: 71.3;NTERA-2: 44.0;SuSa: 57.4;U-2 OS: 80.4;U-266/70: 51.7;U-266/84: 51.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074457			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA074457: AB_2686691"	"unprognostic (3.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.04e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.81e-2)"	46.8	49.4	43.3	11.1	40.5	1.2	35.1	26.0	39.7	70.5	30.4	35.9	11.1	63.7	24.0	16.8	47.2	23.8	34.6	36.7	89.6	13.0	4.5	19.6	10.9	36.0	41.3	69.8	11.8	8.7	56.3	32.6	46.2	27.3	10.7	20.8	12.7	39.3	14.7	11.9	20.8	33.5	36.7	19.1	20.3	18.5	69.6	6.8	17.4	22.4	6.6	31.4	40.4	32.3	0.1	0.0	55.0	0.0	52.9	20.1	0.1	35.4	0.0	0.8	9.6	0.0	0.0	0.0	0.1	10.6	8.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	13.3	0.0	31.8	71.3	0.0	10.2	0.0	0.0	0.0	21.7	1.2	0.0	18.0	0.0	27.6	0.1	44.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.1	0.4	0.0	0.4	0.0	57.4	9.4	0.0	0.0	2.6	80.4	0.0	0.1	51.7	51.7	0.0	5.5	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.2	1.5	0.0	0.0	43.3	40.5	26.0	39.7	36.7	89.6	36.0	41.3	46.2	36.7	69.6	32.3	24.1	25.6	11.0	6.8	0.3	13.0	13.8	0.3	27.9	66.0	2.3	19.8	36.8	15.7	1.4	12.9	20.9	1.9	2.9	18.5	23.5	17.9	2.5	1.4	60.8	18.7	6.7	4.2	7.8	10.7	1.4	103.1	4.1	1.1	0.0	83.9	38.9	0.2	7.3	50.5	21.8	4.3	0.0	7.6	13.3	8.6	236.4	2.8	39.2	9.4	0.7	88.7	0.0	9.5	16.4	4.5	2.6	207.6	0.0	6.9	8.1	1.1	4.1	51.0	98.6	91.4	94.0	28.5	21.8	13.4	8.2	2.5	1.4	121.8	7.1	4.1
NDUFA4L2	"COXFA4L2, FLJ26118, NUOMS"	ENSG00000185633	"NDUFA4 mitochondrial complex associated like 2"	Q9NRX3	12	57234903-57240715	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 304.9"	"Group enriched"	"Detected in many"	4	"Muller glia cells: 627.0;Sertoli cells: 1130.7;Smooth muscle cells: 525.6"	"Cancer enriched"	"Detected in all"	5	"renal cancer: 356.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	7	"AN3-CA: 133.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055323, HPA078265"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria		"HPA055323: , HPA078265: "	"unprognostic (1.25e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.23e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.67e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (9.10e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.74e-2)"	85.6	14.0	41.6	6.8	40.1	0.2	55.1	41.4	61.5	109.3	36.8	17.4	5.8	20.7	2.4	304.9	15.5	17.1	180.1	40.3	41.1	47.6	20.9	62.6	5.8	43.0	42.7	14.0	14.5	12.1	30.9	71.7	48.8	27.3	1.9	29.4	55.8	9.8	43.8	206.9	14.2	7.5	38.9	74.1	18.0	8.7	43.5	3.2	54.5	29.2	4.8	27.7	183.5	45.4	0.9	1.3	0.3	133.9	5.4	3.1	0.4	2.1	1.5	0.6	1.3	0.0	1.5	5.5	5.6	2.1	0.1	1.2	0.7	1.0	0.0	3.0	0.2	0.6	0.3	0.1	18.6	4.1	2.0	12.0	2.5	0.2	4.7	0.9	0.0	7.6	0.5	7.2	0.4	2.7	1.1	0.2	0.3	0.6	2.4	2.1	1.0	11.0	0.1	0.1	7.1	2.5	0.2	0.3	4.7	0.1	1.5	14.5	0.6	1.2	0.1	1.1	0.7	10.0	3.5	2.5	4.9	9.8	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	41.6	40.1	41.4	61.5	40.3	41.1	43.0	42.7	48.8	38.9	43.5	45.4	156.0	0.0	0.5	2.6	2.6	151.2	0.9	89.2	6.8	30.6	2.6	5.8	1.2	0.0	24.8	0.0	18.8	1.0	0.9	0.1	0.0	1.6	1.7	0.4	3.0	91.8	0.0	0.0	2.2	0.0	1.5	21.5	4.6	0.3	8.9	0.1	2.9	1.3	1.9	11.8	3.0	0.2	54.9	0.0	28.9	3.0	3.1	2.0	30.2	18.7	1.0	627.0	0.0	0.5	0.4	4.7	0.0	2.2	1.4	2.0	0.1	0.3	6.2	25.7	1130.7	13.0	525.6	12.3	5.5	20.3	161.4	1.1	1.9	2.5	0.2	1.4
NES	FLJ21841	ENSG00000132688	Nestin	P48681	1	156668763-156677407	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 161.6"	"Group enriched"	"Detected in many"	4	"Adipocytes: 102.2;Cardiomyocytes: 279.9;Endothelial cells: 105.5;Sertoli cells: 105.2;Smooth muscle cells: 70.5"	"Cancer enhanced"	"Detected in all"		"glioma: 147.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 627.3;HUVEC TERT2: 321.5;LHCN-M2: 512.6;RH-30: 518.3;SuSa: 340.7;WM-115: 247.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005889, HPA006286, HPA007007, HPA026111, CAB058692"	Enhanced		Enhanced	"Intermediate filaments"		No	No		100000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Intermediate filaments"		"CAB005889: AB_2251301, CAB058692: AB_2665584, HPA006286: AB_2667550, HPA007007: AB_1854381, HPA026111: AB_1854382"	"unprognostic (7.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.56e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (8.02e-7)"	"unprognostic (2.87e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.11e-3)"	40.0	8.5	24.4	13.8	24.8	0.0	28.2	27.2	22.7	27.1	16.5	16.8	5.3	41.1	12.9	8.2	30.3	11.3	161.6	21.1	26.5	35.2	4.8	42.1	4.8	32.8	27.1	10.1	5.6	10.4	12.8	16.7	25.8	21.2	6.6	8.2	9.7	36.1	55.7	8.6	12.5	30.3	30.0	49.1	10.8	6.2	26.4	2.7	19.9	47.3	2.3	24.2	19.0	30.9	0.2	2.5	627.3	134.7	1.3	33.4	0.6	154.7	120.7	2.3	3.4	102.5	1.9	0.6	35.8	14.9	0.1	2.8	63.9	0.0	1.8	0.0	1.1	0.9	9.7	47.3	5.5	0.3	37.1	28.5	0.0	5.7	0.0	5.3	321.5	0.1	4.9	0.2	512.6	4.3	0.0	0.3	102.3	6.0	88.1	0.7	518.3	0.4	0.6	0.0	1.6	100.4	3.6	4.5	124.9	340.7	1.3	0.9	235.1	0.8	34.5	4.1	8.8	0.2	24.0	0.2	13.4	0.1	247.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	24.8	27.2	22.7	21.1	26.5	32.8	27.1	25.8	30.0	26.4	30.9	102.2	0.0	4.4	0.0	0.7	2.4	0.4	0.2	0.6	0.5	9.4	32.9	279.9	0.0	0.6	18.4	0.0	0.2	1.0	0.6	0.0	2.1	0.4	2.1	31.9	105.5	0.0	0.0	0.3	0.0	1.9	29.4	0.5	2.7	0.0	0.2	26.7	0.1	1.8	0.0	0.6	0.2	0.0	0.8	3.1	0.1	8.1	1.7	1.8	12.2	1.0	17.4	0.0	3.0	2.2	0.3	0.1	4.1	0.1	0.5	0.0	0.1	0.0	1.5	105.2	10.9	70.5	0.5	5.0	1.2	2.4	0.1	1.1	1.4	0.3	0.5
NEURL2	"C20orf163, dJ337O18.6, FLJ30259, Ozz, Ozz-E3"	ENSG00000124257	"Neuralized E3 ubiquitin protein ligase 2"	Q9BR09	20	45888625-45891208	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 26.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 13.1;Proximal tubular cells: 17.3;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 8.2;Hep G2: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043402, HPA059842"	Approved		Approved	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA043402: AB_2678464, HPA059842: AB_2684139"	"unprognostic (6.26e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.73e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.58e-1)"	14.1	9.1	1.8	2.6	3.0	1.3	6.9	4.0	3.1	5.2	4.5	7.3	4.3	6.2	3.0	2.6	7.4	2.9	8.9	2.0	2.1	26.7	8.2	3.9	1.5	2.4	2.3	9.4	4.4	3.8	4.1	3.1	2.3	4.4	2.2	4.2	5.5	2.7	18.1	4.7	6.5	4.0	2.0	5.9	5.0	2.5	2.1	7.6	5.8	8.9	1.3	7.9	4.3	3.2	0.9	0.7	1.9	1.6	3.1	1.3	1.6	1.2	1.4	1.3	0.6	8.2	5.2	1.0	1.7	0.9	2.3	2.7	1.6	0.0	0.8	0.6	1.4	0.6	6.4	8.5	3.9	0.6	1.4	2.9	1.1	1.3	0.5	2.0	1.0	1.6	0.8	2.1	0.7	3.2	1.0	0.6	0.9	0.5	2.9	1.7	1.4	0.5	0.8	0.7	4.2	3.0	1.7	4.1	5.2	0.4	3.1	1.7	2.0	1.5	1.3	1.2	1.2	6.0	1.3	0.2	1.7	0.8	1.4	0.0	0.6	1.8	0.4	0.3	0.2	2.8	0.7	0.6	0.2	1.0	1.5	1.3	0.2	1.0	0.2	0.3	0.5	0.3	1.8	3.0	4.0	3.1	2.0	2.1	2.4	2.3	2.3	2.0	2.1	3.2	1.7	0.0	0.0	2.0	2.3	0.1	2.1	1.0	2.8	3.5	2.2	3.4	5.7	0.0	0.4	0.0	4.2	0.7	0.5	5.0	7.9	3.2	2.8	0.8	2.3	2.7	3.0	1.3	1.4	2.0	0.9	3.3	3.1	0.9	0.0	7.8	5.7	5.7	13.1	0.0	2.3	2.3	0.0	5.1	0.3	8.6	5.3	1.2	0.0	1.0	1.5	2.5	2.1	2.0	1.4	2.9	0.7	3.8	2.2	2.3	6.7	17.3	0.5	3.4	13.1	3.2	6.1	0.0	0.3	1.8	1.1	0.5	0.7	11.0	2.1	1.7
NFATC4	NFAT3	ENSG00000100968	"Nuclear factor of activated T cells 4"	Q14934	14	24365673-24379604	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 58.8;Endometrial stromal cells: 28.3;Fibroblasts: 22.8;Sertoli cells: 26.3;Smooth muscle cells: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.8;BJ hTERT+: 49.5;hTERT-RPE1: 42.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA031641, CAB032859, HPA076526"	Uncertain		Supported	"Nuclear speckles,Cytosol"		No	No				"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles, Cytosol"		"CAB032859: AB_1128521, HPA031641: AB_10600826, HPA076526: AB_2686805"	"unprognostic (3.51e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (1.81e-6)"	"unprognostic (1.47e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.19e-2)"	48.4	54.9	9.1	6.0	9.4	0.6	47.2	8.6	10.5	126.0	9.0	71.9	4.5	82.1	13.7	22.2	82.6	17.8	30.2	9.0	9.3	35.5	5.6	30.2	4.8	10.3	9.4	142.7	13.8	9.0	37.9	18.2	8.8	51.5	5.0	2.8	20.5	16.2	9.0	25.0	29.9	18.8	8.2	17.7	35.5	42.7	9.7	1.7	50.4	2.5	3.6	66.2	65.9	8.5	0.0	0.1	17.8	0.0	25.4	36.8	0.1	17.3	49.5	23.0	20.0	0.0	14.6	14.9	0.5	25.0	1.6	0.0	7.1	0.3	13.9	0.0	0.6	11.3	20.6	0.0	12.3	0.0	0.0	26.8	0.3	13.9	0.1	42.5	18.2	4.7	3.7	0.0	4.5	0.8	0.0	1.7	2.3	1.0	0.1	1.1	1.6	2.0	0.0	0.2	2.9	11.9	0.0	3.3	5.7	8.7	10.3	4.5	10.3	21.3	4.4	20.5	0.0	10.4	1.6	11.0	4.4	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	9.4	8.6	10.5	9.0	9.3	10.3	9.4	8.8	8.2	9.7	8.5	4.1	3.2	8.1	58.8	1.1	4.5	0.9	1.9	0.6	1.3	3.3	2.8	7.8	0.0	4.8	0.0	0.0	0.6	0.0	0.8	0.0	2.8	4.4	2.5	28.3	4.6	7.7	0.0	0.1	0.2	0.6	22.8	3.6	6.4	0.0	4.1	1.4	0.2	0.6	0.0	0.2	3.4	10.2	0.0	6.8	6.5	17.4	0.4	7.2	13.1	0.0	7.6	0.0	1.0	0.2	0.6	0.3	7.5	0.2	0.8	0.4	0.2	2.1	1.5	26.3	4.3	27.1	12.5	2.9	1.0	3.4	0.5	0.9	6.0	1.6	2.3
NKD2	Naked2	ENSG00000145506	"NKD inhibitor of WNT signaling pathway 2"	Q969F2	5	1008802-1038943	"Predicted intracellular proteins"	"Exocytosis, Transport, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 42.1"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 6.8;Fibroblasts: 11.6;Langerhans cells: 7.1;Melanocytes: 7.2;Microglial cells: 7.5;Muller glia cells: 7.1;Spermatogonia: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 24.4;HEK 293: 14.4;MOLT-4: 7.3;NB-4: 13.4;REH: 8.8;RPMI-8226: 22.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049463	Uncertain					NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA049463: AB_2680777"	"unprognostic (6.23e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (6.24e-3)"	"unprognostic (5.87e-3)"	"unprognostic (4.43e-1)"	"prognostic unfavorable (9.97e-4)"	"unprognostic (3.35e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (2.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.52e-1)"	4.7	5.1	0.7	0.2	1.3	0.0	3.8	0.0	2.4	1.6	0.0	4.0	0.1	1.1	0.0	8.5	3.1	0.1	5.5	2.4	0.0	6.9	3.1	42.1	0.0	0.6	0.0	1.3	4.2	0.1	2.0	0.4	0.0	6.1	0.0	0.1	4.9	0.0	0.3	9.6	3.5	0.0	0.0	15.3	2.4	8.0	0.0	0.9	2.3	0.0	0.1	3.8	2.5	0.1	0.0	0.2	0.5	0.2	0.0	0.0	24.4	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.7	0.0	0.0	1.2	7.3	13.4	0.2	1.9	0.0	8.8	0.0	22.1	0.0	1.7	0.2	0.0	0.2	0.0	1.2	0.1	0.0	2.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	2.4	2.4	0.0	0.6	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	6.1	2.8	0.5	4.6	0.2	0.8	1.9	3.3	2.8	0.1	0.0	2.1	0.1	0.2	0.0	0.0	2.9	0.6	2.1	6.8	2.0	0.0	0.0	1.5	0.0	0.1	11.6	0.0	0.5	0.0	0.0	0.7	0.0	0.3	1.7	1.4	0.0	0.0	0.0	7.1	1.3	0.3	0.5	7.2	7.5	0.0	7.1	0.0	0.0	0.2	0.1	0.0	0.4	0.1	2.7	0.0	2.0	0.0	0.1	0.0	0.1	1.9	1.0	11.3	0.5	5.7	0.0	1.3	0.0	0.0	1.2
NMS		ENSG00000204640	"Neuromedin S"	Q5H8A3	2	100470482-100483280	"Predicted secreted proteins"		Neuropeptide		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	7	"brain: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"medulla oblongata: 2.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"HL-60: 8.4;HMC-1: 4.8"	"Group enriched"	"Detected in some"	4	"basal ganglia: 2.4;hypothalamus: 5.4;pons and medulla: 1.3"										"Secreted in brain"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"																					0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.9	2.7	0.1	0.2	1.7	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NOTCH3	"CADASIL, CASIL"	ENSG00000074181	"Notch receptor 3"	Q9UM47	19	15159038-15200995	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 414.2;Skeletal myocytes: 131.6;Smooth muscle cells: 317.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 66.3;MCF7: 66.9;RT4: 41.2;U-87 MG: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005393, HPA044392"	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA		46000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Actin filaments"	"CAB005393: AB_2151246, HPA044392: AB_2678926"	"unprognostic (4.97e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (9.20e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.72e-1)"	"unprognostic (9.04e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (2.53e-7)"	"unprognostic (3.35e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.00e-3)"	85.7	5.3	14.8	10.4	12.4	0.2	50.5	11.0	21.3	49.4	7.1	14.8	5.5	39.9	16.9	74.3	35.8	23.5	43.6	9.5	11.3	26.0	3.2	38.3	9.2	12.0	15.2	18.9	10.7	12.6	10.3	59.8	14.3	22.0	4.2	0.5	24.4	16.5	29.7	82.1	14.3	16.9	8.2	15.0	11.6	3.8	15.8	34.1	32.3	25.1	10.4	26.3	55.1	10.0	13.0	8.1	66.3	30.3	9.2	7.3	29.8	10.2	0.4	0.4	0.3	15.6	13.4	0.4	7.7	18.9	0.1	15.1	12.1	0.2	0.6	0.1	3.1	0.4	12.4	3.5	4.5	0.0	1.2	8.4	7.3	15.5	1.6	0.6	0.8	4.6	0.5	0.6	1.2	66.9	15.9	0.1	38.8	11.2	0.0	0.1	3.7	0.3	0.0	41.2	1.9	21.4	0.1	37.8	0.0	19.6	40.3	0.1	0.0	1.9	21.0	0.3	0.1	0.1	0.7	0.0	45.7	0.4	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	14.8	12.4	11.0	21.3	9.5	11.3	12.0	15.2	14.3	8.2	15.8	10.0	39.6	9.6	1.5	5.9	0.4	24.1	7.8	17.8	4.6	0.4	41.5	30.7	60.7	0.0	28.5	16.5	0.0	20.2	1.0	0.0	5.9	14.8	0.5	4.8	13.5	32.0	0.0	0.0	0.6	0.0	3.9	24.2	2.0	11.8	0.0	5.9	4.2	0.0	2.8	0.0	0.3	0.3	6.1	10.4	12.3	0.1	9.0	4.1	17.8	13.1	0.7	0.8	0.0	0.0	0.2	0.9	0.1	11.7	0.0	13.0	0.1	0.0	4.2	0.8	414.2	131.6	317.0	0.9	1.2	72.1	72.2	31.5	2.0	1.2	0.2	36.0
NR2F2	"ARP1, COUP-TFII, COUPTF2, COUPTFB, NF-E3, SVP40, TFCOUP2"	ENSG00000185551	"Nuclear receptor subfamily 2 group F member 2"	P24468	15	96325938-96340263	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 292.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 542.2;Hepatic stellate cells: 395.5;Leydig cells: 510.4;Peritubular cells: 610.5;Sertoli cells: 486.4;Smooth muscle cells: 385.7;Theca cells: 572.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058974			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA058974: AB_2732629"	"unprognostic (9.28e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-2)"	"unprognostic (8.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.19e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.28e-2)"	95.5	43.1	32.7	18.8	19.2	0.1	59.7	15.0	19.6	128.6	23.5	52.6	21.5	120.9	61.8	22.1	101.5	65.7	44.4	20.0	24.8	79.8	32.1	56.8	42.4	16.2	21.9	292.4	20.0	30.7	20.3	74.7	18.2	60.6	26.7	2.5	22.9	126.4	33.1	24.1	32.1	81.8	12.5	106.2	82.3	26.7	49.3	7.8	46.2	31.5	15.1	46.3	74.5	10.7	154.7	39.1	125.6	78.5	249.1	85.5	41.9	109.1	83.2	111.1	94.3	134.8	153.4	0.1	86.8	55.2	44.1	90.4	22.3	78.3	138.8	0.5	86.5	49.9	48.7	24.6	69.5	38.7	18.0	61.3	26.5	92.5	19.8	130.5	207.3	0.1	135.3	0.4	71.2	105.5	0.1	27.6	1.2	59.6	52.7	0.1	30.9	0.2	244.7	165.7	15.8	0.2	12.3	3.7	17.5	55.0	61.1	2.8	215.3	119.9	39.7	28.3	38.8	0.1	0.4	0.4	67.0	18.9	85.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	19.2	15.0	19.6	20.0	24.8	16.2	21.9	18.2	12.5	49.3	10.7	133.4	28.9	18.1	0.7	1.1	14.4	24.9	71.7	39.3	7.5	51.9	50.8	46.4	203.0	34.6	62.5	25.0	126.2	2.0	35.7	46.9	22.0	3.2	70.9	542.2	166.1	26.4	5.3	0.1	10.9	50.3	125.8	80.0	68.9	0.0	41.5	395.5	51.6	10.3	3.3	24.8	35.5	32.6	12.2	20.1	22.9	510.4	5.0	26.6	36.5	0.6	30.2	0.0	0.0	0.5	15.6	23.9	610.5	2.8	22.3	14.3	65.5	37.3	13.8	486.4	27.8	385.7	6.4	7.9	20.5	10.4	35.3	5.8	572.5	27.1	21.3
NRIP2	DKFZP761G1913	ENSG00000053702	"Nuclear receptor interacting protein 2"	Q9BQI9	12	2825348-2835544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.4"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 6.2;Rod photoreceptor cells: 8.8;Sertoli cells: 26.3;Smooth muscle cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"basophil: 3.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039197, HPA039860"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039197: AB_10673416, HPA039860: AB_10794203"	"unprognostic (3.28e-3)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (8.05e-4)"	"unprognostic (2.10e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.26e-3)"	"unprognostic (5.66e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (8.69e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.55e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.97e-2)"	5.4	3.9	7.7	3.6	12.4	4.0	5.1	23.4	10.2	7.0	4.8	5.3	2.4	7.4	7.2	2.4	4.8	5.9	5.2	5.8	10.6	12.0	1.6	1.8	4.1	12.4	10.0	8.4	3.0	0.6	2.8	2.6	12.9	4.1	3.0	3.9	3.6	4.9	4.9	2.6	4.7	4.9	8.1	9.1	3.6	2.1	12.0	3.0	5.5	7.5	2.6	4.3	4.7	13.3	0.4	0.9	1.5	0.8	0.0	0.0	1.8	1.1	0.0	0.0	0.0	2.3	1.1	1.2	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.9	1.3	2.0	2.9	0.2	0.0	2.4	1.4	0.0	0.0	0.0	0.0	2.2	0.0	1.3	1.1	2.7	0.0	1.0	1.5	1.2	1.5	0.9	0.4	0.9	1.6	0.7	0.0	1.5	1.1	1.7	0.8	1.2	0.3	2.7	0.8	0.4	1.2	0.6	0.7	0.9	1.6	0.4	0.1	1.8	1.5	1.1	0.8	3.7	0.3	0.1	0.5	0.2	0.3	0.7	0.4	0.5	0.2	0.6	0.8	0.3	0.1	0.4	0.1	0.3	0.1	0.1	7.7	12.4	23.4	10.2	5.8	10.6	12.4	10.0	12.9	8.1	12.0	13.3	0.6	0.0	1.1	0.0	0.2	0.1	0.5	0.0	0.0	5.0	0.1	0.9	1.3	0.0	0.0	1.8	6.2	0.3	0.3	0.0	0.0	0.0	1.6	0.2	0.9	0.6	0.0	0.0	1.8	0.0	0.0	1.3	0.0	0.3	0.0	0.2	0.4	0.0	0.1	3.3	3.3	0.0	0.0	0.6	0.3	1.8	0.3	0.5	0.0	2.8	0.0	0.6	3.1	0.5	4.9	0.0	0.0	5.3	0.0	0.3	0.0	0.2	0.0	8.8	26.3	0.5	23.1	0.1	0.3	0.1	0.1	0.0	1.1	0.4	0.0	0.1
NT5DC2	FLJ12442	ENSG00000168268	"5'-nucleotidase domain containing 2"	Q9H857	3	52524385-52535054	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 69.2;Peritubular cells: 135.4;Sertoli cells: 111.7;Smooth muscle cells: 83.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050683	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA050683: AB_2681215"	"unprognostic (1.40e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-2)"	30.3	73.2	26.0	18.6	25.2	15.5	27.9	38.6	29.8	48.0	43.2	18.3	13.7	36.3	27.5	69.4	29.5	12.1	117.5	26.0	30.2	30.6	7.8	33.6	16.3	41.8	46.6	45.3	15.6	16.5	50.8	32.7	64.0	74.9	12.7	8.5	43.5	39.3	10.3	49.0	16.2	20.8	26.8	18.6	16.4	49.7	27.6	9.9	26.3	10.9	22.9	40.7	38.7	25.9	138.8	73.7	238.9	128.4	186.2	252.3	188.3	139.6	121.2	95.4	78.0	216.5	66.8	174.4	15.1	177.9	76.0	47.3	194.9	179.8	90.0	71.0	123.8	104.1	122.1	337.4	274.9	0.1	88.8	333.0	40.9	162.9	49.4	175.4	203.0	125.2	194.9	57.5	112.0	145.5	72.7	179.2	318.1	125.6	234.6	104.6	100.3	168.8	52.7	35.5	111.1	323.3	54.7	101.2	71.8	178.6	96.0	98.5	95.1	123.7	153.8	123.8	298.9	25.9	47.3	129.4	369.4	0.7	152.1	0.0	0.3	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.1	26.0	25.2	38.6	29.8	26.0	30.2	41.8	46.6	64.0	26.8	27.6	25.9	20.9	9.6	11.5	2.6	12.9	7.8	26.6	15.2	30.1	18.4	54.6	69.2	14.0	5.7	13.0	12.9	0.0	3.4	3.3	3.1	17.6	10.1	6.9	5.3	20.0	12.6	12.6	8.0	0.9	2.3	24.8	24.8	8.6	10.8	18.4	36.4	11.0	1.2	10.4	1.7	1.2	6.0	10.2	10.1	8.8	19.7	49.7	7.8	16.0	1.9	2.8	36.6	1.0	5.0	1.5	7.0	0.6	135.4	21.4	23.4	0.6	9.3	2.7	4.7	111.7	18.6	83.4	6.2	37.9	23.5	13.8	2.3	2.8	15.8	7.2	12.7
OAZ2		ENSG00000180304	"Ornithine decarboxylase antizyme 2"	O95190	15	64687573-64703281	"Predicted intracellular proteins"	"Polyamine biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 324.9;Sertoli cells: 374.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 418.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047694	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"HPA047694: AB_2680121"	"unprognostic (2.67e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (9.05e-4)"	"unprognostic (2.09e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.46e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-1)"	65.1	68.5	110.1	49.5	111.8	32.9	55.1	112.2	112.5	61.1	108.0	72.4	28.4	64.7	57.2	44.4	59.8	46.9	79.3	110.1	114.5	68.4	89.3	55.8	50.7	112.6	114.6	56.5	35.9	96.8	75.0	75.1	112.4	53.3	35.8	123.4	45.3	49.1	207.9	45.9	40.9	72.3	114.3	89.8	47.7	80.8	114.4	41.7	65.8	152.5	45.4	56.3	48.3	116.4	71.2	63.5	130.6	43.5	91.8	79.4	24.6	80.5	120.6	113.4	98.5	43.5	62.2	61.6	72.7	113.4	84.5	37.5	126.7	71.6	99.2	82.4	48.3	40.3	48.3	32.5	52.2	35.7	125.7	104.4	49.6	57.0	40.1	147.4	109.2	42.9	30.1	29.6	123.4	45.3	24.5	43.8	223.1	39.1	50.7	57.5	74.5	54.0	102.0	55.7	68.4	125.1	30.4	45.0	80.3	161.6	75.6	52.7	66.0	76.4	102.2	38.0	87.0	65.1	104.6	58.2	87.4	75.2	69.8	22.1	145.3	268.4	29.3	247.8	24.2	30.2	24.6	24.0	91.1	29.1	27.9	25.3	418.0	39.5	209.6	49.4	30.7	115.5	110.1	111.8	112.2	112.5	110.1	114.5	112.6	114.6	112.4	114.3	114.4	116.4	67.5	25.6	43.5	15.3	36.1	121.7	99.5	67.7	47.8	93.8	57.9	40.4	61.9	44.3	41.0	42.3	104.3	114.1	33.4	19.2	168.3	109.5	324.9	35.2	30.0	109.3	81.9	33.3	14.6	66.0	70.9	61.3	14.3	20.5	103.3	36.9	134.6	83.6	133.9	74.0	13.6	26.0	91.6	115.4	238.1	80.9	114.3	86.6	103.2	20.6	114.2	268.2	49.4	12.1	26.9	81.8	25.7	68.1	19.1	88.9	29.2	94.2	51.1	180.8	374.7	68.1	160.9	166.2	83.9	28.0	121.2	68.5	31.7	44.3	27.4	72.4
OLFML2A	FLJ00237	ENSG00000185585	"Olfactomedin like 2A"	Q68BL7	9	124777133-124814885	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 40.1;Endothelial cells: 21.2;Fibroblasts: 29.0;Skeletal myocytes: 63.0;Smooth muscle cells: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 160.0;GAMG: 34.0;HeLa: 39.8;hTERT-RPE1: 38.0;WM-115: 64.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021180, HPA022254"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		240000		"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA021180: AB_1854790, HPA022254: AB_1854791"	"unprognostic (1.12e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (5.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.05e-2)"	15.4	2.9	2.6	2.7	3.1	0.3	11.1	2.2	4.6	25.0	3.3	29.9	3.3	25.3	2.8	8.2	6.4	4.8	16.4	2.2	2.4	4.3	0.7	10.5	2.4	2.8	2.1	12.0	4.8	4.6	2.8	7.0	2.8	7.4	6.2	2.2	7.0	12.2	10.8	16.0	6.9	16.0	2.1	32.8	5.5	1.1	2.6	3.1	19.1	10.0	3.7	17.6	14.6	2.1	0.8	14.6	1.2	0.4	16.8	160.0	0.1	1.8	8.2	3.5	3.5	0.2	2.2	0.0	3.4	0.1	34.0	25.5	0.4	0.8	4.0	0.0	0.1	0.0	39.8	0.1	0.9	0.0	0.1	11.3	2.7	10.2	1.4	38.0	0.0	0.0	0.0	0.2	1.8	0.4	0.0	0.3	3.4	0.0	0.9	0.0	9.5	0.0	0.0	1.2	0.0	0.1	2.9	0.2	4.3	28.6	3.9	0.5	0.1	5.2	4.6	5.5	0.7	1.9	0.0	0.1	15.2	0.8	64.1	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.1	2.6	3.1	2.2	4.6	2.2	2.4	2.8	2.1	2.8	2.1	2.6	2.1	40.1	0.0	1.3	0.7	0.4	12.0	5.9	17.5	6.2	0.6	2.9	8.3	13.8	1.5	5.5	0.0	2.1	0.3	0.5	0.0	0.0	0.1	0.7	0.2	1.5	21.2	0.0	0.0	0.4	0.6	0.3	29.0	0.5	0.2	0.0	0.9	3.6	0.1	0.1	0.0	0.6	0.0	4.1	1.5	7.9	1.4	2.8	0.9	10.6	8.4	0.1	0.3	0.0	0.0	0.1	0.0	0.0	1.5	0.1	4.0	0.0	0.1	11.5	4.0	13.1	63.0	36.4	0.4	0.7	4.5	8.4	0.0	0.6	4.2	0.0	3.5
OPN4	"melanopsin, MOP"	ENSG00000122375	"Opsin 4"	Q9UHM6	10	86654547-86666848	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Biological rhythms, Sensory transduction"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.9;skeletal muscle: 2.5"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 4.6;Excitatory neurons: 2.8;Inhibitory neurons: 1.9;Smooth muscle cells: 2.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 7.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039147	Approved					NA	NA				"Cluster 47: Non-specific - Unknown function"		"Cluster 48: Smooth muscle cells - ECM organization"			"HPA039147: AB_10673304"	"unprognostic (3.67e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.89e-2)"		"unprognostic (3.26e-1)"	"unprognostic (9.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (8.88e-3)"		"unprognostic (1.93e-6)"	"unprognostic (4.10e-2)"		"unprognostic (5.58e-2)"	"unprognostic (6.76e-2)"	2.0	0.1	1.5	0.0	7.9	0.0	0.7	0.0	3.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.3	0.0	0.2	0.0	0.1	1.1	0.6	0.0	2.5	0.7	0.4	0.0	0.1	0.0	0.2	0.0	1.4	0.0	0.8	0.4	0.0	0.2	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	7.9	0.0	3.0	1.6	0.0	0.1	0.1	0.2	0.1	1.4	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4M2		ENSG00000274102	"Olfactory receptor family 4 subfamily M member 2"	Q8NGB6	15	22070241-22083221	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"Sertoli cells: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058889	Uncertain					NA	NA						"Cluster 48: Smooth muscle cells - ECM organization"			"HPA058889: AB_2683845"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR51E1	"GPR136, GPR164, OR51E1P, OR52A3P"	ENSG00000180785	"Olfactory receptor family 51 subfamily E member 1"	Q8TCB6	11	4643420-4655488	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 5.7;placenta: 7.4;prostate: 6.6"	"Group enriched"	"Detected in some"	7	"Adipocytes: 44.1;Enteroendocrine cells: 21.3;Sertoli cells: 26.3;Smooth muscle cells: 31.8"	"Cancer enriched"	"Detected in many"	21	"prostate cancer: 34.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	107	"SCLC-21H: 10.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB019995, HPA051439"	Approved					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB019995: AB_10283600, HPA051439: AB_2681487"	"unprognostic (6.67e-3)"	"unprognostic (2.34e-3)"	"unprognostic (9.71e-2)"	"unprognostic (4.87e-5)"	"unprognostic (3.55e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.94e-3)"	"unprognostic (7.36e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (1.23e-6)"	"unprognostic (2.72e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.86e-1)"	5.7	0.0	0.2	0.7	0.2	0.0	2.4	0.2	0.4	0.5	0.2	1.7	0.4	0.9	0.3	0.1	0.6	0.5	4.6	0.2	0.2	0.7	0.0	0.0	0.1	0.3	0.2	0.5	0.1	0.1	0.5	7.4	0.2	6.6	0.8	0.0	0.2	0.5	2.1	0.2	1.3	1.0	0.2	0.1	0.7	0.2	0.2	0.0	0.5	3.9	0.2	0.6	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	44.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.3	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.3	4.1	21.3	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	1.7	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.5	0.0	0.3	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	3.4	0.1	0.0	0.0	0.0	26.3	0.7	31.8	0.0	0.2	0.1	0.3	0.0	0.1	0.8	0.1	0.2
PCNP		ENSG00000081154	"PEST proteolytic signal containing nuclear protein"	Q8WW12	3	101574180-101594465	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035011, HPA063861"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No		38000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear bodies"	"HPA035011: AB_10601386, HPA063861: "	"unprognostic (4.34e-2)"	"unprognostic (9.65e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.67e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.05e-1)"	47.0	47.6	42.6	43.5	45.3	58.7	53.5	48.6	69.1	48.2	54.5	47.8	38.8	53.8	52.6	48.1	43.8	41.0	57.7	43.1	50.6	51.9	49.6	41.0	57.3	43.7	43.9	69.7	33.3	50.0	39.3	50.5	44.0	47.6	45.2	58.3	42.5	49.1	66.5	39.0	36.1	53.4	45.8	39.8	34.8	28.4	45.8	58.0	49.8	66.4	57.5	50.7	40.0	52.9	135.0	71.1	105.2	82.9	96.1	136.8	113.4	90.0	126.3	94.1	105.1	85.8	73.1	139.4	66.5	100.0	92.8	71.4	138.0	119.6	196.9	102.6	76.6	151.1	84.9	103.4	73.6	141.1	72.1	82.4	115.5	78.0	109.6	134.8	129.6	64.1	143.7	82.6	117.2	55.8	123.8	120.2	162.4	110.8	113.9	71.8	93.2	110.0	123.7	76.7	136.1	108.0	83.4	82.0	132.6	119.3	76.7	105.4	81.5	86.5	113.8	44.1	97.1	62.1	100.2	174.0	84.1	150.9	107.4	58.3	22.4	38.6	22.1	27.0	29.1	29.8	28.9	26.9	23.9	24.1	29.1	27.3	20.2	36.4	36.0	18.9	35.9	40.9	42.6	45.3	48.6	69.1	43.1	50.6	43.7	43.9	44.0	45.8	45.8	52.9	94.9	60.9	101.4	25.5	124.2	232.6	235.2	171.7	126.9	89.5	90.3	65.8	111.5	75.8	106.2	64.4	39.6	120.3	75.0	46.6	266.1	130.3	30.1	89.1	80.4	111.0	81.9	195.9	50.4	95.0	205.7	126.9	55.5	114.6	102.6	53.8	90.3	51.7	90.3	97.6	51.3	70.8	187.2	87.3	242.1	15.0	130.8	105.0	250.8	39.4	131.0	128.4	102.0	36.2	49.1	111.2	51.6	134.6	77.8	207.5	72.2	182.6	85.8	90.5	131.5	110.8	170.3	105.7	70.1	100.6	238.5	235.9	125.1	60.9	78.8	196.3
PDE1B	PDES1B	ENSG00000123360	"Phosphodiesterase 1B"	Q01064	12	54549601-54579239	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 76.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.6;Inhibitory neurons: 10.2;Kupffer cells: 13.0;Macrophages: 9.4;Sertoli cells: 13.1;Smooth muscle cells: 13.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"basal ganglia: 76.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.7;HMC-1: 14.9;NB-4: 10.7;THP-1: 9.0;U-937: 7.2"	"Region enriched"	"Detected in all"	6	"basal ganglia: 999.4"	"Region enriched"	"Detected in all"	7	"basal ganglia: 228.7"	HPA018492	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA018492: AB_1855119"	"unprognostic (2.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.67e-4)"	"unprognostic (5.63e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (6.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.83e-2)"	9.1	1.1	8.4	4.0	76.9	4.8	4.6	0.0	13.7	2.0	0.0	7.4	1.0	2.7	1.8	1.7	2.0	2.2	1.4	6.3	0.1	0.8	1.0	2.3	1.3	0.0	0.0	8.6	0.4	6.1	0.3	0.2	0.0	1.3	1.0	0.4	1.0	1.4	0.6	1.4	3.4	4.0	0.0	4.0	3.3	0.7	2.4	0.9	2.0	1.0	0.8	8.7	1.5	4.9	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	2.1	0.0	0.0	12.7	0.6	4.3	0.0	0.0	0.0	5.5	14.9	0.7	0.0	0.0	0.0	0.0	0.0	5.5	0.0	2.3	0.0	0.0	0.5	10.7	3.5	0.0	0.0	2.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	9.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	2.5	0.0	7.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	76.9	0.0	13.7	6.3	0.1	0.0	0.0	0.0	0.0	2.4	4.9	2.3	0.0	1.1	1.6	1.8	1.0	0.2	0.0	0.6	2.7	0.2	0.6	3.6	0.0	0.6	3.7	0.0	0.1	1.4	0.0	0.0	0.0	6.3	0.1	0.0	0.8	1.8	3.6	18.6	0.0	0.0	1.5	0.0	0.0	0.0	4.4	0.0	0.3	8.5	5.0	10.2	0.0	0.0	13.0	2.5	4.9	2.1	9.4	0.0	2.8	6.7	0.1	4.1	1.0	0.9	0.0	0.0	3.0	2.6	0.4	0.0	0.0	0.0	0.2	13.1	0.6	13.7	0.8	0.6	0.2	0.4	0.3	2.8	0.4	0.1	0.1
PDE5A		ENSG00000138735	"Phosphodiesterase 5A"	O76074	4	119494397-119628804	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 66.1;Inhibitory neurons: 58.3;Oligodendrocyte precursor cells: 56.8;Peritubular cells: 104.9;Smooth muscle cells: 80.9"	"Group enriched"	"Detected in all"	4	"prostate cancer: 7.0;thyroid cancer: 27.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 47.5;HHSteC: 65.9;hTERT-RPE1: 24.6"	"Region enhanced"	"Detected in all"		"cerebellum: 18.2"	"Low region specificity"	"Detected in all"			"HPA004729, HPA012873"	Approved		Approved	Cytosol		NA	NA		850000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA004729: AB_1079588, HPA012873: AB_1855124"	"unprognostic (6.95e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (1.17e-4)"	15.4	11.3	0.9	10.9	3.5	2.1	9.6	4.9	3.7	32.7	12.6	37.0	15.5	14.4	41.5	41.3	22.9	10.4	12.8	1.4	3.6	5.9	1.5	22.1	6.4	4.9	8.2	5.4	12.4	8.3	3.5	13.2	5.2	59.8	25.9	9.6	9.8	49.8	6.9	5.0	18.9	11.4	0.0	5.8	9.6	9.4	3.4	3.7	16.8	5.6	3.5	14.6	15.8	1.9	16.7	0.8	11.0	1.2	3.7	5.5	1.9	10.7	47.5	0.5	1.0	1.0	1.3	1.6	0.5	13.4	3.0	5.8	3.5	1.7	1.3	0.4	7.4	18.5	2.6	0.9	65.9	3.9	1.7	6.1	3.3	1.1	0.1	24.6	1.4	3.7	2.0	2.9	1.6	0.9	5.0	0.6	2.3	1.8	2.8	0.7	5.9	4.3	4.1	4.9	4.3	8.8	13.0	15.3	1.3	8.1	2.7	2.1	2.5	6.2	5.2	3.4	1.5	4.1	2.0	1.5	5.9	1.0	0.9	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.3	0.1	0.0	0.3	0.1	0.2	0.4	0.2	0.1	0.1	0.1	1.2	0.9	3.5	4.9	3.7	1.4	3.6	4.9	8.2	5.2	0.0	3.4	1.9	7.8	6.4	3.9	19.9	1.3	3.4	2.8	1.1	5.7	8.1	11.0	8.4	5.5	14.3	3.7	1.8	14.6	0.4	0.9	15.5	0.0	15.8	30.6	5.0	12.6	7.8	2.4	0.0	66.1	2.9	0.3	28.1	1.1	3.9	1.3	1.6	0.7	0.9	0.3	5.0	58.3	9.5	2.0	0.0	3.5	11.5	20.8	11.3	5.4	40.3	1.3	28.5	2.1	56.8	41.1	3.9	10.3	104.9	1.4	3.6	7.9	0.5	0.8	5.8	19.7	5.5	80.9	5.4	6.3	3.5	2.4	0.3	1.7	7.0	11.1	2.6
PDGFA	"PDGF-A, PDGF1"	ENSG00000197461	"Platelet derived growth factor subunit A"	P04085	7	497258-520296	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 95.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 89.8;Breast myoepithelial cells: 154.9;Paneth cells: 97.0;Smooth muscle cells: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 11.3"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"WM-115: 311.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005579, HPA065024"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		580000	"Cluster 42: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"CAB005579: AB_2161916, HPA065024: "	"unprognostic (2.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.75e-4)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.63e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.87e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (8.67e-4)"	15.4	8.5	29.3	7.9	36.8	1.7	17.0	36.6	32.4	18.1	20.5	29.2	20.2	26.1	11.2	9.6	21.2	11.4	21.1	27.0	27.5	22.2	8.5	24.9	3.5	46.4	37.5	7.7	71.6	6.6	10.2	26.8	40.7	23.3	14.8	5.2	20.3	11.2	95.2	12.5	25.9	10.2	35.8	16.3	32.1	4.5	36.5	6.6	10.0	15.1	2.4	17.8	15.9	58.8	22.9	15.3	1.5	21.6	4.1	0.7	50.7	5.0	2.9	6.4	4.4	23.8	25.3	0.6	8.7	4.3	2.9	56.6	1.5	69.0	3.4	12.9	2.3	0.3	13.3	8.7	26.9	2.4	2.2	3.0	26.8	3.3	21.3	8.5	12.5	1.3	2.3	3.1	15.8	28.7	3.5	5.0	40.1	8.9	3.3	11.6	1.5	2.5	9.0	5.3	2.1	1.8	76.5	4.2	13.3	47.5	10.7	2.6	37.3	13.6	37.8	8.0	31.0	0.9	1.4	0.8	12.3	7.1	311.4	11.3	1.6	2.4	1.6	1.9	2.2	1.9	1.6	1.5	1.5	1.8	1.9	2.0	4.9	3.4	3.3	2.1	1.8	2.1	29.3	36.8	36.6	32.4	27.0	27.5	46.4	37.5	40.7	35.8	36.5	58.8	15.2	89.8	11.9	11.1	1.5	28.0	20.2	12.1	59.7	15.7	12.7	154.9	29.9	15.7	11.0	14.7	8.4	8.8	1.7	76.9	5.9	15.8	0.3	49.0	4.2	19.4	13.1	0.0	7.7	53.3	5.4	12.3	41.8	35.7	10.8	18.1	21.0	1.0	2.0	32.0	5.9	40.5	2.0	1.3	10.4	0.1	2.1	14.8	14.2	6.5	1.5	0.7	1.0	5.0	27.5	72.6	97.0	6.4	4.4	29.4	47.2	8.5	4.5	2.1	39.5	48.9	110.3	0.5	1.8	9.4	9.8	2.9	3.9	0.2	32.1	18.2
PDGFRB	"CD140b, JTK12, PDGFR, PDGFR1"	ENSG00000113721	"Platelet derived growth factor receptor beta"	P09619	5	150113839-150155872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Chemotaxis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Sertoli cells: 1288.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"ASC diff: 1350.1;ASC TERT1: 462.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003842, CAB018144, HPA028499"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA		39000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	"Golgi apparatus"	"CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018"	"unprognostic (4.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.57e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.87e-8)"	"unprognostic (3.13e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (8.11e-4)"	171.2	25.1	25.4	27.5	27.2	0.7	106.3	20.5	33.3	155.9	43.5	41.6	11.9	101.1	24.2	24.1	89.6	124.5	75.7	22.1	23.2	49.7	13.4	98.3	27.5	22.1	24.6	105.5	20.8	21.9	23.0	113.3	22.8	56.2	14.1	6.3	34.5	43.3	38.1	65.0	37.9	68.9	19.4	41.4	27.9	18.4	27.7	8.7	66.5	44.1	13.8	58.3	98.6	21.6	0.1	0.3	8.3	0.4	1350.1	462.7	3.0	48.9	202.3	33.5	56.4	5.4	0.0	0.0	6.4	142.0	19.0	0.1	0.1	0.4	15.8	0.0	0.0	0.1	3.3	3.5	190.7	0.0	0.4	210.0	0.0	46.3	0.6	106.6	0.1	0.1	0.1	5.5	5.5	0.0	0.1	0.6	9.0	0.2	0.2	3.7	2.5	0.2	0.0	0.0	0.1	24.8	0.5	0.1	0.0	38.2	0.1	0.6	0.4	53.7	17.2	23.1	2.8	0.4	0.0	0.3	33.4	0.1	1.5	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.2	25.4	27.2	20.5	33.3	22.1	23.2	22.1	24.6	22.8	19.4	27.7	21.6	50.8	0.0	1.1	81.9	0.5	24.0	0.5	0.0	2.2	6.6	1.4	3.3	17.3	1.5	0.0	1.8	4.2	0.6	6.0	0.3	0.0	0.8	1.6	2.8	99.5	32.2	0.0	0.0	7.9	0.0	1.1	123.5	2.0	2.3	0.0	2.5	6.4	1.9	1.5	0.0	1.3	0.7	0.0	0.0	35.6	10.9	165.3	3.1	24.9	45.0	0.7	50.7	23.7	10.1	3.3	0.1	0.1	203.8	2.3	0.7	0.3	0.1	0.7	2.9	1288.5	6.6	288.3	1.9	1.6	0.8	15.3	0.8	4.8	4.0	0.4	1.1
PEAR1	"FLJ00193, JEDI, MEGF12"	ENSG00000187800	"Platelet endothelial aggregation receptor 1"	Q5VY43	1	156893698-156916434	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 44.6;Endothelial cells: 30.6;Hepatic stellate cells: 40.0;Leydig cells: 44.4;Peritubular cells: 35.7;Sertoli cells: 26.3;Smooth muscle cells: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 19.5;HBEC3-KT: 29.9;HHSteC: 21.6;HUVEC TERT2: 52.2;TIME: 85.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035217	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA		62000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cell Junctions"	Centrosome	"HPA035217: AB_10669902"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.37e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.64e-2)"	19.0	5.0	2.5	2.3	3.0	2.3	12.9	1.2	4.1	12.3	2.0	4.5	1.6	10.0	1.1	2.6	9.1	7.4	8.7	1.2	1.7	4.8	2.1	11.8	3.8	2.0	2.3	9.1	2.3	1.7	3.4	11.7	2.3	4.7	0.9	0.4	2.9	3.7	5.7	4.2	4.1	4.6	1.1	7.0	3.7	3.0	2.9	1.4	9.7	7.6	1.1	6.0	7.3	1.4	0.5	2.9	0.8	0.0	0.0	3.7	0.1	11.7	19.5	4.8	2.8	0.3	0.5	0.0	0.6	8.7	0.4	0.2	0.0	29.9	1.3	0.2	0.0	14.8	0.7	0.8	21.6	0.1	0.0	11.3	0.1	6.5	1.5	1.0	52.2	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	6.9	0.0	0.0	85.2	0.1	6.4	2.6	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	3.0	1.2	4.1	1.2	1.7	2.0	2.3	2.3	1.1	2.9	1.4	44.6	0.0	3.2	0.0	0.4	0.9	0.1	0.7	1.2	2.4	0.6	1.3	7.5	1.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.2	0.2	2.5	30.6	1.8	5.7	0.0	0.4	0.1	10.1	1.5	0.4	1.3	0.1	40.0	0.4	0.5	0.0	0.0	2.3	0.0	1.6	1.5	3.5	44.4	3.0	5.4	12.2	0.4	0.2	0.0	0.0	0.0	1.2	0.0	35.7	0.0	0.2	0.0	0.1	0.2	0.2	26.3	1.7	34.2	1.5	1.5	0.2	1.1	0.3	0.3	1.1	0.3	0.2
PGAM4	"dJ1000K24.1, PGAM-B, PGAM1, PGAM3"	ENSG00000226784	"Phosphoglycerate mutase family member 4"	Q8N0Y7	X	77967949-77969638	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 2.3;Basal respiratory cells: 1.6;Langerhans cells: 1.5;Melanocytes: 3.6;Suprabasal keratinocytes: 2.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 1.3"									"HPA042528, HPA060483"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"		"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA042528: AB_2678039, HPA060483: AB_2684292"	"unprognostic (3.10e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.52e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-3)"	0.1	0.2	0.1	0.2	0.1	0.4	0.1	0.0	0.4	0.1	0.0	0.1	0.2	0.1	0.0	0.3	0.1	0.0	0.2	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.4	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	1.3	0.4	0.1	0.4	0.0	0.0	0.6	0.2	0.0	0.2	0.2	0.0	0.1	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.3	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.8	1.0	0.3	0.0	0.1	0.3	0.1	0.4	0.1	0.1	0.0	0.6	0.2	0.1	0.5	0.2	0.2	0.2	0.0	0.2	0.4	0.4	1.0	0.5	0.4	0.3	1.0	0.7	0.1	0.5	1.0	1.5	0.5	1.0	0.4	0.3	0.5	0.5	0.8	0.3	0.3	0.5	0.6	0.4	1.1	0.2	0.9	1.7	0.1	0.1	0.0	0.4	0.3	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.6	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.4	0.1	0.1	0.0	0.0	0.0
PKIG		ENSG00000168734	"CAMP-dependent protein kinase inhibitor gamma"	Q9Y2B9	20	44531785-44624247	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 233.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"memory B-cell: 370.6;naive B-cell: 377.4"	"Lineage enriched"	"Detected in all"	11	"B-cells: 377.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 540.5;HSkMC: 211.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042703, HPA063690"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA042703: AB_10797018, HPA063690: AB_2685091"	"unprognostic (3.15e-2)"	"unprognostic (5.65e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.90e-5)"	"unprognostic (6.26e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.96e-2)"	90.3	76.6	77.4	59.0	80.0	20.7	74.2	70.9	95.6	105.2	78.0	189.1	30.3	111.4	37.8	76.4	101.7	73.8	289.9	82.7	82.5	104.5	44.5	162.9	49.4	80.9	77.0	57.5	32.3	66.8	69.1	82.3	72.5	102.4	31.5	26.9	45.9	75.3	104.8	31.4	72.2	92.6	73.1	42.7	81.8	68.3	83.4	19.3	68.4	91.1	46.7	169.0	68.9	73.4	27.8	27.9	44.7	28.8	67.0	135.7	6.2	66.0	540.5	73.6	55.4	64.7	12.5	108.3	52.7	58.5	61.2	10.6	9.0	14.4	23.9	54.8	16.3	16.7	4.1	45.7	61.7	2.1	1.1	211.7	28.5	35.8	7.9	36.4	167.5	29.3	13.4	2.6	6.8	35.0	17.2	27.5	23.7	0.2	39.4	2.8	1.2	2.6	40.7	5.5	18.0	58.7	16.9	7.9	45.6	19.3	21.0	13.6	108.5	99.9	44.2	44.8	32.3	13.9	41.9	76.3	49.5	1.9	43.8	2.9	1.8	0.7	1.5	1.7	1.3	370.6	1.9	1.8	9.1	377.4	5.4	8.8	2.2	4.4	1.6	35.8	1.0	17.8	77.4	80.0	70.9	95.6	82.7	82.5	80.9	77.0	72.5	73.1	83.4	73.4	93.3	9.6	6.1	26.8	82.9	25.2	14.4	20.3	10.2	24.6	37.6	45.1	233.6	24.3	15.7	46.0	20.9	15.1	6.2	44.2	127.2	70.6	110.1	104.2	91.5	122.3	44.2	34.9	65.9	30.8	17.8	93.2	5.1	18.5	47.5	27.8	65.0	37.8	8.2	10.1	42.7	15.7	32.6	3.8	20.4	40.1	73.0	14.2	49.8	22.5	8.1	94.1	3.1	25.6	25.4	39.1	46.9	61.3	11.8	11.6	19.3	156.6	78.3	28.7	118.3	19.5	153.0	155.9	27.4	5.3	30.0	36.7	8.5	80.8	29.1	10.2
PLEKHA4	PEPP1	ENSG00000105559	"Pleckstrin homology domain containing A4"	Q9H4M7	19	48837097-48868617	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 53.4;Smooth muscle cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 63.4;BJ hTERT+ SV40 Large T+ RasG12V: 49.5;SK-MEL-30: 77.0"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	6	"spinal cord: 45.0"	"HPA042978, HPA048473"	Uncertain		Approved	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"	"Cytokinetic bridge, Centriolar satellite"	"HPA042978: AB_2678249, HPA048473: AB_2680409"	"prognostic favorable (1.97e-4)"	"unprognostic (4.39e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.98e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.38e-2)"	34.0	24.6	8.8	12.1	8.8	0.7	31.7	8.0	9.5	28.7	10.9	43.0	5.6	34.6	5.0	14.3	30.5	11.1	41.4	8.7	10.6	32.4	32.8	25.7	5.8	16.9	14.7	47.5	13.2	9.5	29.9	5.6	10.4	28.3	3.9	2.5	15.1	8.4	19.3	17.2	16.0	10.7	10.8	16.2	21.1	11.0	12.4	5.5	31.0	13.1	3.3	34.4	21.7	10.3	9.0	0.5	9.9	63.4	14.2	41.7	8.0	7.0	24.7	26.8	49.5	5.9	2.5	0.4	11.8	9.8	10.4	2.7	3.5	3.6	4.2	0.0	3.4	2.3	1.7	6.6	11.0	0.0	14.2	21.5	2.2	15.6	1.0	11.1	8.0	11.2	9.5	5.3	7.4	5.4	3.2	0.5	1.5	6.0	0.8	0.3	31.5	0.6	8.3	0.1	0.0	11.0	3.0	2.6	77.0	2.5	3.9	3.0	1.3	8.5	6.8	11.2	1.8	28.3	25.4	5.3	10.2	0.7	23.0	0.0	0.3	0.9	1.8	0.3	1.3	1.7	1.7	1.1	0.1	3.9	2.8	2.6	0.1	0.8	0.3	1.2	0.6	0.9	8.8	8.8	8.0	9.5	8.7	10.6	16.9	14.7	10.4	10.8	12.4	10.3	6.4	0.0	18.7	2.3	1.4	9.6	31.3	17.6	12.0	0.7	11.4	18.3	37.1	17.2	27.2	7.3	0.0	3.3	2.9	3.2	1.9	23.3	0.8	11.6	34.1	7.0	1.2	3.2	0.4	5.1	6.8	41.7	7.7	11.6	0.0	18.8	6.4	13.3	2.9	0.0	0.5	2.5	4.1	0.8	9.2	2.0	41.3	1.9	12.4	1.9	1.3	9.9	2.1	0.5	0.2	6.9	0.5	53.4	0.7	29.8	0.7	14.6	20.5	1.0	6.6	33.0	48.4	4.0	3.7	5.7	9.8	2.9	2.4	16.0	3.3	21.4
PLEKHH3	FLJ21019	ENSG00000068137	"Pleckstrin homology, MyTH4 and FERM domain containing H3"	Q7Z736	17	42667914-42676994	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 41.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 45.5;T-47d: 48.7;U-266/84: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046234	Uncertain		Approved	"Golgi apparatus"		NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 16: U-266 - Nucleosome"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"HPA046234: AB_2679597"	"unprognostic (1.32e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.05e-3)"	"unprognostic (5.95e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (9.62e-5)"	"unprognostic (1.87e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.30e-3)"	"unprognostic (1.44e-3)"	10.3	11.1	1.3	1.9	1.6	5.2	10.6	3.7	2.4	16.9	0.3	10.6	3.8	15.3	1.6	17.7	16.8	2.8	9.5	0.6	1.3	5.5	7.8	10.1	1.2	2.2	2.4	15.1	41.3	5.2	9.3	3.5	2.0	11.2	1.1	1.3	9.8	6.5	25.8	11.9	4.8	3.6	1.1	4.4	15.6	7.3	2.5	2.5	8.5	4.9	1.2	12.0	14.4	1.2	13.7	12.2	5.7	9.3	7.0	2.9	10.3	5.2	4.7	3.9	3.7	5.7	7.4	2.0	6.1	5.9	6.6	25.1	4.1	6.7	1.2	12.8	9.0	0.9	26.6	4.9	7.6	0.2	8.7	4.8	11.0	5.1	0.8	3.9	2.7	0.8	15.5	30.1	1.7	24.6	0.7	11.0	2.1	6.9	10.8	2.1	5.6	45.5	1.4	15.1	20.4	22.1	8.1	11.1	12.0	1.3	48.7	11.2	4.0	12.2	11.3	14.2	9.3	36.0	42.9	10.5	8.9	3.1	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.6	3.7	2.4	0.6	1.3	2.2	2.4	2.0	1.1	2.5	1.2	13.4	12.8	13.1	16.3	1.7	15.6	22.9	10.3	41.5	63.2	32.4	29.7	11.3	12.8	9.4	9.2	22.9	11.3	2.1	7.6	0.0	2.7	9.8	15.5	18.4	11.2	7.7	24.4	7.0	7.6	4.4	17.0	30.5	18.3	2.5	2.9	12.8	11.8	2.2	33.7	11.3	5.8	12.2	3.5	11.3	2.7	17.7	2.4	16.0	4.7	1.0	18.0	0.0	6.6	3.9	5.6	1.7	22.6	10.5	12.4	0.7	3.2	7.0	23.1	26.3	16.0	38.0	5.1	16.6	49.4	18.6	6.2	1.8	7.7	6.4	20.0
PMEL	"D12S53E, gp100, Pmel17, SI, SIL, SILV"	ENSG00000185664	"Premelanosome protein"	P40967	12	55954105-55973317	"Predicted intracellular proteins, Predicted membrane proteins"	"Melanin biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"cervix: 80.5;endometrium 1: 32.2;skin 1: 115.2"	"Cell type enriched"	"Detected in many"	32	"Melanocytes: 1472.7"	"Cancer enriched"	"Detected in many"	500	"melanoma: 2481.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	68	"SK-MEL-30: 8590.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031649	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA		11000000	"Cluster 6: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"	"Golgi apparatus"	"HPA031649: AB_2673976"	"unprognostic (4.63e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.90e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.98e-1)"	"prognostic favorable (3.70e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.04e-1)"	3.3	0.8	0.2	0.8	0.2	1.8	8.3	0.7	0.5	80.5	0.3	1.3	1.6	32.2	1.5	0.7	1.2	1.6	0.6	0.3	0.0	2.1	5.0	0.9	5.6	0.0	0.4	4.3	2.3	1.7	0.7	2.8	0.1	0.9	1.2	0.4	3.5	0.8	0.3	115.2	2.1	3.5	0.0	0.5	1.1	4.8	0.0	0.7	1.1	0.2	2.2	1.3	4.0	0.3	14.8	1.1	5.6	0.2	83.6	0.6	126.2	0.9	0.8	1.9	2.0	12.8	6.0	2.6	6.1	0.8	0.3	2.5	0.6	1.0	1.6	3.0	2.1	2.4	2.5	0.7	0.3	1.0	1.4	0.5	1.0	1.2	0.6	1.3	1.0	1.1	0.5	1.8	0.5	2.7	0.4	1.0	17.1	2.8	0.3	1.6	3.5	1.5	1.4	2.7	0.5	2.6	0.3	2.5	8590.9	4.6	4.4	8.8	1.4	0.9	6.5	0.7	7.9	2.1	10.4	3.2	1.0	2.7	0.3	0.0	0.3	0.1	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.4	0.0	0.1	0.2	0.2	0.7	0.5	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.8	0.0	0.5	0.0	0.1	45.9	0.8	1.1	2.8	0.0	1.0	0.9	0.4	1.5	2.2	0.0	0.0	12.1	0.0	1.5	0.0	2.1	8.0	0.7	0.2	1.2	0.0	0.8	0.1	2.3	12.4	1.6	1.1	0.5	0.0	11.1	0.0	2.9	1.7	0.0	0.1	1.6	0.0	0.3	14.6	5.3	12.2	0.6	1472.7	1.0	0.6	0.2	0.0	0.0	0.1	1.0	0.6	0.7	1.2	0.5	2.4	2.8	1.0	0.0	0.0	0.2	1.7	3.9	2.6	1.0	10.2	24.9	0.4	1.3	1.6	0.4
PPIAL4D		ENSG00000256374	"Peptidylprolyl isomerase A like 4D"	F5H284	1	145241630-145242124	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Langerhans cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"											HPA058345	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"			"Cluster 48: Smooth muscle cells - ECM organization"			"HPA058345: AB_2683685"					"unprognostic (9.32e-2)"					"unprognostic (1.33e-1)"				"unprognostic (3.05e-2)"				0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.4	0.8	0.1	0.6	1.9	0.6	2.4	1.2	0.8	1.7	1.6	1.1	1.5	0.0	1.2	1.3	1.7	2.2	3.3	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0
PPP1R12A	"M130, MBS, MYPT1"	ENSG00000058272	"Protein phosphatase 1 regulatory subunit 12A"	O14974	12	79773563-79935460	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 353.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041296, HPA071956"	Approved		Supported	"Actin filaments,Cytosol"		NA	NA		270000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments, Cytosol"		"HPA041296: AB_2677394, HPA071956: AB_2732192"	"unprognostic (3.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.60e-3)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.44e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.38e-1)"	31.5	18.6	21.2	32.3	26.6	57.5	21.7	25.3	65.3	34.1	15.0	73.3	22.8	66.2	31.1	71.2	40.9	36.6	28.0	27.7	20.3	18.2	14.2	24.6	31.9	14.3	14.5	27.4	11.0	18.5	11.2	41.6	14.2	67.6	35.4	14.6	19.0	84.8	20.5	17.6	27.6	83.7	14.1	30.8	29.2	23.5	20.7	34.3	24.9	27.2	27.8	64.5	27.7	27.0	42.9	36.5	49.3	28.5	36.8	36.2	45.8	84.0	46.5	53.1	35.2	34.9	20.7	36.9	33.4	113.8	21.4	33.4	38.6	32.9	63.8	51.3	24.3	98.2	40.5	24.1	29.1	64.8	59.5	30.7	24.3	53.6	49.1	60.1	37.2	36.7	41.1	43.0	57.0	27.7	71.4	34.3	39.1	18.8	25.2	57.9	54.4	27.8	31.4	66.6	23.8	17.9	66.3	23.2	28.5	45.1	32.4	30.9	56.8	56.3	29.9	40.1	48.2	28.3	27.8	48.6	19.2	36.3	49.3	155.1	44.4	197.4	62.8	47.5	56.5	56.8	59.7	66.8	41.8	52.8	47.3	61.3	187.2	98.2	70.4	35.3	69.6	46.3	21.2	26.6	25.3	65.3	27.7	20.3	14.3	14.5	14.2	14.1	20.7	27.0	108.4	76.9	65.9	168.5	79.7	84.5	69.0	59.1	57.5	82.2	30.7	69.0	127.4	32.9	61.5	53.3	35.5	66.7	113.4	44.9	15.6	50.9	111.3	47.5	113.6	93.6	44.9	66.3	240.4	40.0	82.0	82.4	42.8	81.2	121.4	66.6	55.0	27.5	78.0	102.6	135.4	37.7	44.7	57.5	100.8	64.2	86.3	92.8	60.5	132.1	112.0	52.2	120.5	353.9	132.9	55.9	42.7	147.4	60.7	52.0	34.3	26.3	41.0	61.4	210.4	74.6	332.7	133.4	89.8	50.9	81.1	83.7	119.7	81.5	41.3	63.6
PPP1R14A	"CPI-17, PPP1INL"	ENSG00000167641	"Protein phosphatase 1 regulatory inhibitor subunit 14A"	Q96A00	19	38251237-38256532	"Plasma proteins, Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 492.0;intestine: 450.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 332.5;Granulosa cells: 435.0;Leydig cells: 341.1;Peritubular cells: 656.0;Sertoli cells: 979.5;Smooth muscle cells: 465.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 299.4;naive B-cell: 283.9;plasmacytoid DC: 246.9"	"Group enriched"	"Detected in many"	24	"B-cells: 299.4;dendritic cells: 246.9"	"Group enriched"	"Detected in some"	4	"A549: 164.1;EFO-21: 112.2;K-562: 64.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005044, CAB009803, HPA042097, HPA054534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		880000	"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear bodies"	"CAB005044: AB_562091, CAB009803: AB_2168720, HPA042097: AB_2677846, HPA054534: AB_2682518"	"unprognostic (5.40e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.18e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.25e-5)"	"prognostic unfavorable (7.12e-4)"	"unprognostic (4.13e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.22e-2)"	134.0	144.2	175.2	22.1	347.5	2.9	111.9	321.5	226.5	149.7	63.2	450.3	18.6	273.5	5.2	47.6	153.7	14.8	94.6	175.2	219.6	53.3	17.9	163.1	2.6	402.3	322.9	125.1	31.1	2.8	12.6	34.1	336.3	142.0	12.6	0.3	19.0	86.1	27.5	28.6	82.1	57.2	222.0	101.2	140.3	77.6	365.3	1.7	25.8	12.3	1.4	301.6	106.1	492.0	0.0	164.1	0.4	0.0	1.0	0.0	6.1	10.8	0.0	0.1	0.0	12.8	0.2	0.0	112.2	1.0	0.0	0.5	13.6	0.2	0.0	1.4	0.0	25.5	0.0	0.0	4.6	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.0	64.5	0.3	0.0	0.8	0.0	0.3	4.9	0.0	0.0	0.2	2.4	0.4	0.4	0.0	3.5	0.2	0.0	0.0	0.1	9.2	0.0	0.4	0.4	0.0	0.8	0.4	0.0	0.4	0.0	0.5	0.2	0.0	0.1	11.3	0.6	1.2	0.1	0.7	0.2	299.4	0.2	0.4	44.3	283.9	0.6	0.1	1.7	8.7	0.2	246.9	0.2	21.6	175.2	347.5	321.5	226.5	175.2	219.6	402.3	322.9	336.3	222.0	365.3	492.0	332.5	0.0	1.1	1.3	29.9	9.6	3.0	1.2	3.4	0.4	8.8	209.8	19.6	2.8	0.7	0.0	0.0	48.3	48.7	32.7	0.0	0.7	14.1	15.4	239.5	108.5	1.8	34.7	0.5	10.9	7.4	66.8	2.0	10.8	3.8	435.0	224.5	2.3	9.5	0.0	0.6	0.4	0.0	5.6	24.6	42.1	341.1	41.4	8.8	14.0	66.1	0.5	4.1	3.5	155.6	2.2	2.6	656.0	4.8	2.4	3.8	0.3	0.0	1.6	979.5	8.7	465.2	9.9	46.2	0.6	8.0	26.4	3.7	66.0	0.4	1.2
PRSS33	EOS	ENSG00000103355	"Serine protease 33"	Q8NF86	16	2783953-2787948	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"fallopian tube: 4.7"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Melanocytes: 1.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 8.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	65	"eosinophil: 1296.1"	"Lineage enriched"	"Detected in many"	391	"granulocytes: 1296.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 2.7;hTERT-RPE1: 5.0;SK-MEL-30: 5.9;U-2 OS: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (4.78e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.86e-2)"		"unprognostic (1.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.42e-2)"			"unprognostic (2.28e-1)"	"unprognostic (1.91e-1)"		"unprognostic (2.70e-2)"	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.9	0.4	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.4	1296.1	0.2	0.4	0.2	0.1	0.1	0.0	0.2	0.2	0.1	0.3	2.1	3.3	0.3	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PTEN	"BZS, MHAM, MMAC1, PTEN1, TEP1"	ENSG00000171862	"Phosphatase and tensin homolog"	P60484	10	87863625-87971930	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Lipid metabolism, Neurogenesis"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 60.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004076, HPA031335"	Approved		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"CAB004076: AB_390810, HPA031335: AB_2797221"	"unprognostic (8.72e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.41e-1)"	64.0	25.4	17.8	18.6	19.3	12.9	47.6	34.5	23.4	54.8	15.6	28.1	12.9	27.4	18.6	28.3	35.2	15.6	29.7	20.4	18.4	22.6	39.2	39.5	21.4	16.6	17.8	28.0	33.2	11.9	17.3	30.5	16.4	26.3	14.6	30.0	19.6	16.5	23.7	25.9	24.5	22.2	14.5	40.0	25.6	28.2	19.7	31.8	26.1	14.0	16.5	28.1	38.4	17.6	23.5	10.8	12.3	11.2	28.5	19.7	10.9	12.5	28.0	14.5	20.4	10.9	28.0	28.1	8.0	20.9	8.3	14.1	16.6	14.3	22.8	14.1	4.7	9.3	28.5	13.8	30.1	31.9	15.3	13.5	38.7	18.0	23.7	60.3	20.8	17.7	7.0	72.6	13.5	18.1	17.8	56.3	4.6	19.9	0.0	27.6	6.4	20.8	22.9	13.4	4.5	19.9	16.6	7.9	23.0	9.7	21.9	45.2	17.9	44.6	10.8	18.3	10.1	23.9	32.9	30.7	14.6	29.2	2.9	21.3	14.2	25.8	6.8	21.8	7.2	7.9	7.2	6.6	10.3	6.8	8.3	8.3	60.5	8.9	15.6	8.2	7.0	4.5	17.8	19.3	34.5	23.4	20.4	18.4	16.6	17.8	16.4	14.5	19.7	17.6	67.2	35.3	63.3	83.6	48.3	56.1	57.4	31.5	47.3	113.0	49.4	41.9	46.5	57.2	31.2	29.5	39.6	25.8	64.4	57.7	33.2	24.7	70.1	40.0	114.5	56.0	31.2	52.0	141.0	30.0	62.2	79.3	39.8	33.6	25.4	39.6	53.9	64.1	35.0	45.4	132.4	44.7	12.2	206.1	97.2	92.1	56.8	105.2	62.2	196.8	101.5	61.6	44.3	139.2	95.7	30.6	39.7	54.5	39.3	45.1	50.1	38.0	31.2	61.2	92.1	66.4	170.7	33.5	25.4	45.2	60.1	57.3	46.3	44.7	46.1	64.0
PTGDR2	"CD294, CRTH2, DP2, GPR44"	ENSG00000183134	"Prostaglandin D2 receptor 2"	Q9Y5Y4	11	60850933-60855950	"CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.2;intestine: 8.2;stomach 1: 9.3"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 2.1;Endothelial cells: 2.2;Fibroblasts: 4.1;granulocytes: 4.5;Intestinal goblet cells: 2.0;Langerhans cells: 2.4;Smooth muscle cells: 6.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 178.1;eosinophil: 234.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 234.1"	"Cell line enhanced"	"Detected in some"		"HEL: 9.6;Hep G2: 4.8;HMC-1: 5.9;K-562: 4.0;MOLT-4: 3.1;NB-4: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014259	Uncertain					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA014259: AB_1849304"	"unprognostic (9.77e-2)"	"unprognostic (1.35e-3)"	"unprognostic (5.45e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.30e-4)"	"unprognostic (2.61e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.99e-2)"	0.6	0.0	4.3	0.6	4.2	0.0	0.6	3.3	11.2	0.4	2.3	8.2	4.4	0.4	0.2	0.8	0.6	0.5	6.7	3.4	3.6	0.1	0.5	0.6	0.1	3.7	4.2	0.1	0.5	3.4	0.3	1.0	3.9	0.5	4.1	0.1	0.1	0.1	7.3	0.4	6.9	0.3	3.0	0.5	9.3	0.3	4.2	5.0	0.1	3.9	0.1	0.5	0.2	3.4	0.0	0.0	0.1	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	9.6	0.0	4.8	1.0	0.0	5.9	1.9	0.1	0.0	0.0	0.0	0.0	0.3	4.0	0.0	0.0	0.1	3.1	14.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	178.1	0.1	234.1	0.0	10.9	0.0	0.0	1.5	1.1	5.2	0.0	0.0	0.0	0.7	0.1	35.8	1.1	1.6	2.3	4.3	4.2	3.3	11.2	3.4	3.6	3.7	4.2	3.9	3.0	4.2	3.4	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.1	0.1	0.6	0.0	0.0	0.0	2.1	0.0	0.4	0.1	0.0	0.0	0.1	0.1	0.0	2.2	1.2	0.0	0.2	0.0	0.0	4.1	0.5	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	2.4	0.0	0.3	0.5	0.0	1.9	0.6	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.9	6.8	0.1	0.0	0.0	0.3	0.0	1.8	0.0	0.1	0.0
PTMS	ParaT	ENSG00000159335	Parathymosin	P20962	12	6765516-6770952	"Predicted intracellular proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 565.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 25.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 25.6"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 672.8"									HPA038186	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	Yes		300000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA038186: AB_10673042"	"unprognostic (3.11e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.69e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (6.18e-5)"	"unprognostic (1.02e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.55e-2)"	138.4	78.4	115.9	37.0	105.9	14.3	121.4	103.2	122.3	188.2	48.6	293.9	33.0	243.9	29.0	128.0	145.3	28.9	98.7	117.0	74.3	186.6	565.2	173.5	22.7	45.9	43.5	239.9	50.3	82.4	96.3	49.4	48.0	194.3	28.9	64.6	94.4	86.8	56.3	116.8	101.1	98.8	31.6	61.4	109.5	32.6	86.0	16.3	109.5	16.2	20.1	176.6	137.5	72.5	49.2	250.8	324.8	320.3	149.8	126.2	127.5	210.9	189.2	157.6	130.1	153.8	190.2	19.5	151.8	321.7	143.2	104.6	178.7	159.3	61.9	672.8	219.1	27.5	160.6	58.1	174.1	7.7	56.6	123.7	68.8	121.4	245.6	237.7	175.3	8.6	175.5	50.6	139.8	144.1	9.2	40.7	347.6	92.2	180.8	4.2	99.8	39.6	124.7	12.5	107.4	363.6	254.7	86.9	186.1	230.0	75.9	23.4	296.7	239.6	344.2	36.6	195.2	42.4	19.3	25.4	196.5	18.1	183.6	25.6	0.4	3.6	1.3	0.1	0.6	0.1	0.1	1.1	0.3	0.0	0.0	0.1	1.3	0.1	0.0	4.4	0.5	0.4	115.9	105.9	103.2	122.3	117.0	74.3	45.9	43.5	48.0	31.6	86.0	72.5	370.5	0.0	14.1	9.4	22.8	289.5	328.0	44.6	257.8	325.5	239.2	275.5	10.4	88.6	16.7	154.5	200.1	153.6	88.4	99.8	234.8	61.9	6.6	73.1	494.8	342.7	513.3	248.6	28.7	34.0	404.0	292.4	66.3	117.5	52.8	216.3	325.2	710.0	491.3	116.1	15.2	229.4	22.4	100.4	309.4	23.1	489.6	136.8	227.7	12.2	76.7	512.6	4.1	13.0	3.1	38.3	141.3	692.1	38.8	399.9	244.2	547.6	11.4	357.7	598.2	232.0	411.7	7.4	32.8	259.4	249.2	163.2	81.3	122.5	198.9	206.7
PTP4A3	"PRL-3, PRL-R, PRL3"	ENSG00000184489	"Protein tyrosine phosphatase 4A3"	O75365	8	141391995-141432454	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 640.3;pituitary gland: 207.5;skeletal muscle: 738.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 102.9;Cardiomyocytes: 272.8;Cone photoreceptor cells: 123.0;Rod photoreceptor cells: 226.5;Smooth muscle cells: 140.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 55.0;non-classical monocyte: 54.1"	"Group enriched"	"Detected in all"	6	"granulocytes: 55.0;monocytes: 54.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 128.7;Karpas-707: 45.9;RPMI-8226: 38.1;U-266/84: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003281	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA003281: AB_1855903"	"unprognostic (1.09e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.73e-3)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.81e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.77e-1)"	48.6	16.6	11.4	2.0	9.8	0.7	43.3	9.0	14.1	87.3	9.2	70.7	2.1	69.9	3.0	15.1	67.2	1.4	640.3	10.1	10.6	48.9	9.8	58.4	1.1	10.5	10.3	46.8	116.2	2.6	207.5	2.3	10.7	73.6	0.7	36.0	29.9	2.1	738.1	22.8	37.4	4.4	9.3	56.8	99.7	22.0	13.3	1.1	35.2	62.1	1.3	40.5	35.7	9.2	0.3	0.9	0.6	0.1	0.0	0.2	0.1	0.5	0.1	0.0	0.0	0.1	2.3	0.0	9.8	0.1	0.1	0.0	0.1	0.1	0.0	128.7	1.9	5.2	0.2	1.8	0.5	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.4	1.0	3.1	45.9	0.1	11.3	0.7	0.2	2.1	1.0	0.7	19.3	0.1	38.1	0.0	0.1	11.4	3.9	0.6	0.1	2.6	1.2	1.8	0.0	0.5	0.1	2.2	0.1	0.0	11.6	42.0	0.3	0.1	2.8	0.1	1.5	3.3	12.5	3.1	28.2	1.8	5.1	5.8	3.0	2.0	1.2	6.5	3.4	55.0	1.5	54.1	8.6	5.3	5.1	11.4	9.8	9.0	14.1	10.1	10.6	10.5	10.3	10.7	9.3	13.3	9.2	52.7	3.2	44.5	5.5	21.1	9.9	5.2	23.7	7.4	102.9	9.8	7.4	272.8	4.3	8.3	7.3	123.0	0.3	5.6	0.8	9.8	8.2	10.9	2.0	3.1	57.7	10.2	0.8	5.3	62.9	0.3	21.7	5.6	2.0	1.3	6.6	15.0	0.3	4.1	15.2	10.3	2.9	26.4	2.8	20.1	7.1	3.7	4.0	21.4	8.4	12.8	36.7	2.1	2.5	0.7	10.8	0.2	1.9	79.8	11.9	0.2	5.0	1.1	226.5	32.9	17.1	140.8	4.4	24.8	1.8	10.2	0.3	13.7	3.4	3.0	3.6
PWP2	"EHOC-17, PWP2H, UTP1"	ENSG00000241945	"PWP2 small subunit processome component"	Q15269	21	44107373-44131181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 10.7;Basal respiratory cells: 9.6;Suprabasal keratinocytes: 8.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 82.9;Daudi: 84.3;U-266/84: 66.6"									HPA024573	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (1.85e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.36e-4)"	"unprognostic (6.37e-5)"	"unprognostic (6.12e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.55e-1)"	4.0	3.2	3.3	3.2	4.4	0.9	3.3	3.6	4.4	4.2	2.4	3.6	1.5	3.3	2.6	3.5	5.7	0.5	3.7	3.5	3.2	2.6	3.0	3.2	3.0	3.5	3.5	2.9	4.1	1.9	2.2	2.5	4.2	3.0	0.3	1.2	3.4	1.4	5.0	4.9	3.7	0.5	3.2	4.5	4.6	3.1	3.4	5.6	2.9	7.2	6.9	4.1	3.2	5.7	4.7	0.5	1.5	3.6	10.4	11.4	28.5	39.2	16.9	44.3	29.5	82.9	1.4	84.3	1.4	0.0	4.5	4.2	1.5	26.4	24.7	24.4	59.5	10.8	15.6	19.2	6.2	6.8	2.9	0.7	0.0	27.1	0.0	10.1	1.7	39.2	32.5	33.8	17.1	1.1	0.2	2.1	1.5	4.1	3.3	4.8	0.2	44.1	0.0	1.2	26.8	5.4	2.2	3.0	24.2	14.6	0.9	3.2	20.9	19.6	3.1	42.4	4.3	47.6	66.6	3.7	1.8	10.6	28.4	0.5	2.2	2.5	4.7	2.7	5.8	5.1	4.0	5.1	1.8	3.4	3.7	4.6	1.1	2.7	3.7	2.2	3.3	3.0	3.3	4.4	3.6	4.4	3.5	3.2	3.5	3.5	4.2	3.2	3.4	5.7	0.4	0.0	2.0	0.3	3.2	10.7	0.1	9.6	3.4	0.7	1.1	0.3	4.5	0.0	5.4	0.0	0.0	0.1	2.3	4.6	1.9	0.0	0.1	0.2	0.2	2.0	2.4	4.8	0.0	0.0	2.0	1.8	1.1	0.4	0.0	0.3	2.2	0.3	1.9	0.0	0.0	3.8	6.1	5.4	4.9	0.0	1.2	0.4	1.8	0.0	0.6	0.5	3.1	0.0	0.0	0.0	2.4	0.0	1.5	1.2	1.8	0.3	4.6	0.3	0.0	1.4	3.7	1.4	1.7	0.8	8.5	0.7	2.6	0.5	4.6	0.3
QPCT	"GCT, QC"	ENSG00000115828	"Glutaminyl-peptide cyclotransferase"	Q16769	2	37342827-37373322	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 170.3;epididymis: 104.0"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 217.0;Ionocytes: 138.4;Langerhans cells: 163.4;Melanocytes: 528.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 97.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 1527.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 1527.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 117.1;SK-MEL-30: 426.8;U-266/84: 341.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008406	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA		390000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA008406: AB_1855981"	"unprognostic (6.25e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.78e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.48e-3)"	"unprognostic (3.62e-3)"	5.6	170.3	8.4	14.2	7.5	47.3	15.8	5.1	11.5	21.2	4.2	25.3	5.6	9.8	104.0	3.4	2.2	10.8	5.1	8.9	27.4	6.1	2.6	5.6	8.1	9.7	11.6	1.0	13.7	14.8	27.0	9.2	14.7	7.2	10.2	11.9	25.5	6.7	4.1	36.3	4.5	8.3	7.8	13.9	7.6	2.0	20.3	5.1	3.8	2.8	12.5	15.2	4.6	6.7	1.0	40.7	0.1	0.0	6.0	13.3	0.1	6.6	86.5	6.4	10.1	2.9	7.1	0.2	3.0	32.6	72.9	0.1	2.7	0.6	10.3	0.6	76.0	18.7	0.3	7.7	0.6	3.0	0.1	8.5	0.0	47.3	0.2	0.4	26.2	0.0	0.0	0.0	0.2	4.5	0.0	1.7	0.6	0.3	0.0	0.0	0.0	0.8	42.6	10.9	117.1	0.2	6.4	1.4	426.8	8.0	0.7	2.9	19.4	0.0	0.2	0.1	0.6	15.3	341.7	0.3	25.8	0.3	0.0	9.8	344.8	3.2	0.4	38.7	1.0	2.6	0.6	0.5	124.7	1.2	0.5	0.3	1527.7	0.2	3.3	2.4	0.1	169.8	8.4	7.5	5.1	11.5	8.9	27.4	9.7	11.6	14.7	7.8	20.3	6.7	1.8	3.2	2.3	0.3	12.5	39.0	13.6	40.0	2.2	21.8	7.9	8.5	1.1	1.5	17.7	22.0	2.1	0.7	0.8	6.1	1.9	45.4	0.6	2.6	24.7	17.5	217.0	1.7	8.5	2.4	6.1	26.7	3.1	4.0	55.3	1.6	22.5	0.3	20.5	43.7	7.3	6.6	138.4	21.2	163.4	2.9	3.1	26.8	528.3	6.5	64.3	0.8	3.1	3.0	1.3	31.8	1.8	23.7	26.0	9.1	0.2	11.7	4.3	3.2	13.1	0.6	6.6	1.7	0.7	0.6	14.5	4.7	5.6	5.0	7.3	5.8
RAP2A	"K-REV, RAP2"	ENSG00000125249	"RAP2A, member of RAS oncogene family"	P10114	13	97434169-97469128	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 83.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018552	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB018552: AB_2177305"	"unprognostic (2.40e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (8.06e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.53e-1)"	14.9	8.2	26.3	10.7	32.4	4.1	11.7	21.9	39.5	11.7	13.2	10.2	7.9	8.7	4.5	15.9	6.7	12.7	11.3	32.5	23.7	14.4	8.6	13.8	18.0	23.8	25.3	6.7	4.8	7.8	7.9	25.4	24.6	6.4	11.2	7.5	5.4	7.2	10.5	7.2	8.1	12.3	27.0	15.1	6.5	4.5	31.2	13.3	6.6	15.3	12.9	11.5	7.7	30.6	18.5	5.2	19.3	13.9	31.2	18.5	7.6	13.4	8.8	12.9	14.4	9.8	10.6	14.1	8.4	22.1	12.6	14.1	16.6	13.4	16.9	26.3	8.6	15.4	19.8	14.5	22.5	13.6	9.5	28.5	17.1	12.8	17.6	19.5	28.2	15.8	5.2	26.2	17.3	6.7	9.4	21.1	11.1	16.0	7.8	12.1	20.7	9.3	12.7	6.0	21.9	37.4	9.5	22.5	19.8	26.1	18.1	6.8	21.2	12.6	12.5	12.5	13.1	18.7	15.8	7.7	35.0	16.1	20.8	0.0	0.3	0.4	1.9	1.4	0.8	0.5	0.7	1.4	1.0	0.2	0.4	1.5	0.1	0.4	2.0	1.6	1.3	0.4	26.3	32.4	21.9	39.5	32.5	23.7	23.8	25.3	24.6	27.0	31.2	30.6	34.0	12.8	6.4	17.3	6.7	22.7	4.5	8.2	8.6	10.7	19.1	15.6	15.8	14.3	6.3	1.8	8.4	2.0	31.1	17.0	9.8	5.3	2.5	7.1	19.6	23.7	16.8	9.9	83.8	6.2	11.5	20.0	7.7	9.8	5.1	12.0	29.6	18.1	32.9	28.6	33.3	13.4	10.2	49.1	66.4	1.9	7.2	33.7	16.0	49.6	22.0	17.6	4.1	54.3	44.1	11.1	16.9	6.0	12.3	8.4	6.5	21.9	4.6	5.9	26.3	11.6	36.0	6.5	8.0	22.3	21.9	3.7	12.7	11.1	12.9	4.5
RASL11A		ENSG00000122035	"RAS like family 11 member A"	Q6T310	13	27270830-27275192	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.6;Fibroblasts: 30.1;Gastric mucus-secreting cells: 42.3;Sertoli cells: 32.9;Smooth muscle cells: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"ASC diff: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA004859, HPA053296"	Supported		Approved	"Nuclear bodies"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear bodies"		"HPA004859: AB_2667270, HPA053296: AB_2682106"	"unprognostic (1.59e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.65e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (3.85e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.34e-1)"	32.9	4.1	1.9	3.1	3.2	2.3	21.8	3.1	3.1	21.4	2.1	20.4	7.7	21.6	3.9	9.8	22.0	3.8	11.3	3.2	1.7	30.4	12.9	13.0	10.8	1.8	2.2	9.5	4.9	1.4	10.6	2.9	2.0	20.3	12.5	0.1	5.3	5.6	3.5	10.1	20.9	5.5	2.2	14.8	13.4	2.9	3.3	1.2	12.1	1.7	10.0	19.1	15.9	2.4	0.3	1.3	0.3	0.6	42.4	4.3	0.2	1.9	1.8	0.1	0.1	8.1	0.8	0.3	0.5	1.4	0.9	0.1	2.5	0.8	0.1	1.7	8.8	1.8	0.2	0.5	6.8	0.6	0.6	5.0	0.7	0.1	0.1	1.7	0.6	0.7	0.3	0.1	0.0	0.8	0.0	2.4	1.5	8.0	10.2	0.5	0.0	0.2	1.4	6.2	0.7	0.3	0.7	3.3	0.2	1.0	0.2	0.8	0.3	0.1	0.3	2.9	0.4	0.1	0.0	0.0	0.4	1.9	0.1	0.4	0.4	0.4	0.0	0.5	0.1	0.1	0.0	0.0	0.2	1.2	0.1	0.1	0.2	0.1	1.3	0.1	0.0	0.1	1.9	3.2	3.1	3.1	3.2	1.7	1.8	2.2	2.0	2.2	3.3	2.4	29.6	16.0	11.2	0.3	6.0	4.6	3.2	0.9	17.6	0.0	6.2	11.9	1.4	0.0	8.6	7.3	0.0	0.7	4.5	9.3	3.9	1.8	0.0	5.1	9.8	5.9	0.0	4.0	0.6	2.4	0.2	30.1	42.3	6.1	0.0	2.1	2.5	0.2	1.4	0.0	0.6	5.6	4.1	0.8	6.5	0.0	0.3	6.1	1.8	1.9	1.7	0.3	0.0	0.5	1.8	0.5	12.7	1.5	17.1	1.1	11.4	1.7	10.3	0.2	32.9	11.6	112.0	0.0	0.0	13.5	4.4	0.8	4.5	1.2	6.7	1.1
RASL12	RIS	ENSG00000103710	"RAS like family 12"	Q9NYN1	15	65053337-65076690	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 22.5;Peritubular cells: 57.9;Sertoli cells: 98.6;Smooth muscle cells: 55.7"	"Cancer enhanced"	"Detected in all"		"glioma: 21.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.0;CACO-2: 14.5;EFO-21: 22.7;NTERA-2: 9.9;SuSa: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (6.13e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (7.20e-5)"	"unprognostic (1.76e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.17e-4)"	27.9	3.9	32.9	5.1	36.8	0.0	15.7	30.8	24.4	49.8	8.5	35.6	3.6	61.6	27.9	19.2	54.7	13.2	53.4	26.0	38.4	6.9	1.1	38.4	3.3	39.4	57.4	16.5	2.4	1.8	7.0	17.0	38.0	52.5	6.7	3.3	8.0	76.4	37.1	12.1	9.4	33.0	38.8	9.6	7.7	15.6	66.1	0.9	8.4	20.6	1.7	40.2	33.5	32.6	0.1	0.1	0.2	0.0	0.6	5.0	0.2	0.0	0.5	0.0	0.0	14.5	0.1	0.0	22.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	9.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	17.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.9	36.8	30.8	24.4	26.0	38.4	39.4	57.4	38.0	38.8	66.1	32.6	7.4	0.0	0.0	22.5	0.0	1.5	3.9	0.0	0.0	0.3	2.0	5.6	16.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4.7	0.3	12.6	3.6	0.0	0.0	0.1	0.0	0.1	15.2	0.5	0.5	0.0	12.3	1.4	0.1	0.3	0.0	0.1	0.0	2.0	0.0	1.3	3.9	13.1	0.2	0.0	2.8	0.0	17.9	0.0	0.0	0.0	0.1	0.0	57.9	0.0	0.4	0.5	0.0	0.0	0.8	98.6	0.9	55.7	0.7	1.1	0.4	0.1	0.3	0.2	0.4	0.2	0.1
RBM27	"ARRS1, KIAA1311, Psc1, ZC3H20"	ENSG00000091009	"RNA binding motif protein 27"	Q9P2N5	5	146203605-146289223	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA035944, HPA036422"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"HPA035944: AB_10670672, HPA036422: AB_10669987"	"unprognostic (8.18e-2)"	"unprognostic (3.17e-1)"	"unprognostic (6.04e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.04e-3)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (4.73e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.51e-2)"	"unprognostic (6.67e-3)"	"unprognostic (4.09e-3)"	7.3	5.4	4.1	8.4	4.2	19.5	9.4	7.0	4.9	8.3	4.0	7.8	7.5	9.3	8.0	7.3	7.4	5.9	7.0	3.9	4.8	8.0	10.6	6.7	11.7	3.5	4.5	10.9	6.0	8.9	3.6	9.2	4.0	7.6	8.3	9.4	6.3	6.4	7.2	7.2	7.3	7.6	4.3	9.4	8.6	10.1	4.6	12.6	10.9	9.2	11.3	9.3	5.9	4.9	15.0	12.1	15.3	24.8	13.1	12.5	17.7	10.9	12.3	15.7	17.2	21.3	18.9	31.7	8.4	12.5	21.5	15.3	23.1	25.2	27.7	24.3	10.2	21.7	12.9	14.9	14.4	34.3	24.1	11.7	13.0	16.9	29.9	12.1	14.2	14.9	24.3	18.7	15.0	13.5	25.0	17.4	21.2	16.5	13.6	22.2	23.7	21.9	16.0	16.6	19.1	13.1	22.5	21.7	17.8	15.6	25.3	18.7	13.5	16.6	17.6	12.5	17.8	17.7	18.1	36.6	12.5	24.7	15.7	1.7	0.8	1.6	1.4	1.3	1.6	1.2	1.4	1.6	1.1	1.4	1.8	1.5	1.2	1.8	1.5	1.3	1.5	0.7	4.1	4.2	7.0	4.9	3.9	4.8	3.5	4.5	4.0	4.3	4.6	4.9	12.7	16.0	17.6	20.5	13.1	66.2	9.5	52.6	6.2	11.2	13.0	8.6	17.3	5.7	32.3	14.7	10.4	9.2	17.6	10.1	1.9	7.8	32.4	15.1	11.8	15.7	10.8	11.8	32.2	6.8	8.3	17.0	11.2	13.9	22.1	12.2	11.4	12.1	11.2	15.2	31.4	13.8	30.5	20.4	40.6	6.6	11.5	14.1	19.6	28.1	16.9	8.4	12.3	28.6	43.8	11.5	8.7	14.7	7.3	17.4	9.9	7.9	36.8	8.7	0.0	16.5	24.1	31.4	13.2	12.0	62.1	9.7	15.7	9.8	12.5	19.7
RBPMS	HERMES	ENSG00000157110	"RNA binding protein, mRNA processing factor"	Q93062	8	30384511-30572256	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 242.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 1.0"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 324.1;RPTEC TERT1: 232.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056999	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA056999: AB_2683306"	"unprognostic (1.65e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.23e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.47e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.16e-3)"	238.3	96.7	22.3	43.8	28.0	1.4	194.8	20.2	24.1	196.9	26.7	350.6	25.2	200.7	90.0	99.9	200.5	95.4	174.7	17.3	25.2	218.7	108.9	119.6	23.3	23.1	27.6	190.0	68.8	68.6	33.0	105.0	28.7	182.6	46.6	10.4	92.1	193.7	31.2	56.6	107.7	171.9	18.7	56.7	159.8	45.4	33.2	23.5	140.7	31.6	20.0	323.4	134.0	18.9	0.7	54.5	58.5	0.4	324.1	96.4	145.8	74.8	101.8	90.2	74.6	76.2	31.2	0.5	39.3	96.7	82.5	29.9	68.0	54.4	107.9	0.1	14.6	1.8	24.7	80.5	139.4	0.5	12.0	112.8	13.8	86.7	11.5	100.8	52.8	2.5	0.5	0.4	44.6	32.6	0.3	1.2	150.9	62.3	34.6	3.5	16.2	4.7	232.2	88.9	1.1	11.6	7.7	55.2	37.7	192.3	11.7	0.0	48.8	44.3	4.2	77.3	12.8	0.1	0.2	0.4	72.8	0.2	20.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	22.3	28.0	20.2	24.1	17.3	25.2	23.1	27.6	28.7	18.7	33.2	18.9	104.0	54.5	98.9	36.6	4.5	9.3	61.8	22.7	14.2	6.7	45.8	64.3	114.4	75.8	48.5	141.6	2.1	108.7	4.1	1.8	113.5	100.0	104.7	31.2	86.3	69.7	1.8	5.0	6.4	94.8	184.8	66.7	18.8	48.2	10.1	18.0	44.3	55.2	39.9	0.0	5.2	0.1	20.3	1.9	10.2	31.5	171.2	4.3	14.2	71.2	2.1	1.0	1.0	2.0	1.6	67.0	0.0	180.2	0.5	101.5	2.0	242.2	30.9	5.7	111.7	6.6	149.9	35.3	22.0	27.8	8.0	41.2	4.4	28.1	1.0	151.7
RCAN2	"DSCR1L1, ZAKI-4"	ENSG00000172348	"Regulator of calcineurin 2"	Q14206	6	46220736-46491972	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 199.5;tongue: 180.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 255.4;Excitatory neurons: 261.4;Inhibitory neurons: 254.4;Muller glia cells: 183.1;Oligodendrocytes: 294.6;Smooth muscle cells: 138.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 25.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"gdT-cell: 1.8;memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.2"	"Group enriched"	"Detected in some"	6	"fHDF/TERT166: 63.3;HDLM-2: 129.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053880	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	Nucleoplasm	"HPA053880: AB_2682290"	"unprognostic (2.82e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.55e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.33e-1)"	"prognostic favorable (2.48e-4)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	38.1	12.6	35.7	7.7	41.2	0.0	17.1	31.7	106.3	20.3	0.0	20.1	9.8	17.5	51.5	25.9	17.0	35.1	199.5	34.0	65.0	32.4	4.9	16.3	4.1	69.6	76.0	24.0	11.1	85.5	17.5	0.6	68.8	25.3	22.6	61.6	9.6	27.0	73.3	17.2	19.1	14.0	20.6	7.1	36.5	5.7	65.5	4.7	20.1	180.1	7.0	44.0	21.4	62.3	0.0	0.0	1.6	0.0	0.7	0.2	0.1	1.1	15.1	1.1	0.1	0.0	0.0	0.0	0.8	63.3	0.0	0.1	0.0	0.0	0.3	129.7	0.8	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.1	0.1	0.0	0.3	0.3	0.0	0.1	5.1	0.0	0.0	0.2	2.7	0.4	0.4	0.4	13.6	0.1	0.2	0.3	4.9	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	1.8	0.1	0.2	6.8	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.1	2.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	35.7	41.2	31.7	106.3	34.0	65.0	69.6	76.0	68.8	20.6	65.5	62.3	7.6	6.4	5.8	13.7	0.6	6.2	4.6	0.0	0.0	24.8	1.8	1.4	255.4	8.6	0.0	3.7	4.2	0.1	0.8	1.0	70.5	5.5	40.2	0.8	0.4	17.1	25.1	0.0	261.4	2.5	0.0	22.2	1.5	0.8	0.0	0.3	0.4	1.2	0.1	30.3	254.4	1.5	34.6	0.3	8.0	14.2	29.2	0.9	32.0	46.9	0.0	183.1	0.0	76.9	294.6	2.9	0.3	50.4	0.4	3.3	0.0	1.9	0.0	9.7	98.6	16.4	138.4	1.5	1.4	0.5	7.4	0.0	4.0	0.8	0.3	1.4
REM1	"GES, REM"	ENSG00000088320	"RRAD and GEM like GTPase 1"	O75628	20	31475288-31484895	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 20.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.7;Peritubular cells: 11.7;Sertoli cells: 59.2;Smooth muscle cells: 28.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	32	"WM-115: 22.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 4.6"	HPA049821	Approved					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA049821: AB_2680898"	"unprognostic (6.16e-2)"	"unprognostic (3.17e-3)"	"unprognostic (2.62e-1)"	"unprognostic (9.65e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.39e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (7.79e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.06e-2)"	13.9	2.2	1.2	1.7	1.1	0.0	7.5	0.9	2.1	20.1	1.3	6.5	1.3	10.5	7.2	2.0	10.0	2.2	6.2	1.0	1.0	3.2	0.8	4.6	3.0	1.0	1.1	3.9	1.1	1.1	2.7	2.1	1.1	5.5	1.0	0.0	1.6	4.9	3.3	3.2	3.7	3.2	0.9	2.5	2.4	1.4	1.3	0.7	4.8	2.4	1.5	4.8	9.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.9	2.1	1.0	1.0	1.0	1.1	1.1	0.9	1.3	1.0	7.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.4	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	7.1	2.3	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.2	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.6	5.6	0.3	3.6	1.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.8	0.0	59.2	0.6	28.1	0.0	0.2	0.1	0.9	0.0	0.1	1.5	0.0	0.0
RERG	MGC15754	ENSG00000134533	"RAS like estrogen regulated growth inhibitor"	Q96A58	12	15107783-15348675	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 104.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 202.7;Breast glandular cells: 80.1;Inhibitory neurons: 94.3;Sertoli cells: 92.1;Smooth muscle cells: 80.2"	"Cancer enhanced"	"Detected in all"		"breast cancer: 19.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 15.2;BEWO: 34.1;T-47d: 66.0;U-2 OS: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041387	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"HPA041387: AB_10796669"	"unprognostic (5.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (8.72e-2)"	"unprognostic (9.42e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.61e-3)"	"unprognostic (3.30e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	30.7	45.4	8.9	6.8	21.0	0.0	42.5	5.9	16.3	32.0	3.5	37.0	4.1	104.7	50.3	15.1	72.7	11.2	14.0	10.2	12.3	37.0	2.5	16.5	4.3	20.7	12.8	29.0	9.8	4.8	1.4	33.3	21.2	17.0	9.3	0.8	10.2	77.5	5.4	10.2	18.0	83.9	7.7	31.4	20.1	9.0	12.8	2.6	5.8	5.8	2.7	17.4	20.0	9.0	0.0	1.6	0.3	15.2	6.0	0.3	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.0	0.1	0.0	0.2	0.2	0.0	0.0	4.3	0.1	5.9	0.0	4.7	0.0	1.9	0.8	1.0	0.0	2.3	0.0	0.0	0.0	0.6	0.0	1.4	0.7	0.2	0.3	1.7	0.0	0.9	0.1	0.0	0.2	5.8	0.3	0.1	2.2	2.5	2.6	0.0	1.0	66.0	0.0	0.0	0.9	21.5	0.4	0.0	0.1	5.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	21.0	5.9	16.3	10.2	12.3	20.7	12.8	21.2	7.7	12.8	9.0	10.7	0.0	2.2	202.7	0.4	3.8	8.6	0.9	6.2	1.3	80.1	36.2	1.0	5.7	4.0	7.3	0.0	12.0	0.7	0.0	15.6	9.8	20.9	6.5	9.8	6.0	1.8	0.0	20.2	9.8	14.6	28.7	2.6	1.0	0.0	0.1	2.2	0.0	2.1	3.3	94.3	0.0	18.3	0.0	2.3	16.1	22.1	1.1	7.2	41.2	0.0	5.0	0.0	3.0	1.1	2.2	0.0	32.0	0.0	3.5	0.0	33.7	0.1	0.5	92.1	8.2	80.2	8.3	15.0	12.6	5.5	14.0	1.2	16.1	0.0	5.8
RERGL	FLJ22655	ENSG00000111404	"RERG like"	Q9H628	12	18080869-18320107	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	37	"Sertoli cells: 164.3;Smooth muscle cells: 381.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	719	"REH: 230.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041740	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA041740: AB_10795694"	"unprognostic (3.53e-2)"	"unprognostic (7.03e-4)"	"unprognostic (6.29e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-2)"		"unprognostic (5.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.66e-2)"	43.5	5.4	14.3	2.5	14.8	0.0	29.1	14.7	41.0	25.3	14.6	14.4	3.0	25.2	37.9	7.2	25.8	10.2	6.6	14.3	16.1	15.9	2.1	4.4	1.2	15.4	15.1	19.8	1.8	1.1	1.6	0.0	15.3	7.1	16.8	0.2	3.8	19.4	6.0	11.9	13.4	16.0	14.6	2.7	7.8	2.9	15.7	1.2	13.4	30.2	1.4	11.2	14.7	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	230.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	14.8	14.7	41.0	14.3	16.1	15.4	15.1	15.3	14.6	15.7	15.0	6.9	0.0	0.0	2.0	0.1	4.5	0.3	0.0	4.0	0.0	2.8	5.2	4.1	1.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.7	0.7	0.7	7.2	0.0	0.0	0.1	0.0	0.5	2.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	6.5	0.4	0.3	0.6	5.4	3.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.5	0.0	0.3	0.0	0.6	0.0	0.1	164.3	0.6	381.7	0.1	1.1	0.8	2.4	0.1	0.9	0.3	0.1	0.4
RGS16	"A28-RGS14, RGS-r"	ENSG00000143333	"Regulator of G protein signaling 16"	O15492	1	182598623-182604389	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 132.2;thyroid gland: 103.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 535.4;Muller glia cells: 265.9;Smooth muscle cells: 581.5;Theca cells: 253.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"thalamus: 132.2"	"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 109.3;NB-4: 60.7;SCLC-21H: 109.6;U-266/70: 124.0;U-698: 162.8"	"Region enriched"	"Detected in all"	5	"thalamus: 79.9"	"Group enriched"	"Detected in many"	7	"midbrain: 76.5;pons: 68.5;thalamus: 124.2"	"HPA053250, HPA055824"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA053250: AB_2682090, HPA055824: AB_2682934"	"unprognostic (4.03e-2)"	"unprognostic (6.08e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.04e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.93e-2)"	"unprognostic (3.65e-2)"	"unprognostic (9.07e-3)"	"unprognostic (5.39e-2)"	39.6	10.4	22.7	11.7	10.0	4.8	7.8	9.6	9.9	2.7	16.5	13.1	2.8	3.3	4.8	6.2	12.1	16.5	9.2	7.5	47.0	15.4	13.1	26.7	17.9	17.5	71.3	4.0	7.8	5.7	50.4	12.1	13.2	4.8	5.3	60.4	6.4	6.3	6.0	5.6	6.8	12.0	12.1	14.3	8.8	1.0	132.2	8.6	103.6	8.9	6.6	38.3	2.9	17.8	0.8	0.1	6.4	0.0	1.0	0.2	48.6	0.2	1.7	0.0	0.1	0.1	0.3	109.3	0.5	0.0	0.0	0.5	11.9	1.0	0.1	12.5	8.8	11.5	1.2	0.0	1.8	18.4	9.5	2.5	17.8	0.0	0.7	0.0	0.0	3.9	0.5	18.6	0.0	12.3	0.6	60.7	34.2	1.0	3.5	0.2	35.1	26.2	0.1	5.1	109.6	11.5	0.2	9.1	0.2	6.4	3.6	14.6	0.1	0.3	2.4	3.1	5.5	124.0	6.1	162.8	0.6	11.8	5.8	2.6	0.3	0.6	0.3	0.4	0.6	4.7	4.3	0.5	0.5	2.2	1.9	0.6	1.2	2.6	0.9	9.7	2.9	1.1	22.7	10.0	9.6	9.9	7.5	47.0	17.5	71.3	13.2	12.1	132.2	17.8	80.8	134.6	185.5	6.2	48.3	82.3	10.0	3.8	37.5	535.4	25.8	94.5	25.7	0.0	18.7	9.2	18.8	8.5	28.7	11.2	0.0	1.6	0.4	21.4	41.5	181.8	50.5	20.4	0.1	2.4	201.9	103.7	17.3	30.5	71.8	0.5	18.9	2.6	19.1	32.0	8.3	12.1	16.2	2.8	116.7	0.0	0.3	18.4	81.8	0.0	11.9	265.9	0.0	0.0	0.7	2.9	4.7	0.4	64.3	12.4	1.1	0.8	2.6	46.9	65.7	47.3	581.5	0.2	2.1	37.0	63.1	34.5	33.5	253.5	6.4	9.7
RGS5		ENSG00000143248	"Regulator of G protein signaling 5"	O15539	1	163111121-163321791	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Sertoli cells: 5114.5;Smooth muscle cells: 1592.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 226.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 1303.0;OE19: 692.4;SH-SY5Y: 4234.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001821		Supported	Supported	Vesicles,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	Vesicles	"HPA001821: AB_1079806"	"unprognostic (3.75e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.31e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.65e-2)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (3.81e-3)"	"unprognostic (7.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.41e-1)"	138.1	312.4	75.5	29.7	87.2	0.1	58.4	84.2	136.5	160.5	73.1	95.7	64.5	73.7	63.1	71.8	65.5	142.7	238.2	65.9	90.7	88.1	34.1	55.5	33.8	95.6	89.1	19.5	30.6	83.3	45.4	19.9	108.2	75.1	42.9	15.3	27.8	190.0	116.5	21.8	75.8	278.0	68.8	16.7	93.5	40.5	99.6	21.2	164.7	236.8	39.4	136.1	60.5	83.7	0.4	0.0	62.9	8.0	1.3	3.0	2.6	1.1	4.4	2.0	1.3	5.3	1.6	0.5	9.2	1.1	0.7	0.4	0.8	0.8	3.3	3.0	1.0	1.3	0.9	0.1	2.6	0.8	0.7	2.0	1.9	2.1	2.6	14.3	1303.0	0.3	0.2	1.2	4.7	0.0	0.9	2.2	38.7	692.4	1.4	0.4	0.1	3.6	0.7	0.0	5.2	4234.9	0.9	0.0	1.5	185.8	0.0	1.3	5.3	1.0	2.3	0.9	2.0	1.5	1.2	0.4	1.4	0.2	2.9	0.0	0.0	0.0	0.0	0.1	0.5	0.5	0.5	0.2	0.1	0.2	0.4	0.4	0.1	0.2	0.1	0.0	0.2	0.1	75.5	87.2	84.2	136.5	65.9	90.7	95.6	89.1	108.2	68.8	99.6	83.7	458.3	3.2	5.6	61.4	1.7	17.1	6.0	1.0	0.6	1.8	9.8	12.1	0.0	0.0	7.3	1.8	4.2	1.5	2.4	0.3	1.9	1.0	32.7	3.4	11.6	353.7	0.0	0.0	24.4	1.1	0.8	43.0	223.3	8.1	1.3	0.9	0.0	0.0	1.2	0.0	60.5	0.2	0.0	0.0	26.3	17.0	6.8	11.9	23.2	80.6	0.6	2.6	0.0	25.1	69.7	3.9	0.2	2.6	0.4	12.7	0.2	2.5	5.9	5.8	5114.5	44.9	1592.3	5.7	1.7	5.2	12.6	1.2	5.8	5.5	0.2	7.0
ROCK2		ENSG00000134318	"Rho associated coiled-coil containing protein kinase 2"	O75116	2	11179759-11348330	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 280.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007459, CAB008666, HPA044109"	Approved		Supported	Cytosol		NA	NA		710000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB008666: AB_1622617, HPA007459: AB_1079828, HPA044109: AB_2678813"	"unprognostic (4.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.18e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.47e-2)"	36.4	9.3	6.7	13.5	16.3	6.8	22.3	19.1	14.3	18.7	0.8	22.6	16.7	22.0	10.3	16.2	13.6	15.6	17.0	12.1	3.5	14.5	16.5	16.9	10.1	1.7	4.4	19.0	11.7	12.8	5.9	24.9	1.4	17.4	26.2	13.5	14.6	18.1	30.4	8.5	19.2	27.9	2.0	16.4	14.1	7.8	6.4	8.4	13.9	28.9	8.8	21.1	11.0	10.4	17.5	41.7	33.8	33.2	59.7	41.6	21.6	40.4	37.7	25.8	27.1	39.8	37.2	21.9	23.4	64.5	31.3	18.9	24.7	23.4	40.6	31.2	14.7	43.8	70.6	79.7	21.4	24.7	12.1	32.6	14.6	31.9	22.6	21.0	42.0	11.9	38.6	8.6	38.8	14.8	18.2	12.7	18.8	36.9	25.3	21.7	74.2	7.0	14.0	48.8	15.9	16.9	79.6	27.4	27.4	25.5	11.3	13.6	57.3	52.9	38.2	21.2	36.0	6.8	8.9	18.8	22.8	28.2	75.4	0.9	0.4	0.4	0.6	0.4	0.7	0.3	0.4	0.4	0.3	0.5	0.4	0.4	0.6	0.8	0.4	0.6	0.4	0.2	6.7	16.3	19.1	14.3	12.1	3.5	1.7	4.4	1.4	2.0	6.4	10.4	114.5	115.4	79.1	81.3	16.0	39.9	43.0	15.3	21.1	35.7	33.5	41.1	107.0	37.1	53.1	22.0	58.4	26.3	20.4	97.7	1.9	27.1	11.0	53.6	141.2	90.3	21.2	22.5	280.4	39.5	19.1	64.0	18.3	55.3	29.0	36.9	56.0	43.1	19.6	80.8	158.1	92.2	10.2	20.3	27.0	4.9	43.8	30.4	23.2	107.7	20.6	38.4	15.5	99.0	66.9	39.1	43.6	78.6	16.2	53.5	45.3	15.7	32.7	48.5	131.5	70.0	118.5	30.3	24.6	19.9	27.8	31.5	18.5	34.2	54.8	40.7
RPP14	P14	ENSG00000163684	"Ribonuclease P/MRP subunit p14"	O95059	3	58306245-58324695	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 40.8;tongue: 39.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA036194: AB_10672082"	"unprognostic (6.05e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-3)"	"unprognostic (3.76e-2)"	"prognostic favorable (3.07e-10)"	"unprognostic (5.19e-3)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (5.78e-2)"	5.1	5.7	3.1	4.6	3.2	4.8	5.0	5.9	4.1	4.6	2.0	6.8	6.8	5.5	3.7	5.9	4.9	4.2	10.9	3.2	2.9	9.1	11.5	4.1	4.0	3.0	2.2	5.5	6.1	7.7	5.9	4.0	3.1	4.7	6.4	5.1	4.9	4.4	40.8	5.3	6.9	7.1	1.7	5.8	5.4	5.1	3.1	6.5	5.5	39.0	6.0	5.2	5.0	3.4	12.3	10.4	11.5	8.2	6.6	9.0	12.3	9.9	11.7	14.5	17.1	15.9	8.0	13.8	2.4	14.4	13.7	7.2	17.6	15.8	14.8	10.6	8.5	12.0	11.9	8.4	7.8	24.4	10.7	8.4	12.1	18.6	16.3	5.2	12.1	18.2	12.0	7.8	14.3	6.5	16.2	7.9	11.9	10.5	17.9	6.8	8.4	14.0	9.6	18.9	6.9	11.8	10.2	9.8	11.9	7.3	11.0	8.6	11.1	10.4	11.7	10.5	20.4	13.0	28.3	22.3	11.2	17.1	6.7	2.1	3.4	2.6	2.1	2.8	3.0	2.1	2.7	3.2	3.9	3.0	3.2	3.5	4.0	5.5	6.0	3.9	1.8	2.1	3.1	3.2	5.9	4.1	3.2	2.9	3.0	2.2	3.1	1.7	3.1	3.4	9.0	9.6	11.9	6.2	8.2	31.2	8.1	21.1	17.1	26.3	8.2	7.6	28.4	7.2	11.8	3.7	25.0	8.4	9.4	14.9	11.7	5.7	0.8	8.2	12.4	10.6	9.6	7.6	18.4	6.2	5.9	11.5	13.3	8.2	3.8	11.5	11.4	21.3	6.2	18.5	18.2	11.8	16.2	11.0	20.0	1.7	12.5	9.7	23.2	13.1	9.2	13.2	7.2	10.6	11.2	7.8	7.6	9.8	14.2	8.1	16.2	11.4	9.7	28.3	0.0	14.1	13.7	11.9	15.3	20.4	43.0	10.3	9.2	15.0	13.7	6.5
RSPO1	"FLJ40906, RSPONDIN"	ENSG00000169218	"R-spondin 1"	Q2MKA7	1	37611350-37634892	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 28.9;endometrium 1: 41.4"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 7.7;Breast myoepithelial cells: 15.6;Fibroblasts: 5.4;Langerhans cells: 2.9"	"Cancer enriched"	"Detected in some"	13	"ovarian cancer: 11.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;THP-1: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA046154, HPA062923"	Uncertain		Approved	Vesicles	"Secreted in female reproductive system"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA046154: AB_10964912, HPA062923: "	"unprognostic (1.50e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.99e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.75e-6)"		"unprognostic (1.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.13e-2)"		"unprognostic (1.93e-2)"	"unprognostic (3.76e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-2)"	11.3	0.1	0.0	0.8	0.1	0.1	7.9	0.1	0.1	28.9	0.0	1.8	1.1	41.4	2.2	3.1	20.0	2.7	0.7	0.1	0.0	0.8	0.1	4.0	1.9	0.1	0.1	2.1	0.5	0.1	0.1	0.4	0.1	6.7	0.5	0.1	1.3	1.8	0.0	6.6	3.3	13.1	0.0	0.8	4.0	0.2	0.1	0.0	0.0	0.5	3.0	1.5	19.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	7.7	15.6	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.9	0.1	0.9	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.4	0.1	0.3	0.0	0.0	0.1
RSPO4	"C20orf182, dJ824F16.3"	ENSG00000101282	"R-spondin 4"	Q2I0M5	20	958452-1002311	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.0;lung: 12.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.7;Early spermatids: 6.6;Late spermatids: 7.3;Oligodendrocyte precursor cells: 8.5;Oligodendrocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;EFO-21: 2.0;fHDF/TERT166: 2.4;NTERA-2: 6.3;SK-BR-3: 4.3;U-2 OS: 6.9"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.2"	"Not detected"	"Not detected"			HPA048887	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA048887: AB_2680545"	"unprognostic (2.36e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (2.98e-6)"	"unprognostic (8.93e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.96e-1)"	"unprognostic (5.68e-9)"	"unprognostic (6.65e-3)"	"unprognostic (4.41e-2)"	"unprognostic (6.18e-3)"	"unprognostic (2.22e-2)"	0.3	0.2	4.3	0.6	4.6	0.0	1.3	2.1	6.7	0.6	1.1	0.3	0.1	0.3	1.4	0.8	1.6	0.4	0.5	3.4	7.6	0.6	0.3	12.6	0.0	13.0	8.4	0.4	0.3	0.3	2.1	0.2	12.6	0.4	0.0	1.2	0.4	0.2	0.1	3.0	0.3	0.0	3.8	0.2	0.2	3.2	9.6	0.0	3.0	0.0	0.4	0.2	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.2	0.0	0.1	0.0	0.0	0.0	0.8	2.0	2.4	0.3	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.3	0.0	0.0	0.1	0.0	0.0	0.0	6.9	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	4.6	2.1	6.7	3.4	7.6	13.0	8.4	12.6	3.8	9.6	2.2	0.0	0.0	0.0	10.7	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	6.6	0.1	0.0	0.3	0.0	0.0	2.9	0.0	0.6	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.8	7.3	0.0	0.0	1.8	1.9	0.0	0.1	0.0	8.5	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	2.1	0.9	0.0	0.4	0.3	0.0	0.0	0.0	0.0
S1PR3	"EDG-3, EDG3"	ENSG00000213694	"Sphingosine-1-phosphate receptor 3"	"Q99500, Q6ZRZ4"	9	88990863-89005155	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 55.5;Sertoli cells: 65.7;Smooth muscle cells: 35.0;Theca cells: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	18	"classical monocyte: 7.0"	"Lineage enriched"	"Detected in single"	18	"monocytes: 7.0"	"Cell line enhanced"	"Detected in many"		"AF22: 116.0;ASC diff: 157.9;ASC TERT1: 158.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"				"prognostic favorable (5.91e-4)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (6.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.77e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (4.43e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.37e-1)"	18.3	25.0	5.8	10.6	6.4	3.2	11.2	6.9	6.7	32.2	10.7	14.8	4.5	17.2	6.2	17.6	26.0	14.2	17.5	6.3	11.2	36.9	6.1	8.9	11.4	16.1	9.8	5.1	11.7	1.7	17.0	15.1	7.7	20.1	3.4	4.2	3.9	11.9	4.4	3.1	10.7	36.0	8.4	13.2	12.5	2.2	12.4	4.7	4.8	8.2	9.4	20.4	20.9	13.2	0.5	17.7	116.0	6.0	157.9	158.7	0.1	24.8	61.4	17.0	17.0	0.2	0.0	0.0	0.3	37.2	16.6	0.2	0.3	18.0	11.5	0.0	1.2	0.0	23.3	0.1	13.7	8.1	0.1	28.6	1.0	22.2	4.0	13.2	29.9	17.0	2.1	0.1	4.7	17.1	14.3	8.7	11.2	0.8	6.2	1.5	0.0	0.1	0.3	7.1	1.5	8.1	23.4	5.7	0.0	22.8	2.7	7.4	60.3	25.4	10.3	27.8	4.1	0.0	0.1	0.0	36.8	7.1	9.1	0.3	7.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	2.1	5.8	6.4	6.9	6.7	6.3	11.2	16.1	9.8	7.7	8.4	12.4	13.2	3.0	0.0	1.7	3.6	0.0	10.1	9.5	1.8	2.8	1.0	9.9	3.7	9.2	1.5	1.7	1.8	2.1	17.9	0.1	0.0	0.0	0.3	0.0	2.1	55.5	10.6	0.0	0.0	0.5	0.5	1.3	21.5	0.5	2.4	0.0	3.8	1.8	1.6	2.4	3.3	1.7	0.0	0.0	1.8	4.0	0.5	3.7	4.4	0.0	7.5	6.9	7.1	0.0	0.0	0.2	0.9	0.0	6.8	0.2	7.0	0.0	1.4	2.9	1.6	65.7	16.1	35.0	0.0	1.2	1.5	3.3	5.5	2.2	65.8	0.0	6.4
SBSPON	"C8orf84, RPESP"	ENSG00000164764	"Somatomedin B and thrombospondin type 1 domain containing"	Q8IVN8	8	73064543-73124088	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 36.5;Collecting duct cells: 42.3;Muller glia cells: 48.5;Peritubular cells: 26.7;Smooth muscle cells: 28.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"medulla oblongata: 7.5;pons: 6.3;spinal cord: 7.7;white matter: 16.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BJ: 9.5;RPTEC TERT1: 16.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA029595	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		40000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA029595: AB_10600763"	"prognostic favorable (7.18e-4)"	"unprognostic (5.08e-3)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (6.14e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.25e-2)"	6.4	3.0	0.4	1.4	0.5	0.3	3.4	1.2	0.6	5.2	0.6	4.7	0.9	4.4	4.5	9.5	8.2	1.3	2.3	0.8	0.8	8.3	0.6	3.9	1.5	7.5	0.9	3.3	1.2	0.1	1.6	9.4	6.3	15.1	1.1	9.0	4.6	10.8	0.6	1.9	2.5	8.9	7.7	1.1	9.6	2.6	0.4	0.2	2.5	1.4	0.2	17.9	4.7	16.7	0.2	0.2	0.4	0.5	0.0	0.0	1.3	9.5	0.0	0.0	0.0	0.1	0.2	0.4	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.3	0.4	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.3	0.0	0.0	0.4	0.3	0.9	0.5	0.2	0.2	0.1	0.0	16.9	0.1	0.5	0.5	1.0	0.4	0.1	3.1	0.2	0.1	0.5	0.1	1.5	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.5	1.2	0.6	0.8	0.8	7.5	0.9	6.3	7.7	0.4	16.7	0.6	9.6	0.0	1.0	0.2	1.3	6.9	0.0	36.5	2.4	5.8	11.6	3.8	4.3	0.0	42.3	2.1	0.2	1.0	0.5	1.9	1.3	10.3	7.2	1.4	1.7	0.0	0.0	0.5	0.0	0.4	13.2	10.7	14.9	0.0	0.2	1.4	0.2	0.4	0.0	0.4	0.2	0.0	0.0	0.4	3.2	12.2	0.4	3.6	0.0	0.0	48.5	0.0	1.0	0.2	0.6	0.0	26.7	0.0	1.8	0.0	3.6	0.0	2.2	6.6	0.9	28.7	11.4	4.4	0.6	1.3	0.4	0.5	0.2	0.1	0.5
SCN4B	LQT10	ENSG00000177098	"Sodium voltage-gated channel beta subunit 4"	Q8IWT1	11	118133377-118152888	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 109.6;tongue: 56.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 12.3;Excitatory neurons: 18.2;Sertoli cells: 46.0;Smooth muscle cells: 38.8"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;HBEC3-KT: 1.0;NTERA-2: 1.4;U-2 OS: 1.2"	"Region enriched"	"Detected in all"	11	"basal ganglia: 816.3"	"Region enriched"	"Detected in many"	4	"basal ganglia: 134.6"	HPA017293	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA017293: AB_2184174"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-3)"	"unprognostic (9.17e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.31e-4)"	23.5	5.4	2.6	1.2	86.6	0.0	9.2	41.3	109.6	2.1	0.0	2.6	2.4	3.1	1.6	5.3	5.4	3.2	11.8	2.1	14.0	2.1	0.4	8.9	2.1	53.3	15.4	0.5	5.1	6.8	2.7	1.8	45.9	2.2	2.1	0.9	2.5	2.3	30.4	3.9	4.7	7.1	15.2	0.0	2.9	0.7	23.1	8.6	14.5	56.8	0.7	3.0	1.4	28.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	86.6	41.3	109.6	2.1	14.0	53.3	15.4	45.9	15.2	23.1	28.5	12.3	0.0	0.0	2.9	0.0	1.3	0.6	2.0	2.8	1.7	0.5	5.7	4.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.1	3.0	0.0	0.0	18.2	0.0	0.1	3.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	2.0	1.2	1.4	8.7	2.1	1.1	0.0	1.9	0.0	0.5	0.0	1.5	1.4	0.0	0.0	1.5	0.0	0.1	0.0	0.1	5.8	0.8	46.0	0.6	38.8	0.1	0.6	0.5	1.1	0.0	0.1	0.0	0.0	0.2
SH3BGRL	MGC117402	ENSG00000131171	"SH3 domain binding glutamate rich protein like"	O75368	X	81202102-81298547	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051248	Approved		Approved	Vesicles		NA	NA		13000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA051248: AB_2681405"	"unprognostic (3.02e-3)"	"unprognostic (4.25e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.73e-1)"	112.1	120.0	92.4	101.1	92.4	176.7	170.8	98.1	126.3	146.2	94.3	180.8	87.6	208.5	148.8	130.4	112.3	149.1	61.1	88.0	108.2	126.0	62.6	133.0	154.9	104.8	95.6	130.7	81.3	112.3	83.5	86.4	105.2	153.1	108.5	24.9	112.5	284.9	16.5	67.1	98.1	231.7	104.4	144.4	87.0	54.3	96.1	145.1	104.7	50.2	126.8	178.3	76.0	116.3	1.0	38.2	133.4	154.1	172.1	232.0	9.2	83.4	158.3	30.1	61.1	12.5	114.6	113.7	70.1	122.9	42.4	20.7	95.9	60.0	48.0	98.7	33.3	151.2	59.7	7.4	41.6	107.3	286.0	135.6	42.9	42.4	37.6	231.4	133.8	75.9	53.0	279.6	165.9	53.9	117.0	138.7	105.2	1.4	62.3	102.0	60.9	60.8	155.7	52.8	0.4	58.5	0.1	4.2	77.9	88.0	44.8	321.2	136.9	82.7	34.1	76.4	35.0	64.3	60.6	105.6	95.1	215.9	62.9	793.9	358.5	570.7	124.9	477.3	134.8	236.3	154.7	147.8	306.2	207.4	140.8	148.8	126.7	183.0	560.5	148.0	257.5	462.3	92.4	92.4	98.1	126.3	88.0	108.2	104.8	95.6	105.2	104.4	96.1	116.3	191.3	112.2	92.6	73.8	216.1	126.3	131.5	150.4	83.1	16.2	174.6	150.2	19.7	72.9	106.4	121.4	0.0	7.1	183.9	33.2	344.4	86.9	6.3	74.9	120.0	130.7	93.3	172.9	62.8	74.7	6.0	152.4	63.2	62.6	219.7	92.8	139.9	17.8	431.4	5.0	82.4	87.0	109.9	400.9	430.7	19.2	174.3	379.0	147.7	102.1	459.0	154.2	224.6	82.9	54.3	48.0	104.2	314.1	114.4	83.5	91.2	214.3	113.6	8.5	263.0	132.4	308.8	4.5	5.9	76.0	119.5	5.7	163.4	205.9	90.3	146.4
SLC26A5	"DFNB61, PRES"	ENSG00000170615	"Solute carrier family 26 member 5"	P58743	7	103352730-103446207	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell shape, Hearing"	"Motor protein"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Astrocytes: 5.5;Excitatory neurons: 4.1;Gastric mucus-secreting cells: 7.1;Hepatic stellate cells: 5.3;Inhibitory neurons: 3.5;Microglial cells: 6.5;Oligodendrocytes: 4.2"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"basal ganglia: 10.4"							NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.86e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.56e-4)"	"unprognostic (4.21e-3)"	"unprognostic (8.92e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.67e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.69e-3)"	0.1	0.1	0.3	0.0	0.3	0.0	0.7	2.2	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.4	0.1	0.4	0.5	0.0	0.2	0.3	0.0	0.0	0.3	0.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.6	0.2	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.2	0.2	0.1	0.4	0.4	0.5	0.3	0.4	0.3	0.5	0.3	6.4	2.6	5.5	0.2	0.3	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4	0.2	0.5	0.0	0.0	4.1	0.0	0.0	2.2	7.1	0.2	0.0	0.0	5.3	0.0	0.0	0.0	3.5	0.0	0.0	0.3	0.3	0.0	0.3	0.0	0.0	6.5	0.0	0.3	0.0	2.0	4.2	0.3	0.0	0.0	0.0	0.8	0.0	0.0	2.2	1.2	0.0	0.2	0.1	0.3	0.5	0.0	0.3	0.0	0.6	0.0	0.0	0.6
SMAD5	"Dwfc, JV5-1, MADH5"	ENSG00000113658	"SMAD family member 5"	Q99717	5	136132845-136188747	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 91.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 91.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058931	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA058931: AB_2683856"	"unprognostic (6.04e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.99e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.49e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.15e-1)"	18.0	13.7	11.0	10.9	17.4	10.1	17.6	33.9	15.4	18.5	10.4	14.1	12.8	25.7	14.4	16.8	16.5	14.2	15.0	7.9	14.5	15.4	20.4	13.0	11.6	13.1	13.9	29.8	13.3	21.2	7.3	24.9	12.6	17.4	16.8	15.7	13.2	16.4	14.9	27.3	11.8	20.1	13.0	14.9	14.2	11.7	15.1	11.3	17.3	21.6	13.5	14.3	15.5	18.7	36.1	30.0	35.3	31.4	37.3	57.2	37.4	48.2	34.0	32.7	48.3	134.1	25.4	39.1	39.8	38.1	33.5	32.0	42.0	56.0	51.9	16.8	26.6	25.7	32.8	24.4	31.0	15.9	26.9	43.2	32.6	50.8	34.2	32.9	40.2	19.3	25.6	26.1	35.0	14.1	13.2	16.2	21.1	12.5	14.8	27.2	68.2	23.1	18.9	37.2	31.8	33.1	42.3	11.0	41.2	42.3	24.6	19.2	46.3	48.1	30.0	35.5	48.5	29.8	37.9	48.3	31.0	19.9	37.6	91.6	12.8	29.3	14.4	8.4	11.2	14.2	8.4	9.7	13.3	14.8	2.6	8.6	2.1	20.8	10.1	15.5	2.6	5.8	11.0	17.4	33.9	15.4	7.9	14.5	13.1	13.9	12.6	13.0	15.1	18.7	95.8	41.7	32.4	34.3	24.1	46.4	38.6	31.1	79.6	29.2	36.1	46.9	38.3	42.9	36.3	31.3	20.9	19.8	25.8	19.7	23.5	24.5	25.7	32.7	80.9	57.5	99.8	17.2	27.2	26.6	12.1	63.9	41.8	38.5	8.8	62.1	53.9	61.3	14.0	52.2	36.3	36.6	22.4	33.7	21.7	24.1	70.8	21.6	21.4	52.5	20.2	50.1	25.7	45.2	57.1	31.5	21.7	72.6	40.5	48.1	10.3	43.9	32.2	27.7	46.0	87.4	58.2	23.3	23.6	66.4	50.6	11.8	18.2	68.7	30.6	35.9
SMARCD3	"BAF60C, CRACD3, Rsc6p"	ENSG00000082014	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3"	Q6STE5	7	151238764-151277896	"Metabolic proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 126.4;skeletal muscle: 129.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 67.5;Peritubular cells: 88.4;Sertoli cells: 65.7"	"Cancer enhanced"	"Detected in all"		"glioma: 28.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.6;granulocytes: 1.9;monocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063955, HPA065517"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA063955: AB_2685159, HPA065517: AB_2685500"	"unprognostic (1.23e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.38e-3)"	"unprognostic (4.67e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.29e-1)"	20.7	40.3	104.0	5.0	101.9	7.1	22.1	70.7	126.4	25.0	59.8	25.2	3.0	22.8	14.7	8.4	30.6	14.6	78.9	105.3	90.4	18.8	2.8	18.8	4.6	79.5	89.8	37.6	14.3	27.2	42.2	5.7	83.2	27.7	3.8	10.0	14.3	23.2	129.0	11.5	11.0	13.4	72.4	9.2	18.3	17.4	99.9	1.9	18.1	69.4	2.5	22.7	18.2	84.8	0.8	6.1	19.6	69.3	30.0	13.3	1.6	13.3	13.0	7.5	4.3	4.5	4.2	7.7	4.7	20.4	3.0	1.3	15.7	1.3	3.0	2.4	10.2	0.0	4.5	1.4	25.9	0.4	12.5	31.8	1.8	2.4	0.2	32.7	1.5	19.5	16.4	2.5	39.5	8.3	1.3	10.3	6.1	2.0	2.5	0.5	31.7	0.3	6.6	0.0	11.2	22.6	12.4	2.1	9.5	3.1	2.0	19.7	2.6	6.1	7.7	15.7	4.9	16.1	0.0	6.5	14.2	17.6	21.6	0.4	5.5	0.0	0.1	1.3	0.1	0.1	0.5	0.0	1.6	0.0	0.3	0.5	1.9	0.0	0.2	0.0	0.4	1.3	104.0	101.9	70.7	126.4	105.3	90.4	79.5	89.8	83.2	72.4	99.9	84.8	7.5	6.4	21.7	33.6	0.7	10.7	38.3	3.1	47.8	15.2	28.5	29.6	67.5	21.5	4.6	11.0	4.2	0.4	1.2	0.2	31.3	24.8	2.5	3.9	24.4	5.2	3.5	1.3	16.7	2.6	0.5	28.0	1.5	3.4	2.5	44.3	2.9	0.5	3.6	11.8	23.9	0.3	0.0	17.0	5.7	14.0	50.7	16.0	7.2	8.4	19.7	23.7	0.0	16.1	7.4	2.8	0.1	88.4	0.1	14.6	0.0	2.1	4.7	5.7	65.7	40.9	56.9	1.7	20.0	1.5	4.7	1.1	4.7	22.8	0.2	9.0
SMIM10	CXorf69	ENSG00000184785	"Small integral membrane protein 10"	Q96HG1	X	134990991-134992473	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 25.5;Endothelial cells: 24.6;Erythroid cells: 39.1;Smooth muscle cells: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.0;NK-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 39.0"															NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.66e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.22e-4)"	"unprognostic (3.63e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (3.69e-6)"	"unprognostic (1.59e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.28e-2)"	16.5	13.9	10.3	3.8	10.3	12.2	11.2	11.6	13.3	14.6	10.0	15.5	2.5	14.3	4.5	5.8	15.6	6.5	12.1	9.7	12.1	7.4	2.1	8.2	2.8	13.8	12.8	11.2	3.6	24.8	6.0	3.4	13.5	12.5	4.1	3.3	5.2	11.1	3.7	4.1	7.0	9.2	13.6	10.8	7.2	27.7	11.4	1.6	8.1	6.2	1.7	15.7	11.1	14.1	0.0	0.0	0.1	0.0	17.3	20.8	6.3	9.0	29.5	5.3	7.9	7.6	0.1	0.0	23.4	9.2	26.5	0.0	16.6	0.1	7.7	25.4	15.9	26.8	35.2	0.0	15.2	24.3	5.4	27.8	0.0	15.8	0.0	7.1	4.2	0.0	13.5	0.0	18.8	0.0	0.0	39.0	0.0	0.0	0.0	0.0	2.2	0.0	1.4	4.8	4.6	0.0	11.1	0.0	17.3	0.4	0.0	17.7	0.8	13.2	8.7	28.2	12.9	0.0	0.0	0.0	10.3	26.7	4.9	1.5	0.3	2.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	3.4	0.2	0.0	0.0	0.1	10.3	10.3	11.6	13.3	9.7	12.1	13.8	12.8	13.5	13.6	11.4	14.1	25.5	3.2	3.6	2.0	0.6	1.8	6.4	0.6	0.0	3.3	3.0	3.9	14.3	1.5	3.8	1.8	0.0	0.9	0.6	0.0	3.9	5.7	4.2	9.3	12.1	24.6	0.0	39.1	0.2	1.2	1.2	13.9	0.5	1.2	9.5	9.5	20.0	0.1	5.5	1.7	0.3	0.2	2.0	2.5	2.4	9.4	18.6	1.3	19.6	2.8	0.5	19.3	1.0	0.5	0.4	0.9	0.2	18.0	0.2	1.0	0.0	1.4	2.2	1.3	6.6	17.6	31.9	3.1	2.9	1.2	1.0	0.5	1.7	8.7	0.5	2.7
SMTN		ENSG00000183963	Smoothelin	P53814	22	31064105-31104757	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 887.2;urinary bladder: 450.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 283.5;Hepatic stellate cells: 121.3;Sertoli cells: 184.1;Smooth muscle cells: 116.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"WM-115: 200.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001721, HPA051778, HPA058590"	Enhanced		Supported	"Nucleoplasm,Actin filaments"		No	Yes		140000	"Cluster 30: Non-specific - Translation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Actin filaments"	"CAB001721: , HPA051778: AB_2681607, HPA058590: AB_2683765"	"unprognostic (1.36e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (2.73e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.41e-3)"	"unprognostic (6.34e-2)"	54.7	19.2	10.8	25.3	12.5	4.7	42.2	10.3	13.1	100.2	7.6	887.2	30.0	251.0	7.0	65.1	132.4	20.8	152.0	9.0	9.3	35.6	15.3	38.2	5.6	11.7	12.5	34.0	25.2	3.3	9.8	17.4	11.0	150.9	29.2	15.2	16.3	177.9	95.7	38.7	151.5	127.2	10.5	54.5	231.2	12.5	12.4	2.9	26.4	26.2	2.5	450.6	91.5	10.0	73.0	21.2	7.2	27.0	11.0	17.2	58.0	106.8	49.1	85.7	58.4	29.9	22.4	32.1	9.3	59.3	17.3	10.6	7.2	62.8	40.4	10.6	58.2	33.9	18.3	36.1	9.7	51.5	57.4	14.2	5.8	114.0	18.7	29.2	74.7	12.3	37.3	25.9	59.6	64.5	5.9	11.4	8.2	36.1	90.0	20.3	20.5	34.6	34.5	23.2	11.5	12.7	33.4	15.9	15.7	7.4	18.8	8.2	118.7	62.1	58.4	59.4	79.8	24.6	32.5	18.8	91.0	19.7	200.5	0.0	1.0	0.0	0.1	0.2	0.0	1.3	0.1	0.3	0.4	0.0	1.0	0.5	0.1	0.1	0.2	0.2	0.0	0.6	10.8	12.5	10.3	13.1	9.0	9.3	11.7	12.5	11.0	10.5	12.4	10.0	94.5	6.4	3.3	23.8	2.0	65.1	33.5	16.1	19.4	46.6	18.6	26.7	39.5	5.7	6.1	9.2	283.5	13.4	2.7	12.8	9.8	14.8	1.2	4.0	52.1	62.8	29.2	0.0	0.2	20.1	68.8	35.9	18.3	7.3	0.0	11.0	121.3	2.6	6.0	5.0	1.9	29.9	14.2	6.8	14.6	1.9	22.4	4.7	14.2	7.5	1.0	31.2	1.0	4.5	2.0	73.2	11.4	48.5	2.1	21.7	5.6	18.4	2.2	54.0	184.1	18.4	116.4	5.7	7.9	9.7	69.3	21.9	3.7	16.3	27.0	14.9
SNAI2	"SLUG, SLUGH, SLUGH1, SNAIL2"	ENSG00000019549	"Snail family transcriptional repressor 2"	O43623	8	48917598-48921740	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Deafness, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 162.8;Basal prostatic cells: 119.4;Basal respiratory cells: 98.9;Endometrial stromal cells: 129.2;Melanocytes: 87.2;Suprabasal keratinocytes: 147.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 243.2;ASC TERT1: 247.8;HSkMC: 181.3;hTERT-HME1: 180.3;LHCN-M2: 228.8;U-138 MG: 206.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB011671	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB011671: AB_777968"	"unprognostic (3.52e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.83e-4)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (4.69e-8)"	"unprognostic (1.65e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.16e-4)"	28.2	10.6	0.5	15.7	0.8	0.4	22.9	3.6	1.4	51.1	1.7	11.6	4.3	43.0	11.3	15.8	34.4	21.8	15.0	0.8	0.5	12.4	9.6	11.1	8.1	0.8	0.5	40.8	8.0	3.6	2.3	16.2	0.6	19.8	7.6	0.1	16.8	23.2	4.6	39.8	11.5	27.5	0.4	14.2	9.4	3.7	0.6	6.9	9.5	7.7	7.9	37.8	51.3	0.5	17.7	0.6	38.5	0.4	243.2	247.8	0.1	38.6	69.0	38.1	52.3	0.0	17.4	0.0	0.0	50.1	56.7	28.9	0.4	111.8	40.2	0.0	0.8	0.0	7.2	0.1	88.5	0.1	0.1	181.3	116.8	31.9	180.3	5.4	1.3	0.0	0.0	18.5	228.8	0.3	0.0	0.1	2.3	0.0	34.7	0.0	122.2	0.2	0.1	6.8	5.1	3.8	3.3	0.1	69.2	18.9	0.2	0.2	10.6	206.6	7.4	36.6	20.9	0.0	0.1	4.2	74.9	0.0	78.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	3.6	1.4	0.8	0.5	0.8	0.5	0.6	0.4	0.6	0.5	11.7	0.0	0.0	0.0	0.1	162.8	119.4	98.9	60.9	1.9	2.1	22.0	1.2	1.5	14.0	0.0	0.0	1.7	0.3	0.0	0.0	3.0	0.6	5.2	129.2	19.5	0.0	0.0	0.6	2.3	0.5	69.9	0.0	4.8	0.0	0.0	40.0	6.8	1.7	0.0	0.5	0.0	10.2	0.8	30.7	1.7	73.7	1.9	87.2	0.0	0.0	0.0	0.0	1.0	0.0	6.1	0.0	67.4	1.4	18.4	0.0	0.0	2.4	0.2	52.6	24.7	59.2	0.2	0.4	32.3	147.9	2.2	2.3	21.8	0.0	25.0
SNAPC2	"PTFdelta, SNAP45"	ENSG00000104976	"Small nuclear RNA activating complex polypeptide 2"	Q13487	19	7920338-7923250	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049843, HPA077597"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049843: AB_2680910, HPA077597: AB_2732354"	"unprognostic (4.56e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.98e-3)"	"unprognostic (8.11e-3)"	"unprognostic (2.03e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.78e-2)"	21.2	21.6	15.4	10.4	17.7	16.7	19.6	14.7	21.4	37.1	11.0	36.1	9.7	50.7	5.7	14.3	35.0	8.3	16.6	17.1	16.0	17.2	11.9	17.1	9.1	15.6	15.2	20.7	17.8	10.1	25.5	6.5	16.4	27.0	3.8	1.8	16.6	17.2	9.0	20.5	15.2	12.4	13.8	21.4	18.7	32.6	16.3	7.6	13.1	9.7	4.9	31.7	25.1	15.3	20.6	22.9	10.8	42.0	14.7	31.1	10.0	21.4	22.6	20.5	18.5	10.6	17.4	17.6	25.8	25.0	16.4	24.7	7.7	15.9	5.9	22.7	19.7	24.5	9.6	15.4	26.6	15.4	38.7	25.5	24.0	24.3	14.9	16.6	23.5	18.1	24.5	28.3	12.7	18.1	19.9	43.6	13.9	10.4	51.8	23.4	10.7	17.6	19.1	7.1	12.7	28.7	11.0	11.8	48.6	4.8	19.2	16.6	30.9	68.8	24.5	65.2	26.8	27.4	48.1	10.8	43.1	31.6	22.2	7.0	23.8	23.5	19.0	30.8	19.2	15.7	16.1	16.5	30.1	14.5	16.6	16.9	3.5	27.7	33.4	19.9	24.0	16.4	15.4	17.7	14.7	21.4	17.1	16.0	15.6	15.2	16.4	13.8	16.3	15.3	19.8	3.2	3.7	3.3	15.4	24.3	20.0	25.1	35.9	8.6	25.8	26.2	3.2	7.2	10.7	11.0	0.0	12.2	22.9	9.8	17.6	21.2	1.9	10.7	25.0	20.7	12.0	20.2	4.1	24.5	24.2	18.5	8.6	15.0	18.4	15.4	12.5	5.2	28.6	23.5	2.6	11.9	14.2	19.6	28.0	6.0	13.7	19.2	19.6	1.0	31.3	6.0	13.4	2.0	3.0	28.9	6.6	14.3	8.4	28.5	16.7	16.1	3.0	6.1	13.1	7.3	30.1	9.5	38.6	19.0	24.3	9.9	18.4	29.2	15.5	24.1
SNCG	"BCSG1, persyn, SR"	ENSG00000173267	"Synuclein gamma"	O76070	10	86958599-86963258	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 268.3;brain: 411.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 164.9;Breast myoepithelial cells: 156.1;Endothelial cells: 143.3;Hepatic stellate cells: 206.0;Smooth muscle cells: 234.3;Urothelial cells: 358.3"	"Group enriched"	"Detected in all"	8	"ovarian cancer: 84.1;urothelial cancer: 301.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 748.2;RT4: 483.5;T-47d: 151.7;TIME: 160.9"	"Region enhanced"	"Detected in all"		"pons and medulla: 279.9"	"Low region specificity"	"Detected in many"			"CAB001452, HPA014404, CAB040581, CAB080022"	Enhanced	Supported				NA	NA		23000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB001452: AB_564020, CAB040581: , CAB080022: , HPA014404: AB_1857715"	"unprognostic (2.06e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.76e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (2.29e-8)"	"prognostic unfavorable (7.15e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.77e-3)"	208.2	268.3	215.6	11.9	150.8	0.0	98.1	199.9	313.3	33.3	44.0	27.0	9.2	22.9	15.1	25.4	64.5	12.7	31.7	190.2	387.7	22.3	4.3	13.9	11.6	411.2	276.4	42.1	5.3	3.3	11.1	11.9	357.8	36.6	4.9	52.7	22.9	101.6	14.6	28.6	18.8	10.1	155.3	64.2	16.4	5.4	304.7	9.0	20.3	13.7	25.6	204.8	38.9	148.8	2.6	6.8	0.7	1.1	0.3	3.9	0.7	0.8	0.0	0.0	0.0	1.1	748.2	0.0	22.6	1.4	0.0	71.0	0.0	3.4	0.0	0.1	1.4	3.6	109.6	2.0	1.4	0.0	1.8	2.8	55.5	0.0	0.6	0.2	49.8	0.0	5.3	0.0	0.0	0.6	0.2	0.4	11.3	0.0	0.4	0.0	0.4	0.3	0.2	483.5	0.1	0.0	6.5	8.7	0.9	1.0	151.7	0.3	160.9	1.1	3.7	0.3	0.0	0.2	0.0	0.0	0.8	3.6	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	215.6	150.8	199.9	313.3	190.2	387.7	411.2	276.4	357.8	155.3	304.7	148.8	164.9	0.0	0.0	7.5	1.5	28.8	65.9	16.3	11.4	32.2	61.1	156.1	1.9	8.6	14.6	55.2	6.2	19.4	2.8	0.1	125.2	3.6	0.6	0.4	0.8	143.3	0.0	2.7	9.9	1.1	0.6	14.2	0.5	0.6	0.0	0.1	206.0	0.8	5.5	87.5	28.0	0.0	20.3	1.8	27.3	3.7	59.0	2.2	23.2	6.5	0.9	66.4	0.0	4.5	7.5	4.7	2.2	9.8	0.0	14.2	0.3	1.3	2.4	109.3	92.1	2.5	234.3	0.6	0.7	2.6	19.7	6.2	2.7	16.9	0.0	358.3
SNRK	"FLJ20224, HSNFRK, KIAA0096"	ENSG00000163788	"SNF related kinase"	Q9NRH2	3	43286512-43424764	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 126.0;TIME: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042163	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Vesicles, Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA042163: AB_10794645"	"prognostic favorable (9.28e-4)"	"unprognostic (8.46e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (9.41e-5)"	"unprognostic (9.21e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.38e-2)"	37.6	10.3	9.7	17.2	9.7	58.4	26.5	27.7	13.2	21.7	9.8	14.6	16.1	23.1	7.8	19.7	13.6	20.4	16.3	9.5	12.5	20.0	25.4	26.4	19.8	14.0	11.5	14.4	22.7	18.5	11.4	33.3	14.7	11.2	11.9	18.8	11.4	10.8	14.3	30.3	17.2	22.9	9.5	33.0	14.4	11.1	13.2	40.5	27.3	21.6	14.7	19.8	21.7	8.7	8.4	5.0	9.1	8.8	26.6	9.5	8.7	8.8	14.8	9.4	9.1	6.9	11.8	13.2	6.8	11.2	6.2	5.3	10.7	18.9	9.6	15.1	8.8	15.0	9.1	8.1	13.8	17.1	16.1	10.5	12.7	10.6	17.9	9.5	126.0	14.9	6.7	14.9	8.7	4.4	17.3	15.0	10.1	4.6	22.6	11.7	6.7	14.0	24.2	14.1	6.4	13.4	7.7	8.1	11.1	7.9	5.5	21.4	74.1	8.2	8.3	9.5	10.4	23.7	18.3	11.0	5.8	20.1	12.0	9.4	4.2	7.6	9.5	7.5	13.0	3.6	8.3	9.6	4.0	3.6	12.1	13.1	27.7	11.0	7.1	1.2	9.7	9.7	9.7	9.7	27.7	13.2	9.5	12.5	14.0	11.5	14.7	9.5	13.2	8.7	88.4	32.1	24.1	30.0	29.0	52.8	10.3	6.4	12.5	52.1	9.7	8.6	17.7	15.7	15.0	16.5	16.7	7.7	57.6	37.0	11.7	10.9	50.4	23.3	16.2	84.2	10.8	10.3	21.6	8.9	3.2	16.4	12.8	19.8	14.5	8.9	98.6	25.2	13.7	30.3	43.2	10.7	12.2	24.8	19.0	7.5	12.5	26.5	23.2	34.7	21.9	16.3	65.9	24.6	10.7	11.2	20.6	11.7	27.3	12.7	25.2	12.2	19.2	18.3	124.9	31.3	49.1	11.1	16.2	13.7	51.3	8.2	61.2	9.5	11.1	18.0
SNX7		ENSG00000162627	"Sorting nexin 7"	Q9UNH6	1	98661701-98760500	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037419	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	"Cell Junctions"	"HPA037419: AB_10671754"	"unprognostic (3.19e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (5.10e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (9.59e-7)"	"unprognostic (1.53e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.77e-1)"	19.5	13.8	10.2	7.5	9.5	0.1	17.1	8.6	9.9	20.6	7.5	30.1	23.5	19.4	12.6	16.6	15.6	16.2	22.1	10.1	13.6	24.9	12.8	11.3	3.4	11.6	12.7	11.3	13.7	15.1	8.4	16.8	10.7	14.3	29.9	3.2	14.1	16.4	5.4	11.0	22.9	25.8	9.8	5.4	16.9	15.7	16.4	3.6	12.2	10.9	4.7	20.3	14.3	10.8	50.4	26.7	15.8	21.6	54.9	86.3	8.9	31.3	56.6	45.9	59.2	15.6	18.4	0.0	39.7	77.1	37.7	14.2	16.8	44.4	45.5	0.2	32.3	0.0	41.2	27.1	32.4	0.0	0.0	43.5	46.8	37.8	16.5	51.7	64.9	0.7	0.0	0.1	73.3	10.3	0.4	0.0	15.2	20.0	38.0	0.0	35.4	0.1	45.3	39.8	7.8	93.5	41.6	39.0	23.7	26.2	0.0	1.8	44.9	44.7	24.8	35.0	64.2	0.0	0.1	0.1	63.3	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.2	9.5	8.6	9.9	10.1	13.6	11.6	12.7	10.7	9.8	16.4	10.8	14.1	19.2	6.7	23.2	0.5	14.7	44.7	60.0	9.6	0.7	16.3	23.0	49.1	27.1	22.0	23.9	0.0	34.1	0.1	37.4	37.2	47.0	19.3	29.4	33.0	17.8	21.0	0.0	18.3	80.7	33.8	37.9	20.9	19.6	1.3	22.4	17.9	12.0	12.9	3.3	25.7	26.6	48.8	2.1	13.7	23.9	34.2	5.0	35.6	12.2	37.2	12.8	0.0	58.8	8.2	56.8	25.7	52.6	0.1	28.5	34.1	69.0	27.2	0.8	32.9	23.1	36.2	15.5	10.5	27.1	16.3	14.1	1.6	30.2	49.1	57.3
SPEG	"APEG1, BPEG, KIAA1297, MGC12676, MYLK6, SPEGalpha, SPEGbeta"	ENSG00000072195	"Striated muscle enriched protein kinase"	Q15772	2	219434843-219493629	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 174.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.7;Cardiomyocytes: 61.5;Late spermatids: 39.6;Sertoli cells: 46.0;Smooth muscle cells: 32.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 45.9;U-87 MG: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018904	Enhanced		Approved	Vesicles		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA018904: AB_1844924"	"unprognostic (3.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.45e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.29e-2)"	"unprognostic (8.66e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.47e-9)"	"unprognostic (1.14e-1)"	"unprognostic (7.01e-2)"	"unprognostic (5.95e-4)"	"unprognostic (1.28e-3)"	16.1	6.8	16.8	7.7	18.7	0.0	15.3	15.5	20.7	75.5	9.7	174.8	5.3	89.5	6.2	15.6	70.0	7.3	48.5	19.8	14.5	4.1	1.3	8.7	0.6	16.1	15.8	21.9	3.4	4.4	34.3	4.5	14.6	58.8	3.8	1.0	10.0	25.5	118.0	7.8	31.9	23.1	15.3	2.4	48.1	5.4	15.3	0.5	5.9	21.7	0.2	87.7	42.1	15.6	6.1	0.5	3.1	4.9	1.6	4.7	1.8	13.1	8.5	8.6	6.4	4.5	1.9	0.0	4.5	9.7	4.3	7.2	2.5	3.1	3.4	0.0	1.7	0.0	6.1	0.3	2.1	0.0	0.5	13.2	4.6	7.8	1.9	45.9	0.0	3.2	3.5	0.0	6.1	1.6	0.1	18.8	6.5	0.0	2.4	2.8	7.0	1.1	8.5	0.0	3.4	15.1	0.6	0.0	0.3	14.3	0.3	0.2	0.0	20.6	21.3	2.4	21.1	0.4	0.0	0.2	23.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	18.7	15.5	20.7	19.8	14.5	16.1	15.8	14.6	15.3	15.3	15.6	2.4	0.0	2.2	45.7	0.4	3.2	6.0	1.3	2.8	5.3	10.3	14.6	61.5	4.3	0.1	1.8	2.1	0.6	1.4	4.1	0.0	1.5	21.8	0.9	3.6	2.2	6.7	2.7	20.5	1.2	0.9	10.0	3.6	1.3	0.0	1.0	5.7	3.1	1.1	5.0	20.9	4.1	0.0	5.6	1.9	39.6	10.5	1.6	3.6	4.7	1.4	8.4	0.0	5.0	1.0	0.2	3.2	18.8	0.9	6.5	8.5	4.3	0.1	0.9	46.0	17.1	32.4	11.6	3.7	0.2	1.4	1.4	1.2	0.4	3.5	5.3
SSTR2		ENSG00000180616	"Somatostatin receptor 2"	P30874	17	73165010-73176633	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 59.1;Enteroendocrine cells: 35.7;Sertoli cells: 32.9;Smooth muscle cells: 56.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 12.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007264	Uncertain		Supported	Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA007264: AB_1080053"	"unprognostic (2.13e-3)"	"unprognostic (2.61e-3)"	"unprognostic (7.43e-2)"	"unprognostic (9.37e-3)"	"unprognostic (6.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.29e-3)"	"unprognostic (7.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.55e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (9.04e-7)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.95e-2)"	2.5	3.6	8.4	0.9	8.9	0.9	1.7	7.2	8.7	0.5	0.3	0.8	1.4	0.7	1.6	0.4	1.1	0.6	0.8	9.0	4.3	5.3	1.4	0.4	1.1	2.2	5.1	0.3	0.7	0.3	2.9	0.1	8.6	1.4	1.1	2.2	0.7	1.4	0.7	0.6	0.9	0.8	2.6	6.1	3.1	0.3	4.8	0.5	1.1	0.2	1.3	0.9	0.7	6.8	0.2	0.3	0.3	0.7	0.1	0.1	0.4	0.1	0.2	0.3	0.3	0.2	0.3	0.3	0.2	0.1	0.9	0.3	0.0	0.1	0.1	0.4	0.6	0.3	0.8	0.3	0.0	0.2	1.5	0.1	0.0	0.1	0.0	0.2	0.0	0.4	0.2	0.7	0.0	0.3	0.2	0.8	1.0	0.1	0.4	0.4	0.4	0.3	0.2	0.3	12.5	0.9	0.2	0.2	0.1	0.5	1.5	0.2	0.1	0.2	1.4	0.4	0.2	0.5	0.2	1.0	0.2	0.3	0.2	1.4	0.2	0.3	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.2	1.2	0.2	0.2	0.2	0.1	0.1	8.4	8.9	7.2	8.7	9.0	4.3	2.2	5.1	8.6	2.6	4.8	6.8	4.9	6.4	2.7	1.6	0.5	1.1	3.2	0.0	0.0	59.1	3.7	2.5	3.6	1.5	1.3	1.8	4.2	0.7	0.9	0.1	0.0	0.2	7.0	2.1	1.7	11.3	35.7	0.0	17.1	0.0	0.7	14.3	3.1	4.9	2.5	3.0	3.9	1.0	1.0	6.7	8.4	8.2	0.0	2.4	3.0	5.7	0.9	2.4	5.4	1.9	1.7	2.4	1.0	2.0	0.7	0.4	0.1	0.7	5.8	5.4	0.6	18.0	0.7	4.8	32.9	10.0	56.0	0.9	1.9	0.3	1.1	1.0	1.4	0.6	0.5	3.3
STEAP4	"FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9"	ENSG00000127954	"STEAP4 metalloreductase"	Q687X5	7	88270892-88306894	"Enzymes, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 113.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 402.5;Club cells: 152.8;Sertoli cells: 460.2;Smooth muscle cells: 255.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 45.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	12	"neutrophil: 163.6"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 163.6"	"Group enriched"	"Detected in some"	6	"HSkMC: 122.1;SiHa: 119.7;U-2197: 166.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065201			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Plasma membrane"		"HPA065201: "	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.96e-2)"	"prognostic favorable (2.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.51e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.53e-2)"	113.7	46.3	1.0	31.7	0.9	7.1	68.6	2.8	1.5	21.3	17.0	13.3	3.8	17.9	7.8	15.4	36.1	22.7	24.1	1.4	1.0	11.8	24.3	67.5	7.2	1.2	0.9	4.4	10.6	16.0	13.0	15.3	0.8	60.0	9.2	1.9	26.8	10.6	13.4	19.3	10.6	29.3	0.4	5.4	10.6	13.4	1.1	7.8	53.1	16.6	5.1	34.3	22.7	1.1	4.9	0.0	0.1	0.1	0.1	1.9	0.3	0.0	0.3	0.0	0.1	0.1	23.6	0.1	0.1	0.0	0.4	18.7	0.1	0.0	0.1	0.0	0.1	0.1	7.9	0.1	0.1	0.1	0.2	122.1	0.1	0.4	0.9	0.0	0.0	0.1	0.3	0.4	0.0	3.0	0.1	0.5	0.1	1.0	0.0	0.2	0.1	0.3	0.0	0.3	0.2	0.2	119.7	9.9	0.0	0.1	0.8	0.0	0.1	0.4	0.3	166.4	0.1	0.1	0.1	0.1	0.2	0.9	0.2	0.4	13.5	1.4	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	163.6	0.2	0.1	0.3	0.0	3.2	1.0	0.9	2.8	1.5	1.4	1.0	1.2	0.9	0.8	0.4	1.1	1.1	77.2	54.5	402.5	0.0	0.8	9.4	5.8	8.6	1.8	1.8	21.6	8.3	9.1	0.0	152.8	0.0	2.1	0.4	1.1	0.4	0.0	14.6	23.8	14.6	20.5	14.7	0.0	0.0	0.5	9.6	10.6	39.8	1.1	51.2	16.4	0.0	15.4	0.7	2.8	0.0	0.8	0.2	16.2	7.2	7.4	10.9	114.9	12.2	5.4	6.5	19.0	2.7	0.0	1.0	0.1	18.6	0.0	9.1	0.2	49.3	0.1	0.1	72.8	0.3	460.2	9.6	255.3	0.9	0.3	1.5	18.8	10.9	3.1	57.7	0.2	16.6
STRN3	"PPP2R6B, S/G2NA, SG2NA"	ENSG00000196792	"Striatin 3"	Q13033	14	30893799-31026401	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003392, HPA004636, CAB069925"	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Nucleoplasm, Actin filaments"	"CAB069925: AB_1146988, HPA003392: AB_1079942, HPA004636: AB_1079940"	"unprognostic (4.08e-1)"	"unprognostic (8.66e-2)"	"unprognostic (8.08e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (7.74e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (9.66e-4)"	"unprognostic (8.74e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.01e-2)"	18.9	13.4	8.4	9.3	8.3	10.0	11.6	14.9	11.2	14.0	8.9	16.1	7.3	12.4	13.8	15.3	9.9	12.4	18.5	7.5	16.4	13.9	21.5	10.0	7.5	7.7	9.8	10.1	12.6	13.9	9.3	11.9	7.5	13.7	12.6	14.2	10.3	14.1	39.2	11.7	9.7	18.0	6.0	10.4	11.2	20.9	10.7	9.4	13.7	28.5	9.0	14.7	11.6	10.6	33.7	29.2	31.0	22.0	27.4	20.4	25.8	33.0	23.2	24.9	26.3	37.7	22.4	18.4	22.0	23.2	12.6	18.2	33.5	18.1	37.7	17.5	12.3	19.2	19.6	73.6	28.8	15.6	19.8	19.9	20.8	19.5	24.8	23.9	21.5	16.7	22.8	17.8	25.4	21.5	21.3	16.3	15.3	24.1	25.5	15.0	35.5	4.9	39.2	47.7	19.1	15.5	32.8	23.6	17.7	28.4	27.7	14.5	28.0	24.8	21.3	14.7	12.4	15.7	21.4	17.8	12.7	11.2	20.5	4.1	3.5	4.7	3.3	4.3	4.4	3.4	4.2	3.7	3.1	3.2	4.1	4.8	4.3	4.2	3.5	5.7	3.6	1.3	8.4	8.3	14.9	11.2	7.5	16.4	7.7	9.8	7.5	6.0	10.7	10.6	37.1	22.4	22.4	82.3	19.5	98.1	57.5	17.9	23.9	27.2	37.1	25.1	51.7	28.6	22.1	31.3	27.1	22.1	17.5	34.1	11.7	38.9	21.8	32.7	48.0	36.0	31.9	43.8	110.9	26.3	19.9	39.6	20.4	46.9	8.8	21.7	35.0	43.1	12.8	37.0	119.0	18.8	16.2	23.9	45.7	13.4	26.8	22.9	44.4	92.8	18.9	24.6	11.3	102.1	139.2	40.3	13.2	27.8	31.3	49.6	13.2	43.3	25.2	30.2	26.3	52.3	51.9	59.8	53.6	31.4	96.5	33.2	21.4	26.1	16.3	53.6
SUSD5	KIAA0527	ENSG00000173705	"Sushi domain containing 5"	O60279	3	33150043-33218810	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 15.4;Inhibitory neurons: 10.5;Oligodendrocyte precursor cells: 61.3;Sertoli cells: 32.9;Smooth muscle cells: 29.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 31.1;HUVEC TERT2: 78.5;LHCN-M2: 30.4;TIME: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052788	Uncertain		Uncertain	"Golgi apparatus,Vesicles"		NA	NA		17000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus, Vesicles"		"HPA052788: AB_2681948"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.39e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.72e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.45e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.89e-2)"	4.6	1.4	2.9	0.9	3.0	0.1	1.9	2.2	4.6	6.3	4.4	1.7	0.8	4.6	2.2	1.3	5.2	5.5	1.5	3.1	4.4	1.5	0.5	1.7	2.3	3.4	3.4	3.8	0.6	1.0	0.8	0.2	3.4	1.3	1.2	0.6	0.7	6.3	1.6	1.9	1.9	4.8	3.8	2.5	1.8	2.1	4.7	0.1	3.2	3.3	5.3	1.5	2.4	3.5	0.0	1.1	1.2	0.7	1.7	0.2	0.1	9.6	3.4	31.1	10.5	0.1	0.0	0.0	8.8	2.5	9.5	0.1	13.7	4.5	12.9	0.3	15.3	0.0	2.0	0.0	0.2	0.1	0.1	1.3	2.4	19.9	3.9	15.2	78.5	0.0	0.0	0.1	30.4	0.0	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.0	1.0	0.1	0.1	2.5	0.7	1.8	1.9	31.3	0.0	14.4	1.2	4.7	0.0	0.7	0.0	0.3	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.9	3.0	2.2	4.6	3.1	4.4	3.4	3.4	3.4	3.8	4.7	3.5	0.1	0.0	0.0	0.3	0.0	1.0	0.1	0.0	0.0	1.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	2.2	0.5	0.0	0.0	15.4	0.0	0.1	1.4	0.0	0.9	0.0	0.2	0.4	0.0	0.0	3.3	10.5	0.0	0.0	2.1	2.0	0.3	0.0	0.1	1.8	0.0	0.0	0.5	0.0	61.3	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	32.9	3.6	29.0	0.1	2.6	0.1	1.0	0.0	0.2	0.1	0.0	0.1
SYNPO2	MYOPODIN	ENSG00000172403	"Synaptopodin 2"	Q9UMS6	4	118850688-119061247	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 991.6;tongue: 493.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 135.4;Endometrial stromal cells: 130.0;Excitatory neurons: 149.6;Peritubular cells: 101.5;Sertoli cells: 131.5;Skeletal myocytes: 93.4;Smooth muscle cells: 206.1"	"Group enriched"	"Detected in all"	5	"prostate cancer: 25.7;stomach cancer: 27.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 57.8;LHCN-M2: 18.5;SH-SY5Y: 83.2"	"Region enriched"	"Detected in all"	4	"thalamus: 27.1"	"Low region specificity"	"Detected in all"			"HPA030665, CAB037231, HPA049707, HPA068563"	Enhanced		Enhanced	"Vesicles,Actin filaments"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Vesicles, Actin filaments"		"CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: AB_2680857, HPA068563: AB_2686006"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.71e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.91e-4)"	57.5	10.8	6.1	47.4	7.9	0.3	35.9	4.1	5.7	55.0	2.2	346.4	34.3	137.1	33.4	197.1	89.5	50.0	66.8	10.7	13.3	8.7	7.0	16.2	10.5	5.4	7.5	39.0	3.8	3.6	7.5	20.8	6.1	180.5	58.0	1.2	16.0	267.4	991.6	17.9	75.5	244.4	9.2	10.2	126.2	6.7	5.8	14.3	16.0	493.5	6.5	226.5	54.0	12.0	0.2	4.2	0.2	0.0	10.5	3.5	0.7	13.4	14.1	0.4	0.5	0.0	0.7	1.5	0.1	57.8	0.9	0.2	0.4	0.3	0.7	5.9	0.1	0.8	1.3	0.0	2.4	0.1	0.2	14.5	0.3	4.0	0.2	3.7	0.2	0.2	0.0	0.7	18.5	0.3	0.7	7.2	1.4	0.0	0.0	0.5	1.5	0.4	0.2	0.3	0.4	83.2	0.4	0.3	0.1	3.3	0.0	7.0	0.4	0.6	0.1	0.2	0.1	0.1	0.3	0.1	1.1	0.6	0.2	0.8	0.1	0.5	0.2	0.0	0.4	0.3	0.4	0.2	0.0	0.4	0.4	0.3	0.2	0.3	0.1	0.0	0.5	0.1	6.1	7.9	4.1	5.7	10.7	13.3	5.4	7.5	6.1	9.2	5.8	12.0	25.5	3.2	1.1	42.7	1.1	13.5	17.9	3.7	46.1	2.5	6.3	30.7	135.4	0.0	0.3	1.8	0.0	1.4	0.5	0.1	0.0	0.1	2.2	6.9	130.0	11.3	0.0	1.7	149.6	1.8	0.5	41.5	0.5	10.6	0.0	16.1	13.9	0.4	1.4	0.0	31.5	0.2	0.0	0.9	11.4	7.0	27.1	3.8	5.4	76.8	12.9	0.0	0.0	6.0	3.0	0.2	0.4	101.5	0.8	24.9	0.1	0.3	2.5	0.5	131.5	93.4	206.1	1.3	0.5	5.3	8.1	0.8	2.6	33.4	0.2	4.0
TAF9B	"DN-7, DN7, TAF9L, TAFII31L, TFIID-31"	ENSG00000187325	"TATA-box binding protein associated factor 9b"	Q9HBM6	X	78129748-78139650	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 56.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045275, HPA058961"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA045275: AB_10962831, HPA058961: AB_2683863"	"unprognostic (3.62e-3)"	"prognostic favorable (5.40e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.20e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.68e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.34e-3)"	"unprognostic (9.47e-2)"	"unprognostic (2.62e-1)"	15.7	11.4	12.8	10.4	14.0	12.0	15.6	13.7	17.5	15.5	12.9	14.5	6.5	23.1	14.2	18.2	16.1	13.5	23.1	13.7	15.1	18.2	14.0	11.0	11.5	13.5	12.4	14.4	9.7	22.9	12.0	13.1	13.4	19.8	10.0	33.6	10.1	17.2	15.4	12.3	8.1	30.7	14.5	10.7	11.0	10.4	12.8	17.0	18.9	14.0	10.7	16.5	10.3	18.0	25.6	21.8	52.7	23.3	20.2	20.5	7.9	22.5	20.7	35.6	19.8	30.7	43.3	29.2	31.2	24.5	29.0	19.8	79.5	18.5	36.9	45.7	27.6	16.0	28.7	28.2	20.1	25.4	17.0	26.3	9.8	39.1	26.7	22.5	21.8	28.7	33.4	61.1	32.0	39.1	40.3	19.8	61.9	33.4	40.4	34.3	68.6	26.9	24.6	51.2	33.3	33.1	62.3	26.7	24.7	27.2	43.3	18.2	23.3	27.4	41.6	30.2	27.4	26.2	56.8	21.3	47.6	50.5	39.3	0.8	4.1	1.2	6.6	4.4	12.5	5.6	15.1	11.5	5.2	5.2	15.1	11.3	1.9	14.2	3.3	6.5	17.7	8.7	12.8	14.0	13.7	17.5	13.7	15.1	13.5	12.4	13.4	14.5	12.8	18.0	14.9	9.6	7.8	2.9	6.6	15.6	26.7	6.1	56.3	16.1	12.2	8.8	26.6	10.0	6.2	20.2	8.4	18.1	4.5	1.4	7.9	6.8	1.0	4.7	8.2	16.4	12.6	14.1	4.0	8.6	16.4	12.9	4.1	5.0	2.5	3.0	13.2	5.6	6.9	8.4	4.0	5.4	12.2	3.5	7.9	1.7	10.5	4.9	23.2	3.7	7.6	22.9	2.1	4.5	8.9	3.9	5.0	13.9	14.1	11.7	1.0	17.6	4.1	13.6	19.7	9.3	20.4	5.9	33.5	23.0	8.8	8.5	9.9	3.0	4.4	13.2
TAGLN	"DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10"	ENSG00000149591	Transgelin	Q01995	11	117199370-117207464	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 9628.1;intestine: 11712.2"	"Group enriched"	"Detected in many"	4	"Breast myoepithelial cells: 2508.6;Peritubular cells: 2306.4;Sertoli cells: 2866.2;Smooth muscle cells: 4563.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 279.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"intermediate monocyte: 41.6;non-classical monocyte: 63.1"	"Lineage enriched"	"Detected in many"	12	"monocytes: 63.1"	"Cell line enhanced"	"Detected in all"		"BJ: 1913.4;BJ hTERT+ SV40 Large T+: 1641.8;CACO-2: 1531.4;EFO-21: 2145.6;fHDF/TERT166: 2094.4;hTERT-RPE1: 1499.7;LHCN-M2: 1377.1;U-138 MG: 1598.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001447, HPA019467"	Enhanced		Approved	Microtubules,Mitochondria,Cytosol		No	No		6300000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Microtubules, Mitochondria"	Cytosol	"CAB001447: AB_564012, HPA019467: AB_1857245"	"unprognostic (1.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (9.58e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.52e-3)"	2235.7	512.7	118.5	963.9	144.4	12.1	1680.5	126.1	215.9	3611.3	172.5	11712.2	451.2	9628.1	693.9	1954.6	4610.6	893.8	1583.5	119.6	120.4	774.5	302.8	1258.6	245.5	137.0	127.0	1643.4	218.6	65.3	254.6	348.0	129.2	4624.1	1154.6	22.9	461.8	6383.6	356.4	619.8	1948.4	7108.7	127.2	532.0	3148.4	202.5	138.2	52.2	723.2	152.4	59.9	5521.7	2331.2	130.0	17.5	5.5	293.3	8.2	140.0	123.8	226.7	1913.4	788.1	1641.8	609.0	1531.4	28.4	3.2	2145.6	2094.4	1.7	46.1	4.4	16.8	543.3	6.8	4.4	5.0	66.9	130.2	708.7	1.7	5.2	304.6	57.5	267.1	36.1	1499.7	3.3	4.5	3.3	6.7	1377.1	4.5	1.7	15.8	84.6	18.8	2.1	2.7	23.1	12.0	4.4	25.8	1.9	9.6	29.9	11.0	1.5	807.6	9.2	5.1	182.0	1598.8	276.9	14.4	86.6	8.9	8.8	21.7	9.1	7.7	6.2	1.8	2.7	0.1	0.3	41.6	0.5	3.6	0.1	0.0	3.2	5.1	0.2	0.1	0.3	0.0	63.1	1.6	0.5	2.1	118.5	144.4	126.1	215.9	119.6	120.4	137.0	127.0	129.2	127.2	138.2	130.0	264.8	38.5	6.1	4.6	10.3	63.9	453.4	248.6	10.8	9.9	74.0	2508.6	1.3	4.3	22.5	40.5	18.8	57.0	8.6	3.1	0.0	577.8	3.3	14.6	455.5	260.3	3.0	2.7	4.5	74.5	35.3	464.4	41.3	12.8	1.3	32.4	639.7	8.9	41.5	1.7	6.5	18.3	24.4	23.1	91.8	23.9	48.4	33.8	96.0	37.5	8.1	4.9	2.1	3.0	11.9	38.4	4.5	2306.4	3.2	414.0	12.1	2.2	23.0	9.9	2866.2	177.6	4563.9	6.0	13.7	8.6	60.9	32.2	15.1	8.3	3.1	62.0
TBC1D1	"KIAA1108, TBC, TBC1"	ENSG00000065882	"TBC1 domain family member 1"	Q86TI0	4	37891084-38139175	"Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 310.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041816, HPA058158"	Approved		Approved	Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli		"HPA041816: AB_10796784, HPA058158: "	"unprognostic (3.77e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"prognostic favorable (1.47e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.21e-1)"	32.0	10.9	21.6	38.3	19.8	64.2	23.0	14.6	19.7	50.4	44.7	123.8	30.7	139.8	46.4	22.9	61.1	44.6	56.1	26.8	12.3	83.5	26.2	32.4	53.8	17.8	14.3	24.7	28.3	134.2	16.8	41.3	15.4	22.7	28.3	9.6	20.5	40.2	110.0	12.2	35.3	91.2	14.4	39.8	34.3	48.1	13.0	59.0	56.7	149.9	41.3	51.6	23.8	16.8	23.2	26.1	46.7	50.5	16.4	45.3	40.2	61.9	103.6	57.3	58.0	15.0	73.8	118.6	15.0	41.5	72.1	1.0	35.8	45.0	87.6	9.4	20.2	45.9	17.1	31.6	26.2	85.7	50.0	55.4	8.9	35.3	24.4	47.7	89.4	81.6	57.0	19.8	60.3	17.7	119.5	80.5	26.3	3.6	23.6	104.9	75.8	34.7	47.3	42.4	40.7	36.5	23.0	21.1	25.6	104.9	20.5	65.4	61.4	75.1	84.3	19.0	91.4	48.1	63.7	310.4	32.8	76.9	68.2	2.9	7.6	23.2	3.8	25.2	6.2	7.1	3.7	3.1	7.4	9.0	3.3	4.2	20.5	9.7	28.2	6.2	3.3	3.9	21.6	19.8	14.6	19.7	26.8	12.3	17.8	14.3	15.4	14.4	13.0	16.8	38.3	12.8	6.7	50.9	42.0	7.9	14.0	5.0	4.6	12.4	15.1	9.8	73.9	22.8	8.3	27.6	0.0	20.1	30.7	26.0	76.3	13.8	27.6	19.4	27.6	39.9	44.3	11.6	75.9	40.8	27.6	15.5	7.1	25.8	2.5	24.3	27.8	19.8	31.0	10.1	37.7	11.9	36.7	68.6	21.4	50.2	23.3	52.2	10.6	91.8	51.0	9.8	25.7	45.8	9.2	38.7	17.6	19.9	40.7	37.3	13.1	77.3	14.8	1.1	39.5	17.4	79.5	13.0	19.4	3.4	8.7	29.1	32.0	7.4	11.9	35.9
TBX18		ENSG00000112837	"T-box transcription factor 18"	O95935	6	84687351-84764598	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 10.3"	"Cell type enriched"	"Detected in some"	5	"Microglial cells: 91.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 57.4;ASC diff: 39.0;ASC TERT1: 40.4;RH-30: 37.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006807			Supported	Nucleoplasm		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA006807: "	"unprognostic (8.04e-2)"	"unprognostic (7.06e-3)"	"unprognostic (9.71e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.88e-14)"	"unprognostic (4.81e-5)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.78e-1)"	10.3	2.0	1.6	0.9	3.1	0.0	6.1	1.1	3.4	1.9	4.6	0.7	0.1	1.4	0.4	3.1	1.8	1.5	6.6	1.3	1.3	0.4	0.2	0.3	1.8	1.7	1.2	2.7	0.5	0.4	1.6	1.8	1.6	0.6	0.4	0.1	1.6	1.1	1.3	4.7	1.1	0.5	1.5	0.0	0.4	1.0	2.1	0.6	1.7	1.4	0.2	4.5	2.9	1.7	0.0	57.4	0.0	0.0	39.0	40.4	0.0	23.5	11.5	17.4	16.5	0.4	0.0	0.1	0.0	9.8	0.0	3.0	0.0	13.8	14.0	0.0	23.2	0.0	0.0	0.0	5.0	0.0	23.1	17.1	1.3	12.1	25.8	0.0	20.2	0.0	30.7	0.2	12.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	37.3	0.0	0.3	0.0	0.2	1.2	0.0	1.0	9.0	1.4	0.0	31.0	18.2	0.0	4.8	17.6	0.0	0.3	0.0	0.0	10.9	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.1	1.1	3.4	1.3	1.3	1.7	1.2	1.6	1.5	2.1	1.7	1.6	0.0	0.0	0.3	0.0	5.5	0.0	0.4	0.0	0.0	0.2	0.3	2.3	0.0	0.3	0.0	0.0	0.1	0.1	0.2	0.0	0.0	6.9	0.0	0.1	1.6	0.0	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.4	0.0	2.1	6.1	2.3	1.2	0.1	8.8	91.8	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	1.0	0.1	0.2	0.1	0.0	1.6	16.9	0.4	3.1	0.1	4.4	0.1	0.8	0.8	0.3	0.0
TBX2		ENSG00000121068	"T-box transcription factor 2"	Q13207	17	61399843-61409466	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 62.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 134.1;Collecting duct cells: 95.6;Muller glia cells: 139.8;Sertoli cells: 170.9;Smooth muscle cells: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 129.3;MCF7: 78.5;SH-SY5Y: 65.4;SK-MEL-30: 49.3;WM-115: 43.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA008586, CAB013636"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"CAB013636: , HPA008586: AB_1080222"	"unprognostic (6.18e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.50e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.34e-3)"	21.1	3.7	2.9	2.6	3.4	0.0	16.1	2.7	4.6	14.5	1.7	9.8	4.9	22.0	14.1	7.1	15.7	4.5	19.9	2.2	3.2	31.7	4.9	62.8	1.0	3.8	4.1	10.2	3.6	2.1	6.2	24.7	3.8	16.3	1.8	6.3	4.2	27.5	8.1	5.6	11.4	4.6	2.3	13.7	11.5	5.4	3.9	0.8	15.9	5.8	0.5	31.2	13.0	2.2	0.5	1.9	0.0	129.3	4.2	4.4	15.6	22.4	21.2	1.0	0.2	3.6	0.4	0.0	1.6	3.3	2.5	0.0	2.4	0.0	0.4	0.0	8.8	2.2	0.0	6.4	14.0	0.4	2.1	8.0	0.2	23.4	1.3	0.3	0.0	0.0	0.5	0.0	1.4	78.5	0.0	0.4	0.1	0.0	9.4	0.0	5.3	0.2	0.0	31.0	0.3	65.4	0.0	0.0	49.3	0.2	1.6	2.5	0.0	2.9	0.0	7.3	4.7	0.1	0.3	0.0	17.6	0.0	43.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.4	2.7	4.6	2.2	3.2	3.8	4.1	3.8	2.3	3.9	2.2	12.7	0.0	0.6	2.3	0.1	0.6	0.3	0.0	0.0	134.1	0.4	1.1	11.1	0.0	0.0	95.6	22.9	0.4	0.5	0.0	1.9	0.1	0.8	1.4	45.7	12.2	0.0	0.0	0.1	0.0	0.4	13.7	0.5	1.6	0.0	0.1	12.1	0.0	0.9	1.7	0.0	0.0	0.0	1.0	1.8	1.1	39.4	1.1	1.8	5.6	0.0	139.8	0.0	0.0	0.1	0.0	0.0	47.4	0.0	0.5	0.0	25.1	0.0	13.4	170.9	0.8	104.0	0.4	0.7	0.1	0.3	0.3	0.9	1.1	0.0	0.2
TCEAL1	"p21, pp21, SIIR, WEX9"	ENSG00000172465	"Transcription elongation factor A like 1"	Q15170	X	103628704-103630953	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Leydig cells: 283.6;Peritubular cells: 387.8;Sertoli cells: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057345, HPA060384, HPA076762"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA057345: , HPA060384: AB_2732648, HPA076762: "	"unprognostic (1.98e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.60e-3)"	"unprognostic (6.09e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.85e-3)"	"unprognostic (6.54e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.56e-2)"	"unprognostic (8.76e-2)"	34.9	54.7	33.9	13.8	35.6	9.9	39.4	33.6	47.1	107.9	32.6	61.1	15.2	140.8	40.3	37.8	114.3	34.8	32.2	36.0	37.8	25.1	19.0	30.5	14.1	31.7	31.4	174.8	20.3	31.9	33.9	17.8	35.2	63.3	16.8	14.7	16.1	79.3	55.1	17.3	29.2	95.0	31.4	26.2	40.3	20.1	35.8	12.2	31.9	33.6	9.8	97.9	58.3	33.6	21.8	20.6	11.4	15.8	48.2	33.2	15.2	30.2	30.3	28.9	31.2	9.1	21.1	10.0	30.4	39.3	43.9	21.2	19.2	16.0	21.4	0.0	23.9	13.6	27.2	17.8	21.7	0.1	19.7	40.9	30.4	22.4	12.3	47.7	30.1	11.4	5.1	5.5	58.7	24.1	12.1	0.3	3.8	19.3	32.9	12.4	36.8	0.1	40.4	21.3	15.7	13.2	30.6	14.4	35.4	8.3	13.5	12.7	24.0	20.9	7.7	49.3	15.7	5.4	18.6	0.3	27.4	0.1	21.3	26.8	13.2	0.8	15.3	9.4	22.5	31.9	13.7	12.9	26.4	24.9	18.2	20.8	1.4	22.6	4.0	20.9	13.2	12.8	33.9	35.6	33.6	47.1	36.0	37.8	31.7	31.4	35.2	31.4	35.8	33.6	26.5	16.0	31.2	9.4	10.4	29.7	52.7	38.4	24.5	21.8	47.3	42.8	32.9	28.6	37.2	25.8	2.1	30.0	8.9	6.2	56.7	22.9	2.5	27.5	50.0	32.2	27.6	9.1	22.1	24.6	29.8	37.4	7.7	21.9	26.6	22.7	46.1	19.7	34.7	21.9	20.4	13.2	30.5	21.0	23.1	11.7	283.6	16.5	19.6	6.5	19.7	38.6	19.6	16.6	10.3	11.7	17.5	387.8	5.1	18.4	15.0	52.8	48.0	12.3	151.2	32.6	45.3	6.0	8.5	15.5	21.3	7.3	11.3	32.5	19.4	17.6
TCEAL7	"MGC23947, WEX5"	ENSG00000182916	"Transcription elongation factor A like 7"	Q9BRU2	X	103330229-103332326	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 126.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 42.9;Fibroblasts: 55.2;Horizontal cells: 48.8;Leydig cells: 43.8;Muller glia cells: 88.3;Oligodendrocytes: 46.5;Peritubular cells: 39.1;Skeletal myocytes: 48.3;Smooth muscle cells: 38.7"	"Cancer enriched"	"Detected in many"	10	"glioma: 39.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 83.8;BJ hTERT+ SV40 Large T+ RasG12V: 75.1;GAMG: 115.3;hTEC/SVTERT24-B: 83.8;LHCN-M2: 72.0;SCLC-21H: 210.1;U-87 MG: 78.9"	"Low region specificity"	"Detected in many"							"HPA051507, HPA065080"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA051507: AB_2681512, HPA065080: AB_2685419"	"unprognostic (1.09e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (4.31e-4)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.62e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.35e-3)"	7.7	27.9	72.4	4.3	73.0	0.0	9.1	75.1	126.3	26.3	40.5	18.6	4.0	48.2	18.3	5.5	17.0	11.9	14.0	72.1	84.5	5.0	2.4	6.1	2.3	80.8	77.5	29.0	1.2	1.1	37.4	2.1	82.3	12.3	7.8	23.5	3.5	13.2	3.7	1.8	8.3	29.9	74.5	5.8	6.5	3.1	77.2	5.1	3.8	9.9	1.4	9.7	15.6	96.0	0.0	0.0	83.8	0.0	36.3	55.5	15.0	12.0	61.9	26.4	75.1	0.0	0.0	0.0	0.0	12.9	115.3	0.0	0.0	1.8	45.5	0.0	0.8	0.3	0.0	0.0	18.2	0.0	0.1	46.6	0.0	83.8	0.1	0.0	27.6	0.0	0.5	0.2	72.0	0.0	0.1	0.3	0.3	0.1	0.0	0.0	53.1	0.3	0.0	0.0	210.1	56.6	0.0	0.4	0.0	0.4	0.0	0.0	0.0	38.8	1.4	0.6	0.0	0.0	0.0	0.0	78.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	72.4	73.0	75.1	126.3	72.1	84.5	80.8	77.5	82.3	74.5	77.2	96.0	4.8	0.0	1.3	5.9	0.0	2.5	5.3	0.3	1.2	36.4	0.9	19.2	13.6	0.0	0.7	3.7	4.2	1.4	0.1	0.0	5.9	0.2	0.2	1.0	42.9	5.2	0.0	0.0	21.2	0.0	0.7	55.2	0.0	0.7	0.0	19.2	1.8	0.0	0.7	48.8	26.5	0.0	0.0	0.0	4.0	1.8	43.8	0.6	8.8	4.7	0.0	88.3	0.0	19.6	46.5	0.3	0.0	39.1	0.1	1.1	0.0	2.1	0.0	12.9	13.1	48.3	38.7	3.0	1.5	0.8	3.1	0.3	0.5	5.1	0.0	0.8
TCF23	"bHLHa24, OUT"	ENSG00000163792	"Transcription factor 23"	Q7RTU1	2	27149004-27156974	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"endometrium 1: 51.2;fallopian tube: 24.6;ovary: 18.5;smooth muscle: 20.4"	"Cell type enhanced"	"Detected in some"		"Leydig cells: 10.5;Peritubular cells: 29.0;Sertoli cells: 52.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	12	"THP-1: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044596			Approved	"Nuclear speckles"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"HPA044596: AB_10797258"	"unprognostic (1.04e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.41e-5)"	"unprognostic (7.58e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.58e-4)"	"unprognostic (2.64e-2)"	0.4	0.0	0.2	0.0	0.2	0.2	0.0	0.5	0.4	4.6	0.2	0.2	0.1	51.2	5.8	0.0	24.6	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.1	18.5	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.5	0.2	0.1	0.1	20.4	0.0	2.3	0.1	2.6	0.2	0.0	0.0	0.0	0.0	0.2	2.9	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.2	0.2	0.1	0.2	0.3	0.3	0.2	0.0	0.4	0.3	0.2	1.1	0.3	0.1	0.4	0.1	0.0	0.2	0.2	0.5	0.4	0.3	0.2	0.1	0.1	0.3	0.0	0.2	0.5	0.1	0.0	2.2	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.3	0.3	0.7	0.0	0.6	0.0	2.1	0.0	0.2	0.1	0.0	0.0	1.7	0.2	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	1.3	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	10.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.7	0.0	0.1	0.0	0.6	52.6	1.0	1.5	0.3	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.6
TGFB1I1	"ARA55, Hic-5, TSC-5"	ENSG00000140682	"Transforming growth factor beta 1 induced transcript 1"	O43294	16	31471585-31477960	"Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 265.6;intestine: 264.4"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 92.2;Peritubular cells: 179.0;Sertoli cells: 223.5;Smooth muscle cells: 176.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 9.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 100.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB020844	Enhanced		Supported	"Focal adhesion sites,Cytosol"		NA	NA		800000	"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Focal adhesion sites"	Cytosol	"CAB020844: "	"unprognostic (5.80e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.06e-8)"	"unprognostic (1.06e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.73e-5)"	65.5	17.0	4.8	22.7	5.1	1.0	52.8	4.6	6.9	119.0	4.4	264.4	14.5	265.6	12.4	38.2	143.2	14.4	48.5	4.6	4.7	26.6	9.7	54.7	4.8	5.6	4.6	78.6	8.2	8.6	8.2	19.7	5.0	87.6	23.9	0.7	21.0	80.8	13.1	28.5	61.7	106.1	4.7	33.0	78.5	10.2	5.1	1.4	26.8	10.5	4.9	171.1	73.6	4.4	13.3	16.6	25.9	0.0	25.4	46.1	0.3	70.8	64.8	43.6	30.1	6.6	4.5	0.0	65.1	62.3	29.1	20.6	6.0	13.3	56.4	0.1	0.3	17.5	29.1	3.7	67.4	0.0	19.8	31.1	18.7	27.5	16.3	100.0	29.2	0.0	1.5	0.0	51.9	0.1	0.0	1.6	1.4	1.4	16.2	0.0	30.9	0.1	12.5	6.6	0.0	19.0	27.5	0.2	14.1	20.9	0.1	1.7	82.4	79.8	19.2	21.4	31.8	0.1	0.1	0.2	34.9	0.8	49.6	9.5	0.0	0.1	0.2	0.0	0.3	0.9	0.9	0.1	0.0	0.2	0.1	0.6	0.2	0.0	0.0	0.3	1.6	1.3	4.8	5.1	4.6	6.9	4.6	4.7	5.6	4.6	5.0	4.7	5.1	4.4	76.9	6.4	4.8	0.0	0.4	12.6	23.9	34.8	14.8	0.4	4.1	71.5	13.4	5.7	3.4	7.3	0.0	1.2	1.5	1.8	7.9	33.3	1.2	3.6	76.2	48.8	0.0	11.0	0.1	22.5	1.2	64.4	4.6	2.9	6.3	35.3	29.6	0.3	14.6	0.0	0.1	4.7	0.0	0.3	15.4	3.3	92.2	9.3	40.9	2.8	4.2	7.0	0.0	3.5	0.1	28.4	2.2	179.0	1.4	20.1	13.3	19.7	1.1	1.4	223.5	17.4	176.0	1.5	3.6	1.9	11.2	1.8	2.6	20.3	5.3	4.6
TIMP3	SFD	ENSG00000100234	"TIMP metallopeptidase inhibitor 3"	P35625	22	32801705-32863041	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision"	"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1663.5;Fibroblasts: 967.5;Leydig cells: 1398.6;Peritubular cells: 1934.1;Sertoli cells: 2327.1;Smooth muscle cells: 1116.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 502.6;BJ: 1173.0;BJ hTERT+: 514.7;fHDF/TERT166: 1073.7;WM-115: 893.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068391			Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		700000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	"Golgi apparatus"	"HPA068391: "	"unprognostic (4.98e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.53e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.42e-2)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (3.92e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.11e-2)"	805.5	288.7	71.7	41.4	74.9	1.1	556.9	68.7	72.6	376.1	221.0	190.4	30.5	393.3	230.4	168.1	373.9	153.5	532.8	64.3	79.2	248.0	92.0	625.1	69.5	83.2	86.7	116.2	81.1	139.5	139.1	999.5	76.0	178.8	81.2	31.7	178.7	341.1	128.1	170.3	122.1	379.6	70.3	187.2	152.1	64.1	106.2	41.1	340.1	325.9	28.8	197.4	261.1	59.5	19.6	0.0	16.9	2.7	502.6	280.6	1.0	1173.0	514.7	94.1	110.8	20.5	0.3	0.1	28.1	1073.7	3.6	18.3	3.2	48.4	135.0	0.1	14.3	147.4	23.5	52.4	197.4	0.1	59.7	47.4	120.4	166.9	9.5	3.4	0.0	0.0	0.1	0.9	44.6	1.2	0.4	5.0	2.5	0.0	0.8	0.1	3.4	0.4	2.1	97.0	12.5	16.8	24.1	0.5	322.9	266.6	0.7	1.3	0.0	7.9	25.2	245.9	19.1	0.2	0.4	0.4	232.3	0.2	893.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	71.7	74.9	68.7	72.6	64.3	79.2	83.2	86.7	76.0	70.3	106.2	59.5	1663.5	365.4	35.9	101.9	5.3	77.4	766.2	49.5	10.2	4.0	31.2	177.2	279.9	14.3	22.2	51.5	4.2	492.2	4.6	0.3	3.9	2.5	14.9	27.9	747.6	677.3	1.8	35.3	26.1	0.7	433.7	967.5	21.4	23.9	89.2	11.4	743.9	102.0	109.2	3.3	15.7	0.0	24.4	39.3	95.0	57.7	1398.6	28.6	76.5	116.2	0.7	146.6	0.0	52.3	0.8	0.9	0.0	1934.1	9.5	159.5	0.0	15.5	8.5	5.5	2327.1	339.2	1116.6	6.2	7.0	14.3	56.4	809.0	21.5	4.8	0.7	163.4
TMEM200B	TTMB	ENSG00000253304	"Transmembrane protein 200B"	Q69YZ2	1	29119429-29123903	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 60.6"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 8.8;Fibroblasts: 6.1;Leydig cells: 12.8;Melanocytes: 8.8;Peritubular cells: 15.1;Sertoli cells: 6.6;Smooth muscle cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 28.2;BJ hTERT+ SV40 Large T+: 26.7;BJ hTERT+ SV40 Large T+ RasG12V: 29.5;fHDF/TERT166: 29.0;HBF TERT88: 25.3"	"Low region specificity"	"Detected in all"							HPA055254	Uncertain					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA055254: AB_2682760"	"unprognostic (2.55e-1)"	"unprognostic (2.12e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-3)"	16.8	4.4	2.0	4.0	6.3	0.0	11.8	6.9	3.3	47.2	6.6	29.5	2.3	60.6	7.8	5.6	21.5	7.3	7.0	1.9	2.4	9.4	8.4	10.5	1.2	2.2	2.1	33.3	2.5	26.1	3.6	6.5	2.2	24.6	4.1	0.3	4.1	39.7	2.2	5.8	9.2	35.1	2.0	6.4	6.4	13.3	2.6	1.0	5.0	2.6	1.3	20.9	24.3	2.1	21.0	0.0	3.4	0.0	28.2	23.4	1.1	14.4	22.6	26.7	29.5	1.1	2.3	0.0	3.5	29.0	9.8	0.4	2.3	0.0	25.3	0.1	0.9	0.1	5.7	1.8	19.6	0.0	0.1	12.5	2.7	20.1	3.9	1.1	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.3	1.9	0.0	5.8	0.0	0.0	0.0	0.3	0.1	0.0	1.7	20.7	0.0	0.1	9.5	0.0	0.0	0.0	9.4	0.4	19.9	0.4	0.0	0.0	0.0	11.6	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.3	6.9	3.3	1.9	2.4	2.2	2.1	2.2	2.0	2.6	2.1	2.0	3.2	0.6	0.7	0.2	1.9	0.4	0.2	2.8	0.8	0.6	1.8	1.0	1.5	0.7	0.0	2.1	0.1	0.2	0.1	0.0	0.0	0.1	1.0	8.8	1.3	0.0	0.0	0.3	0.0	0.5	6.1	0.0	0.6	0.0	0.0	1.1	1.2	0.1	0.0	0.1	0.0	0.0	0.0	1.2	2.4	12.8	0.1	8.8	1.9	0.1	0.1	0.0	0.0	0.1	0.0	0.1	15.1	0.0	0.3	0.0	5.9	0.4	1.9	6.6	1.1	9.5	0.3	0.6	0.2	0.6	0.5	0.4	0.0	0.0	0.3
TMEM47	"BCMP1, DKFZp564E153, DKFZP761J17121, TM4SF10, VAB-9"	ENSG00000147027	"Transmembrane protein 47"	Q9BQJ4	X	34627075-34657285	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 110.7;Astrocytes: 85.5;Leydig cells: 74.3;Muller glia cells: 148.0;Peritubular cells: 92.9;Sertoli cells: 92.1;Skeletal myocytes: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 112.6;fHDF/TERT166: 348.1;RPTEC TERT1: 83.6;U-2197: 74.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046658	Approved		Approved	"Nuclear membrane"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear membrane"		"HPA046658: AB_2679742"	"unprognostic (1.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.74e-3)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.67e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.36e-1)"	"prognostic favorable (4.05e-6)"	"unprognostic (2.69e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.94e-2)"	40.0	20.8	34.8	8.5	38.3	0.0	18.8	27.1	39.5	46.7	41.6	25.9	8.6	45.7	33.4	34.6	35.1	28.6	36.1	30.8	35.8	27.7	24.8	21.9	6.2	36.5	38.7	21.7	11.3	5.6	6.6	1.2	33.7	32.9	14.9	17.8	29.6	45.6	23.8	6.3	11.5	51.0	37.8	7.5	13.8	4.9	39.5	3.1	20.2	31.1	4.2	36.2	20.1	33.4	0.0	1.7	50.7	21.4	43.8	33.1	0.0	112.6	0.3	21.8	18.7	0.1	0.0	0.0	9.2	348.1	0.0	0.1	14.5	4.0	32.0	0.0	9.9	0.0	13.2	0.0	25.3	0.0	0.0	30.0	0.1	8.9	9.7	38.9	24.8	0.0	0.0	0.0	41.6	0.9	0.0	0.0	6.0	0.6	0.3	0.0	25.3	0.0	83.6	33.0	0.5	0.0	0.1	1.3	0.0	5.4	0.2	0.0	0.9	44.0	4.4	74.4	4.8	0.0	0.0	0.0	18.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	38.3	27.1	39.5	30.8	35.8	36.5	38.7	33.7	37.8	39.5	33.4	110.7	19.2	0.6	85.5	0.1	8.2	15.9	0.9	1.8	8.3	10.8	12.7	27.7	10.0	1.5	16.5	6.2	0.0	0.6	0.0	7.9	0.8	0.4	7.6	4.6	29.8	0.0	0.0	4.3	5.3	0.2	48.3	1.1	6.2	2.5	0.7	46.4	17.5	0.1	30.3	25.6	0.0	0.0	0.8	11.7	3.8	74.3	1.2	65.8	13.1	0.0	148.0	0.0	5.0	2.2	3.0	0.0	92.9	0.1	14.3	0.0	13.4	2.0	7.3	92.1	84.7	67.1	0.3	2.1	1.9	5.3	0.1	0.7	0.8	0.0	12.1
TMEM74B	"C20orf46, FLJ11190"	ENSG00000125895	"Transmembrane protein 74B"	Q9NUR3	20	1180561-1185415	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 27.6"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 15.6;Horizontal cells: 18.5;Inhibitory neurons: 16.3;Paneth cells: 15.6;Proximal enterocytes: 21.1;Sertoli cells: 19.7;Smooth muscle cells: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.3;Hep G2: 9.2;K-562: 16.8;Karpas-707: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045213	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Golgi apparatus"		"HPA045213: AB_10961999"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-4)"	"unprognostic (9.58e-2)"	"prognostic favorable (3.07e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.55e-7)"	"unprognostic (1.20e-1)"	"unprognostic (9.77e-2)"	"unprognostic (8.37e-2)"	"unprognostic (5.07e-3)"	5.8	2.0	17.5	1.0	16.2	0.2	4.9	10.3	19.4	1.9	8.8	4.0	18.2	2.0	0.8	4.0	7.4	3.9	11.2	13.5	16.6	4.5	4.7	27.6	2.0	19.8	13.2	1.0	2.0	7.1	10.1	17.2	18.2	3.1	1.8	3.9	6.3	15.7	5.1	9.8	23.1	2.0	10.8	2.8	4.1	4.1	17.8	0.3	4.1	2.2	1.2	1.2	2.0	11.5	0.0	4.4	2.5	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.3	0.6	0.1	0.9	0.0	2.7	0.3	3.4	0.4	0.1	0.0	4.2	1.1	0.0	9.2	0.0	0.0	1.2	0.0	0.9	0.0	0.1	0.1	0.1	0.6	16.8	7.1	0.0	0.0	0.1	0.0	3.0	1.2	0.3	0.0	0.2	0.0	0.7	0.6	0.5	1.9	0.1	0.0	0.1	0.9	0.0	0.0	1.7	0.0	2.9	0.0	0.1	2.7	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	16.2	10.3	19.4	13.5	16.6	19.8	13.2	18.2	10.8	17.8	11.5	3.7	0.0	0.0	0.7	0.1	0.3	0.7	0.9	0.6	10.5	2.2	1.0	2.3	0.0	0.2	0.0	0.0	0.2	0.2	1.0	0.0	0.5	1.0	0.2	0.1	3.3	15.6	0.0	9.7	0.2	1.8	0.8	2.6	0.1	0.0	0.5	4.6	0.8	0.0	18.5	16.3	9.9	2.0	0.6	0.7	0.7	0.0	1.4	1.8	1.9	1.0	0.5	0.0	0.0	1.1	0.9	15.6	0.0	0.1	0.7	21.1	0.6	1.2	4.0	19.7	0.4	13.3	0.2	2.7	0.2	0.9	1.4	0.2	0.3	3.9	0.3
TMSB15B		ENSG00000269226	"Thymosin beta 15B"		X	104063871-104076212	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"ovary: 8.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 13.3;Basal respiratory cells: 12.8;Ionocytes: 20.3;Langerhans cells: 9.3;Melanocytes: 14.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 10.9;AN3-CA: 10.2;Karpas-707: 11.0"															NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (5.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.89e-2)"		"unprognostic (1.04e-1)"	"unprognostic (3.12e-1)"	"unprognostic (6.46e-2)"	"unprognostic (9.11e-3)"	"unprognostic (2.61e-2)"	"unprognostic (4.07e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.07e-2)"	1.5	0.5	1.6	1.6	1.5	1.2	1.5	4.1	1.9	4.8	0.6	2.0	0.5	4.3	1.2	1.0	3.0	1.6	1.1	1.4	2.0	0.5	0.1	0.9	1.8	1.1	1.6	8.7	0.4	1.2	1.0	0.5	1.4	2.1	1.0	2.1	0.8	1.3	0.3	1.0	1.6	2.1	1.2	1.2	1.2	0.7	2.2	3.0	0.7	0.2	1.7	2.1	3.0	1.5	0.0	0.4	10.9	10.2	1.8	2.7	0.3	3.1	1.6	1.7	2.3	0.5	0.2	2.3	1.1	0.8	2.0	0.1	0.1	0.0	2.1	1.2	2.1	0.6	0.2	0.0	1.0	0.3	1.0	1.8	0.5	1.8	0.5	6.1	3.2	2.7	0.2	11.0	2.7	0.6	7.1	0.1	2.9	0.0	1.7	6.4	2.6	1.5	2.3	1.7	1.8	7.4	0.2	0.0	0.4	3.2	0.1	1.0	6.2	3.4	1.8	1.7	2.7	0.8	0.0	2.1	1.4	0.5	1.6	0.8	0.1	0.1	0.2	0.1	0.1	0.7	0.2	0.2	0.1	0.4	0.6	0.5	0.3	0.9	0.1	0.3	0.1	0.2	1.6	1.5	4.1	1.9	1.4	2.0	1.1	1.6	1.4	1.2	2.2	1.5	1.6	0.0	0.0	1.0	2.7	13.3	1.4	12.8	3.4	0.6	1.0	0.9	0.3	0.0	4.2	1.8	0.0	0.1	1.3	0.4	0.0	0.4	0.1	2.9	3.0	1.4	3.0	1.7	2.8	1.2	0.0	5.4	4.1	0.7	1.3	4.6	0.4	0.1	0.2	1.7	2.7	0.2	20.3	0.3	9.3	0.0	2.8	0.2	14.2	0.0	0.6	1.7	2.1	1.5	0.8	0.9	0.1	3.4	2.5	0.7	0.0	0.1	0.5	0.6	0.0	0.5	4.4	0.6	0.6	1.7	6.1	0.1	2.7	2.6	0.6	0.3
TNN	TNW	ENSG00000120332	"Tenascin N"	Q9UQP3	1	175067833-175148075	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 12.0;breast: 4.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 6.1;Fibroblasts: 7.5;Hepatic stellate cells: 2.5;Langerhans cells: 2.5;Smooth muscle cells: 10.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.6;NB-4: 3.6;THP-1: 11.1;U-266/70: 2.7;U-937: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB010907, HPA026726, HPA026764"	Uncertain				"Secreted to extracellular matrix"	NA	NA		34000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB010907: AB_477565, HPA026726: AB_10601771, HPA026764: AB_10601859"	"unprognostic (1.16e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.69e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.76e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.02e-2)"	12.0	0.2	0.0	0.1	0.1	0.0	4.9	0.0	0.1	0.1	0.1	0.3	0.8	0.0	0.0	0.1	0.0	1.7	0.3	0.2	0.0	0.4	1.3	0.4	0.1	0.0	0.1	0.0	0.3	0.8	2.0	0.1	0.0	0.0	0.1	0.0	3.2	0.0	0.0	3.1	0.4	0.4	0.1	0.4	0.4	0.1	0.1	0.1	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	11.1	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	6.1	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.7	0.0	0.1	7.5	0.0	0.1	0.0	0.0	2.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	10.4	0.4	1.4	0.0	1.8	0.1	0.1	0.0	0.0	0.1
TNS1	"DKFZp586K0617, MXRA6, PPP1R155, TNS"	ENSG00000079308	"Tensin 1"	Q9HBL0	2	217799588-218033982	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 173.1;Cardiomyocytes: 339.0;Leydig cells: 169.6;Peritubular cells: 504.0;Sertoli cells: 368.1;Smooth muscle cells: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 135.1;ASC TERT1: 74.1;fHDF/TERT166: 66.6;REH: 75.4;TIME: 63.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018774, HPA036089, HPA036090"	Approved		Enhanced	"Focal adhesion sites"		NA	NA		47000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Focal adhesion sites"		"CAB018774: AB_2207032, HPA036089: AB_10796111, HPA036090: AB_10794322"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (4.13e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.57e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.71e-3)"	"unprognostic (5.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.49e-2)"	"prognostic unfavorable (5.19e-4)"	248.2	60.3	51.6	42.9	98.0	42.3	100.9	71.7	45.5	99.5	45.1	373.4	23.4	253.7	44.3	117.8	136.2	80.4	170.4	34.0	53.4	74.6	39.6	117.2	11.5	82.3	79.2	110.4	55.2	33.2	15.4	54.5	106.4	126.1	41.7	7.7	52.9	225.0	171.6	47.8	78.9	178.0	72.2	70.1	115.2	23.5	80.9	21.5	65.8	207.2	7.5	228.4	82.6	82.9	0.3	0.4	8.9	0.1	135.1	74.1	0.8	22.9	7.8	1.3	0.9	10.0	0.1	0.0	13.1	66.6	1.5	1.7	1.4	1.3	0.7	9.4	0.8	19.8	5.7	2.6	9.8	0.1	2.3	35.2	0.0	24.4	0.2	43.6	32.2	0.1	0.6	2.6	18.8	4.4	0.1	1.4	0.9	0.2	0.4	75.4	16.8	1.0	4.8	0.2	2.1	10.1	3.9	9.7	2.0	6.1	3.1	8.5	63.2	16.6	29.5	17.5	4.9	1.1	0.1	0.1	9.8	2.7	1.2	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.8	51.6	98.0	71.7	45.5	34.0	53.4	82.3	79.2	106.4	72.2	80.9	82.9	93.3	173.1	85.9	29.7	1.1	16.2	48.6	29.5	42.1	4.8	7.2	21.2	339.0	38.6	27.5	14.7	0.0	8.7	0.5	0.1	7.9	36.1	2.2	3.0	29.5	76.6	0.0	143.1	3.9	19.1	1.5	52.4	1.1	3.8	30.4	8.8	71.7	38.5	13.0	42.1	5.3	0.0	6.1	15.3	19.3	11.9	169.6	16.7	10.6	32.8	1.3	14.1	0.0	15.6	52.0	17.0	0.0	504.0	0.4	12.1	0.0	26.1	22.3	1.3	368.1	29.7	183.5	1.1	1.9	5.7	11.8	1.9	4.1	20.7	0.2	17.3
TPM2	"AMCD1, DA1, NEM4"	ENSG00000198467	"Tropomyosin 2"	P07951	9	35681992-35690056	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 39012.3;tongue: 16773.7"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 1066.2;Peritubular cells: 2072.1;Sertoli cells: 2222.0;Smooth muscle cells: 2341.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	812	"plasmacytoid DC: 398.6"	"Lineage enriched"	"Detected in single"	920	"dendritic cells: 398.6"	"Cell line enhanced"	"Detected in many"		"BJ: 2309.6;fHDF/TERT166: 1289.0;hTERT-RPE1: 1399.1"									"HPA047089, HPA053624"	Approved					NA	NA		140000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (5.56e-2)"	"unprognostic (5.37e-2)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.56e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (8.51e-10)"	"unprognostic (1.43e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-2)"	331.1	285.0	88.0	411.0	89.8	16.7	260.8	92.5	117.3	651.3	127.3	3498.4	217.7	1928.1	201.9	1018.0	849.7	442.4	788.5	84.8	81.1	144.0	41.0	283.1	62.2	86.1	79.2	388.4	73.7	24.1	82.6	142.3	80.5	1219.0	238.0	8.0	393.6	1988.7	39012.3	148.5	636.2	2340.8	78.6	140.1	1252.6	82.9	83.3	26.3	138.9	16773.7	21.2	1630.1	454.9	79.8	375.4	291.2	213.9	33.6	335.4	893.3	129.3	2309.6	934.4	983.0	667.9	12.2	24.2	0.4	213.0	1289.0	144.6	9.2	3.7	291.2	457.0	716.2	10.8	9.1	1054.1	11.8	540.2	2.3	102.7	1067.7	44.9	738.8	0.4	1399.1	235.7	25.3	5.6	0.8	1052.1	15.3	2.7	29.1	269.6	1.5	17.0	18.5	391.5	3.0	31.1	7.2	3.8	13.3	470.0	7.9	18.2	273.8	6.8	27.7	30.0	16.5	585.7	11.6	730.6	0.6	2.7	2.9	34.0	6.5	29.2	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.3	0.4	0.0	0.1	0.0	0.4	0.2	0.0	398.6	0.0	2.1	88.0	89.8	92.5	117.3	84.8	81.1	86.1	79.2	80.5	78.6	83.3	79.8	110.0	3.2	4.1	10.4	5.9	57.1	81.2	274.1	24.5	0.8	29.9	1066.2	619.5	4.3	42.1	7.3	0.0	12.1	116.7	1.4	0.0	21.4	4.3	20.3	488.3	80.3	2.4	4.0	2.5	5.7	104.8	332.6	99.4	18.7	2.5	142.0	181.3	1.4	32.4	1.7	4.6	1.9	48.8	3.1	77.9	32.4	283.0	24.2	67.6	9.4	6.5	11.7	1.0	3.0	0.4	8.4	0.1	2072.1	2.9	169.8	0.4	1.3	23.5	0.9	2222.0	594.8	2341.4	2.5	27.3	6.7	42.8	14.6	16.0	106.7	2.8	28.7
TYRP1	"b-PROTEIN, CAS2, CATB, GP75, OCA3, TRP, TYRP"	ENSG00000107165	"Tyrosinase related protein 1"	P17643	9	12685439-12710285	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Melanin biosynthesis"	"Monooxygenase, Oxidoreductase"	"Albinism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"choroid plexus: 44.8;heart muscle: 59.9;skin 1: 145.0"	"Cell type enriched"	"Detected in some"	17	"Melanocytes: 2486.6"	"Cancer enriched"	"Detected in some"	262	"melanoma: 313.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	55	"SK-MEL-30: 1395.0"	"Group enriched"	"Detected in some"	5	"olfactory bulb: 4.6;thalamus: 1.8"	"Low region specificity"	"Detected in all"			"HPA000937, CAB002520"	Enhanced		Approved	Vesicles		NA	NA		51000		"Cluster 61: Skin - Cornification"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"CAB002520: AB_564153, HPA000937: AB_1080437"	"unprognostic (7.48e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.10e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.25e-3)"	"unprognostic (4.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.68e-6)"	"unprognostic (1.27e-1)"	"unprognostic (5.99e-2)"		"unprognostic (1.95e-2)"	0.3	0.0	0.1	0.6	0.4	0.2	4.9	0.3	0.9	0.0	44.8	2.2	5.0	0.0	1.2	10.0	0.2	4.5	59.9	2.6	0.0	16.2	0.0	3.7	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.1	2.1	0.1	5.3	2.7	1.3	0.0	4.8	145.0	4.7	1.8	0.1	0.0	2.1	1.1	0.3	0.0	0.0	7.5	0.0	1.1	0.4	1.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	25.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.0	4.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	1395.0	0.1	19.5	1.5	0.0	0.0	0.7	0.0	0.9	0.0	0.7	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.9	2.6	0.0	1.2	1.1	2.1	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	92.3	0.1	0.0	0.0	11.7	0.0	0.0	44.3	0.0	0.0	3.7	2.1	0.0	0.0	0.0	144.8	0.3	2.5	0.0	0.0	1.3	0.0	0.0	0.9	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	17.5	4.7	0.3	0.0	2486.6	0.0	0.0	15.9	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.6	0.0	0.0	1.4	0.7	0.7	0.0	16.8	0.0	0.5	0.0	0.0	0.2
U2AF1	"RN, RNU2AF1, U2AF35, U2AFBP"	ENSG00000160201	"U2 small nuclear RNA auxiliary factor 1"	Q01081	21	43092956-43107570	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 492.9;Basal respiratory cells: 406.9;Ionocytes: 266.5;Langerhans cells: 374.7;Suprabasal keratinocytes: 433.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 607.7"	"Low region specificity"	"Detected in all"							"HPA044833, HPA052083"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA044833: AB_10960990, HPA052083: AB_2681720"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.29e-4)"	"unprognostic (4.81e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.14e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-2)"	62.9	47.6	36.8	31.1	39.9	85.9	58.7	39.8	46.9	57.6	38.0	79.3	25.8	68.9	27.8	64.3	60.8	18.7	43.0	37.7	41.1	42.8	48.0	57.3	45.2	39.3	40.2	69.3	41.8	32.7	60.1	34.6	38.5	48.0	26.8	28.9	49.1	40.8	74.9	47.5	57.2	35.8	38.3	65.4	58.2	54.4	38.8	61.8	62.6	24.8	55.9	60.7	50.7	40.8	101.1	27.7	250.5	71.3	28.7	38.8	248.1	88.2	82.4	105.4	115.3	486.0	59.8	20.8	35.1	54.3	125.6	33.0	161.1	36.3	104.9	114.6	134.0	607.7	61.2	117.9	77.0	264.0	115.2	45.5	90.6	177.1	100.6	43.5	62.8	238.0	105.8	113.4	97.2	324.4	271.1	358.1	287.6	123.4	108.3	485.1	166.9	211.9	99.8	15.4	125.9	77.6	212.6	98.6	147.6	36.5	125.5	147.5	12.1	79.2	59.6	82.0	236.3	191.4	178.3	48.8	80.3	333.6	118.6	211.9	141.0	153.1	101.2	140.4	106.7	140.2	112.7	95.5	150.4	134.2	112.9	109.1	213.1	93.1	196.9	240.7	149.3	188.7	36.8	39.9	39.8	46.9	37.7	41.1	39.3	40.2	38.5	38.3	38.8	40.8	9.5	19.2	18.1	3.9	37.8	492.9	32.5	406.9	86.6	23.9	5.7	2.8	5.0	17.2	153.5	1.8	43.8	19.5	15.3	16.5	1.9	5.2	3.1	4.2	4.4	51.7	18.2	45.0	5.2	6.0	20.7	51.8	44.4	4.2	28.4	3.8	31.8	16.2	23.2	18.5	4.6	17.0	266.5	33.0	374.7	4.1	18.3	30.6	202.7	4.7	19.3	13.0	27.8	3.0	6.2	4.8	17.0	22.6	60.3	31.1	43.2	3.1	107.6	60.7	6.6	39.1	110.7	16.4	18.9	79.8	433.6	23.8	46.6	1.3	20.2	39.1
UBA2	"FLJ13058, HRIHFB2115, SAE2"	ENSG00000126261	"Ubiquitin like modifier activating enzyme 2"	Q9UBT2	19	34428352-34471251	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 269.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA041436	Supported		Supported	Nucleoplasm		NA	NA		130000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA041436: AB_2677479"	"unprognostic (2.37e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.39e-3)"	"unprognostic (8.72e-3)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (1.96e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-1)"	91.3	36.8	35.9	37.1	37.1	54.9	67.7	44.6	53.1	52.4	35.1	41.6	27.4	55.3	34.8	43.6	47.9	35.7	43.3	36.4	39.3	36.5	36.0	45.3	57.2	36.9	39.1	51.7	40.4	40.8	38.5	60.6	36.5	33.6	35.1	47.2	34.4	34.3	109.4	54.5	37.0	43.0	36.9	32.4	38.6	91.8	38.3	68.5	41.8	57.8	54.8	45.7	46.1	40.7	122.9	175.7	176.2	73.4	93.5	75.8	72.0	93.5	80.0	118.2	130.9	151.7	72.7	227.4	140.3	76.7	73.4	48.8	188.8	72.9	165.4	164.0	126.7	241.6	84.6	152.9	120.3	194.6	100.7	55.3	90.8	83.8	146.2	79.2	94.2	96.2	244.0	125.4	105.0	122.7	151.1	107.4	132.3	190.4	59.9	118.1	121.3	101.9	83.9	126.1	149.0	146.1	85.8	77.3	133.2	113.9	55.7	234.4	61.2	131.9	92.1	85.3	169.6	130.7	200.8	223.1	83.5	146.4	118.8	8.8	4.8	8.1	7.3	4.9	9.9	8.5	9.5	11.1	5.8	8.2	11.5	9.3	0.6	8.0	6.4	10.2	8.0	3.8	35.9	37.1	44.6	53.1	36.4	39.3	36.9	39.1	36.5	36.9	38.3	40.7	58.9	25.6	35.3	25.5	62.1	87.1	72.5	36.4	59.7	90.6	36.3	33.1	36.2	31.5	32.7	18.4	41.7	75.4	53.3	15.9	33.2	49.8	22.1	29.7	47.8	55.9	46.0	60.3	50.8	42.0	95.9	56.4	44.4	36.2	38.7	52.5	25.0	25.0	46.7	47.1	48.9	32.8	24.4	34.9	45.4	23.9	43.5	40.4	76.5	33.7	51.9	50.2	41.2	41.7	56.7	39.6	23.9	53.0	74.5	93.5	19.0	32.0	29.7	42.0	269.5	69.0	206.5	223.9	198.3	57.9	92.9	92.8	58.6	49.9	45.4	73.6
VASN	SLITL2	ENSG00000168140	Vasorin	Q6EMK4	16	4371848-4383538	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 58.7;Fibroblasts: 104.2;Leydig cells: 50.1;Peritubular cells: 60.9;Sertoli cells: 98.6;Smooth muscle cells: 80.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 21.8;MCF7: 18.4;U-2197: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011246, HPA016992"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted - unknown location"	NA	Yes		2000000000		"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA011246: AB_1858720, HPA016992: AB_2732418"	"unprognostic (2.20e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.35e-3)"	"unprognostic (8.91e-3)"	"unprognostic (3.15e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.82e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.95e-3)"	"unprognostic (5.27e-2)"	55.7	15.5	1.5	5.8	2.3	2.7	31.5	0.8	2.3	48.1	3.0	12.1	3.4	30.3	0.0	34.1	24.6	7.3	30.5	1.1	0.5	56.1	31.8	44.9	2.8	6.3	5.5	40.0	10.3	0.0	12.8	10.4	1.7	17.9	0.0	0.3	15.9	0.0	6.9	38.8	11.2	0.0	1.6	13.0	13.4	16.8	4.6	0.0	26.8	0.0	0.0	26.5	38.9	2.7	4.2	0.0	0.6	0.5	0.2	0.2	12.6	21.8	0.1	0.0	0.0	1.9	5.5	0.0	4.5	0.3	2.6	0.3	0.0	0.0	0.0	13.7	2.2	0.9	15.9	14.9	0.6	0.0	0.4	7.9	0.0	0.3	0.0	3.1	0.0	0.1	3.1	0.8	0.0	18.4	1.0	5.3	2.2	0.4	2.4	1.0	0.0	0.0	0.0	0.1	1.4	9.3	6.5	13.5	0.6	2.2	6.8	2.5	0.0	17.5	12.5	78.4	4.6	0.0	0.0	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.3	0.8	2.3	1.1	0.5	6.3	5.5	1.7	1.6	4.6	2.7	10.0	6.4	13.1	5.5	1.4	9.6	7.8	4.2	9.1	0.5	21.9	10.9	16.2	32.9	6.4	23.9	0.0	5.4	2.8	1.5	7.9	13.1	1.1	12.1	58.7	4.6	0.0	0.0	1.1	2.9	7.2	104.2	16.8	20.5	3.8	4.6	2.9	15.3	3.4	0.0	0.9	2.0	2.0	0.6	21.7	2.8	50.1	2.0	14.2	2.8	0.0	18.3	0.0	0.5	0.3	28.3	1.2	60.9	0.8	6.4	0.2	12.3	2.7	0.7	98.6	12.6	80.9	0.8	4.1	3.7	7.5	10.0	3.5	2.3	0.8	4.9
WNT6		ENSG00000115596	"Wnt family member 6"	Q9Y6F9	2	218859805-218874233	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.0"	"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 92.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 8.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 10.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"BEWO: 34.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 7.7"	HPA070759	Approved				"Secreted to extracellular matrix"	NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA070759: AB_2732164"	"unprognostic (1.86e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.34e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.24e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-1)"	3.5	0.6	1.1	0.1	10.0	0.0	3.5	0.3	4.2	4.3	0.5	7.4	0.1	2.4	0.0	1.3	3.2	0.0	3.4	0.9	0.8	1.1	0.3	0.3	0.1	1.0	1.1	3.1	0.8	0.0	2.0	2.0	1.1	3.1	0.0	0.1	1.1	0.1	1.1	2.6	2.8	0.0	0.5	7.2	2.7	3.6	2.5	0.0	1.1	0.0	0.1	1.9	3.7	0.2	0.0	0.0	0.0	1.2	0.0	0.0	34.4	0.0	0.0	0.0	0.0	3.3	0.5	0.0	3.7	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	5.0	1.7	0.0	0.0	3.7	0.1	4.7	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.1	10.0	0.3	4.2	0.9	0.8	1.0	1.1	1.1	0.5	2.5	0.2	2.5	0.0	0.0	0.0	1.6	0.5	21.0	1.1	0.6	3.5	1.4	8.5	0.6	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.0	0.1	3.4	0.4	3.1	5.9	0.0	0.0	0.2	0.0	1.6	2.0	0.0	0.1	0.0	0.4	2.5	0.0	0.8	1.7	0.1	0.0	0.0	0.0	0.3	4.5	0.0	0.3	1.8	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.4	3.1	5.5	0.0	0.0	0.0	2.0	92.1	0.3	15.5	16.9	0.3	0.2	0.1	0.7	0.2	0.1	0.0	1.3
WTAP	"KIAA0105, MGC3925, Mum2"	ENSG00000146457	"WT1 associated protein"	Q15007	6	159725585-159756319	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 560.1;Suprabasal keratinocytes: 455.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010550	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"HPA010550: AB_1858866"	"unprognostic (9.57e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (8.65e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (3.01e-5)"	"unprognostic (7.92e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.32e-2)"	86.2	63.7	35.3	62.3	35.7	245.1	74.9	40.0	41.3	71.7	41.3	54.6	34.9	64.7	65.1	65.0	64.2	52.2	54.3	35.0	42.5	54.8	50.7	68.6	77.5	38.2	38.3	70.5	63.3	53.2	49.8	61.8	39.4	65.1	55.2	35.6	62.0	44.6	179.7	72.5	61.6	51.5	36.9	67.0	58.5	34.9	40.1	89.7	57.4	67.4	80.7	102.6	65.1	41.2	55.5	51.1	115.8	100.2	136.5	147.7	67.1	86.2	299.4	108.7	145.4	95.7	49.0	126.8	50.8	92.6	238.4	70.4	112.2	94.3	138.1	70.0	71.9	135.0	46.7	144.2	108.4	116.1	75.4	172.0	94.7	120.0	155.0	82.6	81.6	130.7	149.1	114.2	116.0	53.5	170.5	165.0	91.9	88.6	44.2	107.4	74.3	94.4	114.0	62.6	104.5	74.5	158.2	83.5	45.7	77.5	41.3	152.6	72.6	70.0	81.4	100.1	125.0	83.9	109.6	206.5	67.8	120.9	76.8	46.6	24.5	31.0	28.1	31.7	31.7	33.1	33.9	34.3	29.1	27.5	29.9	31.4	42.9	32.1	38.3	24.3	40.2	20.2	35.3	35.7	40.0	41.3	35.0	42.5	38.2	38.3	39.4	36.9	40.1	41.2	131.1	35.3	57.3	31.3	138.1	419.0	198.0	52.9	113.8	30.0	144.2	123.6	58.1	74.4	39.9	60.7	35.5	107.3	138.5	61.2	86.1	128.1	47.1	86.4	125.5	118.8	61.6	59.3	41.5	81.4	126.7	226.9	97.9	171.9	40.0	56.7	58.2	90.5	75.4	37.0	36.6	65.7	24.4	99.7	560.1	50.7	65.3	168.6	243.7	33.7	113.7	49.7	88.6	44.7	57.0	75.8	59.7	50.8	111.5	307.5	49.6	106.5	35.3	36.2	72.3	222.2	124.5	93.8	73.9	113.0	455.3	149.3	138.6	54.7	74.0	150.9
WTIP		ENSG00000142279	"WT1 interacting protein"	A6NIX2	19	34481758-34512304	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, RNA-mediated gene silencing, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 51.4;Granulosa cells: 40.0;Late spermatids: 48.4;Sertoli cells: 72.3;Smooth muscle cells: 66.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 52.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.85e-2)"	"unprognostic (8.01e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.03e-3)"	"unprognostic (1.21e-1)"	"unprognostic (6.13e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.28e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.36e-2)"	24.3	4.9	9.6	4.7	9.0	1.1	16.9	9.9	12.0	23.5	11.0	11.6	2.5	21.1	7.4	6.9	18.5	11.7	20.3	8.5	8.1	15.5	2.1	17.5	3.7	8.7	8.3	27.5	9.1	10.3	4.9	9.0	7.8	13.7	3.0	1.9	6.2	16.1	7.2	8.5	7.3	13.5	6.9	6.1	10.0	8.1	8.5	2.2	13.1	23.0	3.4	14.4	13.7	7.8	0.8	17.3	20.7	17.8	28.9	20.2	17.9	25.6	22.2	33.3	17.5	43.4	2.6	1.3	23.1	52.6	15.8	0.8	19.2	9.9	13.1	1.7	2.8	1.3	4.1	16.0	43.4	0.9	1.4	15.1	23.2	10.9	2.3	21.7	13.3	0.7	0.8	2.2	26.5	6.0	2.0	0.5	10.2	0.7	0.4	1.4	14.6	0.7	18.6	4.9	1.3	1.5	16.7	0.3	6.9	17.5	12.9	1.3	16.7	44.4	35.9	0.8	15.6	1.1	1.9	1.0	0.7	0.4	20.6	0.6	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.1	9.6	9.0	9.9	12.0	8.5	8.1	8.7	8.3	7.8	6.9	8.5	7.8	16.6	12.8	8.7	1.0	0.3	3.8	9.1	3.7	9.1	11.4	5.4	13.8	8.3	4.3	6.2	9.2	0.0	6.5	0.5	0.2	0.0	4.7	51.4	6.8	15.6	16.9	0.0	0.0	3.1	0.9	5.0	11.5	0.0	8.2	1.3	40.0	17.5	0.7	0.7	3.3	3.8	0.0	2.0	0.8	0.8	48.4	18.3	1.0	3.6	4.7	0.0	4.8	0.0	6.0	0.9	2.3	0.1	21.1	0.0	15.5	0.2	1.9	3.6	1.8	72.3	14.3	66.5	0.7	5.3	0.6	1.7	1.8	0.9	3.2	0.3	5.4
ZBTB47	"DKFZp434N0615, KIAA1190, ZNF651"	ENSG00000114853	"Zinc finger and BTB domain containing 47"	Q9UFB7	3	42653697-42667580	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 21.9;Inhibitory neurons: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.5;fHDF/TERT166: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074057	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA074057: AB_2686657"	"unprognostic (1.03e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.86e-2)"	"unprognostic (8.99e-2)"	"prognostic favorable (7.96e-5)"	"unprognostic (5.77e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.10e-2)"	23.2	13.7	74.4	9.3	69.3	2.7	17.9	52.6	65.3	21.5	32.9	29.3	3.9	23.0	4.5	11.5	15.2	11.4	70.3	61.0	54.0	9.4	6.2	14.0	2.7	70.5	63.8	15.3	13.4	9.9	12.3	6.2	58.2	23.5	3.3	6.5	17.4	14.5	112.5	16.4	11.2	14.8	59.9	7.2	18.7	9.1	70.8	2.0	19.4	63.1	1.8	23.7	15.9	81.2	6.7	5.9	3.6	2.4	55.5	20.7	1.2	15.1	12.7	6.5	4.7	1.3	2.7	0.1	6.4	30.9	2.5	1.6	0.9	5.9	1.2	0.0	7.2	3.7	18.9	1.6	17.5	0.1	5.3	23.5	10.4	8.5	7.1	17.0	7.3	0.0	3.9	4.8	12.9	1.7	0.2	0.5	2.1	0.2	3.5	5.0	6.7	1.9	3.4	1.3	4.0	6.7	7.3	1.2	6.0	1.5	8.3	8.6	17.3	14.1	8.2	13.9	6.4	0.2	0.0	0.0	13.1	4.8	4.3	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.1	74.4	69.3	52.6	65.3	61.0	54.0	70.5	63.8	58.2	59.9	70.8	81.2	1.8	0.0	1.1	21.9	0.0	4.0	1.5	3.6	3.4	6.4	0.8	0.9	10.5	0.0	1.8	1.8	0.0	0.1	1.6	0.1	0.0	0.7	10.0	0.5	4.5	2.1	0.0	0.0	7.8	1.3	0.2	6.4	4.6	1.2	4.5	2.9	2.2	0.7	1.4	0.0	11.8	0.3	2.0	1.9	4.1	2.5	3.4	2.0	8.8	8.4	0.8	7.7	0.0	9.0	11.5	0.6	1.2	3.0	1.9	2.0	0.0	0.6	1.1	1.9	0.0	7.8	4.4	0.0	0.2	1.3	3.1	0.1	0.4	5.9	0.0	1.1
ZBTB9	"MGC23166, ZNF919"	ENSG00000213588	"Zinc finger and BTB domain containing 9"	Q96C00	6	33453970-33457544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.5;Ionocytes: 6.1;Respiratory ciliated cells: 4.3;Suprabasal keratinocytes: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 11.6;BEWO: 11.3;GAMG: 16.5;HMC-1: 14.2;U-698: 12.0"	"Low region specificity"	"Detected in all"							"HPA036767, HPA058171"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA036767: AB_10696787, HPA058171: "	"unprognostic (1.79e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.85e-4)"	"unprognostic (4.20e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.95e-1)"	2.8	3.9	0.9	1.5	1.0	1.7	2.3	0.8	1.6	2.5	8.6	2.4	2.3	2.6	1.7	3.8	2.5	0.6	3.0	1.9	0.7	4.4	3.2	2.4	1.9	1.2	0.9	3.0	2.9	0.6	10.0	0.5	0.6	2.4	1.4	1.9	2.9	0.1	1.8	3.8	2.7	0.8	0.2	3.5	2.7	7.4	0.4	0.2	2.2	1.0	3.3	2.5	2.2	0.9	1.0	0.3	11.6	2.9	2.1	0.1	11.3	0.6	0.2	0.2	0.1	3.0	0.8	2.7	1.8	0.3	16.5	1.2	4.8	2.4	1.3	3.1	2.0	9.0	2.3	0.0	0.0	2.3	14.2	0.5	0.9	3.3	2.6	0.6	0.1	1.5	3.2	1.8	2.6	1.6	0.6	0.9	4.3	0.5	0.7	5.6	3.0	2.7	2.2	2.3	1.8	1.1	3.3	0.3	1.1	1.1	1.6	0.4	1.9	0.9	1.3	1.3	1.2	0.7	3.5	12.0	0.9	2.9	0.3	5.2	1.1	0.4	2.8	0.8	1.2	0.4	1.2	2.6	1.5	0.8	2.5	1.9	0.8	1.3	1.7	0.3	2.2	0.6	0.9	1.0	0.8	1.6	1.9	0.7	1.2	0.9	0.6	0.2	0.4	0.9	0.1	0.0	0.0	1.3	2.1	4.5	0.0	1.9	1.8	0.0	0.2	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	1.5	0.3	0.4	0.1	0.6	1.8	1.3	1.2	1.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.7	6.1	0.0	1.2	1.1	0.0	0.2	1.8	1.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.6	0.0	0.2	0.1	4.3	0.0	0.0	0.0	0.7	0.1	0.1	0.8	3.7	0.0	0.7	0.1	1.0	0.0
ZFHX3	"ATBF1, C16orf47, FLJ26184, ZNF927"	ENSG00000140836	"Zinc finger homeobox 3"	Q15911	16	72782885-73891871	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Myogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	47	"brain: 501.8"	"Cell type enhanced"	"Detected in all"		"Microglial cells: 285.8;Smooth muscle cells: 177.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebral cortex: 501.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059353	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA059353: AB_2683987"	"prognostic unfavorable (1.55e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.24e-2)"	"unprognostic (6.36e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.16e-2)"	"prognostic favorable (1.37e-5)"	"unprognostic (6.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.15e-2)"	6.0	4.3	5.9	1.9	5.8	0.9	3.6	2.8	501.8	5.2	7.1	6.0	1.5	4.7	4.0	2.0	3.6	4.2	3.5	68.3	12.1	3.2	3.1	4.3	1.2	72.3	13.7	2.8	4.0	9.7	3.9	6.2	49.5	6.9	2.6	4.5	4.0	6.4	9.9	2.6	2.6	4.1	11.3	3.1	3.6	1.8	12.5	1.3	7.4	10.7	0.7	6.8	3.5	56.5	5.0	9.2	14.7	12.3	5.3	6.7	15.1	3.9	4.3	2.5	2.8	10.6	2.9	2.3	5.5	7.5	3.4	3.5	9.4	4.7	3.4	9.3	2.3	0.4	13.1	15.1	4.9	1.6	3.5	2.5	2.8	7.3	6.5	2.3	4.7	1.0	1.1	0.6	6.3	10.9	0.5	3.1	2.4	2.7	1.5	7.0	4.0	0.8	4.0	8.8	10.9	3.9	6.9	2.1	4.8	6.7	3.0	0.7	10.3	6.0	7.0	6.5	4.9	4.7	1.7	1.6	2.9	1.4	4.7	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.2	0.0	0.0	5.9	5.8	2.8	501.8	68.3	12.1	72.3	13.7	49.5	11.3	12.5	56.5	13.6	70.5	26.7	109.7	8.6	17.0	55.6	13.1	37.0	122.0	24.5	20.6	23.7	47.1	34.8	47.8	22.9	47.4	5.2	11.0	5.9	23.0	2.6	94.6	33.1	40.3	26.9	7.4	22.0	23.4	19.4	68.8	25.5	154.6	21.0	20.7	44.6	37.5	67.0	23.5	8.7	23.2	22.4	84.2	142.6	2.8	10.5	72.9	21.4	285.8	40.8	13.9	3.1	83.9	18.5	20.7	22.4	19.9	2.2	77.5	6.9	7.4	29.3	34.1	124.9	153.7	177.3	3.7	16.8	29.5	17.2	62.1	7.7	12.4	31.0	43.8
ZFP92	ZNF897	ENSG00000189420	"ZFP92 zinc finger protein"	A6NM28	X	153418322-153426481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.8;HMC-1: 3.5;THP-1: 2.4;U-937: 6.2"	"Region enhanced"	"Detected in many"		"hypothalamus: 8.8"	"Low region specificity"	"Detected in all"			HPA003030	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA003030: AB_2666758"	"unprognostic (6.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.57e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.51e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.49e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.66e-3)"	1.8	2.2	2.1	0.5	2.0	3.0	1.1	2.6	1.9	1.7	2.4	0.9	0.3	1.2	2.6	0.2	3.2	0.4	1.1	1.4	2.0	1.2	0.6	2.6	0.4	1.3	1.9	3.8	0.7	4.3	2.6	0.7	1.9	0.9	0.2	0.5	0.2	1.6	0.3	0.2	0.9	1.1	0.5	1.1	0.6	0.7	2.6	0.2	0.7	0.5	0.5	0.3	0.3	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.8	0.8	0.4	0.0	0.0	0.5	0.6	0.2	0.4	0.3	0.4	0.6	3.8	0.0	1.4	0.0	0.0	1.4	0.4	3.5	0.2	0.5	0.0	0.0	0.0	1.4	0.9	1.1	0.0	0.0	0.0	0.9	0.3	0.2	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.9	0.0	0.0	0.9	0.0	0.0	2.4	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.9	0.0	6.2	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.0	2.6	1.9	1.4	2.0	1.3	1.9	1.9	0.5	2.6	1.4	3.4	0.0	0.0	1.6	0.2	0.0	0.1	0.0	0.0	0.4	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	1.1	3.1	0.5	0.0	0.0	1.5	0.0	0.0	0.7	0.0	2.2	0.0	1.1	0.4	0.1	0.8	0.0	1.7	0.0	0.0	0.8	0.0	0.2	2.5	0.5	0.0	0.0	0.5	0.2	1.0	2.0	0.1	0.2	0.0	3.4	0.2	0.0	0.0	0.3	0.0	0.2	19.7	0.8	1.4	0.4	0.8	0.0	0.0	0.0	0.3	0.8	0.0	0.0
ZNF580		ENSG00000213015	"Zinc finger protein 580"	Q9UK33	19	55635016-55643470	"Predicted intracellular proteins, Transcription factors"	"Chemotaxis, Inflammatory response, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 279.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054058	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA054058: AB_2682360"	"unprognostic (1.36e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.47e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (3.54e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (2.36e-5)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.79e-6)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.46e-3)"	32.0	46.1	53.1	18.2	49.4	12.9	33.9	47.6	62.0	48.3	47.7	55.3	13.1	59.0	24.0	25.9	48.0	5.4	35.9	52.0	54.4	53.2	17.8	33.4	17.5	53.6	50.8	56.6	43.7	26.5	68.6	8.5	48.5	60.0	9.8	12.4	35.8	20.6	19.3	31.1	39.6	18.1	44.3	44.6	42.0	17.6	48.9	14.5	65.6	5.5	14.3	49.2	33.8	46.6	17.6	31.2	27.0	17.6	29.2	16.4	11.3	24.5	25.6	33.3	39.9	5.5	15.6	13.1	6.6	31.2	7.3	15.1	18.2	19.3	25.1	43.4	279.2	23.6	32.7	14.6	38.6	11.1	53.7	35.4	20.5	15.9	29.6	43.8	23.1	29.9	26.1	32.1	27.8	5.1	50.5	15.9	14.4	10.9	43.0	51.1	10.4	53.1	38.0	19.2	30.2	39.3	15.2	15.0	22.4	14.6	13.3	11.4	30.5	18.0	29.4	13.3	13.2	72.3	22.8	29.7	9.9	17.0	17.9	4.6	3.4	11.5	1.1	5.1	1.2	8.4	2.6	2.5	3.7	12.3	3.1	2.7	5.9	3.1	9.9	4.0	2.2	1.7	53.1	49.4	47.6	62.0	52.0	54.4	53.6	50.8	48.5	44.3	48.9	46.6	41.4	9.6	9.7	18.3	39.7	18.6	44.0	32.6	57.5	33.4	51.0	61.2	10.0	37.1	16.3	57.0	4.2	25.3	36.5	25.1	76.3	47.0	3.5	16.1	46.2	36.6	67.4	21.0	9.9	56.0	20.2	36.6	31.6	16.1	19.1	42.8	48.2	11.9	25.9	20.2	10.8	27.2	18.3	31.4	31.1	8.7	59.4	29.2	39.2	11.2	39.1	44.2	28.8	11.6	13.5	45.7	30.9	70.7	49.7	37.6	49.2	78.2	7.6	22.8	39.5	28.5	48.6	11.3	12.9	49.2	16.9	19.0	22.7	70.5	29.8	35.8